Patient_ID,AI_Predicted_Condition,Patient_Age,nct_id,trial_title
PID-001,Astrocytoma,41,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-001,Astrocytoma,41,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-001,Astrocytoma,41,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-001,Astrocytoma,41,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-001,Astrocytoma,41,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-002,Glioblastoma,67,NCT01102595,Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
PID-002,Glioblastoma,67,NCT03903419,Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
PID-002,Glioblastoma,67,NCT06650605,Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma
PID-002,Glioblastoma,67,NCT05399524,Functional and Ultrasound Guided Resection of Glioblastoma
PID-002,Glioblastoma,67,NCT03990285,[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
PID-002,Glioblastoma,67,NCT00936052,Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01252459,Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03879512,"Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG"
PID-002,Glioblastoma,67,NCT04606316,Surgical Nivolumab And Ipilimumab For Recurrent GBM
PID-002,Glioblastoma,67,NCT01700569,Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
PID-002,Glioblastoma,67,NCT06348693,Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
PID-002,Glioblastoma,67,NCT06869577,A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
PID-002,Glioblastoma,67,NCT05086497,WBSI Guided Personalized Delivery of TTFields
PID-002,Glioblastoma,67,NCT01833273,Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA
PID-002,Glioblastoma,67,NCT05896449,Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
PID-002,Glioblastoma,67,NCT03291314,Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03363659,Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02795364,Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
PID-002,Glioblastoma,67,NCT02772094,Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
PID-002,Glioblastoma,67,NCT04874506,MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT05958485,A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
PID-002,Glioblastoma,67,NCT06939400,Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
PID-002,Glioblastoma,67,NCT02945826,uPAR-PET/MRI in Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04869449,Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
PID-002,Glioblastoma,67,NCT04588454,18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT06271421,NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT06595186,JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT05423210,Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05120284,Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT05589961,Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT06404034,Expanded Access to Gallium Maltolate (GaM)
PID-002,Glioblastoma,67,NCT06466031,Application of MET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05281731,Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
PID-002,Glioblastoma,67,NCT03861598,Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
PID-002,Glioblastoma,67,NCT06451042,FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)
PID-002,Glioblastoma,67,NCT05908669,Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05500612,MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
PID-002,Glioblastoma,67,NCT00337883,A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
PID-002,Glioblastoma,67,NCT04277221,ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT01181193,Vitamin D for Treatment of Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04825275,Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: a Phase 0 Clinical Trial
PID-002,Glioblastoma,67,NCT04752813,A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
PID-002,Glioblastoma,67,NCT05353530,IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
PID-002,Glioblastoma,67,NCT05608395,11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
PID-002,Glioblastoma,67,NCT03075514,Ketogenic Diets as an Adjuvant Therapy in Glioblastoma
PID-002,Glioblastoma,67,NCT06781372,Patient's Derived Organoids for Drug Screening in Glioblastoma
PID-002,Glioblastoma,67,NCT01280552,A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT06533163,Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
PID-002,Glioblastoma,67,NCT04900792,A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
PID-002,Glioblastoma,67,NCT02864368,Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
PID-002,Glioblastoma,67,NCT01268566,A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01301430,Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
PID-002,Glioblastoma,67,NCT01865162,Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
PID-002,Glioblastoma,67,NCT01873469,Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03506139,Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02769806,Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
PID-002,Glioblastoma,67,NCT00730262,Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03344250,Phase I EGFR BATs in Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01317212,Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00190424,Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
PID-002,Glioblastoma,67,NCT03980249,Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
PID-002,Glioblastoma,67,NCT04587830,ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03707457,Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
PID-002,Glioblastoma,67,NCT01269424,BG & TMZ Therapy of Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00990496,A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT00515086,Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT03310372,Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02285959,Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04450160,Trial of AEO in New Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT03291990,5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02997423,Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT02177578,Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00209989,Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05565326,Response Assessment During MR-guided Radiation Therapy for Glioblastoma
PID-002,Glioblastoma,67,NCT05769660,A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT00323115,Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02858895,Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT02853565,A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00768911,CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02344355,A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01349660,Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00376103,Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02619864,mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02283944,TMS Electrochemotherapy for Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05402241,IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study
PID-002,Glioblastoma,67,NCT02586857,"A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)"
PID-002,Glioblastoma,67,NCT02685605,Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00544817,Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00535379,"SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT00892931,Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02296580,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT00677716,Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
PID-002,Glioblastoma,67,NCT00394628,AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00224978,Chloroquine for Treatment of Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02120287,Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01006044,Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection
PID-002,Glioblastoma,67,NCT01209442,Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02507102,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
PID-002,Glioblastoma,67,NCT01800695,Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00615186,Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy
PID-002,Glioblastoma,67,NCT07120620,PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01564914,A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT05917821,New Antigens Against Glioblastoma
PID-002,Glioblastoma,67,NCT01435395,"Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT00817284,Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT00800917,A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00083512,Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03714334,DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01285414,"Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT02844062,Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02331498,Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03347097,Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04019002,Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT00635557,Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02937844,Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04610229,Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.
PID-002,Glioblastoma,67,NCT06687681,Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
PID-002,Glioblastoma,67,NCT01752491,A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04421378,A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02550249,Neoadjuvant Nivolumab in Glioblastoma
PID-002,Glioblastoma,67,NCT05557292,RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02017249,Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01788280,Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab
PID-002,Glioblastoma,67,NCT01588769,A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients
PID-002,Glioblastoma,67,NCT01290692,Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
PID-002,Glioblastoma,67,NCT05798507,Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT02296476,A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)
PID-002,Glioblastoma,67,NCT00650949,Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
PID-002,Glioblastoma,67,NCT06346821,Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data
PID-002,Glioblastoma,67,NCT00311857,"Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)"
PID-002,Glioblastoma,67,NCT05410301,"Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma"
PID-002,Glioblastoma,67,NCT00704288,Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00083447,Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00589095,Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
PID-002,Glioblastoma,67,NCT01508117,Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
PID-002,Glioblastoma,67,NCT00792012,A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00267592,Safety and Efficacy of Talampanel in Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00590681,Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01115491,A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04801147,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00050986,Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04845919,Sonodynamic Therapy with ExAblate System in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT07052877,The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
PID-002,Glioblastoma,67,NCT07162324,"A Multicenter, Prospective Study for Glioblastoma Patients"
PID-002,Glioblastoma,67,NCT02189109,The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma
PID-002,Glioblastoma,67,NCT01663012,Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
PID-002,Glioblastoma,67,NCT05463848,Surgical Pembro +/- Olaparib w TMZ for rGBM
PID-002,Glioblastoma,67,NCT05551013,Treatment of Recurrent GBM With APG-157 Via Expanded Access
PID-002,Glioblastoma,67,NCT01604590,Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01071837,APG101 in Glioblastoma
PID-002,Glioblastoma,67,NCT06657027,Artificial Intelligence-Guided Radiotherapy Planning for Glioblastoma
PID-002,Glioblastoma,67,NCT04590664,Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
PID-002,Glioblastoma,67,NCT07119294,Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
PID-002,Glioblastoma,67,NCT06090903,Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
PID-002,Glioblastoma,67,NCT04790097,FET-PET Directed Simultaneous In-field Boost for Primary GBM
PID-002,Glioblastoma,67,NCT05190315,Chlorpromazine and Standard of Care in Glioblastoma
PID-002,Glioblastoma,67,NCT04530006,Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT06353360,TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
PID-002,Glioblastoma,67,NCT00038493,Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT07093814,A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT05970757,Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
PID-002,Glioblastoma,67,NCT07121842,Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI
PID-002,Glioblastoma,67,NCT04002804,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03866109,A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMT
PID-002,Glioblastoma,67,NCT06176066,PH Sensitive MRI Based Resections of Glioblastoma
PID-002,Glioblastoma,67,NCT02104882,INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
PID-002,Glioblastoma,67,NCT03582514,PreOperative Brain Irradiation in Glioblastoma
PID-002,Glioblastoma,67,NCT06001281,Predictive Value of Soluble CD146 in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT02029573,Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
PID-002,Glioblastoma,67,NCT01091792,Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT01450449,Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05728125,Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients
PID-002,Glioblastoma,67,NCT00984438,Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05222802,A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
PID-002,Glioblastoma,67,NCT05432375,Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
PID-002,Glioblastoma,67,NCT00797940,Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
PID-002,Glioblastoma,67,NCT01526837,Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
PID-002,Glioblastoma,67,NCT04810182,Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
PID-002,Glioblastoma,67,NCT04614909,Study of Pamiparib in Newly Diagnosed and rGBM
PID-002,Glioblastoma,67,NCT04373785,NG101m Adjuvant Therapy in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT01587144,Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
PID-002,Glioblastoma,67,NCT00076986,The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT06764537,Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma
PID-002,Glioblastoma,67,NCT01260506,Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT06749925,Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma
PID-002,Glioblastoma,67,NCT04765098,Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
PID-002,Glioblastoma,67,NCT04118036,Abemaciclib + Pembrolizumab In Glioblastoma
PID-002,Glioblastoma,67,NCT04814329,Glioblastoma Response Prediction to Apatinib
PID-002,Glioblastoma,67,NCT02047214,Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
PID-002,Glioblastoma,67,NCT03849105,131I-IPA and Concurrent XRT in Recurrent GBM
PID-002,Glioblastoma,67,NCT00116376,Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT02410577,89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03212235,Hypofractionated Radiation Therapy for Glioblastoma
PID-002,Glioblastoma,67,NCT07173829,A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
PID-002,Glioblastoma,67,NCT06336291,A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
PID-002,Glioblastoma,67,NCT05512195,Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma
PID-002,Glioblastoma,67,NCT04406272,VB-111 in Surgically Accessible Recurrent/Progressive GBM
PID-002,Glioblastoma,67,NCT05653635,Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
PID-002,Glioblastoma,67,NCT00093964,Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
PID-002,Glioblastoma,67,NCT01402063,PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
PID-002,Glioblastoma,67,NCT06061809,N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT06038604,Glioblastoma Psychosocial Support Program
PID-002,Glioblastoma,67,NCT04492163,Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
PID-002,Glioblastoma,67,NCT02378532,The Addition of Chloroquine to Chemoradiation for Glioblastoma
PID-002,Glioblastoma,67,NCT05708352,A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
PID-002,Glioblastoma,67,NCT01618747,An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse
PID-002,Glioblastoma,67,NCT07141732,Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy
PID-002,Glioblastoma,67,NCT06672575,A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02926222,Regorafenib in Relapsed Glioblastoma
PID-002,Glioblastoma,67,NCT06132438,Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
PID-002,Glioblastoma,67,NCT02751138,Determination of Immune Phenotype in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT00238797,"A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT02928575,"Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma"
PID-002,Glioblastoma,67,NCT05927610,Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
PID-002,Glioblastoma,67,NCT05366179,Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
PID-002,Glioblastoma,67,NCT05641220,Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.
PID-002,Glioblastoma,67,NCT05083754,Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
PID-002,Glioblastoma,67,NCT04977375,Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01933815,Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
PID-002,Glioblastoma,67,NCT04116411,A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT05700955,Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06490497,Expectations and Needs of a Glioblastoma Caregiver
PID-002,Glioblastoma,67,NCT04747145,Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma
PID-002,Glioblastoma,67,NCT06222138,Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00345163,A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
PID-002,Glioblastoma,67,NCT05635734,Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00916409,Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT01778530,TRC105 for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06625684,Key Longitudinal Associations With Risk and Glioblastoma Outcomes
PID-002,Glioblastoma,67,NCT07145112,Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00904852,Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT06512311,Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
PID-002,Glioblastoma,67,NCT05756985,Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
PID-002,Glioblastoma,67,NCT04552977,A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06613841,"Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma"
PID-002,Glioblastoma,67,NCT04772846,Chloroquine for Glioblastoma.
PID-002,Glioblastoma,67,NCT00684567,Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
PID-002,Glioblastoma,67,NCT01259869,A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression
PID-002,Glioblastoma,67,NCT03276286,Nativis Voyager for Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT02176720,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-002,Glioblastoma,67,NCT05781321,"Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study"
PID-002,Glioblastoma,67,NCT06845020,CSF Proteomic Characterization of Glioblastomas
PID-002,Glioblastoma,67,NCT02049489,A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02067156,"Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma"
PID-002,Glioblastoma,67,NCT03712293,ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
PID-002,Glioblastoma,67,NCT01849146,"Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma"
PID-002,Glioblastoma,67,NCT01089868,Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
PID-002,Glioblastoma,67,NCT05986851,Azeliragon in MGMT Unmethylated Glioblastoma
PID-002,Glioblastoma,67,NCT04657146,Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT05669820,Antisecretory Factor Glioblastoma Phase 2
PID-002,Glioblastoma,67,NCT04417933,Tumor Electric Fields Treatment System for Glioblastoma
PID-002,Glioblastoma,67,NCT06780592,Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
PID-002,Glioblastoma,67,NCT03048240,INtraoperative photoDYnamic Therapy of GliOblastoma
PID-002,Glioblastoma,67,NCT05015543,Physical Training in Glioblastoma Patients During Cytotoxic Therapy
PID-002,Glioblastoma,67,NCT05109728,A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
PID-002,Glioblastoma,67,NCT06218524,The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM
PID-002,Glioblastoma,67,NCT04671459,TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine
PID-002,Glioblastoma,67,NCT05556382,Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity
PID-002,Glioblastoma,67,NCT06448286,PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT05186064,Glioblastoma Targeted Treatment Option Maximization by WGS
PID-002,Glioblastoma,67,NCT06556563,EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT05515133,Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients
PID-002,Glioblastoma,67,NCT04319276,Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
PID-002,Glioblastoma,67,NCT02977780,INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
PID-002,Glioblastoma,67,NCT06831526,Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00805961,"RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM"
PID-002,Glioblastoma,67,NCT04656535,AB154 Combined With AB122 for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04391062,Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma
PID-002,Glioblastoma,67,NCT01290263,Amgen 386 for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04752280,Glioblastoma Radiotherapy Using IMRT or Proton Beams
PID-002,Glioblastoma,67,NCT06183983,Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
PID-002,Glioblastoma,67,NCT01851733,MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01493219,Biomarkers for Prognosis of Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT06524063,Targeted Survivin DC Cell Injection for the Treatment of GBM
PID-002,Glioblastoma,67,NCT03862430,A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT02815410,Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
PID-002,Glioblastoma,67,NCT05735171,Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence
PID-002,Glioblastoma,67,NCT03661723,Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06113705,Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
PID-002,Glioblastoma,67,NCT01468324,AZD7451 for Recurrent Gliomas
PID-002,Glioblastoma,67,NCT03419403,UNITE Study: Understanding New Interventions With GBM ThErapy
PID-002,Glioblastoma,67,NCT05938387,Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
PID-002,Glioblastoma,67,NCT03403803,Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
PID-002,Glioblastoma,67,NCT00892177,Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05539339,Personalized Trial in ctDNA-level-relapse Glioblastoma
PID-002,Glioblastoma,67,NCT04856852,Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT07144735,Allogeneic γδT Cells in Glioblastoma
PID-002,Glioblastoma,67,NCT00402116,Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
PID-002,Glioblastoma,67,NCT05664464,Glutamate Inhibitors in Glioblastoma
PID-002,Glioblastoma,67,NCT03687099,Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma
PID-002,Glioblastoma,67,NCT04443010,Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT04243005,Supramarginal Resection in Glioblastoma
PID-002,Glioblastoma,67,NCT00456612,Radiosurgery for Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05656300,Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?
PID-002,Glioblastoma,67,NCT04730869,Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
PID-002,Glioblastoma,67,NCT04959500,Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT05768087,Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients
PID-002,Glioblastoma,67,NCT06600399,Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma
PID-002,Glioblastoma,67,NCT04583020,Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT05303467,A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
PID-002,Glioblastoma,67,NCT04359745,Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression
PID-002,Glioblastoma,67,NCT05541042,Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
PID-002,Glioblastoma,67,NCT04599647,EAP for the Treatment of Glioblastoma With PVSRIPO
PID-002,Glioblastoma,67,NCT06297512,Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
PID-002,Glioblastoma,67,NCT06140875,Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
PID-002,Glioblastoma,67,NCT00704808,Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
PID-002,Glioblastoma,67,NCT00508456,Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
PID-002,Glioblastoma,67,NCT03139916,Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01345370,Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT05074992,A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02546102,"Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma"
PID-002,Glioblastoma,67,NCT05871021,Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
PID-002,Glioblastoma,67,NCT02850744,"Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients"
PID-002,Glioblastoma,67,NCT03194971,NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
PID-002,Glioblastoma,67,NCT03151772,Bioavailability of Disulfiram and Metformin in Glioblastomas
PID-002,Glioblastoma,67,NCT05753007,"A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients"
PID-002,Glioblastoma,67,NCT02709616,Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
PID-002,Glioblastoma,67,NCT07047066,A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02808364,Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)
PID-002,Glioblastoma,67,NCT04536649,Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.
PID-002,Glioblastoma,67,NCT05140902,Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
PID-002,Glioblastoma,67,NCT02286167,Glioma Modified Atkins-based Diet in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT00171938,Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
PID-002,Glioblastoma,67,NCT02715609,Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT05241392,Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00115453,Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
PID-002,Glioblastoma,67,NCT01907165,Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
PID-002,Glioblastoma,67,NCT02092038,Preoperative Chemoradiation for Glioblastoma
PID-002,Glioblastoma,67,NCT02780024,"Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM"
PID-002,Glioblastoma,67,NCT06146738,The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
PID-002,Glioblastoma,67,NCT04863950,Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06924099,TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
PID-002,Glioblastoma,67,NCT02880410,Feasibility Study on LITT for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02394626,Surgery for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06551909,Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
PID-002,Glioblastoma,67,NCT05183204,"Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma"
PID-002,Glioblastoma,67,NCT04716699,Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma
PID-002,Glioblastoma,67,NCT03390569,Exercise in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT04596930,MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma
PID-002,Glioblastoma,67,NCT05811793,Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
PID-002,Glioblastoma,67,NCT04250922,LAM561 With RT and TMZ for Adults With Glioblastoma
PID-002,Glioblastoma,67,NCT01109095,CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
PID-002,Glioblastoma,67,NCT04221061,18F-FluorThanatrace (PET/CT) in Glioblastoma
PID-002,Glioblastoma,67,NCT04922723,Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
PID-002,Glioblastoma,67,NCT06102525,"A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma"
PID-002,Glioblastoma,67,NCT03780569,TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT03055208,Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT03119064,BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01666600,NOA-12: BIBF1120 and R-RT in Glioblastoma
PID-002,Glioblastoma,67,NCT04280848,Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
PID-002,Glioblastoma,67,NCT03395587,Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT03293888,Spectral Analysis Probe to Identify Glioblastoma Cells
PID-002,Glioblastoma,67,NCT03529448,TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT04829097,Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma
PID-002,Glioblastoma,67,NCT04765514,Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients
PID-002,Glioblastoma,67,NCT05793021,FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
PID-002,Glioblastoma,67,NCT01562197,A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04708171,The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
PID-002,Glioblastoma,67,NCT00104091,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-002,Glioblastoma,67,NCT04691960,A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
PID-002,Glioblastoma,67,NCT01474239,A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04516733,Precoce Medical Care by the Mobil Support for Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT04826393,ASP8374 + Cemiplimab in Recurrent Glioma
PID-002,Glioblastoma,67,NCT03739333,Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.
PID-002,Glioblastoma,67,NCT05502991,Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma
PID-002,Glioblastoma,67,NCT02157103,A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT04284306,Immunohistochemical Assessment of Programmed Death ligand1 and LC3B in GBM
PID-002,Glioblastoma,67,NCT04157478,Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01478854,Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
PID-002,Glioblastoma,67,NCT03243851,Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
PID-002,Glioblastoma,67,NCT04629209,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma"
PID-002,Glioblastoma,67,NCT03743662,Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
PID-002,Glioblastoma,67,NCT02206230,Trial of Hypofractionated Radiation Therapy for Glioblastoma
PID-002,Glioblastoma,67,NCT00686725,Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
PID-002,Glioblastoma,67,NCT04881032,AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT06105619,A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
PID-002,Glioblastoma,67,NCT00262730,Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT02379572,Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
PID-002,Glioblastoma,67,NCT05304663,Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression
PID-002,Glioblastoma,67,NCT02663440,Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01777919,Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
PID-002,Glioblastoma,67,NCT02062372,Spatial Analysis and Validation of Glioblastoma on 7 T MRI
PID-002,Glioblastoma,67,NCT04219475,Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients
PID-002,Glioblastoma,67,NCT05698199,"Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)"
PID-002,Glioblastoma,67,NCT01898273,Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02202993,TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM
PID-002,Glioblastoma,67,NCT01622764,89Zr-RO5323441 PET Imaging in Glioblastoma
PID-002,Glioblastoma,67,NCT04963413,RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.
PID-002,Glioblastoma,67,NCT03491683,INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT02841332,Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00068952,Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01169415,Effects of Steroid Tapering on Functional Capacity and Neurocognition
PID-002,Glioblastoma,67,NCT05333588,The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.
PID-002,Glioblastoma,67,NCT04225039,"Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma"
PID-002,Glioblastoma,67,NCT04552886,Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma
PID-002,Glioblastoma,67,NCT02394665,Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
PID-002,Glioblastoma,67,NCT03995706,Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
PID-002,Glioblastoma,67,NCT03663725,Treatment Intensification With Temozolomide in Adults With a Glioblastoma
PID-002,Glioblastoma,67,NCT04642937,Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04195139,Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
PID-002,Glioblastoma,67,NCT03493932,Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
PID-002,Glioblastoma,67,NCT02617745,Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
PID-002,Glioblastoma,67,NCT02715297,Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04471844,"Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM"
PID-002,Glioblastoma,67,NCT05187624,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma"
PID-002,Glioblastoma,67,NCT04933422,CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
PID-002,Glioblastoma,67,NCT03374943,A Trial of KB004 in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT01225510,A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06477939,Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients
PID-002,Glioblastoma,67,NCT04119674,Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT03231501,HMPL-813 in Treating Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT04574856,Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT03770468,"Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma"
PID-002,Glioblastoma,67,NCT04547855,Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
PID-002,Glioblastoma,67,NCT02146066,Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
PID-002,Glioblastoma,67,NCT02336165,Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT07076472,Sonodynamic Therapy With SONALA-001 and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02441322,Evaluating Therapeutic Response to Novo-TTF
PID-002,Glioblastoma,67,NCT04324840,A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01403285,Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT06740955,Hypofractionated Radiotherapy
PID-002,Glioblastoma,67,NCT04019262,Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT04015700,"Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-002,Glioblastoma,67,NCT01473901,A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT06676891,Expanded Access Program for GBM Subjects
PID-002,Glioblastoma,67,NCT03587038,OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02725684,Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
PID-002,Glioblastoma,67,NCT04846257,Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence
PID-002,Glioblastoma,67,NCT03246113,Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
PID-002,Glioblastoma,67,NCT01308632,Metronomic Temozolamide in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01308684,A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01782976,Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT01846871,Tivozanib for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02893137,Enhancing Optune Therapy With Targeted Craniectomy
PID-002,Glioblastoma,67,NCT03926507,F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
PID-002,Glioblastoma,67,NCT04573192,A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
PID-002,Glioblastoma,67,NCT06936046,Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression
PID-002,Glioblastoma,67,NCT02904525,Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model
PID-002,Glioblastoma,67,NCT03567135,Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma
PID-002,Glioblastoma,67,NCT03297125,Assessment of Optune Therapy for Patients with Newly Diagnosed Glioblastoma Using Advanced MRI
PID-002,Glioblastoma,67,NCT02910804,IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT01189513,SCH-900105 in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04485949,A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT00397072,Epothilone in Recurrent Glioblastoma Patients
PID-002,Glioblastoma,67,NCT00821080,Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02511405,"A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)"
PID-002,Glioblastoma,67,NCT02981940,A Study of Abemaciclib in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02630030,Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT03347617,Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT06054529,Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
PID-002,Glioblastoma,67,NCT04121455,Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
PID-002,Glioblastoma,67,NCT02254954,"Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma"
PID-002,Glioblastoma,67,NCT04047706,"Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma"
PID-002,Glioblastoma,67,NCT06973096,CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PID-002,Glioblastoma,67,NCT03388372,Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma
PID-002,Glioblastoma,67,NCT02149225,GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
PID-002,Glioblastoma,67,NCT02478164,Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
PID-002,Glioblastoma,67,NCT03679754,"Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102"
PID-002,Glioblastoma,67,NCT04006119,Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT03687034,A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT03477110,"Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma"
PID-002,Glioblastoma,67,NCT03922984,Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma
PID-002,Glioblastoma,67,NCT04762069,A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05864976,Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
PID-002,Glioblastoma,67,NCT01756352,FET-PET for Evaluation of Response of Recurrent GBM to Avastin
PID-002,Glioblastoma,67,NCT01112527,PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03548571,Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
PID-002,Glioblastoma,67,NCT01939574,A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
PID-002,Glioblastoma,67,NCT03897491,PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
PID-002,Glioblastoma,67,NCT03152708,CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT04224441,Repurposing Chlorpromazine in the Treatment of Glioblastoma
PID-002,Glioblastoma,67,NCT03535350,Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02669173,Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02902757,FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT02728349,Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma
PID-002,Glioblastoma,67,NCT02770378,A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01043536,Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
PID-002,Glioblastoma,67,NCT05376800,A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma
PID-002,Glioblastoma,67,NCT03481231,In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT02330991,A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
PID-002,Glioblastoma,67,NCT02329795,Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
PID-002,Glioblastoma,67,NCT07029100,Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.
PID-002,Glioblastoma,67,NCT04717739,"TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study"
PID-002,Glioblastoma,67,NCT01923922,CT Perfusion in the Prognostication of Cerebral High Grade Glioma
PID-002,Glioblastoma,67,NCT04007185,Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)
PID-002,Glioblastoma,67,NCT03233152,Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03636477,A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
PID-002,Glioblastoma,67,NCT04566185,Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02590497,Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
PID-002,Glioblastoma,67,NCT00509821,"Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma"
PID-002,Glioblastoma,67,NCT03439332,Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma
PID-002,Glioblastoma,67,NCT02876003,Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma
PID-002,Glioblastoma,67,NCT03223103,Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
PID-002,Glioblastoma,67,NCT05108012,Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
PID-002,Glioblastoma,67,NCT00694837,Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
PID-002,Glioblastoma,67,NCT02799238,Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT02342379,TH-302 in Combination With Bevacizumab for Glioblastoma
PID-002,Glioblastoma,67,NCT01443676,Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT05328089,Vacuolar ATPase and Drug Resistance of High Grade Gliomas
PID-002,Glioblastoma,67,NCT00943007,Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors
PID-002,Glioblastoma,67,NCT01499251,Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05664243,"A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma"
PID-002,Glioblastoma,67,NCT03383978,Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
PID-002,Glioblastoma,67,NCT01989884,An Efficacy Study Of Ortataxel In Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05900908,Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy
PID-002,Glioblastoma,67,NCT01811121,MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS
PID-002,Glioblastoma,67,NCT02654964,Cancer Stem Cell High-Throughput Drug Screening Study
PID-002,Glioblastoma,67,NCT01854099,Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens
PID-002,Glioblastoma,67,NCT03393000,Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
PID-002,Glioblastoma,67,NCT03422094,"Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-002,Glioblastoma,67,NCT03631836,"Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma"
PID-002,Glioblastoma,67,NCT03287063,"Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma"
PID-002,Glioblastoma,67,NCT00643825,"Prolonged Adjuvant Temozolomide vs ""Stop & Go"" in Glioblastoma Patients"
PID-002,Glioblastoma,67,NCT01872221,Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study
PID-002,Glioblastoma,67,NCT01260467,Memantine for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01213407,Dendritic Cell Cancer Vaccine for High-grade Glioma
PID-002,Glioblastoma,67,NCT05590689,Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
PID-002,Glioblastoma,67,NCT05342883,GammaTile and Stupp in Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT01867593,MET-PET for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02060955,Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan
PID-002,Glioblastoma,67,NCT00029783,Efficacy of Distant Healing in Glioblastoma Treatment
PID-002,Glioblastoma,67,NCT02359097,Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT03776071,"A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1"
PID-002,Glioblastoma,67,NCT05753995,"Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study"
PID-002,Glioblastoma,67,NCT01759810,Proteome-based Personalized Immunotherapy of Glioblastoma
PID-002,Glioblastoma,67,NCT00906893,Evaluation of [18F]-FMISO for Non Operated Glioblastoma
PID-002,Glioblastoma,67,NCT02718443,VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
PID-002,Glioblastoma,67,NCT02430363,Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
PID-002,Glioblastoma,67,NCT02343406,Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
PID-002,Glioblastoma,67,NCT04726397,UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial
PID-002,Glioblastoma,67,NCT01582269,A Study in Recurrent Glioblastoma (GB)
PID-002,Glioblastoma,67,NCT02939378,Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study
PID-002,Glioblastoma,67,NCT05820191,B-amyloid as a Marker for GBM Bioimaging
PID-002,Glioblastoma,67,NCT00807027,Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
PID-002,Glioblastoma,67,NCT03018288,Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT01331291,Bosutinib in Adult Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02704858,Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
PID-002,Glioblastoma,67,NCT01100177,Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients
PID-002,Glioblastoma,67,NCT02014844,Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
PID-002,Glioblastoma,67,NCT05168423,CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
PID-002,Glioblastoma,67,NCT04868396,Patient-derived Glioma Stem Cell Organoids
PID-002,Glioblastoma,67,NCT00944801,Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02866747,A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02869243,A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
PID-002,Glioblastoma,67,NCT00295815,Enzastaurin Versus Lomustine in Glioblastoma
PID-002,Glioblastoma,67,NCT03382977,"Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects"
PID-002,Glioblastoma,67,NCT01310868,Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
PID-002,Glioblastoma,67,NCT00790452,Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
PID-002,Glioblastoma,67,NCT02648633,Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04321694,Expanded Access for KHK2455
PID-002,Glioblastoma,67,NCT01856933,BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT01430351,"Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy"
PID-002,Glioblastoma,67,NCT06954636,Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
PID-002,Glioblastoma,67,NCT00941460,Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01364064,Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00385853,PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
PID-002,Glioblastoma,67,NCT03939858,Bioenergetic Profiling and Cognition in GBM Patients
PID-002,Glioblastoma,67,NCT01507506,Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
PID-002,Glioblastoma,67,NCT00703859,Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT03970447,A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02078648,"Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT00948389,Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT01310855,Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT01985087,A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
PID-002,Glioblastoma,67,NCT02315534,A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
PID-002,Glioblastoma,67,NCT00762255,A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03149003,A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
PID-002,Glioblastoma,67,NCT02209948,Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
PID-002,Glioblastoma,67,NCT02520635,Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients
PID-002,Glioblastoma,67,NCT03961971,Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
PID-002,Glioblastoma,67,NCT01083719,A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
PID-002,Glioblastoma,67,NCT04385173,Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
PID-002,Glioblastoma,67,NCT01044225,Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
PID-002,Glioblastoma,67,NCT01934361,Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00967330,A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT03454295,Easing Psychosocial Burden for Informal Caregivers
PID-002,Glioblastoma,67,NCT01464177,Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00088400,Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors
PID-002,Glioblastoma,67,NCT04528680,Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03642080,MRI Predictors of Response to Tumor Treating Fields
PID-002,Glioblastoma,67,NCT01339052,Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04313842,A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED
PID-002,Glioblastoma,67,NCT00813943,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status"
PID-002,Glioblastoma,67,NCT02968940,Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
PID-002,Glioblastoma,67,NCT04802447,SurVaxM Expanded Access Protocol
PID-002,Glioblastoma,67,NCT01880008,Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT00392548,URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol
PID-002,Glioblastoma,67,NCT02179086,Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT04838782,Role of Repeat Resection in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00689221,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status"
PID-002,Glioblastoma,67,NCT04205357,Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00725010,Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
PID-002,Glioblastoma,67,NCT03726515,CART-EGFRvIII + Pembrolizumab in GBM
PID-002,Glioblastoma,67,NCT01632228,A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00521482,Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05450744,131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)
PID-002,Glioblastoma,67,NCT03538587,Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
PID-002,Glioblastoma,67,NCT01702792,Derivation of Tumor Specific Hybridomas
PID-002,Glioblastoma,67,NCT04077866,B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
PID-002,Glioblastoma,67,NCT06136611,Preoperative Preradiotherapy TTFields
PID-002,Glioblastoma,67,NCT04915404,Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
PID-002,Glioblastoma,67,NCT03477513,Personalized Radiation Therapy for GBM
PID-002,Glioblastoma,67,NCT03452579,Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
PID-002,Glioblastoma,67,NCT05917145,ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT04474353,Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT05768919,Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
PID-002,Glioblastoma,67,NCT00501891,Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT06146725,The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
PID-002,Glioblastoma,67,NCT03008148,Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT05801159,[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT03869242,NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT05053880,A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00943826,A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01860638,A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
PID-002,Glioblastoma,67,NCT04315584,FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
PID-002,Glioblastoma,67,NCT02654041,Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
PID-002,Glioblastoma,67,NCT05326464,Tofacitinib in Recurrent GBM Patients
PID-002,Glioblastoma,67,NCT05296122,Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
PID-002,Glioblastoma,67,NCT06649851,G-CSF After Chemo-radiation in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT03688178,DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
PID-002,Glioblastoma,67,NCT03782415,Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03250299,Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02337491,Pembrolizumab +/- Bevacizumab for Recurrent GBM
PID-002,Glioblastoma,67,NCT01124539,Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
PID-002,Glioblastoma,67,NCT03927222,Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
PID-002,Glioblastoma,67,NCT02287428,Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT02905643,Discerning Pseudoprogression vs True Tumor Growth in GBMs
PID-002,Glioblastoma,67,NCT03197506,Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT06991101,Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT03258021,TTFields In GErmany in Routine Clinical Care
PID-002,Glioblastoma,67,NCT02458508,Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy
PID-002,Glioblastoma,67,NCT00003456,Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05627323,CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT04545177,Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
PID-002,Glioblastoma,67,NCT05759195,Biomolecular Analysis for Predicting Response to Regorafenib
PID-002,Glioblastoma,67,NCT02367482,Tryptophan Metabolism in Human Brain Tumors-Novocure
PID-002,Glioblastoma,67,NCT00481455,Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT00693095,Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer
PID-002,Glioblastoma,67,NCT05236036,Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
PID-002,Glioblastoma,67,NCT00003474,Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03047473,Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01208909,Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)
PID-002,Glioblastoma,67,NCT05063682,The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
PID-002,Glioblastoma,67,NCT05902169,Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
PID-002,Glioblastoma,67,NCT06815432,GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
PID-002,Glioblastoma,67,NCT03616860,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
PID-002,Glioblastoma,67,NCT03603379,Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
PID-002,Glioblastoma,67,NCT04479241,LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02085304,"Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM"
PID-002,Glioblastoma,67,NCT01186406,"Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)"
PID-002,Glioblastoma,67,NCT06917885,CUE-102 in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00977431,Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
PID-002,Glioblastoma,67,NCT00979017,Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03643549,Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
PID-002,Glioblastoma,67,NCT00290771,Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT02899663,MRI Detection of Microbleeds in Glioma Patients
PID-002,Glioblastoma,67,NCT00895180,Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05653622,Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma
PID-002,Glioblastoma,67,NCT04221503,Niraparib/TTFields in GBM
PID-002,Glioblastoma,67,NCT02698280,Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
PID-002,Glioblastoma,67,NCT05685004,Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT02631655,POSitron Emission Imaging Using 18F-FDOPA in Neurooncology
PID-002,Glioblastoma,67,NCT00576537,Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
PID-002,Glioblastoma,67,NCT02585219,Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas
PID-002,Glioblastoma,67,NCT03278249,Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
PID-002,Glioblastoma,67,NCT00687765,Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
PID-002,Glioblastoma,67,NCT00616005,Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
PID-002,Glioblastoma,67,NCT02302235,Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study
PID-002,Glioblastoma,67,NCT04003649,IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
PID-002,Glioblastoma,67,NCT02843230,Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
PID-002,Glioblastoma,67,NCT02473484,Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas
PID-002,Glioblastoma,67,NCT05432518,Pilot Trial for Treatment of Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03025893,"A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT01602588,A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)
PID-002,Glioblastoma,67,NCT06552260,A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
PID-002,Glioblastoma,67,NCT01011231,Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma
PID-002,Glioblastoma,67,NCT05977738,Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin
PID-002,Glioblastoma,67,NCT06356883,Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
PID-002,Glioblastoma,67,NCT00884741,Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00509301,Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01653834,Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
PID-002,Glioblastoma,67,NCT05868083,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01105988,Evaluating Tumor Pseudoprogression With FLT-PET and MRI
PID-002,Glioblastoma,67,NCT06039709,Sonodynamic Therapy in Patients With Recurrent GBM
PID-002,Glioblastoma,67,NCT05052957,hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
PID-002,Glioblastoma,67,NCT03235934,Glycemic Impact on Glioblastoma Outcomes
PID-002,Glioblastoma,67,NCT01535911,Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
PID-002,Glioblastoma,67,NCT06850766,The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
PID-002,Glioblastoma,67,NCT07100730,Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01251484,BIBF 1120 in Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT06283927,The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
PID-002,Glioblastoma,67,NCT05095441,A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT05131711,Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)
PID-002,Glioblastoma,67,NCT06186440,Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
PID-002,Glioblastoma,67,NCT00611728,Ph I SU011248 + Irinotecan in Treatment of Pts w MG
PID-002,Glioblastoma,67,NCT04469699,Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05663125,LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
PID-002,Glioblastoma,67,NCT01498328,A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PID-002,Glioblastoma,67,NCT00961090,Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
PID-002,Glioblastoma,67,NCT03107780,Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
PID-002,Glioblastoma,67,NCT02474966,Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study
PID-002,Glioblastoma,67,NCT01149850,Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
PID-002,Glioblastoma,67,NCT01737346,Procarbazine and Lomustine in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT07143812,A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00597493,Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM
PID-002,Glioblastoma,67,NCT07134842,A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
PID-002,Glioblastoma,67,NCT02466828,qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.
PID-002,Glioblastoma,67,NCT00574964,Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT06782984,Drug Response Testing and Repurposing Using Glioblastoma Organoid
PID-002,Glioblastoma,67,NCT06835803,Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: a Phase 2 Hybrid Randomized Trial
PID-002,Glioblastoma,67,NCT03480867,Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)
PID-002,Glioblastoma,67,NCT00306618,Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
PID-002,Glioblastoma,67,NCT06616727,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
PID-002,Glioblastoma,67,NCT01591577,Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00412542,Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
PID-002,Glioblastoma,67,NCT05666349,Reirradiation and Niraparib in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00379470,Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT00187486,"Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors"
PID-002,Glioblastoma,67,NCT06757153,Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
PID-002,Glioblastoma,67,NCT07145047,Clinical Study of Oncolytic Virus in Glioblastoma
PID-002,Glioblastoma,67,NCT05577091,Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02137759,MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
PID-002,Glioblastoma,67,NCT03463733,Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
PID-002,Glioblastoma,67,NCT02613988,Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
PID-002,Glioblastoma,67,NCT04952571,Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT01903330,ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03632135,Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04469075,Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
PID-002,Glioblastoma,67,NCT04004975,Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
PID-002,Glioblastoma,67,NCT03557372,Mathematical Model-Adapted Radiation In Glioblastoma
PID-002,Glioblastoma,67,NCT05607407,Methimazole in Patients With Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT04902586,Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT06805305,DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT03681028,Feasibility of Individualized Therapy for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02844439,Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04968366,Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
PID-002,Glioblastoma,67,NCT05737368,Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
PID-002,Glioblastoma,67,NCT06598787,A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06894225,Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
PID-002,Glioblastoma,67,NCT05743595,"Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-002,Glioblastoma,67,NCT03665545,Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
PID-002,Glioblastoma,67,NCT03672721,IA Carboplatin + Radiotherapy in Relapsing GBM
PID-002,Glioblastoma,67,NCT06934889,Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
PID-002,Glioblastoma,67,NCT04523688,Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
PID-002,Glioblastoma,67,NCT00154375,Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT05936216,TVI-Brain-1 in Expanded Access Patient
PID-002,Glioblastoma,67,NCT05736406,A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma
PID-002,Glioblastoma,67,NCT04559230,Sacituzumab Govitecan in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04888611,Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04051606,Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06368934,Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
PID-002,Glioblastoma,67,NCT04842513,Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT03452930,Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
PID-002,Glioblastoma,67,NCT06389591,RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT06418113,Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT03405792,Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
PID-002,Glioblastoma,67,NCT06220552,The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05043701,Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01957956,Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT06069726,A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
PID-002,Glioblastoma,67,NCT05720078,UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)
PID-002,Glioblastoma,67,NCT03430791,"Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma"
PID-002,Glioblastoma,67,NCT04128774,Function and Composition of Regulatory B Cells in Participants With Glioblastoma
PID-002,Glioblastoma,67,NCT06325683,Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05218408,CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
PID-002,Glioblastoma,67,NCT02649582,Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT03225963,Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.
PID-002,Glioblastoma,67,NCT05638451,Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
PID-002,Glioblastoma,67,NCT06097975,A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06011109,Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PID-002,Glioblastoma,67,NCT05911230,Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
PID-002,Glioblastoma,67,NCT02076152,FMISO PET Study of Glioblastoma
PID-002,Glioblastoma,67,NCT04674527,Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
PID-002,Glioblastoma,67,NCT03630289,Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
PID-002,Glioblastoma,67,NCT03181477,"Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas"
PID-002,Glioblastoma,67,NCT01205334,Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04717999,Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06558214,"OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial"
PID-002,Glioblastoma,67,NCT03225300,Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation
PID-002,Glioblastoma,67,NCT05284643,"Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma"
PID-002,Glioblastoma,67,NCT05201326,Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06157541,T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT05076513,Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
PID-002,Glioblastoma,67,NCT05191784,GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients
PID-002,Glioblastoma,67,NCT05540275,Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02152982,Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04116658,"First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma"
PID-002,Glioblastoma,67,NCT00575146,Ketogenic Diet for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04013672,Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
PID-002,Glioblastoma,67,NCT03916757,V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer
PID-002,Glioblastoma,67,NCT02227576,Prevention of Thrombocytopenia in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT05802693,"A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma"
PID-002,Glioblastoma,67,NCT05324501,A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04689087,"A Prospective, Open-label, Single-arm Clinical Study"
PID-002,Glioblastoma,67,NCT00960492,Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
PID-002,Glioblastoma,67,NCT00555399,"Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)"
PID-002,Glioblastoma,67,NCT05341947,Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03451799,Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT01830101,A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03232424,NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02663271,TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02060890,Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT05879120,Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04974983,Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03722342,TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03341806,Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00657267,Dose-Intense Temozolomide in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02364206,Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT03750071,VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT01110876,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)"
PID-002,Glioblastoma,67,NCT02678975,Disulfiram in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05095376,Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
PID-002,Glioblastoma,67,NCT00400322,Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
PID-002,Glioblastoma,67,NCT02207010,A Phase 0 Study of AZD1775 in Recurrent GBM Patients
PID-002,Glioblastoma,67,NCT03137888,Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
PID-002,Glioblastoma,67,NCT03856099,TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
PID-002,Glioblastoma,67,NCT05118776,Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
PID-002,Glioblastoma,67,NCT04201873,Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04988750,Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
PID-002,Glioblastoma,67,NCT03216499,HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03865355,Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
PID-002,Glioblastoma,67,NCT01349036,A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04047303,"CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma"
PID-002,Glioblastoma,67,NCT04555577,"Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma"
PID-002,Glioblastoma,67,NCT02366728,DC Migration Study for Newly-Diagnosed GBM
PID-002,Glioblastoma,67,NCT03514069,Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
PID-002,Glioblastoma,67,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-002,Glioblastoma,67,NCT04397679,"Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma"
PID-002,Glioblastoma,67,NCT02599090,Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-002,Glioblastoma,67,NCT07138001,Phase 2 Clinical Trial of KH617
PID-002,Glioblastoma,67,NCT02345824,Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
PID-002,Glioblastoma,67,NCT02919332,Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01113398,AMG 102 and Avastin for Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT00441142,Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
PID-002,Glioblastoma,67,NCT03034135,"Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma"
PID-002,Glioblastoma,67,NCT03522298,"Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma"
PID-002,Glioblastoma,67,NCT03033524,Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03867123,A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
PID-002,Glioblastoma,67,NCT02974621,Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02530502,Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02133183,Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06186401,Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
PID-002,Glioblastoma,67,NCT00921167,A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
PID-002,Glioblastoma,67,NCT00841555,Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
PID-002,Glioblastoma,67,NCT02933736,Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
PID-002,Glioblastoma,67,NCT02129335,"Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner"
PID-002,Glioblastoma,67,NCT05879250,WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02340156,Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01866449,Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02781792,Temozolomide Chronotherapy for High Grade Glioma
PID-002,Glioblastoma,67,NCT00250887,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research"
PID-002,Glioblastoma,67,NCT03401866,Multi-site Validation and Application of a Consensus DSC-MRI Protocol
PID-002,Glioblastoma,67,NCT01756729,Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
PID-002,Glioblastoma,67,NCT06419946,Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
PID-002,Glioblastoma,67,NCT03573986,Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
PID-002,Glioblastoma,67,NCT03174197,Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT05318612,Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)
PID-002,Glioblastoma,67,NCT02455557,SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00045968,Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
PID-002,Glioblastoma,67,NCT01813877,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-002,Glioblastoma,67,NCT04715620,Niraparib Combined With Radiotherapy in rGBM
PID-002,Glioblastoma,67,NCT00777153,Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04681677,Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
PID-002,Glioblastoma,67,NCT03744026,Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
PID-002,Glioblastoma,67,NCT04223999,Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)
PID-002,Glioblastoma,67,NCT01135875,Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
PID-002,Glioblastoma,67,NCT00525525,Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
PID-002,Glioblastoma,67,NCT02573324,A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
PID-002,Glioblastoma,67,NCT00365222,Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02754362,A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00734526,Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-002,Glioblastoma,67,NCT05565521,UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly
PID-002,Glioblastoma,67,NCT01987830,Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
PID-002,Glioblastoma,67,NCT05431348,Effect of StRess and ExeRcize on the Outcome After Chemo-Radiation
PID-002,Glioblastoma,67,NCT01754350,"Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma"
PID-002,Glioblastoma,67,NCT04440358,Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
PID-002,Glioblastoma,67,NCT02017717,A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT02885272,FDG PET Imaging in Diagnosing Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT04417088,Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
PID-002,Glioblastoma,67,NCT01165671,Carbon Ion Radiotherapy for Primary Glioblastoma
PID-002,Glioblastoma,67,NCT05271240,Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT05864534,Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00071539,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-002,Glioblastoma,67,NCT07089758,A Study for Cerebral Open Flow Microperfusion
PID-002,Glioblastoma,67,NCT02046187,Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01115036,A Panobinostat Presurgery
PID-002,Glioblastoma,67,NCT00612989,Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM
PID-002,Glioblastoma,67,NCT05182905,AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
PID-002,Glioblastoma,67,NCT00612339,Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
PID-002,Glioblastoma,67,NCT02717962,"Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting"
PID-002,Glioblastoma,67,NCT03158389,NCT Neuro Master Match - N²M² (NOA-20)
PID-002,Glioblastoma,67,NCT03291977,Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)
PID-002,Glioblastoma,67,NCT00250211,Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
PID-002,Glioblastoma,67,NCT00200161,Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
PID-002,Glioblastoma,67,NCT05914935,Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00335075,Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
PID-002,Glioblastoma,67,NCT02062827,Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT03014804,Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04222309,Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-002,Glioblastoma,67,NCT06095375,"Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients"
PID-002,Glioblastoma,67,NCT01956734,Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03277638,Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
PID-002,Glioblastoma,67,NCT01836536,Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients
PID-002,Glioblastoma,67,NCT05100641,AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT04105374,"Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma"
PID-002,Glioblastoma,67,NCT00615927,Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
PID-002,Glioblastoma,67,NCT00672243,Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
PID-002,Glioblastoma,67,NCT03877861,Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms
PID-002,Glioblastoma,67,NCT03868943,Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
PID-002,Glioblastoma,67,NCT01567202,Study of DC Vaccination Against Glioblastoma
PID-002,Glioblastoma,67,NCT03551249,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
PID-002,Glioblastoma,67,NCT03532295,Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
PID-002,Glioblastoma,67,NCT01702610,Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT06585527,Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT02510950,Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00613028,Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
PID-002,Glioblastoma,67,NCT05879367,Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
PID-002,Glioblastoma,67,NCT00613132,Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
PID-002,Glioblastoma,67,NCT03149575,VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
PID-002,Glioblastoma,67,NCT00611325,Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT01413438,Bevacizumab With or Without Surgery for Adult Glioblastomas
PID-002,Glioblastoma,67,NCT02010606,Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02833701,Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
PID-002,Glioblastoma,67,NCT01180816,Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
PID-002,Glioblastoma,67,NCT06455189,Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
PID-002,Glioblastoma,67,NCT02664363,EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
PID-002,Glioblastoma,67,NCT01269853,Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
PID-002,Glioblastoma,67,NCT05326334,THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)
PID-002,Glioblastoma,67,NCT00612430,Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
PID-002,Glioblastoma,67,NCT01386710,Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
PID-002,Glioblastoma,67,NCT00968240,Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
PID-002,Glioblastoma,67,NCT03722355,Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
PID-002,Glioblastoma,67,NCT00671970,Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
PID-002,Glioblastoma,67,NCT01986348,Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas
PID-002,Glioblastoma,67,NCT02026271,A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
PID-002,Glioblastoma,67,NCT06622434,"New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study"
PID-002,Glioblastoma,67,NCT01811498,Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT01067469,Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT02022384,Immunophenotyping From Blood of Patients With Malignant Gliomas
PID-002,Glioblastoma,67,NCT05990556,Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT02605746,Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis
PID-002,Glioblastoma,67,NCT02270034,Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01547546,A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT04674579,Automatic Segmentation MRI Cerebral Glioma
PID-002,Glioblastoma,67,NCT00735436,A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
PID-002,Glioblastoma,67,NCT01954576,NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00354913,Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
PID-002,Glioblastoma,67,NCT00609999,Ph I Dasatinib + Erlotinib in Recurrent MG
PID-002,Glioblastoma,67,NCT05624736,Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning
PID-002,Glioblastoma,67,NCT00586508,Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas
PID-002,Glioblastoma,67,NCT05363826,Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®
PID-002,Glioblastoma,67,NCT05660369,CARv3-TEAM-E T Cells in Glioblastoma
PID-002,Glioblastoma,67,NCT00883298,Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05941234,"Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma"
PID-002,Glioblastoma,67,NCT03050736,Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
PID-002,Glioblastoma,67,NCT00613054,Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT06279767,Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00613223,Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
PID-002,Glioblastoma,67,NCT03997136,Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.
PID-002,Glioblastoma,67,NCT00669669,O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
PID-002,Glioblastoma,67,NCT06562621,Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT00612638,Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
PID-002,Glioblastoma,67,NCT03360708,Vaccine Therapy in Treating Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03332355,Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
PID-002,Glioblastoma,67,NCT05235737,The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab
PID-002,Glioblastoma,67,NCT03170141,Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05954858,Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
PID-002,Glioblastoma,67,NCT05432804,"Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment"
PID-002,Glioblastoma,67,NCT04266977,Restrictive Use of Dexamethasone in Glioblastoma
PID-002,Glioblastoma,67,NCT00540176,The Safety and Efficacy of DCA for the Treatment of Brain Cancer
PID-002,Glioblastoma,67,NCT06327451,Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
PID-002,Glioblastoma,67,NCT02006563,Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors
PID-002,Glioblastoma,67,NCT01351519,A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
PID-002,Glioblastoma,67,NCT04780009,Loupe-Based Intraoperative Fluorescence Imaging
PID-002,Glioblastoma,67,NCT06632236,5G-EMERALD: Amivantamab in Malignant Brain Tumours
PID-002,Glioblastoma,67,NCT06630260,5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
PID-002,Glioblastoma,67,NCT02227901,"Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT02414165,The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
PID-002,Glioblastoma,67,NCT06359379,Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
PID-002,Glioblastoma,67,NCT01478178,Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT05842746,Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT03115138,Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
PID-002,Glioblastoma,67,NCT03020017,NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
PID-002,Glioblastoma,67,NCT04188535,Serial MRI Scans During Radiation Therapy
PID-002,Glioblastoma,67,NCT01174537,"New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma"
PID-002,Glioblastoma,67,NCT02590263,Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
PID-002,Glioblastoma,67,NCT04910022,Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03345095,A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01124240,Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene
PID-002,Glioblastoma,67,NCT00005856,Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02743078,Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05773664,Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma
PID-002,Glioblastoma,67,NCT06964815,"Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients"
PID-002,Glioblastoma,67,NCT03603405,HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT05694416,Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT02768389,Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05772767,Modulation of Ciliogenesis in Glioma Stem Cells
PID-002,Glioblastoma,67,NCT03294486,"Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients"
PID-002,Glioblastoma,67,NCT03144167,Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
PID-002,Glioblastoma,67,NCT00316849,"Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT00058097,Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02898012,Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
PID-002,Glioblastoma,67,NCT04391595,LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
PID-002,Glioblastoma,67,NCT04926168,6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT01805453,"Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma"
PID-002,Glioblastoma,67,NCT03834740,A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
PID-002,Glioblastoma,67,NCT00606008,A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-002,Glioblastoma,67,NCT00004262,Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT03615404,"Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma"
PID-002,Glioblastoma,67,NCT06816927,Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
PID-002,Glioblastoma,67,NCT04200066,A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03423628,A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
PID-002,Glioblastoma,67,NCT06319027,"Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial"
PID-002,Glioblastoma,67,NCT05447195,Phase 2 Study of CAN008 in Subjects With GBM
PID-002,Glioblastoma,67,NCT05600491,A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
PID-002,Glioblastoma,67,NCT00049387,"Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-002,Glioblastoma,67,NCT06177964,Lerapolturev (PVSRIPO) in GBM
PID-002,Glioblastoma,67,NCT00305864,"Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-002,Glioblastoma,67,NCT05979064,Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-002,Glioblastoma,67,NCT00052208,Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05695976,GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
PID-002,Glioblastoma,67,NCT02626364,Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
PID-002,Glioblastoma,67,NCT02761070,"Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III"
PID-002,Glioblastoma,67,NCT01811992,Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma
PID-002,Glioblastoma,67,NCT03705351,Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT00777686,Measuring Non-Enhancing Glioblastoma Progression
PID-002,Glioblastoma,67,NCT03596086,HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
PID-002,Glioblastoma,67,NCT00479765,A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
PID-002,Glioblastoma,67,NCT00039494,Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
PID-002,Glioblastoma,67,NCT00660543,MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
PID-002,Glioblastoma,67,NCT01331616,Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
PID-002,Glioblastoma,67,NCT00085254,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT01540513,PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
PID-002,Glioblastoma,67,NCT03115333,DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04741984,Monocyte Antigen Carrier Cells for Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT04937413,The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation
PID-002,Glioblastoma,67,NCT00943462,Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
PID-002,Glioblastoma,67,NCT01124461,BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor
PID-002,Glioblastoma,67,NCT05163080,SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
PID-002,Glioblastoma,67,NCT02465268,Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02375841,"Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers"
PID-002,Glioblastoma,67,NCT05091866,Natural Progesterone for the Treatment of Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03778294,18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
PID-002,Glioblastoma,67,NCT05375318,"BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels"
PID-002,Glioblastoma,67,NCT03899857,Pembrolizumab for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00613093,Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
PID-002,Glioblastoma,67,NCT05772741,Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs
PID-002,Glioblastoma,67,NCT00014170,Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05380349,Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
PID-002,Glioblastoma,67,NCT04725214,Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma
PID-002,Glioblastoma,67,NCT00902577,MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04840069,Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01609790,Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
PID-002,Glioblastoma,67,NCT01465347,Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT05033587,Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
PID-002,Glioblastoma,67,NCT00731731,"Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT02337426,"Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT05084430,Study of Pembrolizumab and M032 (NSC 733972)
PID-002,Glioblastoma,67,NCT04945148,Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
PID-002,Glioblastoma,67,NCT02395692,Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00846456,Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma
PID-002,Glioblastoma,67,NCT01022918,Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
PID-002,Glioblastoma,67,NCT05116137,The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
PID-002,Glioblastoma,67,NCT00864864,Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02575027,Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01120639,Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
PID-002,Glioblastoma,67,NCT04600817,A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)
PID-002,Glioblastoma,67,NCT04065087,Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT03619239,Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT03020602,BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab
PID-002,Glioblastoma,67,NCT02197169,DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
PID-002,Glioblastoma,67,NCT01111097,Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors
PID-002,Glioblastoma,67,NCT00761280,Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
PID-002,Glioblastoma,67,NCT07003542,A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
PID-002,Glioblastoma,67,NCT02820584,A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06329570,Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
PID-002,Glioblastoma,67,NCT04327011,A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
PID-002,Glioblastoma,67,NCT00409214,Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
PID-002,Glioblastoma,67,NCT03400917,Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT03626896,Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
PID-002,Glioblastoma,67,NCT02311920,Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-002,Glioblastoma,67,NCT06797661,Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.
PID-002,Glioblastoma,67,NCT00001148,Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
PID-002,Glioblastoma,67,NCT02047058,Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
PID-002,Glioblastoma,67,NCT00115440,BNCT to Treat Glioma That Has Progressed Following Radiotherapy
PID-002,Glioblastoma,67,NCT05513859,Investigational Imaging Technique During Brain Surgery
PID-002,Glioblastoma,67,NCT02709226,Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04998864,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
PID-002,Glioblastoma,67,NCT04903795,Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PID-002,Glioblastoma,67,NCT00165477,Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05023551,Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-002,Glioblastoma,67,NCT04424966,Infigratinib in Recurrent High-Grade Glioma Patients
PID-002,Glioblastoma,67,NCT05171127,Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
PID-002,Glioblastoma,67,NCT03861299,The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
PID-002,Glioblastoma,67,NCT06496971,A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
PID-002,Glioblastoma,67,NCT00662506,"Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma"
PID-002,Glioblastoma,67,NCT00179907,A Phase I/II Study of the Photon Radiosurgery System
PID-002,Glioblastoma,67,NCT04967690,"A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM"
PID-002,Glioblastoma,67,NCT06480721,FET-PET-Guided Management of Pseudoprogression in Glioblastoma
PID-002,Glioblastoma,67,NCT03460782,An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
PID-002,Glioblastoma,67,NCT00004146,Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
PID-002,Glioblastoma,67,NCT03951142,Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study
PID-002,Glioblastoma,67,NCT05718466,Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy
PID-002,Glioblastoma,67,NCT05904119,Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
PID-002,Glioblastoma,67,NCT04854044,ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03649464,Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
PID-002,Glioblastoma,67,NCT03732352,18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05977322,A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
PID-002,Glioblastoma,67,NCT02330562,Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab
PID-002,Glioblastoma,67,NCT06193538,The Safety and Effectiveness of NV-A01 in Glioma Patients
PID-002,Glioblastoma,67,NCT01905228,A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
PID-002,Glioblastoma,67,NCT06910306,A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02666066,Radiomics for Prediction of Survival in GBM
PID-002,Glioblastoma,67,NCT00074646,Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas
PID-002,Glioblastoma,67,NCT02903069,Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
PID-002,Glioblastoma,67,NCT00548938,"Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM"
PID-002,Glioblastoma,67,NCT02490930,A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
PID-002,Glioblastoma,67,NCT02025231,Image Guided Reirradiation of High-grade Glioma
PID-002,Glioblastoma,67,NCT06129760,Glioblastoma Remote Monitoring and Care - Research Protocol
PID-002,Glioblastoma,67,NCT06684899,Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT06773481,BC008-1A Injection for Recurrent CNS WHO G4 Glioma
PID-002,Glioblastoma,67,NCT00686387,Establishment of a Brain and Spinal Tumor Tissue Bank
PID-002,Glioblastoma,67,NCT06344130,Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01266031,Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01516905,PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
PID-002,Glioblastoma,67,NCT03370926,FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
PID-002,Glioblastoma,67,NCT06328036,Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01931098,Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
PID-002,Glioblastoma,67,NCT01502241,Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
PID-002,Glioblastoma,67,NCT00939991,"Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas"
PID-002,Glioblastoma,67,NCT03426891,Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT06719440,Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
PID-002,Glioblastoma,67,NCT00723827,Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
PID-002,Glioblastoma,67,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-002,Glioblastoma,67,NCT00431561,Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
PID-002,Glioblastoma,67,NCT01317888,Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas
PID-002,Glioblastoma,67,NCT05039281,Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05017610,Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
PID-002,Glioblastoma,67,NCT06824662,Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas
PID-002,Glioblastoma,67,NCT03618667,GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
PID-002,Glioblastoma,67,NCT00089427,"IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma"
PID-002,Glioblastoma,67,NCT00028158,"Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer"
PID-002,Glioblastoma,67,NCT01925573,Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
PID-002,Glioblastoma,67,NCT04822688,"Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues"
PID-002,Glioblastoma,67,NCT05383872,Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
PID-002,Glioblastoma,67,NCT02337686,Pembrolizumab in Treating Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03296696,Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
PID-002,Glioblastoma,67,NCT01086345,Radiosurgery Plus Bevacizumab in Glioblastoma
PID-002,Glioblastoma,67,NCT06072586,A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
PID-002,Glioblastoma,67,NCT04216329,Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT06455605,D2C7-IT + 2141-V11 Combination Post-resection in rGBM
PID-002,Glioblastoma,67,NCT01044966,A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04763031,Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT
PID-002,Glioblastoma,67,NCT04446416,Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
PID-002,Glioblastoma,67,NCT01582516,Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00753246,Nimotuzumab in Adults With Glioblastoma Multiforma
PID-002,Glioblastoma,67,NCT01227434,A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
PID-002,Glioblastoma,67,NCT03224104,Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
PID-002,Glioblastoma,67,NCT06691308,WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients
PID-002,Glioblastoma,67,NCT01004874,Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
PID-002,Glioblastoma,67,NCT02871843,RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
PID-002,Glioblastoma,67,NCT00045565,Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
PID-002,Glioblastoma,67,NCT06058988,Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
PID-002,Glioblastoma,67,NCT04817254,Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-002,Glioblastoma,67,NCT00597402,"Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas"
PID-002,Glioblastoma,67,NCT00645385,Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
PID-002,Glioblastoma,67,NCT00576641,Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
PID-002,Glioblastoma,67,NCT01520870,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
PID-002,Glioblastoma,67,NCT01240460,Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection
PID-002,Glioblastoma,67,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-002,Glioblastoma,67,NCT03633552,Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
PID-002,Glioblastoma,67,NCT05929456,Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)
PID-002,Glioblastoma,67,NCT01062425,Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT04608812,Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
PID-002,Glioblastoma,67,NCT03631823,Gut Microbiota and Glioblastoma Multiforme Prognosis
PID-002,Glioblastoma,67,NCT05565118,Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
PID-002,Glioblastoma,67,NCT04045847,CD147-CART Cells in Patients With Recurrent Malignant Glioma.
PID-002,Glioblastoma,67,NCT04289155,Individual Patient Compassionate Use of GX-I7
PID-002,Glioblastoma,67,NCT01242566,Temozolomide in Elderly Patients With KPS < 70
PID-002,Glioblastoma,67,NCT01290939,Bevacizumab and Lomustine for Recurrent GBM
PID-002,Glioblastoma,67,NCT05683808,Venous Thromboembolism Prevention in Outpatients With Glioma
PID-002,Glioblastoma,67,NCT04396860,Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
PID-002,Glioblastoma,67,NCT01294735,Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
PID-002,Glioblastoma,67,NCT04209790,Neoadjuvant Chemoradiation for Resectable Glioblastoma
PID-002,Glioblastoma,67,NCT04677049,Study of Niacin in Glioblastoma
PID-002,Glioblastoma,67,NCT05739942,Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT02253212,Safety of BBB Opening With the SonoCloud
PID-002,Glioblastoma,67,NCT06504381,"DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma"
PID-002,Glioblastoma,67,NCT01711580,Re-irradiation of High Grade Gliomas: a Quality of Life Study
PID-002,Glioblastoma,67,NCT06710249,Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
PID-002,Glioblastoma,67,NCT06883747,Clinical Trial of BMS-986504 in Recurrent GBM Patients
PID-002,Glioblastoma,67,NCT07111195,Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
PID-002,Glioblastoma,67,NCT00923117,Sunitinib to Treat Recurrent Brain Cancer
PID-002,Glioblastoma,67,NCT05671016,Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy
PID-002,Glioblastoma,67,NCT00715013,Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT02431572,A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
PID-002,Glioblastoma,67,NCT00016328,CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00540722,Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00423735,Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
PID-002,Glioblastoma,67,NCT04699773,LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
PID-002,Glioblastoma,67,NCT06273176,The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06059690,Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
PID-002,Glioblastoma,67,NCT00747253,Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
PID-002,Glioblastoma,67,NCT00980343,GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-002,Glioblastoma,67,NCT00591058,Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT03283631,Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
PID-002,Glioblastoma,67,NCT00504660,"6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients"
PID-002,Glioblastoma,67,NCT02794883,Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT00641706,"Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme"
PID-002,Glioblastoma,67,NCT00107003,GW572016 to Treat Recurrent Malignant Brain Tumors
PID-002,Glioblastoma,67,NCT06385132,Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer
PID-002,Glioblastoma,67,NCT00445588,Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT02529072,Nivolumab With DC Vaccines for Recurrent Brain Tumors
PID-002,Glioblastoma,67,NCT00612651,PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
PID-002,Glioblastoma,67,NCT01238237,Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA
PID-002,Glioblastoma,67,NCT03275558,Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma
PID-002,Glioblastoma,67,NCT00503204,Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
PID-002,Glioblastoma,67,NCT02386826,INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00704080,A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
PID-002,Glioblastoma,67,NCT04116138,Antisecretory Factor in Primary Glioblastoma 1
PID-002,Glioblastoma,67,NCT06806228,Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)
PID-002,Glioblastoma,67,NCT01790503,A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT00751270,Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
PID-002,Glioblastoma,67,NCT00610571,Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
PID-002,Glioblastoma,67,NCT00780819,Borderzone Sampling
PID-002,Glioblastoma,67,NCT00683761,A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT00473408,The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
PID-002,Glioblastoma,67,NCT07021339,Anterior Temporal Lobectomy in Temporal Glioblastoma
PID-002,Glioblastoma,67,NCT00305656,AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00335764,"Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma"
PID-002,Glioblastoma,67,NCT01081223,Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
PID-002,Glioblastoma,67,NCT00087451,Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)
PID-002,Glioblastoma,67,NCT00392171,The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
PID-002,Glioblastoma,67,NCT05734560,D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
PID-002,Glioblastoma,67,NCT00132158,ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
PID-002,Glioblastoma,67,NCT00238303,Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01575275,Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00075491,Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT05267106,Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
PID-002,Glioblastoma,67,NCT01894061,NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00112502,Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04776980,Multimodality MRI and Liquid Biopsy in GBM
PID-002,Glioblastoma,67,NCT02887417,Glioblastoma Platelet Activation Study
PID-002,Glioblastoma,67,NCT00112866,Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT04444427,Evaluation of GLR2007 for Advanced Solid Tumors
PID-002,Glioblastoma,67,NCT00895960,Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT04657315,"Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients"
PID-002,Glioblastoma,67,NCT02052648,Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
PID-002,Glioblastoma,67,NCT03027388,"Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma"
PID-002,Glioblastoma,67,NCT02661282,Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT04712721,Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
PID-002,Glioblastoma,67,NCT06241391,Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
PID-002,Glioblastoma,67,NCT04388475,Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT04143425,Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01967758,Phase I Study of Safety and Immunogenicity of ADU-623
PID-002,Glioblastoma,67,NCT03746080,Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT05561374,Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT04181684,LITT Followed by Hypofractionated RT for Recurrent Gliomas
PID-002,Glioblastoma,67,NCT03673787,A Trial of Ipatasertib in Combination With Atezolizumab
PID-002,Glioblastoma,67,NCT03367715,"Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma"
PID-002,Glioblastoma,67,NCT00459381,Pazopanib in Treating Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT05909618,Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
PID-002,Glioblastoma,67,NCT01730950,Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01753713,Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT01117155,A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
PID-002,Glioblastoma,67,NCT01475006,AMG 595 First-in-Human in Recurrent Gliomas
PID-002,Glioblastoma,67,NCT01491893,PVSRIPO for Recurrent Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT00979862,Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03539731,[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
PID-002,Glioblastoma,67,NCT01122901,Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT03176160,LITT Palliative Treatment for Patients With Malignant Gliomas
PID-002,Glioblastoma,67,NCT05929495,"Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma"
PID-002,Glioblastoma,67,NCT01972750,Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma
PID-002,Glioblastoma,67,NCT05054400,Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
PID-002,Glioblastoma,67,NCT06017063,Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields
PID-002,Glioblastoma,67,NCT01434602,Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
PID-002,Glioblastoma,67,NCT03213002,Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
PID-002,Glioblastoma,67,NCT01967810,ANG1005 in Patients With Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT03581292,"Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations"
PID-002,Glioblastoma,67,NCT03975959,Memory Perception Assessment in Central/Non-central Nervous System Cancers
PID-002,Glioblastoma,67,NCT01808820,Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
PID-002,Glioblastoma,67,NCT06623565,Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
PID-002,Glioblastoma,67,NCT02629757,A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas
PID-002,Glioblastoma,67,NCT00624728,Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
PID-002,Glioblastoma,67,NCT00562419,CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
PID-002,Glioblastoma,67,NCT02658981,Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
PID-002,Glioblastoma,67,NCT00031538,Genetic Analysis of Brain Tumors
PID-002,Glioblastoma,67,NCT00870181,ADV-TK Improves Outcome of Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT04729959,"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma"
PID-002,Glioblastoma,67,NCT00031083,Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
PID-002,Glioblastoma,67,NCT01765088,A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
PID-002,Glioblastoma,67,NCT04145115,A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden
PID-002,Glioblastoma,67,NCT02750891,A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
PID-002,Glioblastoma,67,NCT01985256,Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
PID-002,Glioblastoma,67,NCT03475186,Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
PID-002,Glioblastoma,67,NCT02540135,Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
PID-002,Glioblastoma,67,NCT01738646,Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
PID-002,Glioblastoma,67,NCT04623931,Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
PID-002,Glioblastoma,67,NCT06430424,"Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma"
PID-002,Glioblastoma,67,NCT01810744,Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
PID-002,Glioblastoma,67,NCT02942264,Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-002,Glioblastoma,67,NCT06501911,A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
PID-002,Glioblastoma,67,NCT01975701,A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
PID-002,Glioblastoma,67,NCT03657576,Trial of C134 in Patients With Recurrent GBM
PID-002,Glioblastoma,67,NCT01712542,Curcumin Bioavailability in Glioblastoma Patients
PID-002,Glioblastoma,67,NCT01470794,Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
PID-002,Glioblastoma,67,NCT01107522,Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
PID-002,Glioblastoma,67,NCT02525692,Oral ONC201 in Adult Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT07091864,Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
PID-002,Glioblastoma,67,NCT03311542,Expanded Access for Pembrolizumab (MK-3475)
PID-002,Glioblastoma,67,NCT00734864,Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT03561207,3D Prediction of Patient-Specific Response
PID-002,Glioblastoma,67,NCT03914768,Immune Modulatory DC Vaccine Against Brain Tumor
PID-002,Glioblastoma,67,NCT00102648,Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
PID-002,Glioblastoma,67,NCT07067905,Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
PID-002,Glioblastoma,67,NCT06617208,Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery
PID-002,Glioblastoma,67,NCT01814813,Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-002,Glioblastoma,67,NCT05062772,Brain Tumor Intraoperative Ultrasound Database
PID-002,Glioblastoma,67,NCT06108206,Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
PID-002,Glioblastoma,67,NCT00041587,Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
PID-002,Glioblastoma,67,NCT00024570,Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT05106296,Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
PID-002,Glioblastoma,67,NCT04267978,Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
PID-002,Glioblastoma,67,NCT00001171,Evaluation of Factors in Human Brain Tumors
PID-002,Glioblastoma,67,NCT05131763,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-002,Glioblastoma,67,NCT00114309,131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT04477200,Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
PID-002,Glioblastoma,67,NCT04270461,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-002,Glioblastoma,67,NCT01454596,CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
PID-002,Glioblastoma,67,NCT06016452,A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma
PID-002,Glioblastoma,67,NCT00379080,Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT00390299,Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT00080054,A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
PID-002,Glioblastoma,67,NCT01122888,Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT06160206,Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT06894979,"Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma"
PID-002,Glioblastoma,67,NCT00734682,A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
PID-002,Glioblastoma,67,NCT05495295,"First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours"
PID-002,Glioblastoma,67,NCT04933942,Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
PID-002,Glioblastoma,67,NCT05629702,ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
PID-002,Glioblastoma,67,NCT06118723,The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
PID-002,Glioblastoma,67,NCT01342757,Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT00009035,Natural History of Patients With Brain and Spinal Cord Tumors
PID-002,Glioblastoma,67,NCT01441388,A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
PID-002,Glioblastoma,67,NCT00575887,Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
PID-002,Glioblastoma,67,NCT04478279,A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
PID-002,Glioblastoma,67,NCT06614855,A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT04074785,Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6
PID-002,Glioblastoma,67,NCT05765812,A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT02348255,NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
PID-002,Glioblastoma,67,NCT00589875,Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
PID-002,Glioblastoma,67,NCT06492486,Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
PID-002,Glioblastoma,67,NCT05686798,Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
PID-002,Glioblastoma,67,NCT04323046,Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
PID-002,Glioblastoma,67,NCT01156584,A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT00062504,Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
PID-002,Glioblastoma,67,NCT06929819,Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
PID-002,Glioblastoma,67,NCT00272870,Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
PID-002,Glioblastoma,67,NCT06810544,Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
PID-002,Glioblastoma,67,NCT06388733,"A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma"
PID-002,Glioblastoma,67,NCT05773326,Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
PID-002,Glioblastoma,67,NCT00433381,Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
PID-002,Glioblastoma,67,NCT03022578,Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
PID-002,Glioblastoma,67,NCT04630379,Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
PID-002,Glioblastoma,67,NCT04218019,Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation
PID-002,Glioblastoma,67,NCT01999270,Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
PID-002,Glioblastoma,67,NCT04489420,Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
PID-002,Glioblastoma,67,NCT04991870,Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
PID-002,Glioblastoma,67,NCT01902771,Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
PID-002,Glioblastoma,67,NCT06038760,Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
PID-002,Glioblastoma,67,NCT00995007,A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
PID-002,Glioblastoma,67,NCT01281982,(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
PID-002,Glioblastoma,67,NCT04049669,Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
PID-002,Glioblastoma,67,NCT01316809,AZD8055 for Adults With Recurrent Gliomas
PID-002,Glioblastoma,67,NCT03593993,A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
PID-002,Glioblastoma,67,NCT01478321,Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
PID-002,Glioblastoma,67,NCT02039778,Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma
PID-002,Glioblastoma,67,NCT02655601,"Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001"
PID-002,Glioblastoma,67,NCT05465954,Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT00329719,Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT01656980,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
PID-002,Glioblastoma,67,NCT01637753,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT02885324,Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
PID-002,Glioblastoma,67,NCT01204684,Dendritic Cell Vaccine for Patients With Brain Tumors
PID-002,Glioblastoma,67,NCT03463265,Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT04314674,Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors Resection
PID-002,Glioblastoma,67,NCT01171469,Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
PID-002,Glioblastoma,67,NCT00973557,The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
PID-002,Glioblastoma,67,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
PID-002,Glioblastoma,67,NCT00179803,Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
PID-002,Glioblastoma,67,NCT04782609,Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT00024557,Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
PID-002,Glioblastoma,67,NCT01836549,Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
PID-002,Glioblastoma,67,NCT01250470,Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
PID-002,Glioblastoma,67,NCT00064779,Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT01648348,Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT06665724,Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
PID-002,Glioblastoma,67,NCT06410248,Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
PID-002,Glioblastoma,67,NCT03717142,Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
PID-002,Glioblastoma,67,NCT06902350,"Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors"
PID-002,Glioblastoma,67,NCT04614493,Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.
PID-002,Glioblastoma,67,NCT05297864,PARP Inhibition for Gliomas (PI-4G or π4g)
PID-002,Glioblastoma,67,NCT05099068,Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)
PID-002,Glioblastoma,67,NCT02722512,Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
PID-002,Glioblastoma,67,NCT01514201,"Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas"
PID-002,Glioblastoma,67,NCT04047264,Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
PID-002,Glioblastoma,67,NCT03971734,Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
PID-002,Glioblastoma,67,NCT01740258,Bevacizumab Beyond Progression (BBP)
PID-002,Glioblastoma,67,NCT03607643,"A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies"
PID-002,Glioblastoma,67,NCT00823797,Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
PID-002,Glioblastoma,67,NCT01861990,Valproic Acid in Childhood Progressive Brain Tumors
PID-002,Glioblastoma,67,NCT06193174,Re-Administration of C134 in Patients with Recurrent GBM (C134-HSV-1)
PID-002,Glioblastoma,67,NCT02168270,Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT00884416,Sorafenib in Newly Diagnosed High Grade Glioma
PID-002,Glioblastoma,67,NCT00004688,"Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms"
PID-002,Glioblastoma,67,NCT00243490,Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
PID-002,Glioblastoma,67,NCT01822275,Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-002,Glioblastoma,67,NCT01380782,BIBF 1120 for Recurrent High-Grade Gliomas
PID-002,Glioblastoma,67,NCT02758366,Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
PID-002,Glioblastoma,67,NCT06860594,"Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma"
PID-002,Glioblastoma,67,NCT01095094,Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT02055196,Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-002,Glioblastoma,67,NCT01144247,Cellular Immunotherapy Study for Brain Cancer
PID-002,Glioblastoma,67,NCT04488783,Potentiation of Chemotherapy in Brain Tumors by Zinc
PID-002,Glioblastoma,67,NCT01189240,RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT04661384,"Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma"
PID-002,Glioblastoma,67,NCT04479696,Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
PID-002,Glioblastoma,67,NCT06989086,FearLess in NeuroOncology
PID-002,Glioblastoma,67,NCT00006773,Bortezomib in Treating Patients With Recurrent Glioma
PID-002,Glioblastoma,67,NCT03956706,Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
PID-002,Glioblastoma,67,NCT06160596,Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
PID-002,Glioblastoma,67,NCT03251027,Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
PID-002,Glioblastoma,67,NCT06796335,Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
PID-002,Glioblastoma,67,NCT04734444,SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
PID-002,Glioblastoma,67,NCT03392545,Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)
PID-002,Glioblastoma,67,NCT05039346,Quality of Life and Patient Needs in Advanced High Grade Gliomas
PID-002,Glioblastoma,67,NCT05139277,Evaluation of the CONVIVO System
PID-002,Glioblastoma,67,NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection
PID-002,Glioblastoma,67,NCT00650923,"Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma"
PID-002,Glioblastoma,67,NCT06333899,Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
PID-002,Glioblastoma,67,NCT01151670,Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
PID-002,Glioblastoma,67,NCT00667394,Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
PID-002,Glioblastoma,67,NCT06975332,"Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression"
PID-002,Glioblastoma,67,NCT03914742,BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
PID-002,Glioblastoma,67,NCT05843253,Study of Ribociclib and Everolimus in HGG and DIPG
PID-002,Glioblastoma,67,NCT05839379,Targeted Pediatric High-Grade Glioma Therapy
PID-002,Glioblastoma,67,NCT01798771,Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
PID-002,Glioblastoma,67,NCT02015819,"Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas"
PID-002,Glioblastoma,67,NCT05873946,Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
PID-002,Glioblastoma,67,NCT04295759,INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
PID-002,Glioblastoma,67,NCT04482933,HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT02031965,Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
PID-002,Glioblastoma,67,NCT05789394,Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
PID-002,Glioblastoma,67,NCT05698524,A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
PID-002,Glioblastoma,67,NCT03718767,Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
PID-002,Glioblastoma,67,NCT03123952,Expanded Access to ABT-414
PID-002,Glioblastoma,67,NCT02861898,Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
PID-002,Glioblastoma,67,NCT01721577,Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
PID-002,Glioblastoma,67,NCT02238496,Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
PID-002,Glioblastoma,67,NCT04982926,A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
PID-002,Glioblastoma,67,NCT04214392,Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
PID-002,Glioblastoma,67,NCT01996527,3T MRI Biomarkers of Glioma Treatment Response
PID-002,Glioblastoma,67,NCT06926075,Early Phase Study of Kesonotide in Participants With Solid Tumours
PID-002,Glioblastoma,67,NCT01378481,High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma
PID-002,Glioblastoma,67,NCT01148966,Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
PID-002,Glioblastoma,67,NCT01975116,p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
PID-002,Glioblastoma,67,NCT00268385,Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
PID-002,Glioblastoma,67,NCT02142803,TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
PID-002,Glioblastoma,67,NCT01383135,Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
PID-002,Glioblastoma,67,NCT04573140,A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
PID-002,Glioblastoma,67,NCT01269411,RO4929097 in Treating Patients With Recurrent Invasive Gliomas
PID-002,Glioblastoma,67,NCT06640582,TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
PID-002,Glioblastoma,67,NCT03389230,Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
PID-002,Glioblastoma,67,NCT07042620,A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
PID-002,Glioblastoma,67,NCT06041555,MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
PID-002,Glioblastoma,67,NCT04740190,Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd
PID-002,Glioblastoma,67,NCT05231655,Ex VIvo DEtermiNed Cancer Therapy
PID-002,Glioblastoma,67,NCT00499473,Sunitinib in Treating Patients With Recurrent Malignant Gliomas
PID-002,Glioblastoma,67,NCT02502708,"Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors"
PID-002,Glioblastoma,67,NCT06896110,Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
PID-002,Glioblastoma,67,NCT01817751,"Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma"
PID-002,Glioblastoma,67,NCT06047379,"Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis"
PID-002,Glioblastoma,67,NCT00095940,Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
PID-002,Glioblastoma,67,NCT03749187,BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
PID-002,Glioblastoma,67,NCT06625047,Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
PID-002,Glioblastoma,67,NCT01291420,Dendritic Cell Vaccination for Patients with Solid Tumors
PID-002,Glioblastoma,67,NCT05737212,"Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas"
PID-002,Glioblastoma,67,NCT03072134,Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
PID-002,Glioblastoma,67,NCT00100802,"Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas"
PID-002,Glioblastoma,67,NCT02208362,Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
PID-002,Glioblastoma,67,NCT01977677,Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
PID-002,Glioblastoma,67,NCT05370079,Control Cohort CTRL COH
PID-002,Glioblastoma,67,NCT00042991,Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
PID-002,Glioblastoma,67,NCT02800486,"Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA"
PID-002,Glioblastoma,67,NCT04978727,"A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma"
PID-002,Glioblastoma,67,NCT04678648,A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
PID-002,Glioblastoma,67,NCT01353625,"Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies."
PID-002,Glioblastoma,67,NCT03152318,A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PID-002,Glioblastoma,67,NCT06815029,Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
PID-002,Glioblastoma,67,NCT01103375,Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT01051557,Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-002,Glioblastoma,67,NCT02974738,"A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)"
PID-002,Glioblastoma,67,NCT03896568,MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT03739372,Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
PID-002,Glioblastoma,67,NCT06439420,CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
PID-002,Glioblastoma,67,NCT01598597,"An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)"
PID-002,Glioblastoma,67,NCT02465528,Ceritinib Rare Indications Study in ALK+ Tumors
PID-002,Glioblastoma,67,NCT04388033,Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
PID-002,Glioblastoma,67,NCT01723020,A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
PID-002,Glioblastoma,67,NCT00879437,"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma"
PID-002,Glioblastoma,67,NCT03973918,Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
PID-002,Glioblastoma,67,NCT03389802,Phase I Study of APX005M in Pediatric Central Nervous System Tumors
PID-002,Glioblastoma,67,NCT01849952,Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
PID-002,Glioblastoma,67,NCT00045708,A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
PID-002,Glioblastoma,67,NCT04135807,Implantable Microdevice In Primary Brain Tumors
PID-002,Glioblastoma,67,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-002,Glioblastoma,67,NCT02798406,Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
PID-002,Glioblastoma,67,NCT05956821,Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
PID-002,Glioblastoma,67,NCT04044937,Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
PID-002,Glioblastoma,67,NCT01082926,"Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2"
PID-002,Glioblastoma,67,NCT03919071,Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
PID-002,Glioblastoma,67,NCT03893487,Fimepinostat in Treating Brain Tumors in Children and Young Adults
PID-002,Glioblastoma,67,NCT03212274,"Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations"
PID-002,Glioblastoma,67,NCT02372409,Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
PID-002,Glioblastoma,67,NCT05330559,"Fluorescence, Light-microscopy, Ultrasound Integrated / Intraoperative Diagnosis to MAXimise Resection"
PID-002,Glioblastoma,67,NCT06690216,Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
PID-002,Glioblastoma,67,NCT02365662,A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
PID-002,Glioblastoma,67,NCT04970615,Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models
PID-002,Glioblastoma,67,NCT00045110,Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
PID-002,Glioblastoma,67,NCT03734913,A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
PID-002,Glioblastoma,67,NCT01234740,Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
PID-002,Glioblastoma,67,NCT02101905,Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT02457845,HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
PID-002,Glioblastoma,67,NCT02444546,Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
PID-002,Glioblastoma,67,NCT02644291,Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
PID-002,Glioblastoma,67,NCT01579253,Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
PID-002,Glioblastoma,67,NCT01884740,Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
PID-002,Glioblastoma,67,NCT01904123,STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain
PID-002,Glioblastoma,67,NCT03684811,A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
PID-002,Glioblastoma,67,NCT01922076,Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
PID-002,Glioblastoma,67,NCT00959946,Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer
PID-002,Glioblastoma,67,NCT03244995,Mind-Body Intervention in Glioma Couples
PID-002,Glioblastoma,67,NCT02498665,A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
PID-002,Glioblastoma,67,NCT03958240,Deciphering Mechanisms Underlying Cancer Immunogenicity
PID-002,Glioblastoma,67,NCT02323880,Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
PID-002,Glioblastoma,67,NCT00369590,VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
PID-002,Glioblastoma,67,NCT00093613,Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-002,Glioblastoma,67,NCT00085540,FR901228 in Treating Patients With Recurrent High-Grade Gliomas
PID-002,Glioblastoma,67,NCT06804655,Pharmacoscopy for Patients with Refractory Primary Brain Tumors
PID-002,Glioblastoma,67,NCT02709889,Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
PID-002,Glioblastoma,67,NCT01421524,"Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma"
PID-002,Glioblastoma,67,NCT01445691,More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
PID-002,Glioblastoma,67,NCT01837862,A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
PID-002,Glioblastoma,67,NCT02038699,A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer
PID-002,Glioblastoma,67,NCT02327078,"A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)"
PID-002,Glioblastoma,67,NCT00112736,Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT06717295,The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
PID-002,Glioblastoma,67,NCT06521567,A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
PID-002,Glioblastoma,67,NCT05538572,A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
PID-002,Glioblastoma,67,NCT05139056,Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
PID-002,Glioblastoma,67,NCT00679354,Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
PID-002,Glioblastoma,67,NCT06469138,A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
PID-002,Glioblastoma,67,NCT02192359,Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-002,Glioblastoma,67,NCT01172964,A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
PID-002,Glioblastoma,67,NCT00430079,Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
PID-002,Glioblastoma,67,NCT03797326,Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
PID-002,Glioblastoma,67,NCT01177397,"Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma"
PID-002,Glioblastoma,67,NCT05835687,Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
PID-002,Glioblastoma,67,NCT04427384,Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
PID-002,Glioblastoma,67,NCT03355794,A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
PID-002,Glioblastoma,67,NCT01339039,Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
PID-002,Glioblastoma,67,NCT04732065,"ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors"
PID-002,Glioblastoma,67,NCT01392209,Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
PID-002,Glioblastoma,67,NCT02186509,Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
PID-002,Glioblastoma,67,NCT06814496,Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
PID-002,Glioblastoma,67,NCT01576666,"Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors"
PID-002,Glioblastoma,67,NCT02966509,Engagement of Patients With Advanced Cancer
PID-002,Glioblastoma,67,NCT03243461,International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
PID-002,Glioblastoma,67,NCT01165632,Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
PID-002,Glioblastoma,67,NCT03043391,Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
PID-002,Glioblastoma,67,NCT02684058,Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
PID-002,Glioblastoma,67,NCT06645808,PET-imaging of Two Vartumabs in Patients With Solid Tumors
PID-002,Glioblastoma,67,NCT02255461,"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors"
PID-002,Glioblastoma,67,NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PID-002,Glioblastoma,67,NCT04541082,Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
PID-002,Glioblastoma,67,NCT02374255,Improving Goals of Care Discussion in Advanced Cancer Patients
PID-002,Glioblastoma,67,NCT02611024,Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
PID-002,Glioblastoma,67,NCT01392352,HYPAZ: Hypertension Induced by Pazopanib
PID-002,Glioblastoma,67,NCT04541225,Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
PID-002,Glioblastoma,67,NCT02223052,Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
PID-002,Glioblastoma,67,NCT02175745,18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
PID-002,Glioblastoma,67,NCT02335918,A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
PID-002,Glioblastoma,67,NCT05934630,"Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors"
PID-002,Glioblastoma,67,NCT01234805,Yoga Therapy in Treating Patients With Malignant Brain Tumors
PID-002,Glioblastoma,67,NCT01929720,"Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors"
PID-002,Glioblastoma,67,NCT03787056,Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
PID-002,Glioblastoma,67,NCT04913337,Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
PID-002,Glioblastoma,67,NCT05563272,89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
PID-002,Glioblastoma,67,NCT01631552,Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
PID-002,Glioblastoma,67,NCT05974410,Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
PID-002,Glioblastoma,67,NCT04604158,Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
PID-002,Glioblastoma,67,NCT02967380,"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases"
PID-002,Glioblastoma,67,NCT03911388,HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
PID-002,Glioblastoma,67,NCT05131815,The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
PID-002,Glioblastoma,67,NCT00110032,Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
PID-002,Glioblastoma,67,NCT03975829,Pediatric Long-Term Follow-up and Rollover Study
PID-002,Glioblastoma,67,NCT01119599,"RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma"
PID-002,Glioblastoma,67,NCT04566393,Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies
PID-002,Glioblastoma,67,NCT02194452,Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
PID-002,Glioblastoma,67,NCT03434262,SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
PID-002,Glioblastoma,67,NCT03896958,The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
PID-002,Glioblastoma,67,NCT01522820,Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
PID-002,Glioblastoma,67,NCT01131234,Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
PID-002,Glioblastoma,67,NCT03452774,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
PID-002,Glioblastoma,67,NCT01806675,18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
PID-002,Glioblastoma,67,NCT05969860,At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
PID-002,Glioblastoma,67,NCT04028479,The Registry of Oncology Outcomes Associated with Testing and Treatment
PID-002,Glioblastoma,67,NCT00030498,Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
PID-002,Glioblastoma,67,NCT03154190,Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
PID-003,Glioblastoma,36,NCT01102595,Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
PID-003,Glioblastoma,36,NCT03903419,Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
PID-003,Glioblastoma,36,NCT06650605,Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma
PID-003,Glioblastoma,36,NCT05399524,Functional and Ultrasound Guided Resection of Glioblastoma
PID-003,Glioblastoma,36,NCT03990285,[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
PID-003,Glioblastoma,36,NCT00936052,Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01252459,Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03879512,"Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG"
PID-003,Glioblastoma,36,NCT04606316,Surgical Nivolumab And Ipilimumab For Recurrent GBM
PID-003,Glioblastoma,36,NCT01700569,Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
PID-003,Glioblastoma,36,NCT06348693,Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
PID-003,Glioblastoma,36,NCT06869577,A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
PID-003,Glioblastoma,36,NCT05086497,WBSI Guided Personalized Delivery of TTFields
PID-003,Glioblastoma,36,NCT01833273,Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA
PID-003,Glioblastoma,36,NCT05896449,Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
PID-003,Glioblastoma,36,NCT03291314,Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03363659,Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02795364,Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
PID-003,Glioblastoma,36,NCT02772094,Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
PID-003,Glioblastoma,36,NCT04874506,MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT05958485,A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
PID-003,Glioblastoma,36,NCT06939400,Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
PID-003,Glioblastoma,36,NCT02945826,uPAR-PET/MRI in Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04869449,Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
PID-003,Glioblastoma,36,NCT04588454,18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT06271421,NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT06595186,JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT05423210,Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05120284,Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT05589961,Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT06404034,Expanded Access to Gallium Maltolate (GaM)
PID-003,Glioblastoma,36,NCT06466031,Application of MET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05281731,Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
PID-003,Glioblastoma,36,NCT03861598,Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
PID-003,Glioblastoma,36,NCT06451042,FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)
PID-003,Glioblastoma,36,NCT05908669,Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05500612,MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
PID-003,Glioblastoma,36,NCT00337883,A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
PID-003,Glioblastoma,36,NCT04277221,ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT01181193,Vitamin D for Treatment of Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04825275,Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: a Phase 0 Clinical Trial
PID-003,Glioblastoma,36,NCT04752813,A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
PID-003,Glioblastoma,36,NCT05353530,IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
PID-003,Glioblastoma,36,NCT05608395,11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
PID-003,Glioblastoma,36,NCT03075514,Ketogenic Diets as an Adjuvant Therapy in Glioblastoma
PID-003,Glioblastoma,36,NCT06781372,Patient's Derived Organoids for Drug Screening in Glioblastoma
PID-003,Glioblastoma,36,NCT01280552,A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT06533163,Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
PID-003,Glioblastoma,36,NCT04900792,A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
PID-003,Glioblastoma,36,NCT02864368,Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
PID-003,Glioblastoma,36,NCT01268566,A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01301430,Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
PID-003,Glioblastoma,36,NCT01865162,Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
PID-003,Glioblastoma,36,NCT01873469,Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03506139,Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02769806,Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
PID-003,Glioblastoma,36,NCT00730262,Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03344250,Phase I EGFR BATs in Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01317212,Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00190424,Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
PID-003,Glioblastoma,36,NCT03980249,Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
PID-003,Glioblastoma,36,NCT04587830,ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03707457,Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
PID-003,Glioblastoma,36,NCT01269424,BG & TMZ Therapy of Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00990496,A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT00515086,Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT03310372,Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02285959,Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04450160,Trial of AEO in New Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT03291990,5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02997423,Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT02177578,Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00209989,Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05565326,Response Assessment During MR-guided Radiation Therapy for Glioblastoma
PID-003,Glioblastoma,36,NCT05769660,A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT00323115,Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02858895,Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT02853565,A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00768911,CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02344355,A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01349660,Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00376103,Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02619864,mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02283944,TMS Electrochemotherapy for Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05402241,IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study
PID-003,Glioblastoma,36,NCT02586857,"A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)"
PID-003,Glioblastoma,36,NCT02685605,Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00544817,Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00535379,"SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT00892931,Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02296580,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT00677716,Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
PID-003,Glioblastoma,36,NCT00394628,AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00224978,Chloroquine for Treatment of Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02120287,Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01006044,Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection
PID-003,Glioblastoma,36,NCT01209442,Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02507102,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
PID-003,Glioblastoma,36,NCT01800695,Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00615186,Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy
PID-003,Glioblastoma,36,NCT07120620,PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01564914,A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT05917821,New Antigens Against Glioblastoma
PID-003,Glioblastoma,36,NCT01435395,"Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT00817284,Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT00800917,A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00083512,Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03714334,DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01285414,"Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT02844062,Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02331498,Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03347097,Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04019002,Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT00635557,Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02937844,Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04610229,Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.
PID-003,Glioblastoma,36,NCT06687681,Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
PID-003,Glioblastoma,36,NCT01752491,A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04421378,A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02550249,Neoadjuvant Nivolumab in Glioblastoma
PID-003,Glioblastoma,36,NCT05557292,RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02017249,Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01788280,Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab
PID-003,Glioblastoma,36,NCT01588769,A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients
PID-003,Glioblastoma,36,NCT01290692,Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
PID-003,Glioblastoma,36,NCT05798507,Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT02296476,A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)
PID-003,Glioblastoma,36,NCT00650949,Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
PID-003,Glioblastoma,36,NCT06346821,Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data
PID-003,Glioblastoma,36,NCT00311857,"Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)"
PID-003,Glioblastoma,36,NCT05410301,"Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma"
PID-003,Glioblastoma,36,NCT00704288,Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00083447,Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00589095,Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
PID-003,Glioblastoma,36,NCT01508117,Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
PID-003,Glioblastoma,36,NCT00792012,A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00267592,Safety and Efficacy of Talampanel in Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00590681,Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01115491,A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04801147,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00050986,Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04845919,Sonodynamic Therapy with ExAblate System in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT07052877,The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
PID-003,Glioblastoma,36,NCT07162324,"A Multicenter, Prospective Study for Glioblastoma Patients"
PID-003,Glioblastoma,36,NCT02189109,The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma
PID-003,Glioblastoma,36,NCT01663012,Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
PID-003,Glioblastoma,36,NCT05463848,Surgical Pembro +/- Olaparib w TMZ for rGBM
PID-003,Glioblastoma,36,NCT05551013,Treatment of Recurrent GBM With APG-157 Via Expanded Access
PID-003,Glioblastoma,36,NCT01604590,Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01071837,APG101 in Glioblastoma
PID-003,Glioblastoma,36,NCT06657027,Artificial Intelligence-Guided Radiotherapy Planning for Glioblastoma
PID-003,Glioblastoma,36,NCT04590664,Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
PID-003,Glioblastoma,36,NCT07119294,Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
PID-003,Glioblastoma,36,NCT06090903,Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
PID-003,Glioblastoma,36,NCT04790097,FET-PET Directed Simultaneous In-field Boost for Primary GBM
PID-003,Glioblastoma,36,NCT05190315,Chlorpromazine and Standard of Care in Glioblastoma
PID-003,Glioblastoma,36,NCT04530006,Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT06353360,TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
PID-003,Glioblastoma,36,NCT00038493,Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT07093814,A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT05970757,Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
PID-003,Glioblastoma,36,NCT07121842,Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI
PID-003,Glioblastoma,36,NCT04002804,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03866109,A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMT
PID-003,Glioblastoma,36,NCT06176066,PH Sensitive MRI Based Resections of Glioblastoma
PID-003,Glioblastoma,36,NCT02104882,INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
PID-003,Glioblastoma,36,NCT03582514,PreOperative Brain Irradiation in Glioblastoma
PID-003,Glioblastoma,36,NCT06001281,Predictive Value of Soluble CD146 in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT02029573,Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
PID-003,Glioblastoma,36,NCT01091792,Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT01450449,Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05728125,Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients
PID-003,Glioblastoma,36,NCT00984438,Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05222802,A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
PID-003,Glioblastoma,36,NCT05432375,Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
PID-003,Glioblastoma,36,NCT00797940,Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
PID-003,Glioblastoma,36,NCT01526837,Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
PID-003,Glioblastoma,36,NCT04810182,Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
PID-003,Glioblastoma,36,NCT04614909,Study of Pamiparib in Newly Diagnosed and rGBM
PID-003,Glioblastoma,36,NCT04373785,NG101m Adjuvant Therapy in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT01587144,Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
PID-003,Glioblastoma,36,NCT00076986,The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT06764537,Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma
PID-003,Glioblastoma,36,NCT01260506,Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT06749925,Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma
PID-003,Glioblastoma,36,NCT04765098,Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
PID-003,Glioblastoma,36,NCT04118036,Abemaciclib + Pembrolizumab In Glioblastoma
PID-003,Glioblastoma,36,NCT04814329,Glioblastoma Response Prediction to Apatinib
PID-003,Glioblastoma,36,NCT02047214,Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
PID-003,Glioblastoma,36,NCT03849105,131I-IPA and Concurrent XRT in Recurrent GBM
PID-003,Glioblastoma,36,NCT00116376,Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT02410577,89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03212235,Hypofractionated Radiation Therapy for Glioblastoma
PID-003,Glioblastoma,36,NCT07173829,A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
PID-003,Glioblastoma,36,NCT06336291,A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
PID-003,Glioblastoma,36,NCT05512195,Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma
PID-003,Glioblastoma,36,NCT04406272,VB-111 in Surgically Accessible Recurrent/Progressive GBM
PID-003,Glioblastoma,36,NCT05653635,Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
PID-003,Glioblastoma,36,NCT00093964,Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
PID-003,Glioblastoma,36,NCT01402063,PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
PID-003,Glioblastoma,36,NCT06061809,N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT06038604,Glioblastoma Psychosocial Support Program
PID-003,Glioblastoma,36,NCT04492163,Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
PID-003,Glioblastoma,36,NCT02378532,The Addition of Chloroquine to Chemoradiation for Glioblastoma
PID-003,Glioblastoma,36,NCT05708352,A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
PID-003,Glioblastoma,36,NCT01618747,An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse
PID-003,Glioblastoma,36,NCT07141732,Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy
PID-003,Glioblastoma,36,NCT06672575,A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02926222,Regorafenib in Relapsed Glioblastoma
PID-003,Glioblastoma,36,NCT06132438,Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
PID-003,Glioblastoma,36,NCT02751138,Determination of Immune Phenotype in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT00238797,"A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT02928575,"Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma"
PID-003,Glioblastoma,36,NCT05927610,Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
PID-003,Glioblastoma,36,NCT05366179,Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
PID-003,Glioblastoma,36,NCT05641220,Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.
PID-003,Glioblastoma,36,NCT05083754,Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
PID-003,Glioblastoma,36,NCT04977375,Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01933815,Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
PID-003,Glioblastoma,36,NCT04116411,A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT05700955,Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06490497,Expectations and Needs of a Glioblastoma Caregiver
PID-003,Glioblastoma,36,NCT04747145,Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma
PID-003,Glioblastoma,36,NCT06222138,Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00345163,A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
PID-003,Glioblastoma,36,NCT05635734,Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00916409,Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT01778530,TRC105 for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06625684,Key Longitudinal Associations With Risk and Glioblastoma Outcomes
PID-003,Glioblastoma,36,NCT07145112,Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00904852,Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT06512311,Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
PID-003,Glioblastoma,36,NCT05756985,Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
PID-003,Glioblastoma,36,NCT04552977,A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06613841,"Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma"
PID-003,Glioblastoma,36,NCT04772846,Chloroquine for Glioblastoma.
PID-003,Glioblastoma,36,NCT00684567,Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
PID-003,Glioblastoma,36,NCT01259869,A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression
PID-003,Glioblastoma,36,NCT03276286,Nativis Voyager for Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT02176720,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-003,Glioblastoma,36,NCT05781321,"Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study"
PID-003,Glioblastoma,36,NCT06845020,CSF Proteomic Characterization of Glioblastomas
PID-003,Glioblastoma,36,NCT02049489,A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02067156,"Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma"
PID-003,Glioblastoma,36,NCT03712293,ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
PID-003,Glioblastoma,36,NCT01849146,"Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma"
PID-003,Glioblastoma,36,NCT01089868,Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
PID-003,Glioblastoma,36,NCT05986851,Azeliragon in MGMT Unmethylated Glioblastoma
PID-003,Glioblastoma,36,NCT04657146,Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT05669820,Antisecretory Factor Glioblastoma Phase 2
PID-003,Glioblastoma,36,NCT04417933,Tumor Electric Fields Treatment System for Glioblastoma
PID-003,Glioblastoma,36,NCT06780592,Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
PID-003,Glioblastoma,36,NCT03048240,INtraoperative photoDYnamic Therapy of GliOblastoma
PID-003,Glioblastoma,36,NCT05015543,Physical Training in Glioblastoma Patients During Cytotoxic Therapy
PID-003,Glioblastoma,36,NCT05109728,A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
PID-003,Glioblastoma,36,NCT06218524,The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM
PID-003,Glioblastoma,36,NCT04671459,TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine
PID-003,Glioblastoma,36,NCT05556382,Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity
PID-003,Glioblastoma,36,NCT06448286,PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT05186064,Glioblastoma Targeted Treatment Option Maximization by WGS
PID-003,Glioblastoma,36,NCT06556563,EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT05515133,Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients
PID-003,Glioblastoma,36,NCT04319276,Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
PID-003,Glioblastoma,36,NCT02977780,INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
PID-003,Glioblastoma,36,NCT06831526,Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00805961,"RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM"
PID-003,Glioblastoma,36,NCT04656535,AB154 Combined With AB122 for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04391062,Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma
PID-003,Glioblastoma,36,NCT01290263,Amgen 386 for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04752280,Glioblastoma Radiotherapy Using IMRT or Proton Beams
PID-003,Glioblastoma,36,NCT06183983,Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
PID-003,Glioblastoma,36,NCT01851733,MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01493219,Biomarkers for Prognosis of Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT06524063,Targeted Survivin DC Cell Injection for the Treatment of GBM
PID-003,Glioblastoma,36,NCT03862430,A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT02815410,Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
PID-003,Glioblastoma,36,NCT05735171,Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence
PID-003,Glioblastoma,36,NCT03661723,Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06113705,Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
PID-003,Glioblastoma,36,NCT01468324,AZD7451 for Recurrent Gliomas
PID-003,Glioblastoma,36,NCT03419403,UNITE Study: Understanding New Interventions With GBM ThErapy
PID-003,Glioblastoma,36,NCT05938387,Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
PID-003,Glioblastoma,36,NCT03403803,Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
PID-003,Glioblastoma,36,NCT00892177,Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05539339,Personalized Trial in ctDNA-level-relapse Glioblastoma
PID-003,Glioblastoma,36,NCT04856852,Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT07144735,Allogeneic γδT Cells in Glioblastoma
PID-003,Glioblastoma,36,NCT00402116,Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
PID-003,Glioblastoma,36,NCT05664464,Glutamate Inhibitors in Glioblastoma
PID-003,Glioblastoma,36,NCT03687099,Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma
PID-003,Glioblastoma,36,NCT04443010,Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT04243005,Supramarginal Resection in Glioblastoma
PID-003,Glioblastoma,36,NCT00456612,Radiosurgery for Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05656300,Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?
PID-003,Glioblastoma,36,NCT04730869,Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
PID-003,Glioblastoma,36,NCT04959500,Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT05768087,Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients
PID-003,Glioblastoma,36,NCT06600399,Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma
PID-003,Glioblastoma,36,NCT04583020,Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT05303467,A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
PID-003,Glioblastoma,36,NCT04359745,Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression
PID-003,Glioblastoma,36,NCT05541042,Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
PID-003,Glioblastoma,36,NCT04599647,EAP for the Treatment of Glioblastoma With PVSRIPO
PID-003,Glioblastoma,36,NCT06297512,Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
PID-003,Glioblastoma,36,NCT06140875,Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
PID-003,Glioblastoma,36,NCT00704808,Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
PID-003,Glioblastoma,36,NCT00508456,Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
PID-003,Glioblastoma,36,NCT03139916,Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01345370,Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT05074992,A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02546102,"Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma"
PID-003,Glioblastoma,36,NCT05871021,Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
PID-003,Glioblastoma,36,NCT02850744,"Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients"
PID-003,Glioblastoma,36,NCT03194971,NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
PID-003,Glioblastoma,36,NCT03151772,Bioavailability of Disulfiram and Metformin in Glioblastomas
PID-003,Glioblastoma,36,NCT05753007,"A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients"
PID-003,Glioblastoma,36,NCT02709616,Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
PID-003,Glioblastoma,36,NCT07047066,A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02808364,Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)
PID-003,Glioblastoma,36,NCT04536649,Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.
PID-003,Glioblastoma,36,NCT05140902,Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
PID-003,Glioblastoma,36,NCT02286167,Glioma Modified Atkins-based Diet in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT00171938,Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
PID-003,Glioblastoma,36,NCT02715609,Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT05241392,Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00115453,Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
PID-003,Glioblastoma,36,NCT01907165,Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
PID-003,Glioblastoma,36,NCT02092038,Preoperative Chemoradiation for Glioblastoma
PID-003,Glioblastoma,36,NCT02780024,"Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM"
PID-003,Glioblastoma,36,NCT06146738,The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
PID-003,Glioblastoma,36,NCT04863950,Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06924099,TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
PID-003,Glioblastoma,36,NCT02880410,Feasibility Study on LITT for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02394626,Surgery for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06551909,Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
PID-003,Glioblastoma,36,NCT05183204,"Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma"
PID-003,Glioblastoma,36,NCT04716699,Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma
PID-003,Glioblastoma,36,NCT03390569,Exercise in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT04596930,MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma
PID-003,Glioblastoma,36,NCT05811793,Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
PID-003,Glioblastoma,36,NCT04250922,LAM561 With RT and TMZ for Adults With Glioblastoma
PID-003,Glioblastoma,36,NCT01109095,CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
PID-003,Glioblastoma,36,NCT04221061,18F-FluorThanatrace (PET/CT) in Glioblastoma
PID-003,Glioblastoma,36,NCT04922723,Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
PID-003,Glioblastoma,36,NCT06102525,"A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma"
PID-003,Glioblastoma,36,NCT03780569,TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT03055208,Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT03119064,BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01666600,NOA-12: BIBF1120 and R-RT in Glioblastoma
PID-003,Glioblastoma,36,NCT04280848,Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
PID-003,Glioblastoma,36,NCT03395587,Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT03293888,Spectral Analysis Probe to Identify Glioblastoma Cells
PID-003,Glioblastoma,36,NCT03529448,TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT04829097,Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma
PID-003,Glioblastoma,36,NCT04765514,Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients
PID-003,Glioblastoma,36,NCT05793021,FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
PID-003,Glioblastoma,36,NCT01562197,A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04708171,The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
PID-003,Glioblastoma,36,NCT00104091,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-003,Glioblastoma,36,NCT04691960,A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
PID-003,Glioblastoma,36,NCT01474239,A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04516733,Precoce Medical Care by the Mobil Support for Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT04826393,ASP8374 + Cemiplimab in Recurrent Glioma
PID-003,Glioblastoma,36,NCT03739333,Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.
PID-003,Glioblastoma,36,NCT05502991,Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma
PID-003,Glioblastoma,36,NCT02157103,A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT04284306,Immunohistochemical Assessment of Programmed Death ligand1 and LC3B in GBM
PID-003,Glioblastoma,36,NCT04157478,Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01478854,Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
PID-003,Glioblastoma,36,NCT03243851,Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
PID-003,Glioblastoma,36,NCT04629209,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma"
PID-003,Glioblastoma,36,NCT03743662,Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
PID-003,Glioblastoma,36,NCT02206230,Trial of Hypofractionated Radiation Therapy for Glioblastoma
PID-003,Glioblastoma,36,NCT00686725,Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
PID-003,Glioblastoma,36,NCT04881032,AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT06105619,A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
PID-003,Glioblastoma,36,NCT00262730,Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT02379572,Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
PID-003,Glioblastoma,36,NCT05304663,Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression
PID-003,Glioblastoma,36,NCT02663440,Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01777919,Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
PID-003,Glioblastoma,36,NCT02062372,Spatial Analysis and Validation of Glioblastoma on 7 T MRI
PID-003,Glioblastoma,36,NCT04219475,Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients
PID-003,Glioblastoma,36,NCT05698199,"Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)"
PID-003,Glioblastoma,36,NCT01898273,Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02202993,TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM
PID-003,Glioblastoma,36,NCT01622764,89Zr-RO5323441 PET Imaging in Glioblastoma
PID-003,Glioblastoma,36,NCT04963413,RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.
PID-003,Glioblastoma,36,NCT03491683,INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT02841332,Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00068952,Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01169415,Effects of Steroid Tapering on Functional Capacity and Neurocognition
PID-003,Glioblastoma,36,NCT05333588,The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.
PID-003,Glioblastoma,36,NCT04225039,"Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma"
PID-003,Glioblastoma,36,NCT04552886,Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma
PID-003,Glioblastoma,36,NCT02394665,Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
PID-003,Glioblastoma,36,NCT03995706,Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
PID-003,Glioblastoma,36,NCT03663725,Treatment Intensification With Temozolomide in Adults With a Glioblastoma
PID-003,Glioblastoma,36,NCT04642937,Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03493932,Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
PID-003,Glioblastoma,36,NCT02617745,Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
PID-003,Glioblastoma,36,NCT02715297,Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04471844,"Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM"
PID-003,Glioblastoma,36,NCT05187624,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma"
PID-003,Glioblastoma,36,NCT04933422,CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
PID-003,Glioblastoma,36,NCT03374943,A Trial of KB004 in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT01225510,A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06477939,Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients
PID-003,Glioblastoma,36,NCT04119674,Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT03231501,HMPL-813 in Treating Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT04574856,Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT03770468,"Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma"
PID-003,Glioblastoma,36,NCT04547855,Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
PID-003,Glioblastoma,36,NCT02146066,Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
PID-003,Glioblastoma,36,NCT02336165,Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT07076472,Sonodynamic Therapy With SONALA-001 and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02441322,Evaluating Therapeutic Response to Novo-TTF
PID-003,Glioblastoma,36,NCT04324840,A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01403285,Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT06740955,Hypofractionated Radiotherapy
PID-003,Glioblastoma,36,NCT04019262,Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT04015700,"Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-003,Glioblastoma,36,NCT01473901,A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT06676891,Expanded Access Program for GBM Subjects
PID-003,Glioblastoma,36,NCT03587038,OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02725684,Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
PID-003,Glioblastoma,36,NCT04846257,Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence
PID-003,Glioblastoma,36,NCT03246113,Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
PID-003,Glioblastoma,36,NCT01308632,Metronomic Temozolamide in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01308684,A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01782976,Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT01846871,Tivozanib for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02893137,Enhancing Optune Therapy With Targeted Craniectomy
PID-003,Glioblastoma,36,NCT03926507,F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
PID-003,Glioblastoma,36,NCT04573192,A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
PID-003,Glioblastoma,36,NCT06936046,Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression
PID-003,Glioblastoma,36,NCT02904525,Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model
PID-003,Glioblastoma,36,NCT03567135,Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma
PID-003,Glioblastoma,36,NCT03297125,Assessment of Optune Therapy for Patients with Newly Diagnosed Glioblastoma Using Advanced MRI
PID-003,Glioblastoma,36,NCT02910804,IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT01189513,SCH-900105 in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04485949,A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT00397072,Epothilone in Recurrent Glioblastoma Patients
PID-003,Glioblastoma,36,NCT00821080,Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02511405,"A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)"
PID-003,Glioblastoma,36,NCT02981940,A Study of Abemaciclib in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02630030,Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT03347617,Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT06054529,Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
PID-003,Glioblastoma,36,NCT04121455,Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
PID-003,Glioblastoma,36,NCT02254954,"Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma"
PID-003,Glioblastoma,36,NCT04047706,"Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma"
PID-003,Glioblastoma,36,NCT06973096,CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PID-003,Glioblastoma,36,NCT03388372,Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma
PID-003,Glioblastoma,36,NCT02149225,GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
PID-003,Glioblastoma,36,NCT02478164,Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
PID-003,Glioblastoma,36,NCT03679754,"Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102"
PID-003,Glioblastoma,36,NCT04006119,Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT03687034,A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT03477110,"Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma"
PID-003,Glioblastoma,36,NCT03922984,Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma
PID-003,Glioblastoma,36,NCT04762069,A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05864976,Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
PID-003,Glioblastoma,36,NCT01756352,FET-PET for Evaluation of Response of Recurrent GBM to Avastin
PID-003,Glioblastoma,36,NCT01112527,PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03548571,Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
PID-003,Glioblastoma,36,NCT01939574,A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
PID-003,Glioblastoma,36,NCT03897491,PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
PID-003,Glioblastoma,36,NCT03152708,CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT04224441,Repurposing Chlorpromazine in the Treatment of Glioblastoma
PID-003,Glioblastoma,36,NCT03535350,Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02669173,Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02902757,FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT02728349,Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma
PID-003,Glioblastoma,36,NCT02770378,A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01043536,Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
PID-003,Glioblastoma,36,NCT05376800,A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma
PID-003,Glioblastoma,36,NCT03481231,In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT02330991,A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
PID-003,Glioblastoma,36,NCT02329795,Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
PID-003,Glioblastoma,36,NCT07029100,Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.
PID-003,Glioblastoma,36,NCT04717739,"TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study"
PID-003,Glioblastoma,36,NCT01923922,CT Perfusion in the Prognostication of Cerebral High Grade Glioma
PID-003,Glioblastoma,36,NCT04007185,Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)
PID-003,Glioblastoma,36,NCT03233152,Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03636477,A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
PID-003,Glioblastoma,36,NCT04566185,Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02590497,Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
PID-003,Glioblastoma,36,NCT00509821,"Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma"
PID-003,Glioblastoma,36,NCT03439332,Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma
PID-003,Glioblastoma,36,NCT02876003,Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma
PID-003,Glioblastoma,36,NCT03223103,Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
PID-003,Glioblastoma,36,NCT05108012,Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
PID-003,Glioblastoma,36,NCT00694837,Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
PID-003,Glioblastoma,36,NCT02799238,Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT02342379,TH-302 in Combination With Bevacizumab for Glioblastoma
PID-003,Glioblastoma,36,NCT01443676,Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT05328089,Vacuolar ATPase and Drug Resistance of High Grade Gliomas
PID-003,Glioblastoma,36,NCT00943007,Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors
PID-003,Glioblastoma,36,NCT01499251,Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05664243,"A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma"
PID-003,Glioblastoma,36,NCT03383978,Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
PID-003,Glioblastoma,36,NCT01989884,An Efficacy Study Of Ortataxel In Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05900908,Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy
PID-003,Glioblastoma,36,NCT01811121,MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS
PID-003,Glioblastoma,36,NCT02654964,Cancer Stem Cell High-Throughput Drug Screening Study
PID-003,Glioblastoma,36,NCT01854099,Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens
PID-003,Glioblastoma,36,NCT03393000,Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
PID-003,Glioblastoma,36,NCT03422094,"Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-003,Glioblastoma,36,NCT03631836,"Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma"
PID-003,Glioblastoma,36,NCT03287063,"Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma"
PID-003,Glioblastoma,36,NCT00643825,"Prolonged Adjuvant Temozolomide vs ""Stop & Go"" in Glioblastoma Patients"
PID-003,Glioblastoma,36,NCT01872221,Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study
PID-003,Glioblastoma,36,NCT01260467,Memantine for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01213407,Dendritic Cell Cancer Vaccine for High-grade Glioma
PID-003,Glioblastoma,36,NCT05590689,Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
PID-003,Glioblastoma,36,NCT05342883,GammaTile and Stupp in Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT01867593,MET-PET for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02060955,Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan
PID-003,Glioblastoma,36,NCT00029783,Efficacy of Distant Healing in Glioblastoma Treatment
PID-003,Glioblastoma,36,NCT02359097,Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT03776071,"A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1"
PID-003,Glioblastoma,36,NCT05753995,"Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study"
PID-003,Glioblastoma,36,NCT01759810,Proteome-based Personalized Immunotherapy of Glioblastoma
PID-003,Glioblastoma,36,NCT00906893,Evaluation of [18F]-FMISO for Non Operated Glioblastoma
PID-003,Glioblastoma,36,NCT02718443,VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
PID-003,Glioblastoma,36,NCT02430363,Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
PID-003,Glioblastoma,36,NCT02343406,Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
PID-003,Glioblastoma,36,NCT04726397,UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial
PID-003,Glioblastoma,36,NCT01582269,A Study in Recurrent Glioblastoma (GB)
PID-003,Glioblastoma,36,NCT02939378,Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study
PID-003,Glioblastoma,36,NCT05820191,B-amyloid as a Marker for GBM Bioimaging
PID-003,Glioblastoma,36,NCT00807027,Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
PID-003,Glioblastoma,36,NCT03018288,Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT01331291,Bosutinib in Adult Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02704858,Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
PID-003,Glioblastoma,36,NCT01100177,Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients
PID-003,Glioblastoma,36,NCT02014844,Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
PID-003,Glioblastoma,36,NCT05168423,CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
PID-003,Glioblastoma,36,NCT04868396,Patient-derived Glioma Stem Cell Organoids
PID-003,Glioblastoma,36,NCT00944801,Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02866747,A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02869243,A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
PID-003,Glioblastoma,36,NCT00295815,Enzastaurin Versus Lomustine in Glioblastoma
PID-003,Glioblastoma,36,NCT03382977,"Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects"
PID-003,Glioblastoma,36,NCT01310868,Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
PID-003,Glioblastoma,36,NCT00790452,Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
PID-003,Glioblastoma,36,NCT02648633,Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04321694,Expanded Access for KHK2455
PID-003,Glioblastoma,36,NCT01856933,BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT01430351,"Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy"
PID-003,Glioblastoma,36,NCT06954636,Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
PID-003,Glioblastoma,36,NCT00941460,Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01364064,Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00385853,PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
PID-003,Glioblastoma,36,NCT03939858,Bioenergetic Profiling and Cognition in GBM Patients
PID-003,Glioblastoma,36,NCT01507506,Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
PID-003,Glioblastoma,36,NCT00703859,Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT03970447,A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02078648,"Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT00948389,Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT01310855,Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT01985087,A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
PID-003,Glioblastoma,36,NCT02315534,A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
PID-003,Glioblastoma,36,NCT00762255,A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03149003,A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
PID-003,Glioblastoma,36,NCT02209948,Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
PID-003,Glioblastoma,36,NCT02520635,Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients
PID-003,Glioblastoma,36,NCT03961971,Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
PID-003,Glioblastoma,36,NCT01083719,A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
PID-003,Glioblastoma,36,NCT04385173,Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
PID-003,Glioblastoma,36,NCT01044225,Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
PID-003,Glioblastoma,36,NCT01934361,Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00967330,A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT03454295,Easing Psychosocial Burden for Informal Caregivers
PID-003,Glioblastoma,36,NCT01464177,Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00088400,Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors
PID-003,Glioblastoma,36,NCT04528680,Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03642080,MRI Predictors of Response to Tumor Treating Fields
PID-003,Glioblastoma,36,NCT01339052,Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04313842,A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED
PID-003,Glioblastoma,36,NCT00813943,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status"
PID-003,Glioblastoma,36,NCT02968940,Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
PID-003,Glioblastoma,36,NCT04802447,SurVaxM Expanded Access Protocol
PID-003,Glioblastoma,36,NCT01880008,Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT00392548,URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol
PID-003,Glioblastoma,36,NCT02179086,Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT04838782,Role of Repeat Resection in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00689221,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status"
PID-003,Glioblastoma,36,NCT04205357,Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00725010,Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
PID-003,Glioblastoma,36,NCT03726515,CART-EGFRvIII + Pembrolizumab in GBM
PID-003,Glioblastoma,36,NCT01632228,A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00521482,Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05450744,131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)
PID-003,Glioblastoma,36,NCT03538587,Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
PID-003,Glioblastoma,36,NCT01702792,Derivation of Tumor Specific Hybridomas
PID-003,Glioblastoma,36,NCT04077866,B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
PID-003,Glioblastoma,36,NCT06136611,Preoperative Preradiotherapy TTFields
PID-003,Glioblastoma,36,NCT04915404,Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
PID-003,Glioblastoma,36,NCT03477513,Personalized Radiation Therapy for GBM
PID-003,Glioblastoma,36,NCT03452579,Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
PID-003,Glioblastoma,36,NCT05917145,ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT04474353,Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT05768919,Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
PID-003,Glioblastoma,36,NCT00501891,Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT06146725,The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
PID-003,Glioblastoma,36,NCT03008148,Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT05801159,[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT03869242,NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT05053880,A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00943826,A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01860638,A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
PID-003,Glioblastoma,36,NCT04315584,FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
PID-003,Glioblastoma,36,NCT02654041,Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
PID-003,Glioblastoma,36,NCT05326464,Tofacitinib in Recurrent GBM Patients
PID-003,Glioblastoma,36,NCT05296122,Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
PID-003,Glioblastoma,36,NCT06649851,G-CSF After Chemo-radiation in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT03688178,DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
PID-003,Glioblastoma,36,NCT03782415,Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03250299,Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02337491,Pembrolizumab +/- Bevacizumab for Recurrent GBM
PID-003,Glioblastoma,36,NCT01124539,Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
PID-003,Glioblastoma,36,NCT03927222,Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
PID-003,Glioblastoma,36,NCT02287428,Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT02905643,Discerning Pseudoprogression vs True Tumor Growth in GBMs
PID-003,Glioblastoma,36,NCT03197506,Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT06991101,Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT03258021,TTFields In GErmany in Routine Clinical Care
PID-003,Glioblastoma,36,NCT02458508,Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy
PID-003,Glioblastoma,36,NCT00003456,Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05627323,CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT04545177,Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
PID-003,Glioblastoma,36,NCT05759195,Biomolecular Analysis for Predicting Response to Regorafenib
PID-003,Glioblastoma,36,NCT02367482,Tryptophan Metabolism in Human Brain Tumors-Novocure
PID-003,Glioblastoma,36,NCT00481455,Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT00693095,Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer
PID-003,Glioblastoma,36,NCT05236036,Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
PID-003,Glioblastoma,36,NCT00003474,Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03047473,Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01208909,Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)
PID-003,Glioblastoma,36,NCT05063682,The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
PID-003,Glioblastoma,36,NCT05902169,Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
PID-003,Glioblastoma,36,NCT06815432,GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
PID-003,Glioblastoma,36,NCT03616860,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
PID-003,Glioblastoma,36,NCT03603379,Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
PID-003,Glioblastoma,36,NCT04479241,LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02085304,"Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM"
PID-003,Glioblastoma,36,NCT01186406,"Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)"
PID-003,Glioblastoma,36,NCT06917885,CUE-102 in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00977431,Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
PID-003,Glioblastoma,36,NCT00979017,Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03643549,Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
PID-003,Glioblastoma,36,NCT00290771,Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT02899663,MRI Detection of Microbleeds in Glioma Patients
PID-003,Glioblastoma,36,NCT00895180,Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05653622,Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma
PID-003,Glioblastoma,36,NCT04221503,Niraparib/TTFields in GBM
PID-003,Glioblastoma,36,NCT02698280,Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
PID-003,Glioblastoma,36,NCT05685004,Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT02631655,POSitron Emission Imaging Using 18F-FDOPA in Neurooncology
PID-003,Glioblastoma,36,NCT00576537,Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
PID-003,Glioblastoma,36,NCT02585219,Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas
PID-003,Glioblastoma,36,NCT03278249,Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
PID-003,Glioblastoma,36,NCT00687765,Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
PID-003,Glioblastoma,36,NCT00616005,Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
PID-003,Glioblastoma,36,NCT02302235,Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study
PID-003,Glioblastoma,36,NCT04003649,IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
PID-003,Glioblastoma,36,NCT02843230,Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
PID-003,Glioblastoma,36,NCT02473484,Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas
PID-003,Glioblastoma,36,NCT05432518,Pilot Trial for Treatment of Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03025893,"A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT01602588,A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)
PID-003,Glioblastoma,36,NCT06552260,A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
PID-003,Glioblastoma,36,NCT01011231,Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma
PID-003,Glioblastoma,36,NCT05977738,Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin
PID-003,Glioblastoma,36,NCT06356883,Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
PID-003,Glioblastoma,36,NCT00884741,Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00509301,Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01653834,Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
PID-003,Glioblastoma,36,NCT05868083,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01105988,Evaluating Tumor Pseudoprogression With FLT-PET and MRI
PID-003,Glioblastoma,36,NCT06039709,Sonodynamic Therapy in Patients With Recurrent GBM
PID-003,Glioblastoma,36,NCT05052957,hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
PID-003,Glioblastoma,36,NCT03235934,Glycemic Impact on Glioblastoma Outcomes
PID-003,Glioblastoma,36,NCT01535911,Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
PID-003,Glioblastoma,36,NCT06850766,The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
PID-003,Glioblastoma,36,NCT07100730,Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01251484,BIBF 1120 in Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT06283927,The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
PID-003,Glioblastoma,36,NCT05095441,A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT05131711,Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)
PID-003,Glioblastoma,36,NCT06186440,Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
PID-003,Glioblastoma,36,NCT00611728,Ph I SU011248 + Irinotecan in Treatment of Pts w MG
PID-003,Glioblastoma,36,NCT04469699,Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05663125,LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
PID-003,Glioblastoma,36,NCT01498328,A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PID-003,Glioblastoma,36,NCT00961090,Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
PID-003,Glioblastoma,36,NCT03107780,Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
PID-003,Glioblastoma,36,NCT02474966,Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study
PID-003,Glioblastoma,36,NCT01149850,Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
PID-003,Glioblastoma,36,NCT01737346,Procarbazine and Lomustine in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT07143812,A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00597493,Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM
PID-003,Glioblastoma,36,NCT07134842,A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
PID-003,Glioblastoma,36,NCT02466828,qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.
PID-003,Glioblastoma,36,NCT00574964,Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT06782984,Drug Response Testing and Repurposing Using Glioblastoma Organoid
PID-003,Glioblastoma,36,NCT06835803,Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: a Phase 2 Hybrid Randomized Trial
PID-003,Glioblastoma,36,NCT03480867,Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)
PID-003,Glioblastoma,36,NCT00306618,Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
PID-003,Glioblastoma,36,NCT06616727,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
PID-003,Glioblastoma,36,NCT01591577,Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00412542,Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
PID-003,Glioblastoma,36,NCT05666349,Reirradiation and Niraparib in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00379470,Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT00187486,"Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors"
PID-003,Glioblastoma,36,NCT06757153,Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
PID-003,Glioblastoma,36,NCT07145047,Clinical Study of Oncolytic Virus in Glioblastoma
PID-003,Glioblastoma,36,NCT05577091,Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02137759,MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
PID-003,Glioblastoma,36,NCT03463733,Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
PID-003,Glioblastoma,36,NCT02613988,Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
PID-003,Glioblastoma,36,NCT04952571,Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT01903330,ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03632135,Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04469075,Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
PID-003,Glioblastoma,36,NCT04004975,Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
PID-003,Glioblastoma,36,NCT03557372,Mathematical Model-Adapted Radiation In Glioblastoma
PID-003,Glioblastoma,36,NCT05607407,Methimazole in Patients With Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT04902586,Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT06805305,DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT03681028,Feasibility of Individualized Therapy for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02844439,Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04968366,Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
PID-003,Glioblastoma,36,NCT05737368,Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
PID-003,Glioblastoma,36,NCT06598787,A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06894225,Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
PID-003,Glioblastoma,36,NCT05743595,"Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-003,Glioblastoma,36,NCT03665545,Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
PID-003,Glioblastoma,36,NCT03672721,IA Carboplatin + Radiotherapy in Relapsing GBM
PID-003,Glioblastoma,36,NCT06934889,Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
PID-003,Glioblastoma,36,NCT04523688,Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
PID-003,Glioblastoma,36,NCT00154375,Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT05936216,TVI-Brain-1 in Expanded Access Patient
PID-003,Glioblastoma,36,NCT05736406,A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma
PID-003,Glioblastoma,36,NCT04559230,Sacituzumab Govitecan in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04888611,Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04051606,Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06368934,Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
PID-003,Glioblastoma,36,NCT04842513,Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT03452930,Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
PID-003,Glioblastoma,36,NCT06389591,RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT06418113,Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT03405792,Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
PID-003,Glioblastoma,36,NCT06220552,The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05043701,Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01957956,Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT06069726,A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
PID-003,Glioblastoma,36,NCT05720078,UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)
PID-003,Glioblastoma,36,NCT03430791,"Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma"
PID-003,Glioblastoma,36,NCT04128774,Function and Composition of Regulatory B Cells in Participants With Glioblastoma
PID-003,Glioblastoma,36,NCT06325683,Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05218408,CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
PID-003,Glioblastoma,36,NCT02649582,Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT03225963,Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.
PID-003,Glioblastoma,36,NCT05638451,Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
PID-003,Glioblastoma,36,NCT06097975,A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06011109,Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PID-003,Glioblastoma,36,NCT05911230,Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
PID-003,Glioblastoma,36,NCT02076152,FMISO PET Study of Glioblastoma
PID-003,Glioblastoma,36,NCT04674527,Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
PID-003,Glioblastoma,36,NCT03630289,Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
PID-003,Glioblastoma,36,NCT03181477,"Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas"
PID-003,Glioblastoma,36,NCT01205334,Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04717999,Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06558214,"OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial"
PID-003,Glioblastoma,36,NCT03225300,Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation
PID-003,Glioblastoma,36,NCT05284643,"Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma"
PID-003,Glioblastoma,36,NCT05201326,Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06157541,T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT05076513,Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
PID-003,Glioblastoma,36,NCT05191784,GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients
PID-003,Glioblastoma,36,NCT05540275,Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02152982,Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04116658,"First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma"
PID-003,Glioblastoma,36,NCT00575146,Ketogenic Diet for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04013672,Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
PID-003,Glioblastoma,36,NCT03916757,V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer
PID-003,Glioblastoma,36,NCT02227576,Prevention of Thrombocytopenia in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT05802693,"A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma"
PID-003,Glioblastoma,36,NCT05324501,A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04689087,"A Prospective, Open-label, Single-arm Clinical Study"
PID-003,Glioblastoma,36,NCT00960492,Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
PID-003,Glioblastoma,36,NCT00555399,"Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)"
PID-003,Glioblastoma,36,NCT05341947,Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03451799,Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT01830101,A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03232424,NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02663271,TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02060890,Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT05879120,Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04974983,Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03722342,TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03341806,Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00657267,Dose-Intense Temozolomide in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02364206,Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT03750071,VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT01110876,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)"
PID-003,Glioblastoma,36,NCT02678975,Disulfiram in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05095376,Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
PID-003,Glioblastoma,36,NCT00400322,Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
PID-003,Glioblastoma,36,NCT02207010,A Phase 0 Study of AZD1775 in Recurrent GBM Patients
PID-003,Glioblastoma,36,NCT03137888,Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
PID-003,Glioblastoma,36,NCT03856099,TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
PID-003,Glioblastoma,36,NCT05118776,Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
PID-003,Glioblastoma,36,NCT04201873,Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04988750,Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
PID-003,Glioblastoma,36,NCT03216499,HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03865355,Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
PID-003,Glioblastoma,36,NCT01349036,A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04047303,"CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma"
PID-003,Glioblastoma,36,NCT04555577,"Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma"
PID-003,Glioblastoma,36,NCT02366728,DC Migration Study for Newly-Diagnosed GBM
PID-003,Glioblastoma,36,NCT03514069,Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
PID-003,Glioblastoma,36,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-003,Glioblastoma,36,NCT04397679,"Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma"
PID-003,Glioblastoma,36,NCT02599090,Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-003,Glioblastoma,36,NCT07138001,Phase 2 Clinical Trial of KH617
PID-003,Glioblastoma,36,NCT02345824,Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
PID-003,Glioblastoma,36,NCT02919332,Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01113398,AMG 102 and Avastin for Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT00441142,Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
PID-003,Glioblastoma,36,NCT03034135,"Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma"
PID-003,Glioblastoma,36,NCT03522298,"Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma"
PID-003,Glioblastoma,36,NCT03033524,Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03867123,A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
PID-003,Glioblastoma,36,NCT02974621,Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02530502,Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02133183,Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06186401,Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
PID-003,Glioblastoma,36,NCT00921167,A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
PID-003,Glioblastoma,36,NCT00841555,Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
PID-003,Glioblastoma,36,NCT02933736,Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
PID-003,Glioblastoma,36,NCT02129335,"Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner"
PID-003,Glioblastoma,36,NCT05879250,WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02340156,Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01866449,Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02781792,Temozolomide Chronotherapy for High Grade Glioma
PID-003,Glioblastoma,36,NCT00250887,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research"
PID-003,Glioblastoma,36,NCT03401866,Multi-site Validation and Application of a Consensus DSC-MRI Protocol
PID-003,Glioblastoma,36,NCT01756729,Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
PID-003,Glioblastoma,36,NCT06419946,Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
PID-003,Glioblastoma,36,NCT03573986,Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
PID-003,Glioblastoma,36,NCT03174197,Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02455557,SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00045968,Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
PID-003,Glioblastoma,36,NCT01813877,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-003,Glioblastoma,36,NCT04715620,Niraparib Combined With Radiotherapy in rGBM
PID-003,Glioblastoma,36,NCT00777153,Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04681677,Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
PID-003,Glioblastoma,36,NCT03744026,Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
PID-003,Glioblastoma,36,NCT04223999,Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)
PID-003,Glioblastoma,36,NCT01135875,Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
PID-003,Glioblastoma,36,NCT00525525,Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
PID-003,Glioblastoma,36,NCT02573324,A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
PID-003,Glioblastoma,36,NCT00365222,Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02754362,A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00734526,Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-003,Glioblastoma,36,NCT05565521,UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly
PID-003,Glioblastoma,36,NCT01987830,Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
PID-003,Glioblastoma,36,NCT05431348,Effect of StRess and ExeRcize on the Outcome After Chemo-Radiation
PID-003,Glioblastoma,36,NCT01754350,"Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma"
PID-003,Glioblastoma,36,NCT04440358,Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
PID-003,Glioblastoma,36,NCT02017717,A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT02885272,FDG PET Imaging in Diagnosing Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT04417088,Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
PID-003,Glioblastoma,36,NCT01165671,Carbon Ion Radiotherapy for Primary Glioblastoma
PID-003,Glioblastoma,36,NCT05271240,Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT05864534,Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00071539,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-003,Glioblastoma,36,NCT07089758,A Study for Cerebral Open Flow Microperfusion
PID-003,Glioblastoma,36,NCT02046187,Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01115036,A Panobinostat Presurgery
PID-003,Glioblastoma,36,NCT00612989,Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM
PID-003,Glioblastoma,36,NCT05182905,AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
PID-003,Glioblastoma,36,NCT00612339,Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
PID-003,Glioblastoma,36,NCT02717962,"Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting"
PID-003,Glioblastoma,36,NCT03158389,NCT Neuro Master Match - N²M² (NOA-20)
PID-003,Glioblastoma,36,NCT03291977,Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)
PID-003,Glioblastoma,36,NCT00250211,Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
PID-003,Glioblastoma,36,NCT00200161,Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
PID-003,Glioblastoma,36,NCT05914935,Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00335075,Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
PID-003,Glioblastoma,36,NCT02062827,Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT03014804,Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04222309,Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-003,Glioblastoma,36,NCT06095375,"Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients"
PID-003,Glioblastoma,36,NCT01956734,Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03277638,Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
PID-003,Glioblastoma,36,NCT01836536,Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients
PID-003,Glioblastoma,36,NCT05100641,AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT04105374,"Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma"
PID-003,Glioblastoma,36,NCT00615927,Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
PID-003,Glioblastoma,36,NCT00672243,Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
PID-003,Glioblastoma,36,NCT03877861,Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms
PID-003,Glioblastoma,36,NCT03868943,Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
PID-003,Glioblastoma,36,NCT01567202,Study of DC Vaccination Against Glioblastoma
PID-003,Glioblastoma,36,NCT03551249,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
PID-003,Glioblastoma,36,NCT03532295,Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
PID-003,Glioblastoma,36,NCT01702610,Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT06585527,Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT02510950,Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00613028,Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
PID-003,Glioblastoma,36,NCT05879367,Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
PID-003,Glioblastoma,36,NCT00613132,Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
PID-003,Glioblastoma,36,NCT03149575,VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
PID-003,Glioblastoma,36,NCT00611325,Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT01413438,Bevacizumab With or Without Surgery for Adult Glioblastomas
PID-003,Glioblastoma,36,NCT02010606,Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02833701,Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
PID-003,Glioblastoma,36,NCT01180816,Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
PID-003,Glioblastoma,36,NCT06455189,Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
PID-003,Glioblastoma,36,NCT02664363,EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
PID-003,Glioblastoma,36,NCT01269853,Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
PID-003,Glioblastoma,36,NCT05326334,THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)
PID-003,Glioblastoma,36,NCT00612430,Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
PID-003,Glioblastoma,36,NCT01386710,Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
PID-003,Glioblastoma,36,NCT00968240,Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
PID-003,Glioblastoma,36,NCT03722355,Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
PID-003,Glioblastoma,36,NCT00671970,Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
PID-003,Glioblastoma,36,NCT01986348,Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas
PID-003,Glioblastoma,36,NCT02026271,A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
PID-003,Glioblastoma,36,NCT06622434,"New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study"
PID-003,Glioblastoma,36,NCT01811498,Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT01067469,Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT02022384,Immunophenotyping From Blood of Patients With Malignant Gliomas
PID-003,Glioblastoma,36,NCT05990556,Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT02605746,Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis
PID-003,Glioblastoma,36,NCT02270034,Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01547546,A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT04674579,Automatic Segmentation MRI Cerebral Glioma
PID-003,Glioblastoma,36,NCT00735436,A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
PID-003,Glioblastoma,36,NCT01954576,NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00354913,Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
PID-003,Glioblastoma,36,NCT00609999,Ph I Dasatinib + Erlotinib in Recurrent MG
PID-003,Glioblastoma,36,NCT05624736,Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning
PID-003,Glioblastoma,36,NCT00586508,Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas
PID-003,Glioblastoma,36,NCT05363826,Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®
PID-003,Glioblastoma,36,NCT05660369,CARv3-TEAM-E T Cells in Glioblastoma
PID-003,Glioblastoma,36,NCT00883298,Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05941234,"Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma"
PID-003,Glioblastoma,36,NCT03050736,Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
PID-003,Glioblastoma,36,NCT00613054,Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT06279767,Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00613223,Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
PID-003,Glioblastoma,36,NCT03997136,Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.
PID-003,Glioblastoma,36,NCT00669669,O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
PID-003,Glioblastoma,36,NCT06562621,Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT00612638,Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
PID-003,Glioblastoma,36,NCT03360708,Vaccine Therapy in Treating Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03332355,Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
PID-003,Glioblastoma,36,NCT05235737,The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab
PID-003,Glioblastoma,36,NCT03170141,Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05954858,Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
PID-003,Glioblastoma,36,NCT05432804,"Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment"
PID-003,Glioblastoma,36,NCT04266977,Restrictive Use of Dexamethasone in Glioblastoma
PID-003,Glioblastoma,36,NCT00540176,The Safety and Efficacy of DCA for the Treatment of Brain Cancer
PID-003,Glioblastoma,36,NCT06327451,Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
PID-003,Glioblastoma,36,NCT02006563,Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors
PID-003,Glioblastoma,36,NCT01351519,A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
PID-003,Glioblastoma,36,NCT04780009,Loupe-Based Intraoperative Fluorescence Imaging
PID-003,Glioblastoma,36,NCT06632236,5G-EMERALD: Amivantamab in Malignant Brain Tumours
PID-003,Glioblastoma,36,NCT06630260,5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
PID-003,Glioblastoma,36,NCT02227901,"Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT02414165,The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
PID-003,Glioblastoma,36,NCT06359379,Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
PID-003,Glioblastoma,36,NCT01478178,Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT05842746,Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT03115138,Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
PID-003,Glioblastoma,36,NCT03020017,NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
PID-003,Glioblastoma,36,NCT04188535,Serial MRI Scans During Radiation Therapy
PID-003,Glioblastoma,36,NCT01174537,"New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma"
PID-003,Glioblastoma,36,NCT02590263,Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
PID-003,Glioblastoma,36,NCT04910022,Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03345095,A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01124240,Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene
PID-003,Glioblastoma,36,NCT00005856,Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02743078,Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05773664,Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma
PID-003,Glioblastoma,36,NCT06964815,"Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients"
PID-003,Glioblastoma,36,NCT03603405,HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT05694416,Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT02768389,Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05772767,Modulation of Ciliogenesis in Glioma Stem Cells
PID-003,Glioblastoma,36,NCT03294486,"Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients"
PID-003,Glioblastoma,36,NCT03144167,Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
PID-003,Glioblastoma,36,NCT00316849,"Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT00058097,Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02898012,Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
PID-003,Glioblastoma,36,NCT04391595,LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
PID-003,Glioblastoma,36,NCT04926168,6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT01805453,"Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma"
PID-003,Glioblastoma,36,NCT03834740,A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
PID-003,Glioblastoma,36,NCT00606008,A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-003,Glioblastoma,36,NCT00004262,Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT03615404,"Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma"
PID-003,Glioblastoma,36,NCT06816927,Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
PID-003,Glioblastoma,36,NCT04200066,A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03423628,A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
PID-003,Glioblastoma,36,NCT06319027,"Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial"
PID-003,Glioblastoma,36,NCT05447195,Phase 2 Study of CAN008 in Subjects With GBM
PID-003,Glioblastoma,36,NCT05600491,A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
PID-003,Glioblastoma,36,NCT00049387,"Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-003,Glioblastoma,36,NCT06177964,Lerapolturev (PVSRIPO) in GBM
PID-003,Glioblastoma,36,NCT00305864,"Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-003,Glioblastoma,36,NCT05979064,Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-003,Glioblastoma,36,NCT00052208,Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05695976,GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
PID-003,Glioblastoma,36,NCT02626364,Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
PID-003,Glioblastoma,36,NCT02761070,"Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III"
PID-003,Glioblastoma,36,NCT01811992,Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma
PID-003,Glioblastoma,36,NCT03705351,Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT00777686,Measuring Non-Enhancing Glioblastoma Progression
PID-003,Glioblastoma,36,NCT03596086,HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
PID-003,Glioblastoma,36,NCT00479765,A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
PID-003,Glioblastoma,36,NCT00039494,Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
PID-003,Glioblastoma,36,NCT00660543,MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
PID-003,Glioblastoma,36,NCT01331616,Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
PID-003,Glioblastoma,36,NCT00085254,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT01540513,PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
PID-003,Glioblastoma,36,NCT03115333,DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04741984,Monocyte Antigen Carrier Cells for Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT04937413,The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation
PID-003,Glioblastoma,36,NCT00943462,Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
PID-003,Glioblastoma,36,NCT01124461,BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor
PID-003,Glioblastoma,36,NCT05163080,SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
PID-003,Glioblastoma,36,NCT02465268,Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02375841,"Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers"
PID-003,Glioblastoma,36,NCT05091866,Natural Progesterone for the Treatment of Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03778294,18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
PID-003,Glioblastoma,36,NCT05375318,"BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels"
PID-003,Glioblastoma,36,NCT03899857,Pembrolizumab for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00613093,Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
PID-003,Glioblastoma,36,NCT05772741,Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs
PID-003,Glioblastoma,36,NCT00014170,Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05380349,Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
PID-003,Glioblastoma,36,NCT04725214,Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma
PID-003,Glioblastoma,36,NCT00902577,MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04840069,Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01609790,Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
PID-003,Glioblastoma,36,NCT01465347,Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT05033587,Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
PID-003,Glioblastoma,36,NCT00731731,"Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT02337426,"Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT05084430,Study of Pembrolizumab and M032 (NSC 733972)
PID-003,Glioblastoma,36,NCT04945148,Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
PID-003,Glioblastoma,36,NCT02395692,Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00846456,Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma
PID-003,Glioblastoma,36,NCT01022918,Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
PID-003,Glioblastoma,36,NCT05116137,The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
PID-003,Glioblastoma,36,NCT00864864,Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02575027,Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01120639,Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
PID-003,Glioblastoma,36,NCT04600817,A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)
PID-003,Glioblastoma,36,NCT04065087,Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT03619239,Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT03020602,BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab
PID-003,Glioblastoma,36,NCT02197169,DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
PID-003,Glioblastoma,36,NCT01111097,Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors
PID-003,Glioblastoma,36,NCT00761280,Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
PID-003,Glioblastoma,36,NCT07003542,A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
PID-003,Glioblastoma,36,NCT02820584,A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06329570,Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
PID-003,Glioblastoma,36,NCT04327011,A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
PID-003,Glioblastoma,36,NCT00409214,Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
PID-003,Glioblastoma,36,NCT03400917,Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT03626896,Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
PID-003,Glioblastoma,36,NCT02311920,Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-003,Glioblastoma,36,NCT06797661,Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.
PID-003,Glioblastoma,36,NCT00001148,Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
PID-003,Glioblastoma,36,NCT02047058,Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
PID-003,Glioblastoma,36,NCT00115440,BNCT to Treat Glioma That Has Progressed Following Radiotherapy
PID-003,Glioblastoma,36,NCT05513859,Investigational Imaging Technique During Brain Surgery
PID-003,Glioblastoma,36,NCT02709226,Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04998864,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
PID-003,Glioblastoma,36,NCT04903795,Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PID-003,Glioblastoma,36,NCT00165477,Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05023551,Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-003,Glioblastoma,36,NCT04424966,Infigratinib in Recurrent High-Grade Glioma Patients
PID-003,Glioblastoma,36,NCT05171127,Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
PID-003,Glioblastoma,36,NCT03861299,The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
PID-003,Glioblastoma,36,NCT06496971,A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
PID-003,Glioblastoma,36,NCT00662506,"Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma"
PID-003,Glioblastoma,36,NCT00179907,A Phase I/II Study of the Photon Radiosurgery System
PID-003,Glioblastoma,36,NCT04967690,"A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM"
PID-003,Glioblastoma,36,NCT06480721,FET-PET-Guided Management of Pseudoprogression in Glioblastoma
PID-003,Glioblastoma,36,NCT03460782,An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
PID-003,Glioblastoma,36,NCT00004146,Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
PID-003,Glioblastoma,36,NCT03951142,Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study
PID-003,Glioblastoma,36,NCT05718466,Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy
PID-003,Glioblastoma,36,NCT05904119,Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
PID-003,Glioblastoma,36,NCT04854044,ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03649464,Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
PID-003,Glioblastoma,36,NCT03732352,18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05977322,A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
PID-003,Glioblastoma,36,NCT02330562,Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab
PID-003,Glioblastoma,36,NCT06193538,The Safety and Effectiveness of NV-A01 in Glioma Patients
PID-003,Glioblastoma,36,NCT01905228,A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
PID-003,Glioblastoma,36,NCT06910306,A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02666066,Radiomics for Prediction of Survival in GBM
PID-003,Glioblastoma,36,NCT00074646,Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas
PID-003,Glioblastoma,36,NCT02903069,Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
PID-003,Glioblastoma,36,NCT00548938,"Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM"
PID-003,Glioblastoma,36,NCT02490930,A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
PID-003,Glioblastoma,36,NCT02025231,Image Guided Reirradiation of High-grade Glioma
PID-003,Glioblastoma,36,NCT06129760,Glioblastoma Remote Monitoring and Care - Research Protocol
PID-003,Glioblastoma,36,NCT06684899,Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT06773481,BC008-1A Injection for Recurrent CNS WHO G4 Glioma
PID-003,Glioblastoma,36,NCT00686387,Establishment of a Brain and Spinal Tumor Tissue Bank
PID-003,Glioblastoma,36,NCT06344130,Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01266031,Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01516905,PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
PID-003,Glioblastoma,36,NCT03370926,FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
PID-003,Glioblastoma,36,NCT06328036,Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01931098,Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
PID-003,Glioblastoma,36,NCT01502241,Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
PID-003,Glioblastoma,36,NCT00939991,"Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas"
PID-003,Glioblastoma,36,NCT03426891,Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT06719440,Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
PID-003,Glioblastoma,36,NCT00723827,Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
PID-003,Glioblastoma,36,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-003,Glioblastoma,36,NCT00431561,Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
PID-003,Glioblastoma,36,NCT01317888,Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas
PID-003,Glioblastoma,36,NCT05039281,Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05017610,Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
PID-003,Glioblastoma,36,NCT06824662,Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas
PID-003,Glioblastoma,36,NCT03618667,GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
PID-003,Glioblastoma,36,NCT00089427,"IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma"
PID-003,Glioblastoma,36,NCT00028158,"Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer"
PID-003,Glioblastoma,36,NCT01925573,Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
PID-003,Glioblastoma,36,NCT04822688,"Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues"
PID-003,Glioblastoma,36,NCT05383872,Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
PID-003,Glioblastoma,36,NCT02337686,Pembrolizumab in Treating Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03296696,Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
PID-003,Glioblastoma,36,NCT01086345,Radiosurgery Plus Bevacizumab in Glioblastoma
PID-003,Glioblastoma,36,NCT06072586,A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
PID-003,Glioblastoma,36,NCT04216329,Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT06455605,D2C7-IT + 2141-V11 Combination Post-resection in rGBM
PID-003,Glioblastoma,36,NCT01044966,A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04763031,Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT
PID-003,Glioblastoma,36,NCT04446416,Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
PID-003,Glioblastoma,36,NCT01582516,Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00753246,Nimotuzumab in Adults With Glioblastoma Multiforma
PID-003,Glioblastoma,36,NCT01227434,A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
PID-003,Glioblastoma,36,NCT03224104,Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
PID-003,Glioblastoma,36,NCT06691308,WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients
PID-003,Glioblastoma,36,NCT01004874,Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
PID-003,Glioblastoma,36,NCT02871843,RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
PID-003,Glioblastoma,36,NCT00045565,Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
PID-003,Glioblastoma,36,NCT06058988,Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
PID-003,Glioblastoma,36,NCT04817254,Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-003,Glioblastoma,36,NCT00597402,"Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas"
PID-003,Glioblastoma,36,NCT00645385,Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
PID-003,Glioblastoma,36,NCT00576641,Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
PID-003,Glioblastoma,36,NCT01520870,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
PID-003,Glioblastoma,36,NCT01240460,Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection
PID-003,Glioblastoma,36,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-003,Glioblastoma,36,NCT03633552,Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
PID-003,Glioblastoma,36,NCT05929456,Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)
PID-003,Glioblastoma,36,NCT01062425,Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT04608812,Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
PID-003,Glioblastoma,36,NCT03631823,Gut Microbiota and Glioblastoma Multiforme Prognosis
PID-003,Glioblastoma,36,NCT05565118,Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
PID-003,Glioblastoma,36,NCT04045847,CD147-CART Cells in Patients With Recurrent Malignant Glioma.
PID-003,Glioblastoma,36,NCT04289155,Individual Patient Compassionate Use of GX-I7
PID-003,Glioblastoma,36,NCT01242566,Temozolomide in Elderly Patients With KPS < 70
PID-003,Glioblastoma,36,NCT01290939,Bevacizumab and Lomustine for Recurrent GBM
PID-003,Glioblastoma,36,NCT05683808,Venous Thromboembolism Prevention in Outpatients With Glioma
PID-003,Glioblastoma,36,NCT04396860,Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
PID-003,Glioblastoma,36,NCT01294735,Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
PID-003,Glioblastoma,36,NCT04209790,Neoadjuvant Chemoradiation for Resectable Glioblastoma
PID-003,Glioblastoma,36,NCT04677049,Study of Niacin in Glioblastoma
PID-003,Glioblastoma,36,NCT05739942,Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT02253212,Safety of BBB Opening With the SonoCloud
PID-003,Glioblastoma,36,NCT06504381,"DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma"
PID-003,Glioblastoma,36,NCT01711580,Re-irradiation of High Grade Gliomas: a Quality of Life Study
PID-003,Glioblastoma,36,NCT06710249,Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
PID-003,Glioblastoma,36,NCT06883747,Clinical Trial of BMS-986504 in Recurrent GBM Patients
PID-003,Glioblastoma,36,NCT07111195,Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
PID-003,Glioblastoma,36,NCT00923117,Sunitinib to Treat Recurrent Brain Cancer
PID-003,Glioblastoma,36,NCT05671016,Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy
PID-003,Glioblastoma,36,NCT00715013,Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT02431572,A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
PID-003,Glioblastoma,36,NCT00016328,CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00540722,Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00423735,Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
PID-003,Glioblastoma,36,NCT04699773,LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
PID-003,Glioblastoma,36,NCT06273176,The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06059690,Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
PID-003,Glioblastoma,36,NCT00747253,Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
PID-003,Glioblastoma,36,NCT00980343,GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-003,Glioblastoma,36,NCT00591058,Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT03283631,Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
PID-003,Glioblastoma,36,NCT00504660,"6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients"
PID-003,Glioblastoma,36,NCT02794883,Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT00641706,"Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme"
PID-003,Glioblastoma,36,NCT00107003,GW572016 to Treat Recurrent Malignant Brain Tumors
PID-003,Glioblastoma,36,NCT06385132,Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer
PID-003,Glioblastoma,36,NCT00445588,Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT02529072,Nivolumab With DC Vaccines for Recurrent Brain Tumors
PID-003,Glioblastoma,36,NCT00612651,PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
PID-003,Glioblastoma,36,NCT01238237,Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA
PID-003,Glioblastoma,36,NCT03275558,Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma
PID-003,Glioblastoma,36,NCT00503204,Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
PID-003,Glioblastoma,36,NCT02386826,INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00704080,A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
PID-003,Glioblastoma,36,NCT04116138,Antisecretory Factor in Primary Glioblastoma 1
PID-003,Glioblastoma,36,NCT06806228,Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)
PID-003,Glioblastoma,36,NCT01790503,A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT00751270,Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
PID-003,Glioblastoma,36,NCT00610571,Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
PID-003,Glioblastoma,36,NCT00780819,Borderzone Sampling
PID-003,Glioblastoma,36,NCT00683761,A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT00473408,The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
PID-003,Glioblastoma,36,NCT07021339,Anterior Temporal Lobectomy in Temporal Glioblastoma
PID-003,Glioblastoma,36,NCT00305656,AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00335764,"Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma"
PID-003,Glioblastoma,36,NCT01081223,Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
PID-003,Glioblastoma,36,NCT00087451,Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)
PID-003,Glioblastoma,36,NCT00392171,The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
PID-003,Glioblastoma,36,NCT05734560,D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
PID-003,Glioblastoma,36,NCT00132158,ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
PID-003,Glioblastoma,36,NCT00238303,Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01575275,Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00075491,Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT05267106,Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
PID-003,Glioblastoma,36,NCT01894061,NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00112502,Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04776980,Multimodality MRI and Liquid Biopsy in GBM
PID-003,Glioblastoma,36,NCT02887417,Glioblastoma Platelet Activation Study
PID-003,Glioblastoma,36,NCT00112866,Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT04444427,Evaluation of GLR2007 for Advanced Solid Tumors
PID-003,Glioblastoma,36,NCT00895960,Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT04657315,"Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients"
PID-003,Glioblastoma,36,NCT02052648,Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
PID-003,Glioblastoma,36,NCT03027388,"Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma"
PID-003,Glioblastoma,36,NCT02661282,Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT04712721,Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
PID-003,Glioblastoma,36,NCT06241391,Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
PID-003,Glioblastoma,36,NCT04388475,Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT04143425,Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01967758,Phase I Study of Safety and Immunogenicity of ADU-623
PID-003,Glioblastoma,36,NCT03746080,Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT05561374,Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT04181684,LITT Followed by Hypofractionated RT for Recurrent Gliomas
PID-003,Glioblastoma,36,NCT03673787,A Trial of Ipatasertib in Combination With Atezolizumab
PID-003,Glioblastoma,36,NCT03367715,"Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma"
PID-003,Glioblastoma,36,NCT00459381,Pazopanib in Treating Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT05909618,Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
PID-003,Glioblastoma,36,NCT01730950,Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01753713,Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT01117155,A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
PID-003,Glioblastoma,36,NCT01475006,AMG 595 First-in-Human in Recurrent Gliomas
PID-003,Glioblastoma,36,NCT01491893,PVSRIPO for Recurrent Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT00979862,Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03539731,[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
PID-003,Glioblastoma,36,NCT01122901,Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT03176160,LITT Palliative Treatment for Patients With Malignant Gliomas
PID-003,Glioblastoma,36,NCT05929495,"Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma"
PID-003,Glioblastoma,36,NCT01972750,Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma
PID-003,Glioblastoma,36,NCT05054400,Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
PID-003,Glioblastoma,36,NCT06017063,Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields
PID-003,Glioblastoma,36,NCT01434602,Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
PID-003,Glioblastoma,36,NCT03213002,Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
PID-003,Glioblastoma,36,NCT01967810,ANG1005 in Patients With Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT03581292,"Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations"
PID-003,Glioblastoma,36,NCT03975959,Memory Perception Assessment in Central/Non-central Nervous System Cancers
PID-003,Glioblastoma,36,NCT01808820,Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
PID-003,Glioblastoma,36,NCT06623565,Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
PID-003,Glioblastoma,36,NCT02629757,A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas
PID-003,Glioblastoma,36,NCT00624728,Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
PID-003,Glioblastoma,36,NCT00562419,CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
PID-003,Glioblastoma,36,NCT02658981,Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
PID-003,Glioblastoma,36,NCT00031538,Genetic Analysis of Brain Tumors
PID-003,Glioblastoma,36,NCT00870181,ADV-TK Improves Outcome of Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT04729959,"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma"
PID-003,Glioblastoma,36,NCT00031083,Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
PID-003,Glioblastoma,36,NCT01765088,A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
PID-003,Glioblastoma,36,NCT04145115,A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden
PID-003,Glioblastoma,36,NCT02750891,A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
PID-003,Glioblastoma,36,NCT01985256,Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
PID-003,Glioblastoma,36,NCT03475186,Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
PID-003,Glioblastoma,36,NCT02540135,Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
PID-003,Glioblastoma,36,NCT01738646,Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
PID-003,Glioblastoma,36,NCT04623931,Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
PID-003,Glioblastoma,36,NCT06430424,"Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma"
PID-003,Glioblastoma,36,NCT01810744,Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
PID-003,Glioblastoma,36,NCT02942264,Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-003,Glioblastoma,36,NCT06501911,A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
PID-003,Glioblastoma,36,NCT01975701,A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
PID-003,Glioblastoma,36,NCT03657576,Trial of C134 in Patients With Recurrent GBM
PID-003,Glioblastoma,36,NCT01712542,Curcumin Bioavailability in Glioblastoma Patients
PID-003,Glioblastoma,36,NCT01470794,Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
PID-003,Glioblastoma,36,NCT01107522,Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
PID-003,Glioblastoma,36,NCT02525692,Oral ONC201 in Adult Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT07091864,Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
PID-003,Glioblastoma,36,NCT03311542,Expanded Access for Pembrolizumab (MK-3475)
PID-003,Glioblastoma,36,NCT00734864,Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT03561207,3D Prediction of Patient-Specific Response
PID-003,Glioblastoma,36,NCT03914768,Immune Modulatory DC Vaccine Against Brain Tumor
PID-003,Glioblastoma,36,NCT00102648,Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
PID-003,Glioblastoma,36,NCT07067905,Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
PID-003,Glioblastoma,36,NCT06617208,Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery
PID-003,Glioblastoma,36,NCT01814813,Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-003,Glioblastoma,36,NCT05062772,Brain Tumor Intraoperative Ultrasound Database
PID-003,Glioblastoma,36,NCT06108206,Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
PID-003,Glioblastoma,36,NCT00041587,Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
PID-003,Glioblastoma,36,NCT00024570,Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT05106296,Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
PID-003,Glioblastoma,36,NCT04267978,Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
PID-003,Glioblastoma,36,NCT00001171,Evaluation of Factors in Human Brain Tumors
PID-003,Glioblastoma,36,NCT05131763,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-003,Glioblastoma,36,NCT00114309,131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT04477200,Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
PID-003,Glioblastoma,36,NCT04270461,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-003,Glioblastoma,36,NCT01454596,CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
PID-003,Glioblastoma,36,NCT06016452,A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma
PID-003,Glioblastoma,36,NCT00379080,Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT00390299,Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT00080054,A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
PID-003,Glioblastoma,36,NCT01122888,Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT06160206,Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT06894979,"Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma"
PID-003,Glioblastoma,36,NCT00734682,A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
PID-003,Glioblastoma,36,NCT05495295,"First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours"
PID-003,Glioblastoma,36,NCT04933942,Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
PID-003,Glioblastoma,36,NCT05629702,ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
PID-003,Glioblastoma,36,NCT06118723,The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
PID-003,Glioblastoma,36,NCT01342757,Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT00009035,Natural History of Patients With Brain and Spinal Cord Tumors
PID-003,Glioblastoma,36,NCT01441388,A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
PID-003,Glioblastoma,36,NCT00575887,Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
PID-003,Glioblastoma,36,NCT04478279,A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
PID-003,Glioblastoma,36,NCT06614855,A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT04074785,Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6
PID-003,Glioblastoma,36,NCT05765812,A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT02348255,NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
PID-003,Glioblastoma,36,NCT00589875,Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
PID-003,Glioblastoma,36,NCT06492486,Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
PID-003,Glioblastoma,36,NCT05686798,Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
PID-003,Glioblastoma,36,NCT04323046,Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
PID-003,Glioblastoma,36,NCT01156584,A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT00062504,Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
PID-003,Glioblastoma,36,NCT06929819,Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
PID-003,Glioblastoma,36,NCT00272870,Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
PID-003,Glioblastoma,36,NCT06810544,Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
PID-003,Glioblastoma,36,NCT06388733,"A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma"
PID-003,Glioblastoma,36,NCT05773326,Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
PID-003,Glioblastoma,36,NCT00433381,Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
PID-003,Glioblastoma,36,NCT03022578,Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
PID-003,Glioblastoma,36,NCT04630379,Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
PID-003,Glioblastoma,36,NCT04218019,Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation
PID-003,Glioblastoma,36,NCT01999270,Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
PID-003,Glioblastoma,36,NCT04489420,Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
PID-003,Glioblastoma,36,NCT04991870,Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
PID-003,Glioblastoma,36,NCT01902771,Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
PID-003,Glioblastoma,36,NCT06038760,Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
PID-003,Glioblastoma,36,NCT00995007,A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
PID-003,Glioblastoma,36,NCT01281982,(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
PID-003,Glioblastoma,36,NCT04049669,Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
PID-003,Glioblastoma,36,NCT01316809,AZD8055 for Adults With Recurrent Gliomas
PID-003,Glioblastoma,36,NCT03593993,A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
PID-003,Glioblastoma,36,NCT01478321,Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
PID-003,Glioblastoma,36,NCT02039778,Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma
PID-003,Glioblastoma,36,NCT02655601,"Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001"
PID-003,Glioblastoma,36,NCT05465954,Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT00329719,Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT01656980,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
PID-003,Glioblastoma,36,NCT01637753,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT02885324,Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
PID-003,Glioblastoma,36,NCT01204684,Dendritic Cell Vaccine for Patients With Brain Tumors
PID-003,Glioblastoma,36,NCT03463265,Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT04314674,Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors Resection
PID-003,Glioblastoma,36,NCT01171469,Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
PID-003,Glioblastoma,36,NCT00973557,The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
PID-003,Glioblastoma,36,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
PID-003,Glioblastoma,36,NCT00179803,Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
PID-003,Glioblastoma,36,NCT04782609,Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT00024557,Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
PID-003,Glioblastoma,36,NCT01836549,Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
PID-003,Glioblastoma,36,NCT01250470,Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
PID-003,Glioblastoma,36,NCT00064779,Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT01648348,Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT06665724,Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
PID-003,Glioblastoma,36,NCT06410248,Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
PID-003,Glioblastoma,36,NCT03717142,Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
PID-003,Glioblastoma,36,NCT06902350,"Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors"
PID-003,Glioblastoma,36,NCT04614493,Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.
PID-003,Glioblastoma,36,NCT05297864,PARP Inhibition for Gliomas (PI-4G or π4g)
PID-003,Glioblastoma,36,NCT05099068,Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)
PID-003,Glioblastoma,36,NCT02722512,Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
PID-003,Glioblastoma,36,NCT01514201,"Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas"
PID-003,Glioblastoma,36,NCT04047264,Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
PID-003,Glioblastoma,36,NCT03971734,Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
PID-003,Glioblastoma,36,NCT01740258,Bevacizumab Beyond Progression (BBP)
PID-003,Glioblastoma,36,NCT03607643,"A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies"
PID-003,Glioblastoma,36,NCT00823797,Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
PID-003,Glioblastoma,36,NCT01861990,Valproic Acid in Childhood Progressive Brain Tumors
PID-003,Glioblastoma,36,NCT06193174,Re-Administration of C134 in Patients with Recurrent GBM (C134-HSV-1)
PID-003,Glioblastoma,36,NCT02168270,Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT00884416,Sorafenib in Newly Diagnosed High Grade Glioma
PID-003,Glioblastoma,36,NCT00004688,"Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms"
PID-003,Glioblastoma,36,NCT00243490,Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
PID-003,Glioblastoma,36,NCT01822275,Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-003,Glioblastoma,36,NCT01380782,BIBF 1120 for Recurrent High-Grade Gliomas
PID-003,Glioblastoma,36,NCT02758366,Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
PID-003,Glioblastoma,36,NCT06860594,"Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma"
PID-003,Glioblastoma,36,NCT01095094,Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT02055196,Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-003,Glioblastoma,36,NCT01144247,Cellular Immunotherapy Study for Brain Cancer
PID-003,Glioblastoma,36,NCT04488783,Potentiation of Chemotherapy in Brain Tumors by Zinc
PID-003,Glioblastoma,36,NCT01189240,RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT04661384,"Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma"
PID-003,Glioblastoma,36,NCT04479696,Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
PID-003,Glioblastoma,36,NCT06989086,FearLess in NeuroOncology
PID-003,Glioblastoma,36,NCT00006773,Bortezomib in Treating Patients With Recurrent Glioma
PID-003,Glioblastoma,36,NCT03956706,Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
PID-003,Glioblastoma,36,NCT06160596,Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
PID-003,Glioblastoma,36,NCT03251027,Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
PID-003,Glioblastoma,36,NCT06796335,Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
PID-003,Glioblastoma,36,NCT04734444,SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
PID-003,Glioblastoma,36,NCT03392545,Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)
PID-003,Glioblastoma,36,NCT05039346,Quality of Life and Patient Needs in Advanced High Grade Gliomas
PID-003,Glioblastoma,36,NCT05139277,Evaluation of the CONVIVO System
PID-003,Glioblastoma,36,NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection
PID-003,Glioblastoma,36,NCT00650923,"Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma"
PID-003,Glioblastoma,36,NCT06333899,Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
PID-003,Glioblastoma,36,NCT01151670,Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
PID-003,Glioblastoma,36,NCT00667394,Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
PID-003,Glioblastoma,36,NCT06975332,"Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression"
PID-003,Glioblastoma,36,NCT03914742,BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
PID-003,Glioblastoma,36,NCT05843253,Study of Ribociclib and Everolimus in HGG and DIPG
PID-003,Glioblastoma,36,NCT05839379,Targeted Pediatric High-Grade Glioma Therapy
PID-003,Glioblastoma,36,NCT01798771,Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
PID-003,Glioblastoma,36,NCT02015819,"Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas"
PID-003,Glioblastoma,36,NCT05873946,Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
PID-003,Glioblastoma,36,NCT04295759,INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
PID-003,Glioblastoma,36,NCT04482933,HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT02031965,Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
PID-003,Glioblastoma,36,NCT05789394,Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
PID-003,Glioblastoma,36,NCT05698524,A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
PID-003,Glioblastoma,36,NCT03718767,Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
PID-003,Glioblastoma,36,NCT03123952,Expanded Access to ABT-414
PID-003,Glioblastoma,36,NCT02861898,Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
PID-003,Glioblastoma,36,NCT01721577,Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
PID-003,Glioblastoma,36,NCT02238496,Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
PID-003,Glioblastoma,36,NCT04982926,A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
PID-003,Glioblastoma,36,NCT04214392,Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
PID-003,Glioblastoma,36,NCT01996527,3T MRI Biomarkers of Glioma Treatment Response
PID-003,Glioblastoma,36,NCT06926075,Early Phase Study of Kesonotide in Participants With Solid Tumours
PID-003,Glioblastoma,36,NCT01378481,High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma
PID-003,Glioblastoma,36,NCT01148966,Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
PID-003,Glioblastoma,36,NCT01975116,p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
PID-003,Glioblastoma,36,NCT00268385,Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
PID-003,Glioblastoma,36,NCT02142803,TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
PID-003,Glioblastoma,36,NCT01383135,Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
PID-003,Glioblastoma,36,NCT04573140,A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
PID-003,Glioblastoma,36,NCT01269411,RO4929097 in Treating Patients With Recurrent Invasive Gliomas
PID-003,Glioblastoma,36,NCT06640582,TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
PID-003,Glioblastoma,36,NCT03389230,Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
PID-003,Glioblastoma,36,NCT07042620,A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
PID-003,Glioblastoma,36,NCT06041555,MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
PID-003,Glioblastoma,36,NCT04740190,Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd
PID-003,Glioblastoma,36,NCT05231655,Ex VIvo DEtermiNed Cancer Therapy
PID-003,Glioblastoma,36,NCT00499473,Sunitinib in Treating Patients With Recurrent Malignant Gliomas
PID-003,Glioblastoma,36,NCT02502708,"Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors"
PID-003,Glioblastoma,36,NCT06896110,Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
PID-003,Glioblastoma,36,NCT01817751,"Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma"
PID-003,Glioblastoma,36,NCT06047379,"Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis"
PID-003,Glioblastoma,36,NCT00095940,Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
PID-003,Glioblastoma,36,NCT03749187,BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
PID-003,Glioblastoma,36,NCT06625047,Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
PID-003,Glioblastoma,36,NCT01291420,Dendritic Cell Vaccination for Patients with Solid Tumors
PID-003,Glioblastoma,36,NCT05737212,"Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas"
PID-003,Glioblastoma,36,NCT03072134,Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
PID-003,Glioblastoma,36,NCT00100802,"Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas"
PID-003,Glioblastoma,36,NCT02208362,Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
PID-003,Glioblastoma,36,NCT01977677,Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
PID-003,Glioblastoma,36,NCT05370079,Control Cohort CTRL COH
PID-003,Glioblastoma,36,NCT00042991,Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
PID-003,Glioblastoma,36,NCT02800486,"Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA"
PID-003,Glioblastoma,36,NCT04978727,"A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma"
PID-003,Glioblastoma,36,NCT04678648,A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
PID-003,Glioblastoma,36,NCT01353625,"Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies."
PID-003,Glioblastoma,36,NCT03152318,A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PID-003,Glioblastoma,36,NCT06815029,Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
PID-003,Glioblastoma,36,NCT01103375,Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT01051557,Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-003,Glioblastoma,36,NCT02974738,"A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)"
PID-003,Glioblastoma,36,NCT03896568,MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT03739372,Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
PID-003,Glioblastoma,36,NCT06439420,CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
PID-003,Glioblastoma,36,NCT01598597,"An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)"
PID-003,Glioblastoma,36,NCT02465528,Ceritinib Rare Indications Study in ALK+ Tumors
PID-003,Glioblastoma,36,NCT04388033,Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
PID-003,Glioblastoma,36,NCT01723020,A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
PID-003,Glioblastoma,36,NCT00879437,"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma"
PID-003,Glioblastoma,36,NCT03973918,Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
PID-003,Glioblastoma,36,NCT03389802,Phase I Study of APX005M in Pediatric Central Nervous System Tumors
PID-003,Glioblastoma,36,NCT01849952,Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
PID-003,Glioblastoma,36,NCT00045708,A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
PID-003,Glioblastoma,36,NCT04135807,Implantable Microdevice In Primary Brain Tumors
PID-003,Glioblastoma,36,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-003,Glioblastoma,36,NCT02798406,Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
PID-003,Glioblastoma,36,NCT05956821,Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
PID-003,Glioblastoma,36,NCT04044937,Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
PID-003,Glioblastoma,36,NCT01082926,"Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2"
PID-003,Glioblastoma,36,NCT03919071,Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
PID-003,Glioblastoma,36,NCT03893487,Fimepinostat in Treating Brain Tumors in Children and Young Adults
PID-003,Glioblastoma,36,NCT03212274,"Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations"
PID-003,Glioblastoma,36,NCT02372409,Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
PID-003,Glioblastoma,36,NCT05330559,"Fluorescence, Light-microscopy, Ultrasound Integrated / Intraoperative Diagnosis to MAXimise Resection"
PID-003,Glioblastoma,36,NCT06690216,Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
PID-003,Glioblastoma,36,NCT02365662,A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
PID-003,Glioblastoma,36,NCT04970615,Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models
PID-003,Glioblastoma,36,NCT00045110,Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
PID-003,Glioblastoma,36,NCT03734913,A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
PID-003,Glioblastoma,36,NCT01234740,Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
PID-003,Glioblastoma,36,NCT02101905,Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT02457845,HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
PID-003,Glioblastoma,36,NCT02444546,Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
PID-003,Glioblastoma,36,NCT02644291,Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
PID-003,Glioblastoma,36,NCT01579253,Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
PID-003,Glioblastoma,36,NCT01884740,Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
PID-003,Glioblastoma,36,NCT01904123,STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain
PID-003,Glioblastoma,36,NCT03684811,A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
PID-003,Glioblastoma,36,NCT01922076,Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
PID-003,Glioblastoma,36,NCT00959946,Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer
PID-003,Glioblastoma,36,NCT03244995,Mind-Body Intervention in Glioma Couples
PID-003,Glioblastoma,36,NCT02498665,A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
PID-003,Glioblastoma,36,NCT03958240,Deciphering Mechanisms Underlying Cancer Immunogenicity
PID-003,Glioblastoma,36,NCT02323880,Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
PID-003,Glioblastoma,36,NCT00369590,VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
PID-003,Glioblastoma,36,NCT00093613,Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-003,Glioblastoma,36,NCT00085540,FR901228 in Treating Patients With Recurrent High-Grade Gliomas
PID-003,Glioblastoma,36,NCT06804655,Pharmacoscopy for Patients with Refractory Primary Brain Tumors
PID-003,Glioblastoma,36,NCT02709889,Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
PID-003,Glioblastoma,36,NCT01421524,"Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma"
PID-003,Glioblastoma,36,NCT01445691,More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
PID-003,Glioblastoma,36,NCT01837862,A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
PID-003,Glioblastoma,36,NCT02038699,A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer
PID-003,Glioblastoma,36,NCT02327078,"A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)"
PID-003,Glioblastoma,36,NCT00112736,Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT06717295,The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
PID-003,Glioblastoma,36,NCT06521567,A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
PID-003,Glioblastoma,36,NCT05538572,A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
PID-003,Glioblastoma,36,NCT05139056,Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
PID-003,Glioblastoma,36,NCT00679354,Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
PID-003,Glioblastoma,36,NCT06469138,A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
PID-003,Glioblastoma,36,NCT02192359,Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-003,Glioblastoma,36,NCT01172964,A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
PID-003,Glioblastoma,36,NCT00430079,Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
PID-003,Glioblastoma,36,NCT03797326,Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
PID-003,Glioblastoma,36,NCT01177397,"Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma"
PID-003,Glioblastoma,36,NCT05835687,Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
PID-003,Glioblastoma,36,NCT04427384,Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
PID-003,Glioblastoma,36,NCT03355794,A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
PID-003,Glioblastoma,36,NCT01339039,Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
PID-003,Glioblastoma,36,NCT04732065,"ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors"
PID-003,Glioblastoma,36,NCT01392209,Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
PID-003,Glioblastoma,36,NCT02186509,Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
PID-003,Glioblastoma,36,NCT06814496,Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
PID-003,Glioblastoma,36,NCT01576666,"Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors"
PID-003,Glioblastoma,36,NCT02966509,Engagement of Patients With Advanced Cancer
PID-003,Glioblastoma,36,NCT03243461,International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
PID-003,Glioblastoma,36,NCT01165632,Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
PID-003,Glioblastoma,36,NCT03043391,Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
PID-003,Glioblastoma,36,NCT02684058,Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
PID-003,Glioblastoma,36,NCT06645808,PET-imaging of Two Vartumabs in Patients With Solid Tumors
PID-003,Glioblastoma,36,NCT02255461,"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors"
PID-003,Glioblastoma,36,NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PID-003,Glioblastoma,36,NCT04541082,Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
PID-003,Glioblastoma,36,NCT02374255,Improving Goals of Care Discussion in Advanced Cancer Patients
PID-003,Glioblastoma,36,NCT02611024,Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
PID-003,Glioblastoma,36,NCT01392352,HYPAZ: Hypertension Induced by Pazopanib
PID-003,Glioblastoma,36,NCT04541225,Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
PID-003,Glioblastoma,36,NCT02223052,Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
PID-003,Glioblastoma,36,NCT02175745,18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
PID-003,Glioblastoma,36,NCT02335918,A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
PID-003,Glioblastoma,36,NCT05934630,"Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors"
PID-003,Glioblastoma,36,NCT01234805,Yoga Therapy in Treating Patients With Malignant Brain Tumors
PID-003,Glioblastoma,36,NCT01929720,"Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors"
PID-003,Glioblastoma,36,NCT03787056,Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
PID-003,Glioblastoma,36,NCT04913337,Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
PID-003,Glioblastoma,36,NCT05563272,89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
PID-003,Glioblastoma,36,NCT01631552,Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
PID-003,Glioblastoma,36,NCT05974410,Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
PID-003,Glioblastoma,36,NCT04604158,Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
PID-003,Glioblastoma,36,NCT02967380,"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases"
PID-003,Glioblastoma,36,NCT03911388,HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
PID-003,Glioblastoma,36,NCT05131815,The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
PID-003,Glioblastoma,36,NCT00110032,Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
PID-003,Glioblastoma,36,NCT03975829,Pediatric Long-Term Follow-up and Rollover Study
PID-003,Glioblastoma,36,NCT01119599,"RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma"
PID-003,Glioblastoma,36,NCT04566393,Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies
PID-003,Glioblastoma,36,NCT02194452,Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
PID-003,Glioblastoma,36,NCT03434262,SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
PID-003,Glioblastoma,36,NCT03896958,The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
PID-003,Glioblastoma,36,NCT01522820,Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
PID-003,Glioblastoma,36,NCT01131234,Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
PID-003,Glioblastoma,36,NCT03452774,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
PID-003,Glioblastoma,36,NCT01806675,18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
PID-003,Glioblastoma,36,NCT05969860,At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
PID-003,Glioblastoma,36,NCT04028479,The Registry of Oncology Outcomes Associated with Testing and Treatment
PID-003,Glioblastoma,36,NCT00030498,Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
PID-003,Glioblastoma,36,NCT03154190,Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
PID-005,Glioblastoma,52,NCT01102595,Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
PID-005,Glioblastoma,52,NCT03903419,Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
PID-005,Glioblastoma,52,NCT06650605,Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma
PID-005,Glioblastoma,52,NCT05399524,Functional and Ultrasound Guided Resection of Glioblastoma
PID-005,Glioblastoma,52,NCT03990285,[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
PID-005,Glioblastoma,52,NCT00936052,Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01252459,Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03879512,"Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG"
PID-005,Glioblastoma,52,NCT04606316,Surgical Nivolumab And Ipilimumab For Recurrent GBM
PID-005,Glioblastoma,52,NCT01700569,Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
PID-005,Glioblastoma,52,NCT06348693,Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
PID-005,Glioblastoma,52,NCT06869577,A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
PID-005,Glioblastoma,52,NCT05086497,WBSI Guided Personalized Delivery of TTFields
PID-005,Glioblastoma,52,NCT01833273,Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA
PID-005,Glioblastoma,52,NCT05896449,Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
PID-005,Glioblastoma,52,NCT03291314,Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03363659,Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02795364,Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
PID-005,Glioblastoma,52,NCT02772094,Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
PID-005,Glioblastoma,52,NCT04874506,MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT05958485,A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
PID-005,Glioblastoma,52,NCT06939400,Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
PID-005,Glioblastoma,52,NCT02945826,uPAR-PET/MRI in Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04869449,Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
PID-005,Glioblastoma,52,NCT04588454,18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT06271421,NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT06595186,JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT05423210,Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05120284,Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT05589961,Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT06404034,Expanded Access to Gallium Maltolate (GaM)
PID-005,Glioblastoma,52,NCT06466031,Application of MET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05281731,Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
PID-005,Glioblastoma,52,NCT03861598,Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
PID-005,Glioblastoma,52,NCT06451042,FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)
PID-005,Glioblastoma,52,NCT05908669,Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05500612,MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
PID-005,Glioblastoma,52,NCT00337883,A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
PID-005,Glioblastoma,52,NCT04277221,ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT01181193,Vitamin D for Treatment of Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04825275,Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: a Phase 0 Clinical Trial
PID-005,Glioblastoma,52,NCT04752813,A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
PID-005,Glioblastoma,52,NCT05353530,IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
PID-005,Glioblastoma,52,NCT05608395,11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
PID-005,Glioblastoma,52,NCT03075514,Ketogenic Diets as an Adjuvant Therapy in Glioblastoma
PID-005,Glioblastoma,52,NCT06781372,Patient's Derived Organoids for Drug Screening in Glioblastoma
PID-005,Glioblastoma,52,NCT01280552,A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT06533163,Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
PID-005,Glioblastoma,52,NCT04900792,A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
PID-005,Glioblastoma,52,NCT02864368,Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
PID-005,Glioblastoma,52,NCT01268566,A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01301430,Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
PID-005,Glioblastoma,52,NCT01865162,Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
PID-005,Glioblastoma,52,NCT01873469,Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03506139,Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02769806,Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
PID-005,Glioblastoma,52,NCT00730262,Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03344250,Phase I EGFR BATs in Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01317212,Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00190424,Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
PID-005,Glioblastoma,52,NCT03980249,Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
PID-005,Glioblastoma,52,NCT04587830,ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03707457,Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
PID-005,Glioblastoma,52,NCT01269424,BG & TMZ Therapy of Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00990496,A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT00515086,Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT03310372,Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02285959,Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04450160,Trial of AEO in New Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT03291990,5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02997423,Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT02177578,Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00209989,Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05565326,Response Assessment During MR-guided Radiation Therapy for Glioblastoma
PID-005,Glioblastoma,52,NCT05769660,A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT00323115,Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02858895,Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT02853565,A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00768911,CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02344355,A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01349660,Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00376103,Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02619864,mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02283944,TMS Electrochemotherapy for Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05402241,IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study
PID-005,Glioblastoma,52,NCT02586857,"A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)"
PID-005,Glioblastoma,52,NCT02685605,Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00544817,Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00535379,"SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT00892931,Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02296580,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT00677716,Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
PID-005,Glioblastoma,52,NCT00394628,AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00224978,Chloroquine for Treatment of Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02120287,Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01006044,Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection
PID-005,Glioblastoma,52,NCT01209442,Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02507102,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
PID-005,Glioblastoma,52,NCT01800695,Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00615186,Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy
PID-005,Glioblastoma,52,NCT07120620,PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01564914,A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT05917821,New Antigens Against Glioblastoma
PID-005,Glioblastoma,52,NCT01435395,"Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT00817284,Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT00800917,A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00083512,Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03714334,DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01285414,"Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT02844062,Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02331498,Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03347097,Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04019002,Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT00635557,Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02937844,Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04610229,Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.
PID-005,Glioblastoma,52,NCT06687681,Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
PID-005,Glioblastoma,52,NCT01752491,A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04421378,A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02550249,Neoadjuvant Nivolumab in Glioblastoma
PID-005,Glioblastoma,52,NCT05557292,RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02017249,Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01788280,Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab
PID-005,Glioblastoma,52,NCT01588769,A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients
PID-005,Glioblastoma,52,NCT01290692,Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
PID-005,Glioblastoma,52,NCT05798507,Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT02296476,A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)
PID-005,Glioblastoma,52,NCT00650949,Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
PID-005,Glioblastoma,52,NCT06346821,Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data
PID-005,Glioblastoma,52,NCT00311857,"Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)"
PID-005,Glioblastoma,52,NCT05410301,"Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma"
PID-005,Glioblastoma,52,NCT00704288,Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00083447,Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00589095,Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
PID-005,Glioblastoma,52,NCT01508117,Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
PID-005,Glioblastoma,52,NCT00792012,A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00267592,Safety and Efficacy of Talampanel in Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00590681,Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01115491,A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04801147,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00050986,Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04845919,Sonodynamic Therapy with ExAblate System in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT07052877,The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
PID-005,Glioblastoma,52,NCT07162324,"A Multicenter, Prospective Study for Glioblastoma Patients"
PID-005,Glioblastoma,52,NCT02189109,The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma
PID-005,Glioblastoma,52,NCT01663012,Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
PID-005,Glioblastoma,52,NCT05463848,Surgical Pembro +/- Olaparib w TMZ for rGBM
PID-005,Glioblastoma,52,NCT05551013,Treatment of Recurrent GBM With APG-157 Via Expanded Access
PID-005,Glioblastoma,52,NCT01604590,Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01071837,APG101 in Glioblastoma
PID-005,Glioblastoma,52,NCT06657027,Artificial Intelligence-Guided Radiotherapy Planning for Glioblastoma
PID-005,Glioblastoma,52,NCT04590664,Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
PID-005,Glioblastoma,52,NCT07119294,Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
PID-005,Glioblastoma,52,NCT06090903,Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
PID-005,Glioblastoma,52,NCT04790097,FET-PET Directed Simultaneous In-field Boost for Primary GBM
PID-005,Glioblastoma,52,NCT05190315,Chlorpromazine and Standard of Care in Glioblastoma
PID-005,Glioblastoma,52,NCT04530006,Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT06353360,TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
PID-005,Glioblastoma,52,NCT00038493,Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT07093814,A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT05970757,Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
PID-005,Glioblastoma,52,NCT07121842,Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI
PID-005,Glioblastoma,52,NCT04002804,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03866109,A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMT
PID-005,Glioblastoma,52,NCT06176066,PH Sensitive MRI Based Resections of Glioblastoma
PID-005,Glioblastoma,52,NCT02104882,INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
PID-005,Glioblastoma,52,NCT03582514,PreOperative Brain Irradiation in Glioblastoma
PID-005,Glioblastoma,52,NCT06001281,Predictive Value of Soluble CD146 in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT02029573,Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
PID-005,Glioblastoma,52,NCT01091792,Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT01450449,Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05728125,Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients
PID-005,Glioblastoma,52,NCT00984438,Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05222802,A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
PID-005,Glioblastoma,52,NCT05432375,Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
PID-005,Glioblastoma,52,NCT00797940,Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
PID-005,Glioblastoma,52,NCT01526837,Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
PID-005,Glioblastoma,52,NCT04810182,Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
PID-005,Glioblastoma,52,NCT04614909,Study of Pamiparib in Newly Diagnosed and rGBM
PID-005,Glioblastoma,52,NCT04373785,NG101m Adjuvant Therapy in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT01587144,Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
PID-005,Glioblastoma,52,NCT00076986,The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT06764537,Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma
PID-005,Glioblastoma,52,NCT01260506,Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT06749925,Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma
PID-005,Glioblastoma,52,NCT04765098,Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
PID-005,Glioblastoma,52,NCT04118036,Abemaciclib + Pembrolizumab In Glioblastoma
PID-005,Glioblastoma,52,NCT04814329,Glioblastoma Response Prediction to Apatinib
PID-005,Glioblastoma,52,NCT02047214,Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
PID-005,Glioblastoma,52,NCT03849105,131I-IPA and Concurrent XRT in Recurrent GBM
PID-005,Glioblastoma,52,NCT00116376,Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT02410577,89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03212235,Hypofractionated Radiation Therapy for Glioblastoma
PID-005,Glioblastoma,52,NCT07173829,A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
PID-005,Glioblastoma,52,NCT06336291,A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
PID-005,Glioblastoma,52,NCT05512195,Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma
PID-005,Glioblastoma,52,NCT04406272,VB-111 in Surgically Accessible Recurrent/Progressive GBM
PID-005,Glioblastoma,52,NCT05653635,Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
PID-005,Glioblastoma,52,NCT00093964,Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
PID-005,Glioblastoma,52,NCT01402063,PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
PID-005,Glioblastoma,52,NCT06061809,N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT06038604,Glioblastoma Psychosocial Support Program
PID-005,Glioblastoma,52,NCT04492163,Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
PID-005,Glioblastoma,52,NCT02378532,The Addition of Chloroquine to Chemoradiation for Glioblastoma
PID-005,Glioblastoma,52,NCT05708352,A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
PID-005,Glioblastoma,52,NCT01618747,An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse
PID-005,Glioblastoma,52,NCT07141732,Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy
PID-005,Glioblastoma,52,NCT06672575,A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02926222,Regorafenib in Relapsed Glioblastoma
PID-005,Glioblastoma,52,NCT06132438,Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
PID-005,Glioblastoma,52,NCT02751138,Determination of Immune Phenotype in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT00238797,"A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT02928575,"Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma"
PID-005,Glioblastoma,52,NCT05927610,Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
PID-005,Glioblastoma,52,NCT05366179,Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
PID-005,Glioblastoma,52,NCT05641220,Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.
PID-005,Glioblastoma,52,NCT05083754,Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
PID-005,Glioblastoma,52,NCT04977375,Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01933815,Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
PID-005,Glioblastoma,52,NCT04116411,A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT05700955,Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06490497,Expectations and Needs of a Glioblastoma Caregiver
PID-005,Glioblastoma,52,NCT04747145,Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma
PID-005,Glioblastoma,52,NCT06222138,Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00345163,A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
PID-005,Glioblastoma,52,NCT05635734,Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00916409,Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT01778530,TRC105 for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06625684,Key Longitudinal Associations With Risk and Glioblastoma Outcomes
PID-005,Glioblastoma,52,NCT07145112,Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00904852,Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT06512311,Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
PID-005,Glioblastoma,52,NCT05756985,Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
PID-005,Glioblastoma,52,NCT04552977,A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06613841,"Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma"
PID-005,Glioblastoma,52,NCT04772846,Chloroquine for Glioblastoma.
PID-005,Glioblastoma,52,NCT00684567,Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
PID-005,Glioblastoma,52,NCT01259869,A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression
PID-005,Glioblastoma,52,NCT03276286,Nativis Voyager for Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT02176720,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-005,Glioblastoma,52,NCT05781321,"Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study"
PID-005,Glioblastoma,52,NCT06845020,CSF Proteomic Characterization of Glioblastomas
PID-005,Glioblastoma,52,NCT02049489,A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02067156,"Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma"
PID-005,Glioblastoma,52,NCT03712293,ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
PID-005,Glioblastoma,52,NCT01849146,"Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma"
PID-005,Glioblastoma,52,NCT01089868,Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
PID-005,Glioblastoma,52,NCT05986851,Azeliragon in MGMT Unmethylated Glioblastoma
PID-005,Glioblastoma,52,NCT04657146,Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT05669820,Antisecretory Factor Glioblastoma Phase 2
PID-005,Glioblastoma,52,NCT04417933,Tumor Electric Fields Treatment System for Glioblastoma
PID-005,Glioblastoma,52,NCT06780592,Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
PID-005,Glioblastoma,52,NCT03048240,INtraoperative photoDYnamic Therapy of GliOblastoma
PID-005,Glioblastoma,52,NCT05015543,Physical Training in Glioblastoma Patients During Cytotoxic Therapy
PID-005,Glioblastoma,52,NCT05109728,A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
PID-005,Glioblastoma,52,NCT06218524,The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM
PID-005,Glioblastoma,52,NCT04671459,TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine
PID-005,Glioblastoma,52,NCT05556382,Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity
PID-005,Glioblastoma,52,NCT06448286,PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT05186064,Glioblastoma Targeted Treatment Option Maximization by WGS
PID-005,Glioblastoma,52,NCT06556563,EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT05515133,Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients
PID-005,Glioblastoma,52,NCT04319276,Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
PID-005,Glioblastoma,52,NCT02977780,INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
PID-005,Glioblastoma,52,NCT06831526,Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00805961,"RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM"
PID-005,Glioblastoma,52,NCT04656535,AB154 Combined With AB122 for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04391062,Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma
PID-005,Glioblastoma,52,NCT01290263,Amgen 386 for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04752280,Glioblastoma Radiotherapy Using IMRT or Proton Beams
PID-005,Glioblastoma,52,NCT06183983,Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
PID-005,Glioblastoma,52,NCT01851733,MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01493219,Biomarkers for Prognosis of Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT06524063,Targeted Survivin DC Cell Injection for the Treatment of GBM
PID-005,Glioblastoma,52,NCT03862430,A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT02815410,Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
PID-005,Glioblastoma,52,NCT05735171,Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence
PID-005,Glioblastoma,52,NCT03661723,Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06113705,Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
PID-005,Glioblastoma,52,NCT01468324,AZD7451 for Recurrent Gliomas
PID-005,Glioblastoma,52,NCT03419403,UNITE Study: Understanding New Interventions With GBM ThErapy
PID-005,Glioblastoma,52,NCT05938387,Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
PID-005,Glioblastoma,52,NCT03403803,Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
PID-005,Glioblastoma,52,NCT00892177,Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05539339,Personalized Trial in ctDNA-level-relapse Glioblastoma
PID-005,Glioblastoma,52,NCT04856852,Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT07144735,Allogeneic γδT Cells in Glioblastoma
PID-005,Glioblastoma,52,NCT00402116,Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
PID-005,Glioblastoma,52,NCT05664464,Glutamate Inhibitors in Glioblastoma
PID-005,Glioblastoma,52,NCT03687099,Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma
PID-005,Glioblastoma,52,NCT04443010,Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT04243005,Supramarginal Resection in Glioblastoma
PID-005,Glioblastoma,52,NCT00456612,Radiosurgery for Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05656300,Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?
PID-005,Glioblastoma,52,NCT04730869,Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
PID-005,Glioblastoma,52,NCT04959500,Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT05768087,Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients
PID-005,Glioblastoma,52,NCT06600399,Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma
PID-005,Glioblastoma,52,NCT04583020,Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT05303467,A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
PID-005,Glioblastoma,52,NCT04359745,Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression
PID-005,Glioblastoma,52,NCT05541042,Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
PID-005,Glioblastoma,52,NCT04599647,EAP for the Treatment of Glioblastoma With PVSRIPO
PID-005,Glioblastoma,52,NCT06297512,Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
PID-005,Glioblastoma,52,NCT06140875,Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
PID-005,Glioblastoma,52,NCT00704808,Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
PID-005,Glioblastoma,52,NCT00508456,Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
PID-005,Glioblastoma,52,NCT03139916,Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01345370,Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT05074992,A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02546102,"Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma"
PID-005,Glioblastoma,52,NCT05871021,Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
PID-005,Glioblastoma,52,NCT02850744,"Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients"
PID-005,Glioblastoma,52,NCT03194971,NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
PID-005,Glioblastoma,52,NCT03151772,Bioavailability of Disulfiram and Metformin in Glioblastomas
PID-005,Glioblastoma,52,NCT05753007,"A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients"
PID-005,Glioblastoma,52,NCT02709616,Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
PID-005,Glioblastoma,52,NCT07047066,A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02808364,Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)
PID-005,Glioblastoma,52,NCT04536649,Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.
PID-005,Glioblastoma,52,NCT05140902,Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
PID-005,Glioblastoma,52,NCT02286167,Glioma Modified Atkins-based Diet in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT00171938,Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
PID-005,Glioblastoma,52,NCT02715609,Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT05241392,Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00115453,Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
PID-005,Glioblastoma,52,NCT01907165,Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
PID-005,Glioblastoma,52,NCT02092038,Preoperative Chemoradiation for Glioblastoma
PID-005,Glioblastoma,52,NCT02780024,"Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM"
PID-005,Glioblastoma,52,NCT06146738,The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
PID-005,Glioblastoma,52,NCT04863950,Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06924099,TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
PID-005,Glioblastoma,52,NCT02880410,Feasibility Study on LITT for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02394626,Surgery for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06551909,Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
PID-005,Glioblastoma,52,NCT05183204,"Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma"
PID-005,Glioblastoma,52,NCT04716699,Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma
PID-005,Glioblastoma,52,NCT03390569,Exercise in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT04596930,MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma
PID-005,Glioblastoma,52,NCT05811793,Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
PID-005,Glioblastoma,52,NCT04250922,LAM561 With RT and TMZ for Adults With Glioblastoma
PID-005,Glioblastoma,52,NCT01109095,CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
PID-005,Glioblastoma,52,NCT04221061,18F-FluorThanatrace (PET/CT) in Glioblastoma
PID-005,Glioblastoma,52,NCT04922723,Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
PID-005,Glioblastoma,52,NCT06102525,"A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma"
PID-005,Glioblastoma,52,NCT03780569,TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT03055208,Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT03119064,BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01666600,NOA-12: BIBF1120 and R-RT in Glioblastoma
PID-005,Glioblastoma,52,NCT04280848,Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
PID-005,Glioblastoma,52,NCT03395587,Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT03293888,Spectral Analysis Probe to Identify Glioblastoma Cells
PID-005,Glioblastoma,52,NCT03529448,TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT04829097,Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma
PID-005,Glioblastoma,52,NCT04765514,Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients
PID-005,Glioblastoma,52,NCT05793021,FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
PID-005,Glioblastoma,52,NCT01562197,A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04708171,The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
PID-005,Glioblastoma,52,NCT00104091,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-005,Glioblastoma,52,NCT04691960,A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
PID-005,Glioblastoma,52,NCT01474239,A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04516733,Precoce Medical Care by the Mobil Support for Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT04826393,ASP8374 + Cemiplimab in Recurrent Glioma
PID-005,Glioblastoma,52,NCT03739333,Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.
PID-005,Glioblastoma,52,NCT05502991,Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma
PID-005,Glioblastoma,52,NCT02157103,A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT04284306,Immunohistochemical Assessment of Programmed Death ligand1 and LC3B in GBM
PID-005,Glioblastoma,52,NCT04157478,Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01478854,Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
PID-005,Glioblastoma,52,NCT03243851,Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
PID-005,Glioblastoma,52,NCT04629209,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma"
PID-005,Glioblastoma,52,NCT03743662,Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
PID-005,Glioblastoma,52,NCT02206230,Trial of Hypofractionated Radiation Therapy for Glioblastoma
PID-005,Glioblastoma,52,NCT00686725,Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
PID-005,Glioblastoma,52,NCT04881032,AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT06105619,A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
PID-005,Glioblastoma,52,NCT00262730,Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT02379572,Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
PID-005,Glioblastoma,52,NCT05304663,Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression
PID-005,Glioblastoma,52,NCT02663440,Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01777919,Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
PID-005,Glioblastoma,52,NCT02062372,Spatial Analysis and Validation of Glioblastoma on 7 T MRI
PID-005,Glioblastoma,52,NCT04219475,Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients
PID-005,Glioblastoma,52,NCT05698199,"Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)"
PID-005,Glioblastoma,52,NCT01898273,Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02202993,TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM
PID-005,Glioblastoma,52,NCT01622764,89Zr-RO5323441 PET Imaging in Glioblastoma
PID-005,Glioblastoma,52,NCT04963413,RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.
PID-005,Glioblastoma,52,NCT03491683,INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT02841332,Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00068952,Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01169415,Effects of Steroid Tapering on Functional Capacity and Neurocognition
PID-005,Glioblastoma,52,NCT05333588,The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.
PID-005,Glioblastoma,52,NCT04225039,"Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma"
PID-005,Glioblastoma,52,NCT04552886,Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma
PID-005,Glioblastoma,52,NCT02394665,Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
PID-005,Glioblastoma,52,NCT03995706,Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
PID-005,Glioblastoma,52,NCT03663725,Treatment Intensification With Temozolomide in Adults With a Glioblastoma
PID-005,Glioblastoma,52,NCT04642937,Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03493932,Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
PID-005,Glioblastoma,52,NCT02617745,Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
PID-005,Glioblastoma,52,NCT02715297,Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04471844,"Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM"
PID-005,Glioblastoma,52,NCT05187624,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma"
PID-005,Glioblastoma,52,NCT04933422,CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
PID-005,Glioblastoma,52,NCT03374943,A Trial of KB004 in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT01225510,A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06477939,Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients
PID-005,Glioblastoma,52,NCT04119674,Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT03231501,HMPL-813 in Treating Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT04574856,Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT03770468,"Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma"
PID-005,Glioblastoma,52,NCT04547855,Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
PID-005,Glioblastoma,52,NCT02146066,Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
PID-005,Glioblastoma,52,NCT02336165,Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT07076472,Sonodynamic Therapy With SONALA-001 and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02441322,Evaluating Therapeutic Response to Novo-TTF
PID-005,Glioblastoma,52,NCT04324840,A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01403285,Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT06740955,Hypofractionated Radiotherapy
PID-005,Glioblastoma,52,NCT04019262,Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT04015700,"Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-005,Glioblastoma,52,NCT01473901,A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT06676891,Expanded Access Program for GBM Subjects
PID-005,Glioblastoma,52,NCT03587038,OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02725684,Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
PID-005,Glioblastoma,52,NCT04846257,Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence
PID-005,Glioblastoma,52,NCT03246113,Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
PID-005,Glioblastoma,52,NCT01308632,Metronomic Temozolamide in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01308684,A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01782976,Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT01846871,Tivozanib for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02893137,Enhancing Optune Therapy With Targeted Craniectomy
PID-005,Glioblastoma,52,NCT03926507,F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
PID-005,Glioblastoma,52,NCT04573192,A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
PID-005,Glioblastoma,52,NCT06936046,Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression
PID-005,Glioblastoma,52,NCT02904525,Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model
PID-005,Glioblastoma,52,NCT03567135,Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma
PID-005,Glioblastoma,52,NCT03297125,Assessment of Optune Therapy for Patients with Newly Diagnosed Glioblastoma Using Advanced MRI
PID-005,Glioblastoma,52,NCT02910804,IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT01189513,SCH-900105 in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04485949,A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT00397072,Epothilone in Recurrent Glioblastoma Patients
PID-005,Glioblastoma,52,NCT00821080,Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02511405,"A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)"
PID-005,Glioblastoma,52,NCT02981940,A Study of Abemaciclib in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02630030,Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT03347617,Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT06054529,Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
PID-005,Glioblastoma,52,NCT04121455,Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
PID-005,Glioblastoma,52,NCT02254954,"Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma"
PID-005,Glioblastoma,52,NCT04047706,"Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma"
PID-005,Glioblastoma,52,NCT06973096,CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PID-005,Glioblastoma,52,NCT03388372,Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma
PID-005,Glioblastoma,52,NCT02149225,GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
PID-005,Glioblastoma,52,NCT02478164,Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
PID-005,Glioblastoma,52,NCT03679754,"Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102"
PID-005,Glioblastoma,52,NCT04006119,Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT03687034,A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT03477110,"Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma"
PID-005,Glioblastoma,52,NCT03922984,Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma
PID-005,Glioblastoma,52,NCT04762069,A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05864976,Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
PID-005,Glioblastoma,52,NCT01756352,FET-PET for Evaluation of Response of Recurrent GBM to Avastin
PID-005,Glioblastoma,52,NCT01112527,PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03548571,Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
PID-005,Glioblastoma,52,NCT01939574,A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
PID-005,Glioblastoma,52,NCT03897491,PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
PID-005,Glioblastoma,52,NCT03152708,CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT04224441,Repurposing Chlorpromazine in the Treatment of Glioblastoma
PID-005,Glioblastoma,52,NCT03535350,Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02669173,Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02902757,FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT02728349,Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma
PID-005,Glioblastoma,52,NCT02770378,A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01043536,Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
PID-005,Glioblastoma,52,NCT05376800,A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma
PID-005,Glioblastoma,52,NCT03481231,In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT02330991,A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
PID-005,Glioblastoma,52,NCT02329795,Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
PID-005,Glioblastoma,52,NCT07029100,Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.
PID-005,Glioblastoma,52,NCT04717739,"TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study"
PID-005,Glioblastoma,52,NCT01923922,CT Perfusion in the Prognostication of Cerebral High Grade Glioma
PID-005,Glioblastoma,52,NCT04007185,Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)
PID-005,Glioblastoma,52,NCT03233152,Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03636477,A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
PID-005,Glioblastoma,52,NCT04566185,Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02590497,Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
PID-005,Glioblastoma,52,NCT00509821,"Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma"
PID-005,Glioblastoma,52,NCT03439332,Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma
PID-005,Glioblastoma,52,NCT02876003,Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma
PID-005,Glioblastoma,52,NCT03223103,Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
PID-005,Glioblastoma,52,NCT05108012,Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
PID-005,Glioblastoma,52,NCT00694837,Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
PID-005,Glioblastoma,52,NCT02799238,Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT02342379,TH-302 in Combination With Bevacizumab for Glioblastoma
PID-005,Glioblastoma,52,NCT01443676,Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT05328089,Vacuolar ATPase and Drug Resistance of High Grade Gliomas
PID-005,Glioblastoma,52,NCT00943007,Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors
PID-005,Glioblastoma,52,NCT01499251,Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05664243,"A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma"
PID-005,Glioblastoma,52,NCT03383978,Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
PID-005,Glioblastoma,52,NCT01989884,An Efficacy Study Of Ortataxel In Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05900908,Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy
PID-005,Glioblastoma,52,NCT01811121,MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS
PID-005,Glioblastoma,52,NCT02654964,Cancer Stem Cell High-Throughput Drug Screening Study
PID-005,Glioblastoma,52,NCT01854099,Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens
PID-005,Glioblastoma,52,NCT03393000,Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
PID-005,Glioblastoma,52,NCT03422094,"Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-005,Glioblastoma,52,NCT03631836,"Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma"
PID-005,Glioblastoma,52,NCT03287063,"Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma"
PID-005,Glioblastoma,52,NCT00643825,"Prolonged Adjuvant Temozolomide vs ""Stop & Go"" in Glioblastoma Patients"
PID-005,Glioblastoma,52,NCT01872221,Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study
PID-005,Glioblastoma,52,NCT01260467,Memantine for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01213407,Dendritic Cell Cancer Vaccine for High-grade Glioma
PID-005,Glioblastoma,52,NCT05590689,Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
PID-005,Glioblastoma,52,NCT05342883,GammaTile and Stupp in Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT01867593,MET-PET for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02060955,Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan
PID-005,Glioblastoma,52,NCT00029783,Efficacy of Distant Healing in Glioblastoma Treatment
PID-005,Glioblastoma,52,NCT02359097,Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT03776071,"A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1"
PID-005,Glioblastoma,52,NCT05753995,"Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study"
PID-005,Glioblastoma,52,NCT01759810,Proteome-based Personalized Immunotherapy of Glioblastoma
PID-005,Glioblastoma,52,NCT00906893,Evaluation of [18F]-FMISO for Non Operated Glioblastoma
PID-005,Glioblastoma,52,NCT02718443,VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
PID-005,Glioblastoma,52,NCT02430363,Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
PID-005,Glioblastoma,52,NCT02343406,Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
PID-005,Glioblastoma,52,NCT04726397,UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial
PID-005,Glioblastoma,52,NCT01582269,A Study in Recurrent Glioblastoma (GB)
PID-005,Glioblastoma,52,NCT02939378,Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study
PID-005,Glioblastoma,52,NCT05820191,B-amyloid as a Marker for GBM Bioimaging
PID-005,Glioblastoma,52,NCT00807027,Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
PID-005,Glioblastoma,52,NCT03018288,Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT01331291,Bosutinib in Adult Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02704858,Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
PID-005,Glioblastoma,52,NCT01100177,Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients
PID-005,Glioblastoma,52,NCT02014844,Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
PID-005,Glioblastoma,52,NCT05168423,CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
PID-005,Glioblastoma,52,NCT04868396,Patient-derived Glioma Stem Cell Organoids
PID-005,Glioblastoma,52,NCT00944801,Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02866747,A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02869243,A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
PID-005,Glioblastoma,52,NCT00295815,Enzastaurin Versus Lomustine in Glioblastoma
PID-005,Glioblastoma,52,NCT03382977,"Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects"
PID-005,Glioblastoma,52,NCT01310868,Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
PID-005,Glioblastoma,52,NCT00790452,Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
PID-005,Glioblastoma,52,NCT02648633,Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04321694,Expanded Access for KHK2455
PID-005,Glioblastoma,52,NCT01856933,BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT01430351,"Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy"
PID-005,Glioblastoma,52,NCT06954636,Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
PID-005,Glioblastoma,52,NCT00941460,Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01364064,Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00385853,PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
PID-005,Glioblastoma,52,NCT03939858,Bioenergetic Profiling and Cognition in GBM Patients
PID-005,Glioblastoma,52,NCT01507506,Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
PID-005,Glioblastoma,52,NCT00703859,Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT03970447,A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02078648,"Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT00948389,Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT01310855,Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT01985087,A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
PID-005,Glioblastoma,52,NCT02315534,A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
PID-005,Glioblastoma,52,NCT00762255,A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03149003,A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
PID-005,Glioblastoma,52,NCT02209948,Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
PID-005,Glioblastoma,52,NCT02520635,Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients
PID-005,Glioblastoma,52,NCT03961971,Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
PID-005,Glioblastoma,52,NCT01083719,A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
PID-005,Glioblastoma,52,NCT04385173,Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
PID-005,Glioblastoma,52,NCT01044225,Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
PID-005,Glioblastoma,52,NCT01934361,Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00967330,A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT03454295,Easing Psychosocial Burden for Informal Caregivers
PID-005,Glioblastoma,52,NCT01464177,Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00088400,Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors
PID-005,Glioblastoma,52,NCT04528680,Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03642080,MRI Predictors of Response to Tumor Treating Fields
PID-005,Glioblastoma,52,NCT01339052,Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04313842,A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED
PID-005,Glioblastoma,52,NCT00813943,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status"
PID-005,Glioblastoma,52,NCT02968940,Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
PID-005,Glioblastoma,52,NCT04802447,SurVaxM Expanded Access Protocol
PID-005,Glioblastoma,52,NCT01880008,Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT00392548,URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol
PID-005,Glioblastoma,52,NCT02179086,Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT04838782,Role of Repeat Resection in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00689221,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status"
PID-005,Glioblastoma,52,NCT04205357,Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00725010,Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
PID-005,Glioblastoma,52,NCT03726515,CART-EGFRvIII + Pembrolizumab in GBM
PID-005,Glioblastoma,52,NCT01632228,A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00521482,Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05450744,131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)
PID-005,Glioblastoma,52,NCT03538587,Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
PID-005,Glioblastoma,52,NCT01702792,Derivation of Tumor Specific Hybridomas
PID-005,Glioblastoma,52,NCT04077866,B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
PID-005,Glioblastoma,52,NCT06136611,Preoperative Preradiotherapy TTFields
PID-005,Glioblastoma,52,NCT04915404,Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
PID-005,Glioblastoma,52,NCT03477513,Personalized Radiation Therapy for GBM
PID-005,Glioblastoma,52,NCT03452579,Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
PID-005,Glioblastoma,52,NCT05917145,ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT04474353,Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT05768919,Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
PID-005,Glioblastoma,52,NCT00501891,Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT06146725,The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
PID-005,Glioblastoma,52,NCT03008148,Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT05801159,[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT03869242,NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT05053880,A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00943826,A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01860638,A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
PID-005,Glioblastoma,52,NCT04315584,FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
PID-005,Glioblastoma,52,NCT02654041,Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
PID-005,Glioblastoma,52,NCT05326464,Tofacitinib in Recurrent GBM Patients
PID-005,Glioblastoma,52,NCT05296122,Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
PID-005,Glioblastoma,52,NCT06649851,G-CSF After Chemo-radiation in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT03688178,DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
PID-005,Glioblastoma,52,NCT03782415,Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03250299,Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02337491,Pembrolizumab +/- Bevacizumab for Recurrent GBM
PID-005,Glioblastoma,52,NCT01124539,Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
PID-005,Glioblastoma,52,NCT03927222,Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
PID-005,Glioblastoma,52,NCT02287428,Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT02905643,Discerning Pseudoprogression vs True Tumor Growth in GBMs
PID-005,Glioblastoma,52,NCT03197506,Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT06991101,Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT03258021,TTFields In GErmany in Routine Clinical Care
PID-005,Glioblastoma,52,NCT02458508,Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy
PID-005,Glioblastoma,52,NCT00003456,Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05627323,CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT04545177,Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
PID-005,Glioblastoma,52,NCT05759195,Biomolecular Analysis for Predicting Response to Regorafenib
PID-005,Glioblastoma,52,NCT02367482,Tryptophan Metabolism in Human Brain Tumors-Novocure
PID-005,Glioblastoma,52,NCT00481455,Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT00693095,Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer
PID-005,Glioblastoma,52,NCT05236036,Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
PID-005,Glioblastoma,52,NCT00003474,Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03047473,Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01208909,Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)
PID-005,Glioblastoma,52,NCT05063682,The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
PID-005,Glioblastoma,52,NCT05902169,Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
PID-005,Glioblastoma,52,NCT06815432,GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
PID-005,Glioblastoma,52,NCT03616860,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
PID-005,Glioblastoma,52,NCT03603379,Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
PID-005,Glioblastoma,52,NCT04479241,LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02085304,"Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM"
PID-005,Glioblastoma,52,NCT01186406,"Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)"
PID-005,Glioblastoma,52,NCT06917885,CUE-102 in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00977431,Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
PID-005,Glioblastoma,52,NCT00979017,Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03643549,Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
PID-005,Glioblastoma,52,NCT00290771,Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT02899663,MRI Detection of Microbleeds in Glioma Patients
PID-005,Glioblastoma,52,NCT00895180,Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05653622,Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma
PID-005,Glioblastoma,52,NCT04221503,Niraparib/TTFields in GBM
PID-005,Glioblastoma,52,NCT02698280,Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
PID-005,Glioblastoma,52,NCT05685004,Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT02631655,POSitron Emission Imaging Using 18F-FDOPA in Neurooncology
PID-005,Glioblastoma,52,NCT00576537,Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
PID-005,Glioblastoma,52,NCT02585219,Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas
PID-005,Glioblastoma,52,NCT03278249,Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
PID-005,Glioblastoma,52,NCT00687765,Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
PID-005,Glioblastoma,52,NCT00616005,Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
PID-005,Glioblastoma,52,NCT02302235,Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study
PID-005,Glioblastoma,52,NCT04003649,IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
PID-005,Glioblastoma,52,NCT02843230,Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
PID-005,Glioblastoma,52,NCT02473484,Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas
PID-005,Glioblastoma,52,NCT05432518,Pilot Trial for Treatment of Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03025893,"A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT01602588,A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)
PID-005,Glioblastoma,52,NCT06552260,A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
PID-005,Glioblastoma,52,NCT01011231,Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma
PID-005,Glioblastoma,52,NCT05977738,Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin
PID-005,Glioblastoma,52,NCT06356883,Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
PID-005,Glioblastoma,52,NCT00884741,Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00509301,Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01653834,Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
PID-005,Glioblastoma,52,NCT05868083,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01105988,Evaluating Tumor Pseudoprogression With FLT-PET and MRI
PID-005,Glioblastoma,52,NCT06039709,Sonodynamic Therapy in Patients With Recurrent GBM
PID-005,Glioblastoma,52,NCT05052957,hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
PID-005,Glioblastoma,52,NCT03235934,Glycemic Impact on Glioblastoma Outcomes
PID-005,Glioblastoma,52,NCT01535911,Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
PID-005,Glioblastoma,52,NCT06850766,The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
PID-005,Glioblastoma,52,NCT07100730,Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01251484,BIBF 1120 in Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT06283927,The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
PID-005,Glioblastoma,52,NCT05095441,A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT05131711,Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)
PID-005,Glioblastoma,52,NCT06186440,Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
PID-005,Glioblastoma,52,NCT00611728,Ph I SU011248 + Irinotecan in Treatment of Pts w MG
PID-005,Glioblastoma,52,NCT04469699,Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05663125,LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
PID-005,Glioblastoma,52,NCT01498328,A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PID-005,Glioblastoma,52,NCT00961090,Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
PID-005,Glioblastoma,52,NCT03107780,Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
PID-005,Glioblastoma,52,NCT02474966,Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study
PID-005,Glioblastoma,52,NCT01149850,Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
PID-005,Glioblastoma,52,NCT01737346,Procarbazine and Lomustine in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT07143812,A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00597493,Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM
PID-005,Glioblastoma,52,NCT07134842,A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
PID-005,Glioblastoma,52,NCT02466828,qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.
PID-005,Glioblastoma,52,NCT00574964,Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT06782984,Drug Response Testing and Repurposing Using Glioblastoma Organoid
PID-005,Glioblastoma,52,NCT06835803,Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: a Phase 2 Hybrid Randomized Trial
PID-005,Glioblastoma,52,NCT03480867,Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)
PID-005,Glioblastoma,52,NCT00306618,Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
PID-005,Glioblastoma,52,NCT06616727,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
PID-005,Glioblastoma,52,NCT01591577,Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00412542,Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
PID-005,Glioblastoma,52,NCT05666349,Reirradiation and Niraparib in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00379470,Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT00187486,"Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors"
PID-005,Glioblastoma,52,NCT06757153,Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
PID-005,Glioblastoma,52,NCT07145047,Clinical Study of Oncolytic Virus in Glioblastoma
PID-005,Glioblastoma,52,NCT05577091,Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02137759,MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
PID-005,Glioblastoma,52,NCT03463733,Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
PID-005,Glioblastoma,52,NCT02613988,Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
PID-005,Glioblastoma,52,NCT04952571,Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT01903330,ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03632135,Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04469075,Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
PID-005,Glioblastoma,52,NCT04004975,Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
PID-005,Glioblastoma,52,NCT03557372,Mathematical Model-Adapted Radiation In Glioblastoma
PID-005,Glioblastoma,52,NCT05607407,Methimazole in Patients With Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT04902586,Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT06805305,DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT03681028,Feasibility of Individualized Therapy for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02844439,Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04968366,Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
PID-005,Glioblastoma,52,NCT05737368,Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
PID-005,Glioblastoma,52,NCT06598787,A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06894225,Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
PID-005,Glioblastoma,52,NCT05743595,"Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-005,Glioblastoma,52,NCT03665545,Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
PID-005,Glioblastoma,52,NCT03672721,IA Carboplatin + Radiotherapy in Relapsing GBM
PID-005,Glioblastoma,52,NCT06934889,Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
PID-005,Glioblastoma,52,NCT04523688,Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
PID-005,Glioblastoma,52,NCT00154375,Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT05936216,TVI-Brain-1 in Expanded Access Patient
PID-005,Glioblastoma,52,NCT05736406,A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma
PID-005,Glioblastoma,52,NCT04559230,Sacituzumab Govitecan in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04888611,Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04051606,Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06368934,Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
PID-005,Glioblastoma,52,NCT04842513,Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT03452930,Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
PID-005,Glioblastoma,52,NCT06389591,RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT06418113,Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT03405792,Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
PID-005,Glioblastoma,52,NCT06220552,The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05043701,Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01957956,Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT06069726,A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
PID-005,Glioblastoma,52,NCT05720078,UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)
PID-005,Glioblastoma,52,NCT03430791,"Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma"
PID-005,Glioblastoma,52,NCT04128774,Function and Composition of Regulatory B Cells in Participants With Glioblastoma
PID-005,Glioblastoma,52,NCT06325683,Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05218408,CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
PID-005,Glioblastoma,52,NCT02649582,Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT03225963,Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.
PID-005,Glioblastoma,52,NCT05638451,Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
PID-005,Glioblastoma,52,NCT06097975,A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06011109,Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PID-005,Glioblastoma,52,NCT05911230,Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
PID-005,Glioblastoma,52,NCT02076152,FMISO PET Study of Glioblastoma
PID-005,Glioblastoma,52,NCT04674527,Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
PID-005,Glioblastoma,52,NCT03630289,Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
PID-005,Glioblastoma,52,NCT03181477,"Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas"
PID-005,Glioblastoma,52,NCT01205334,Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04717999,Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06558214,"OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial"
PID-005,Glioblastoma,52,NCT03225300,Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation
PID-005,Glioblastoma,52,NCT05284643,"Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma"
PID-005,Glioblastoma,52,NCT05201326,Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06157541,T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT05076513,Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
PID-005,Glioblastoma,52,NCT05191784,GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients
PID-005,Glioblastoma,52,NCT05540275,Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02152982,Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04116658,"First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma"
PID-005,Glioblastoma,52,NCT00575146,Ketogenic Diet for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04013672,Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
PID-005,Glioblastoma,52,NCT03916757,V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer
PID-005,Glioblastoma,52,NCT02227576,Prevention of Thrombocytopenia in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT05802693,"A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma"
PID-005,Glioblastoma,52,NCT05324501,A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04689087,"A Prospective, Open-label, Single-arm Clinical Study"
PID-005,Glioblastoma,52,NCT00960492,Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
PID-005,Glioblastoma,52,NCT00555399,"Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)"
PID-005,Glioblastoma,52,NCT05341947,Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03451799,Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT01830101,A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03232424,NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02663271,TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02060890,Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT05879120,Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04974983,Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03722342,TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03341806,Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00657267,Dose-Intense Temozolomide in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02364206,Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT03750071,VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT01110876,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)"
PID-005,Glioblastoma,52,NCT02678975,Disulfiram in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05095376,Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
PID-005,Glioblastoma,52,NCT00400322,Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
PID-005,Glioblastoma,52,NCT02207010,A Phase 0 Study of AZD1775 in Recurrent GBM Patients
PID-005,Glioblastoma,52,NCT03137888,Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
PID-005,Glioblastoma,52,NCT03856099,TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
PID-005,Glioblastoma,52,NCT05118776,Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
PID-005,Glioblastoma,52,NCT04201873,Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04988750,Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
PID-005,Glioblastoma,52,NCT03216499,HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03865355,Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
PID-005,Glioblastoma,52,NCT01349036,A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04047303,"CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma"
PID-005,Glioblastoma,52,NCT04555577,"Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma"
PID-005,Glioblastoma,52,NCT02366728,DC Migration Study for Newly-Diagnosed GBM
PID-005,Glioblastoma,52,NCT03514069,Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
PID-005,Glioblastoma,52,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-005,Glioblastoma,52,NCT04397679,"Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma"
PID-005,Glioblastoma,52,NCT02599090,Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-005,Glioblastoma,52,NCT07138001,Phase 2 Clinical Trial of KH617
PID-005,Glioblastoma,52,NCT02345824,Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
PID-005,Glioblastoma,52,NCT02919332,Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01113398,AMG 102 and Avastin for Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT00441142,Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
PID-005,Glioblastoma,52,NCT03034135,"Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma"
PID-005,Glioblastoma,52,NCT03522298,"Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma"
PID-005,Glioblastoma,52,NCT03033524,Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03867123,A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
PID-005,Glioblastoma,52,NCT02974621,Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02530502,Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02133183,Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06186401,Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
PID-005,Glioblastoma,52,NCT00921167,A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
PID-005,Glioblastoma,52,NCT00841555,Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
PID-005,Glioblastoma,52,NCT02933736,Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
PID-005,Glioblastoma,52,NCT02129335,"Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner"
PID-005,Glioblastoma,52,NCT05879250,WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02340156,Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01866449,Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02781792,Temozolomide Chronotherapy for High Grade Glioma
PID-005,Glioblastoma,52,NCT00250887,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research"
PID-005,Glioblastoma,52,NCT03401866,Multi-site Validation and Application of a Consensus DSC-MRI Protocol
PID-005,Glioblastoma,52,NCT01756729,Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
PID-005,Glioblastoma,52,NCT06419946,Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
PID-005,Glioblastoma,52,NCT03573986,Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
PID-005,Glioblastoma,52,NCT03174197,Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02455557,SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00045968,Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
PID-005,Glioblastoma,52,NCT01813877,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-005,Glioblastoma,52,NCT04715620,Niraparib Combined With Radiotherapy in rGBM
PID-005,Glioblastoma,52,NCT00777153,Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04681677,Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
PID-005,Glioblastoma,52,NCT03744026,Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
PID-005,Glioblastoma,52,NCT04223999,Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)
PID-005,Glioblastoma,52,NCT01135875,Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
PID-005,Glioblastoma,52,NCT00525525,Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
PID-005,Glioblastoma,52,NCT02573324,A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
PID-005,Glioblastoma,52,NCT00365222,Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02754362,A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00734526,Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-005,Glioblastoma,52,NCT05565521,UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly
PID-005,Glioblastoma,52,NCT01987830,Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
PID-005,Glioblastoma,52,NCT05431348,Effect of StRess and ExeRcize on the Outcome After Chemo-Radiation
PID-005,Glioblastoma,52,NCT01754350,"Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma"
PID-005,Glioblastoma,52,NCT04440358,Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
PID-005,Glioblastoma,52,NCT02017717,A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT02885272,FDG PET Imaging in Diagnosing Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT04417088,Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
PID-005,Glioblastoma,52,NCT01165671,Carbon Ion Radiotherapy for Primary Glioblastoma
PID-005,Glioblastoma,52,NCT05271240,Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT05864534,Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00071539,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-005,Glioblastoma,52,NCT07089758,A Study for Cerebral Open Flow Microperfusion
PID-005,Glioblastoma,52,NCT02046187,Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01115036,A Panobinostat Presurgery
PID-005,Glioblastoma,52,NCT00612989,Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM
PID-005,Glioblastoma,52,NCT05182905,AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
PID-005,Glioblastoma,52,NCT00612339,Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
PID-005,Glioblastoma,52,NCT02717962,"Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting"
PID-005,Glioblastoma,52,NCT03158389,NCT Neuro Master Match - N²M² (NOA-20)
PID-005,Glioblastoma,52,NCT03291977,Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)
PID-005,Glioblastoma,52,NCT00250211,Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
PID-005,Glioblastoma,52,NCT00200161,Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
PID-005,Glioblastoma,52,NCT05914935,Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00335075,Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
PID-005,Glioblastoma,52,NCT02062827,Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT03014804,Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04222309,Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-005,Glioblastoma,52,NCT06095375,"Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients"
PID-005,Glioblastoma,52,NCT01956734,Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03277638,Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
PID-005,Glioblastoma,52,NCT01836536,Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients
PID-005,Glioblastoma,52,NCT05100641,AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT04105374,"Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma"
PID-005,Glioblastoma,52,NCT00615927,Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
PID-005,Glioblastoma,52,NCT00672243,Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
PID-005,Glioblastoma,52,NCT03877861,Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms
PID-005,Glioblastoma,52,NCT03868943,Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
PID-005,Glioblastoma,52,NCT01567202,Study of DC Vaccination Against Glioblastoma
PID-005,Glioblastoma,52,NCT03551249,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
PID-005,Glioblastoma,52,NCT03532295,Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
PID-005,Glioblastoma,52,NCT01702610,Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT06585527,Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT02510950,Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00613028,Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
PID-005,Glioblastoma,52,NCT05879367,Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
PID-005,Glioblastoma,52,NCT00613132,Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
PID-005,Glioblastoma,52,NCT03149575,VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
PID-005,Glioblastoma,52,NCT00611325,Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT01413438,Bevacizumab With or Without Surgery for Adult Glioblastomas
PID-005,Glioblastoma,52,NCT02010606,Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02833701,Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
PID-005,Glioblastoma,52,NCT01180816,Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
PID-005,Glioblastoma,52,NCT06455189,Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
PID-005,Glioblastoma,52,NCT02664363,EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
PID-005,Glioblastoma,52,NCT01269853,Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
PID-005,Glioblastoma,52,NCT05326334,THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)
PID-005,Glioblastoma,52,NCT00612430,Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
PID-005,Glioblastoma,52,NCT01386710,Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
PID-005,Glioblastoma,52,NCT00968240,Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
PID-005,Glioblastoma,52,NCT03722355,Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
PID-005,Glioblastoma,52,NCT00671970,Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
PID-005,Glioblastoma,52,NCT01986348,Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas
PID-005,Glioblastoma,52,NCT02026271,A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
PID-005,Glioblastoma,52,NCT06622434,"New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study"
PID-005,Glioblastoma,52,NCT01811498,Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT01067469,Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT02022384,Immunophenotyping From Blood of Patients With Malignant Gliomas
PID-005,Glioblastoma,52,NCT05990556,Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT02605746,Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis
PID-005,Glioblastoma,52,NCT02270034,Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01547546,A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT04674579,Automatic Segmentation MRI Cerebral Glioma
PID-005,Glioblastoma,52,NCT00735436,A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
PID-005,Glioblastoma,52,NCT01954576,NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00354913,Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
PID-005,Glioblastoma,52,NCT00609999,Ph I Dasatinib + Erlotinib in Recurrent MG
PID-005,Glioblastoma,52,NCT05624736,Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning
PID-005,Glioblastoma,52,NCT00586508,Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas
PID-005,Glioblastoma,52,NCT05363826,Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®
PID-005,Glioblastoma,52,NCT05660369,CARv3-TEAM-E T Cells in Glioblastoma
PID-005,Glioblastoma,52,NCT00883298,Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05941234,"Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma"
PID-005,Glioblastoma,52,NCT03050736,Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
PID-005,Glioblastoma,52,NCT00613054,Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT06279767,Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00613223,Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
PID-005,Glioblastoma,52,NCT03997136,Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.
PID-005,Glioblastoma,52,NCT00669669,O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
PID-005,Glioblastoma,52,NCT06562621,Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT00612638,Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
PID-005,Glioblastoma,52,NCT03360708,Vaccine Therapy in Treating Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03332355,Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
PID-005,Glioblastoma,52,NCT05235737,The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab
PID-005,Glioblastoma,52,NCT03170141,Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05954858,Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
PID-005,Glioblastoma,52,NCT05432804,"Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment"
PID-005,Glioblastoma,52,NCT04266977,Restrictive Use of Dexamethasone in Glioblastoma
PID-005,Glioblastoma,52,NCT00540176,The Safety and Efficacy of DCA for the Treatment of Brain Cancer
PID-005,Glioblastoma,52,NCT06327451,Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
PID-005,Glioblastoma,52,NCT02006563,Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors
PID-005,Glioblastoma,52,NCT01351519,A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
PID-005,Glioblastoma,52,NCT04780009,Loupe-Based Intraoperative Fluorescence Imaging
PID-005,Glioblastoma,52,NCT06632236,5G-EMERALD: Amivantamab in Malignant Brain Tumours
PID-005,Glioblastoma,52,NCT06630260,5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
PID-005,Glioblastoma,52,NCT02227901,"Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT02414165,The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
PID-005,Glioblastoma,52,NCT06359379,Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
PID-005,Glioblastoma,52,NCT01478178,Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT05842746,Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT03115138,Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
PID-005,Glioblastoma,52,NCT03020017,NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
PID-005,Glioblastoma,52,NCT04188535,Serial MRI Scans During Radiation Therapy
PID-005,Glioblastoma,52,NCT01174537,"New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma"
PID-005,Glioblastoma,52,NCT02590263,Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
PID-005,Glioblastoma,52,NCT04910022,Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03345095,A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01124240,Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene
PID-005,Glioblastoma,52,NCT00005856,Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02743078,Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05773664,Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma
PID-005,Glioblastoma,52,NCT06964815,"Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients"
PID-005,Glioblastoma,52,NCT03603405,HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT05694416,Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT02768389,Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05772767,Modulation of Ciliogenesis in Glioma Stem Cells
PID-005,Glioblastoma,52,NCT03294486,"Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients"
PID-005,Glioblastoma,52,NCT03144167,Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
PID-005,Glioblastoma,52,NCT00316849,"Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT00058097,Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02898012,Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
PID-005,Glioblastoma,52,NCT04391595,LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
PID-005,Glioblastoma,52,NCT04926168,6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT01805453,"Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma"
PID-005,Glioblastoma,52,NCT03834740,A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
PID-005,Glioblastoma,52,NCT00606008,A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-005,Glioblastoma,52,NCT00004262,Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT03615404,"Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma"
PID-005,Glioblastoma,52,NCT06816927,Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
PID-005,Glioblastoma,52,NCT04200066,A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03423628,A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
PID-005,Glioblastoma,52,NCT06319027,"Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial"
PID-005,Glioblastoma,52,NCT05447195,Phase 2 Study of CAN008 in Subjects With GBM
PID-005,Glioblastoma,52,NCT05600491,A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
PID-005,Glioblastoma,52,NCT00049387,"Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-005,Glioblastoma,52,NCT06177964,Lerapolturev (PVSRIPO) in GBM
PID-005,Glioblastoma,52,NCT00305864,"Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-005,Glioblastoma,52,NCT05979064,Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-005,Glioblastoma,52,NCT00052208,Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05695976,GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
PID-005,Glioblastoma,52,NCT02626364,Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
PID-005,Glioblastoma,52,NCT02761070,"Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III"
PID-005,Glioblastoma,52,NCT01811992,Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma
PID-005,Glioblastoma,52,NCT03705351,Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT00777686,Measuring Non-Enhancing Glioblastoma Progression
PID-005,Glioblastoma,52,NCT03596086,HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
PID-005,Glioblastoma,52,NCT00479765,A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
PID-005,Glioblastoma,52,NCT00039494,Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
PID-005,Glioblastoma,52,NCT00660543,MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
PID-005,Glioblastoma,52,NCT01331616,Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
PID-005,Glioblastoma,52,NCT00085254,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT01540513,PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
PID-005,Glioblastoma,52,NCT03115333,DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04741984,Monocyte Antigen Carrier Cells for Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT04937413,The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation
PID-005,Glioblastoma,52,NCT00943462,Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
PID-005,Glioblastoma,52,NCT01124461,BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor
PID-005,Glioblastoma,52,NCT05163080,SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
PID-005,Glioblastoma,52,NCT02465268,Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02375841,"Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers"
PID-005,Glioblastoma,52,NCT05091866,Natural Progesterone for the Treatment of Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03778294,18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
PID-005,Glioblastoma,52,NCT05375318,"BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels"
PID-005,Glioblastoma,52,NCT03899857,Pembrolizumab for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00613093,Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
PID-005,Glioblastoma,52,NCT05772741,Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs
PID-005,Glioblastoma,52,NCT00014170,Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05380349,Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
PID-005,Glioblastoma,52,NCT04725214,Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma
PID-005,Glioblastoma,52,NCT00902577,MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04840069,Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01609790,Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
PID-005,Glioblastoma,52,NCT01465347,Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT05033587,Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
PID-005,Glioblastoma,52,NCT00731731,"Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT02337426,"Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT05084430,Study of Pembrolizumab and M032 (NSC 733972)
PID-005,Glioblastoma,52,NCT04945148,Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
PID-005,Glioblastoma,52,NCT02395692,Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00846456,Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma
PID-005,Glioblastoma,52,NCT01022918,Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
PID-005,Glioblastoma,52,NCT05116137,The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
PID-005,Glioblastoma,52,NCT00864864,Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02575027,Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01120639,Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
PID-005,Glioblastoma,52,NCT04600817,A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)
PID-005,Glioblastoma,52,NCT04065087,Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT03619239,Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT03020602,BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab
PID-005,Glioblastoma,52,NCT02197169,DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
PID-005,Glioblastoma,52,NCT01111097,Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors
PID-005,Glioblastoma,52,NCT00761280,Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
PID-005,Glioblastoma,52,NCT07003542,A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
PID-005,Glioblastoma,52,NCT02820584,A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06329570,Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
PID-005,Glioblastoma,52,NCT04327011,A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
PID-005,Glioblastoma,52,NCT00409214,Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
PID-005,Glioblastoma,52,NCT03400917,Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT03626896,Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
PID-005,Glioblastoma,52,NCT02311920,Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-005,Glioblastoma,52,NCT06797661,Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.
PID-005,Glioblastoma,52,NCT00001148,Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
PID-005,Glioblastoma,52,NCT02047058,Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
PID-005,Glioblastoma,52,NCT00115440,BNCT to Treat Glioma That Has Progressed Following Radiotherapy
PID-005,Glioblastoma,52,NCT05513859,Investigational Imaging Technique During Brain Surgery
PID-005,Glioblastoma,52,NCT02709226,Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04998864,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
PID-005,Glioblastoma,52,NCT04903795,Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PID-005,Glioblastoma,52,NCT00165477,Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05023551,Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-005,Glioblastoma,52,NCT04424966,Infigratinib in Recurrent High-Grade Glioma Patients
PID-005,Glioblastoma,52,NCT05171127,Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
PID-005,Glioblastoma,52,NCT03861299,The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
PID-005,Glioblastoma,52,NCT06496971,A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
PID-005,Glioblastoma,52,NCT00662506,"Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma"
PID-005,Glioblastoma,52,NCT00179907,A Phase I/II Study of the Photon Radiosurgery System
PID-005,Glioblastoma,52,NCT04967690,"A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM"
PID-005,Glioblastoma,52,NCT06480721,FET-PET-Guided Management of Pseudoprogression in Glioblastoma
PID-005,Glioblastoma,52,NCT03460782,An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
PID-005,Glioblastoma,52,NCT00004146,Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
PID-005,Glioblastoma,52,NCT03951142,Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study
PID-005,Glioblastoma,52,NCT05718466,Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy
PID-005,Glioblastoma,52,NCT05904119,Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
PID-005,Glioblastoma,52,NCT04854044,ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03649464,Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
PID-005,Glioblastoma,52,NCT03732352,18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05977322,A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
PID-005,Glioblastoma,52,NCT02330562,Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab
PID-005,Glioblastoma,52,NCT06193538,The Safety and Effectiveness of NV-A01 in Glioma Patients
PID-005,Glioblastoma,52,NCT01905228,A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
PID-005,Glioblastoma,52,NCT06910306,A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02666066,Radiomics for Prediction of Survival in GBM
PID-005,Glioblastoma,52,NCT00074646,Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas
PID-005,Glioblastoma,52,NCT02903069,Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
PID-005,Glioblastoma,52,NCT00548938,"Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM"
PID-005,Glioblastoma,52,NCT02490930,A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
PID-005,Glioblastoma,52,NCT02025231,Image Guided Reirradiation of High-grade Glioma
PID-005,Glioblastoma,52,NCT06129760,Glioblastoma Remote Monitoring and Care - Research Protocol
PID-005,Glioblastoma,52,NCT06684899,Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT06773481,BC008-1A Injection for Recurrent CNS WHO G4 Glioma
PID-005,Glioblastoma,52,NCT00686387,Establishment of a Brain and Spinal Tumor Tissue Bank
PID-005,Glioblastoma,52,NCT06344130,Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01266031,Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01516905,PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
PID-005,Glioblastoma,52,NCT03370926,FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
PID-005,Glioblastoma,52,NCT06328036,Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01931098,Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
PID-005,Glioblastoma,52,NCT01502241,Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
PID-005,Glioblastoma,52,NCT00939991,"Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas"
PID-005,Glioblastoma,52,NCT03426891,Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT06719440,Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
PID-005,Glioblastoma,52,NCT00723827,Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
PID-005,Glioblastoma,52,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-005,Glioblastoma,52,NCT00431561,Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
PID-005,Glioblastoma,52,NCT01317888,Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas
PID-005,Glioblastoma,52,NCT05039281,Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05017610,Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
PID-005,Glioblastoma,52,NCT06824662,Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas
PID-005,Glioblastoma,52,NCT03618667,GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
PID-005,Glioblastoma,52,NCT00089427,"IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma"
PID-005,Glioblastoma,52,NCT00028158,"Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer"
PID-005,Glioblastoma,52,NCT01925573,Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
PID-005,Glioblastoma,52,NCT04822688,"Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues"
PID-005,Glioblastoma,52,NCT05383872,Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
PID-005,Glioblastoma,52,NCT02337686,Pembrolizumab in Treating Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03296696,Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
PID-005,Glioblastoma,52,NCT01086345,Radiosurgery Plus Bevacizumab in Glioblastoma
PID-005,Glioblastoma,52,NCT06072586,A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
PID-005,Glioblastoma,52,NCT04216329,Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT06455605,D2C7-IT + 2141-V11 Combination Post-resection in rGBM
PID-005,Glioblastoma,52,NCT01044966,A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04763031,Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT
PID-005,Glioblastoma,52,NCT04446416,Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
PID-005,Glioblastoma,52,NCT01582516,Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00753246,Nimotuzumab in Adults With Glioblastoma Multiforma
PID-005,Glioblastoma,52,NCT01227434,A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
PID-005,Glioblastoma,52,NCT03224104,Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
PID-005,Glioblastoma,52,NCT06691308,WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients
PID-005,Glioblastoma,52,NCT01004874,Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
PID-005,Glioblastoma,52,NCT02871843,RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
PID-005,Glioblastoma,52,NCT00045565,Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
PID-005,Glioblastoma,52,NCT06058988,Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
PID-005,Glioblastoma,52,NCT04817254,Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-005,Glioblastoma,52,NCT00597402,"Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas"
PID-005,Glioblastoma,52,NCT00645385,Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
PID-005,Glioblastoma,52,NCT00576641,Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
PID-005,Glioblastoma,52,NCT01520870,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
PID-005,Glioblastoma,52,NCT01240460,Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection
PID-005,Glioblastoma,52,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-005,Glioblastoma,52,NCT03633552,Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
PID-005,Glioblastoma,52,NCT05929456,Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)
PID-005,Glioblastoma,52,NCT01062425,Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT04608812,Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
PID-005,Glioblastoma,52,NCT03631823,Gut Microbiota and Glioblastoma Multiforme Prognosis
PID-005,Glioblastoma,52,NCT05565118,Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
PID-005,Glioblastoma,52,NCT04045847,CD147-CART Cells in Patients With Recurrent Malignant Glioma.
PID-005,Glioblastoma,52,NCT04289155,Individual Patient Compassionate Use of GX-I7
PID-005,Glioblastoma,52,NCT01242566,Temozolomide in Elderly Patients With KPS < 70
PID-005,Glioblastoma,52,NCT01290939,Bevacizumab and Lomustine for Recurrent GBM
PID-005,Glioblastoma,52,NCT05683808,Venous Thromboembolism Prevention in Outpatients With Glioma
PID-005,Glioblastoma,52,NCT04396860,Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
PID-005,Glioblastoma,52,NCT01294735,Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
PID-005,Glioblastoma,52,NCT04209790,Neoadjuvant Chemoradiation for Resectable Glioblastoma
PID-005,Glioblastoma,52,NCT04677049,Study of Niacin in Glioblastoma
PID-005,Glioblastoma,52,NCT05739942,Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT02253212,Safety of BBB Opening With the SonoCloud
PID-005,Glioblastoma,52,NCT06504381,"DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma"
PID-005,Glioblastoma,52,NCT01711580,Re-irradiation of High Grade Gliomas: a Quality of Life Study
PID-005,Glioblastoma,52,NCT06710249,Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
PID-005,Glioblastoma,52,NCT06883747,Clinical Trial of BMS-986504 in Recurrent GBM Patients
PID-005,Glioblastoma,52,NCT07111195,Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
PID-005,Glioblastoma,52,NCT00923117,Sunitinib to Treat Recurrent Brain Cancer
PID-005,Glioblastoma,52,NCT05671016,Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy
PID-005,Glioblastoma,52,NCT00715013,Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT02431572,A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
PID-005,Glioblastoma,52,NCT00016328,CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00540722,Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00423735,Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
PID-005,Glioblastoma,52,NCT04699773,LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
PID-005,Glioblastoma,52,NCT06273176,The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06059690,Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
PID-005,Glioblastoma,52,NCT00747253,Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
PID-005,Glioblastoma,52,NCT00980343,GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-005,Glioblastoma,52,NCT00591058,Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT03283631,Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
PID-005,Glioblastoma,52,NCT00504660,"6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients"
PID-005,Glioblastoma,52,NCT02794883,Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT00641706,"Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme"
PID-005,Glioblastoma,52,NCT00107003,GW572016 to Treat Recurrent Malignant Brain Tumors
PID-005,Glioblastoma,52,NCT06385132,Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer
PID-005,Glioblastoma,52,NCT00445588,Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT02529072,Nivolumab With DC Vaccines for Recurrent Brain Tumors
PID-005,Glioblastoma,52,NCT00612651,PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
PID-005,Glioblastoma,52,NCT01238237,Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA
PID-005,Glioblastoma,52,NCT03275558,Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma
PID-005,Glioblastoma,52,NCT00503204,Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
PID-005,Glioblastoma,52,NCT02386826,INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00704080,A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
PID-005,Glioblastoma,52,NCT04116138,Antisecretory Factor in Primary Glioblastoma 1
PID-005,Glioblastoma,52,NCT06806228,Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)
PID-005,Glioblastoma,52,NCT01790503,A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT00751270,Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
PID-005,Glioblastoma,52,NCT00610571,Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
PID-005,Glioblastoma,52,NCT00780819,Borderzone Sampling
PID-005,Glioblastoma,52,NCT00683761,A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT00473408,The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
PID-005,Glioblastoma,52,NCT07021339,Anterior Temporal Lobectomy in Temporal Glioblastoma
PID-005,Glioblastoma,52,NCT00305656,AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00335764,"Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma"
PID-005,Glioblastoma,52,NCT01081223,Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
PID-005,Glioblastoma,52,NCT00087451,Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)
PID-005,Glioblastoma,52,NCT00392171,The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
PID-005,Glioblastoma,52,NCT05734560,D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
PID-005,Glioblastoma,52,NCT00132158,ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
PID-005,Glioblastoma,52,NCT00238303,Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01575275,Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00075491,Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT05267106,Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
PID-005,Glioblastoma,52,NCT01894061,NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00112502,Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04776980,Multimodality MRI and Liquid Biopsy in GBM
PID-005,Glioblastoma,52,NCT02887417,Glioblastoma Platelet Activation Study
PID-005,Glioblastoma,52,NCT00112866,Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT04444427,Evaluation of GLR2007 for Advanced Solid Tumors
PID-005,Glioblastoma,52,NCT00895960,Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT04657315,"Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients"
PID-005,Glioblastoma,52,NCT02052648,Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
PID-005,Glioblastoma,52,NCT03027388,"Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma"
PID-005,Glioblastoma,52,NCT02661282,Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT04712721,Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
PID-005,Glioblastoma,52,NCT06241391,Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
PID-005,Glioblastoma,52,NCT04388475,Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT04143425,Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01967758,Phase I Study of Safety and Immunogenicity of ADU-623
PID-005,Glioblastoma,52,NCT03746080,Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT05561374,Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT04181684,LITT Followed by Hypofractionated RT for Recurrent Gliomas
PID-005,Glioblastoma,52,NCT03673787,A Trial of Ipatasertib in Combination With Atezolizumab
PID-005,Glioblastoma,52,NCT03367715,"Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma"
PID-005,Glioblastoma,52,NCT00459381,Pazopanib in Treating Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT05909618,Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
PID-005,Glioblastoma,52,NCT01730950,Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01753713,Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT01117155,A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
PID-005,Glioblastoma,52,NCT01475006,AMG 595 First-in-Human in Recurrent Gliomas
PID-005,Glioblastoma,52,NCT01491893,PVSRIPO for Recurrent Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT00979862,Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03539731,[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
PID-005,Glioblastoma,52,NCT01122901,Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT03176160,LITT Palliative Treatment for Patients With Malignant Gliomas
PID-005,Glioblastoma,52,NCT05929495,"Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma"
PID-005,Glioblastoma,52,NCT01972750,Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma
PID-005,Glioblastoma,52,NCT05054400,Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
PID-005,Glioblastoma,52,NCT06017063,Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields
PID-005,Glioblastoma,52,NCT01434602,Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
PID-005,Glioblastoma,52,NCT03213002,Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
PID-005,Glioblastoma,52,NCT01967810,ANG1005 in Patients With Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT03581292,"Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations"
PID-005,Glioblastoma,52,NCT03975959,Memory Perception Assessment in Central/Non-central Nervous System Cancers
PID-005,Glioblastoma,52,NCT01808820,Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
PID-005,Glioblastoma,52,NCT06623565,Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
PID-005,Glioblastoma,52,NCT02629757,A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas
PID-005,Glioblastoma,52,NCT00624728,Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
PID-005,Glioblastoma,52,NCT00562419,CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
PID-005,Glioblastoma,52,NCT02658981,Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
PID-005,Glioblastoma,52,NCT00031538,Genetic Analysis of Brain Tumors
PID-005,Glioblastoma,52,NCT00870181,ADV-TK Improves Outcome of Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT04729959,"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma"
PID-005,Glioblastoma,52,NCT00031083,Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
PID-005,Glioblastoma,52,NCT01765088,A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
PID-005,Glioblastoma,52,NCT04145115,A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden
PID-005,Glioblastoma,52,NCT02750891,A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
PID-005,Glioblastoma,52,NCT01985256,Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
PID-005,Glioblastoma,52,NCT03475186,Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
PID-005,Glioblastoma,52,NCT02540135,Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
PID-005,Glioblastoma,52,NCT01738646,Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
PID-005,Glioblastoma,52,NCT04623931,Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
PID-005,Glioblastoma,52,NCT06430424,"Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma"
PID-005,Glioblastoma,52,NCT01810744,Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
PID-005,Glioblastoma,52,NCT02942264,Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-005,Glioblastoma,52,NCT06501911,A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
PID-005,Glioblastoma,52,NCT01975701,A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
PID-005,Glioblastoma,52,NCT03657576,Trial of C134 in Patients With Recurrent GBM
PID-005,Glioblastoma,52,NCT01712542,Curcumin Bioavailability in Glioblastoma Patients
PID-005,Glioblastoma,52,NCT01470794,Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
PID-005,Glioblastoma,52,NCT01107522,Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
PID-005,Glioblastoma,52,NCT02525692,Oral ONC201 in Adult Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT07091864,Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
PID-005,Glioblastoma,52,NCT03311542,Expanded Access for Pembrolizumab (MK-3475)
PID-005,Glioblastoma,52,NCT00734864,Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT03561207,3D Prediction of Patient-Specific Response
PID-005,Glioblastoma,52,NCT03914768,Immune Modulatory DC Vaccine Against Brain Tumor
PID-005,Glioblastoma,52,NCT00102648,Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
PID-005,Glioblastoma,52,NCT07067905,Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
PID-005,Glioblastoma,52,NCT06617208,Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery
PID-005,Glioblastoma,52,NCT01814813,Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-005,Glioblastoma,52,NCT05062772,Brain Tumor Intraoperative Ultrasound Database
PID-005,Glioblastoma,52,NCT06108206,Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
PID-005,Glioblastoma,52,NCT00041587,Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
PID-005,Glioblastoma,52,NCT00024570,Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT05106296,Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
PID-005,Glioblastoma,52,NCT04267978,Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
PID-005,Glioblastoma,52,NCT00001171,Evaluation of Factors in Human Brain Tumors
PID-005,Glioblastoma,52,NCT05131763,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-005,Glioblastoma,52,NCT00114309,131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT04477200,Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
PID-005,Glioblastoma,52,NCT04270461,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-005,Glioblastoma,52,NCT01454596,CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
PID-005,Glioblastoma,52,NCT06016452,A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma
PID-005,Glioblastoma,52,NCT00379080,Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT00390299,Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT00080054,A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
PID-005,Glioblastoma,52,NCT01122888,Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT06160206,Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT06894979,"Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma"
PID-005,Glioblastoma,52,NCT00734682,A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
PID-005,Glioblastoma,52,NCT05495295,"First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours"
PID-005,Glioblastoma,52,NCT04933942,Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
PID-005,Glioblastoma,52,NCT05629702,ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
PID-005,Glioblastoma,52,NCT06118723,The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
PID-005,Glioblastoma,52,NCT01342757,Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT00009035,Natural History of Patients With Brain and Spinal Cord Tumors
PID-005,Glioblastoma,52,NCT01441388,A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
PID-005,Glioblastoma,52,NCT00575887,Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
PID-005,Glioblastoma,52,NCT04478279,A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
PID-005,Glioblastoma,52,NCT06614855,A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT04074785,Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6
PID-005,Glioblastoma,52,NCT05765812,A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT02348255,NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
PID-005,Glioblastoma,52,NCT00589875,Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
PID-005,Glioblastoma,52,NCT06492486,Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
PID-005,Glioblastoma,52,NCT05686798,Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
PID-005,Glioblastoma,52,NCT04323046,Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
PID-005,Glioblastoma,52,NCT01156584,A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT00062504,Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
PID-005,Glioblastoma,52,NCT06929819,Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
PID-005,Glioblastoma,52,NCT00272870,Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
PID-005,Glioblastoma,52,NCT06810544,Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
PID-005,Glioblastoma,52,NCT06388733,"A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma"
PID-005,Glioblastoma,52,NCT05773326,Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
PID-005,Glioblastoma,52,NCT00433381,Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
PID-005,Glioblastoma,52,NCT03022578,Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
PID-005,Glioblastoma,52,NCT04630379,Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
PID-005,Glioblastoma,52,NCT04218019,Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation
PID-005,Glioblastoma,52,NCT01999270,Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
PID-005,Glioblastoma,52,NCT04489420,Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
PID-005,Glioblastoma,52,NCT04991870,Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
PID-005,Glioblastoma,52,NCT01902771,Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
PID-005,Glioblastoma,52,NCT06038760,Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
PID-005,Glioblastoma,52,NCT00995007,A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
PID-005,Glioblastoma,52,NCT01281982,(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
PID-005,Glioblastoma,52,NCT04049669,Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
PID-005,Glioblastoma,52,NCT01316809,AZD8055 for Adults With Recurrent Gliomas
PID-005,Glioblastoma,52,NCT03593993,A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
PID-005,Glioblastoma,52,NCT01478321,Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
PID-005,Glioblastoma,52,NCT02039778,Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma
PID-005,Glioblastoma,52,NCT02655601,"Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001"
PID-005,Glioblastoma,52,NCT05465954,Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT00329719,Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT01656980,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
PID-005,Glioblastoma,52,NCT01637753,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT02885324,Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
PID-005,Glioblastoma,52,NCT01204684,Dendritic Cell Vaccine for Patients With Brain Tumors
PID-005,Glioblastoma,52,NCT03463265,Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT04314674,Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors Resection
PID-005,Glioblastoma,52,NCT01171469,Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
PID-005,Glioblastoma,52,NCT00973557,The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
PID-005,Glioblastoma,52,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
PID-005,Glioblastoma,52,NCT00179803,Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
PID-005,Glioblastoma,52,NCT04782609,Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT00024557,Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
PID-005,Glioblastoma,52,NCT01836549,Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
PID-005,Glioblastoma,52,NCT01250470,Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
PID-005,Glioblastoma,52,NCT00064779,Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT01648348,Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT06665724,Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
PID-005,Glioblastoma,52,NCT06410248,Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
PID-005,Glioblastoma,52,NCT03717142,Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
PID-005,Glioblastoma,52,NCT06902350,"Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors"
PID-005,Glioblastoma,52,NCT04614493,Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.
PID-005,Glioblastoma,52,NCT05297864,PARP Inhibition for Gliomas (PI-4G or π4g)
PID-005,Glioblastoma,52,NCT05099068,Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)
PID-005,Glioblastoma,52,NCT02722512,Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
PID-005,Glioblastoma,52,NCT01514201,"Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas"
PID-005,Glioblastoma,52,NCT04047264,Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
PID-005,Glioblastoma,52,NCT03971734,Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
PID-005,Glioblastoma,52,NCT01740258,Bevacizumab Beyond Progression (BBP)
PID-005,Glioblastoma,52,NCT03607643,"A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies"
PID-005,Glioblastoma,52,NCT00823797,Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
PID-005,Glioblastoma,52,NCT01861990,Valproic Acid in Childhood Progressive Brain Tumors
PID-005,Glioblastoma,52,NCT06193174,Re-Administration of C134 in Patients with Recurrent GBM (C134-HSV-1)
PID-005,Glioblastoma,52,NCT02168270,Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT00884416,Sorafenib in Newly Diagnosed High Grade Glioma
PID-005,Glioblastoma,52,NCT00004688,"Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms"
PID-005,Glioblastoma,52,NCT00243490,Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
PID-005,Glioblastoma,52,NCT01822275,Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-005,Glioblastoma,52,NCT01380782,BIBF 1120 for Recurrent High-Grade Gliomas
PID-005,Glioblastoma,52,NCT02758366,Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
PID-005,Glioblastoma,52,NCT06860594,"Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma"
PID-005,Glioblastoma,52,NCT01095094,Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT02055196,Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-005,Glioblastoma,52,NCT01144247,Cellular Immunotherapy Study for Brain Cancer
PID-005,Glioblastoma,52,NCT04488783,Potentiation of Chemotherapy in Brain Tumors by Zinc
PID-005,Glioblastoma,52,NCT01189240,RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT04661384,"Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma"
PID-005,Glioblastoma,52,NCT04479696,Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
PID-005,Glioblastoma,52,NCT06989086,FearLess in NeuroOncology
PID-005,Glioblastoma,52,NCT00006773,Bortezomib in Treating Patients With Recurrent Glioma
PID-005,Glioblastoma,52,NCT03956706,Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
PID-005,Glioblastoma,52,NCT06160596,Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
PID-005,Glioblastoma,52,NCT03251027,Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
PID-005,Glioblastoma,52,NCT06796335,Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
PID-005,Glioblastoma,52,NCT04734444,SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
PID-005,Glioblastoma,52,NCT03392545,Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)
PID-005,Glioblastoma,52,NCT05039346,Quality of Life and Patient Needs in Advanced High Grade Gliomas
PID-005,Glioblastoma,52,NCT05139277,Evaluation of the CONVIVO System
PID-005,Glioblastoma,52,NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection
PID-005,Glioblastoma,52,NCT00650923,"Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma"
PID-005,Glioblastoma,52,NCT06333899,Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
PID-005,Glioblastoma,52,NCT01151670,Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
PID-005,Glioblastoma,52,NCT00667394,Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
PID-005,Glioblastoma,52,NCT06975332,"Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression"
PID-005,Glioblastoma,52,NCT03914742,BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
PID-005,Glioblastoma,52,NCT05843253,Study of Ribociclib and Everolimus in HGG and DIPG
PID-005,Glioblastoma,52,NCT05839379,Targeted Pediatric High-Grade Glioma Therapy
PID-005,Glioblastoma,52,NCT01798771,Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
PID-005,Glioblastoma,52,NCT02015819,"Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas"
PID-005,Glioblastoma,52,NCT05873946,Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
PID-005,Glioblastoma,52,NCT04295759,INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
PID-005,Glioblastoma,52,NCT04482933,HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT02031965,Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
PID-005,Glioblastoma,52,NCT05789394,Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
PID-005,Glioblastoma,52,NCT05698524,A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
PID-005,Glioblastoma,52,NCT03718767,Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
PID-005,Glioblastoma,52,NCT03123952,Expanded Access to ABT-414
PID-005,Glioblastoma,52,NCT02861898,Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
PID-005,Glioblastoma,52,NCT01721577,Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
PID-005,Glioblastoma,52,NCT02238496,Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
PID-005,Glioblastoma,52,NCT04982926,A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
PID-005,Glioblastoma,52,NCT04214392,Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
PID-005,Glioblastoma,52,NCT01996527,3T MRI Biomarkers of Glioma Treatment Response
PID-005,Glioblastoma,52,NCT06926075,Early Phase Study of Kesonotide in Participants With Solid Tumours
PID-005,Glioblastoma,52,NCT01378481,High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma
PID-005,Glioblastoma,52,NCT01148966,Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
PID-005,Glioblastoma,52,NCT01975116,p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
PID-005,Glioblastoma,52,NCT00268385,Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
PID-005,Glioblastoma,52,NCT02142803,TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
PID-005,Glioblastoma,52,NCT01383135,Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
PID-005,Glioblastoma,52,NCT04573140,A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
PID-005,Glioblastoma,52,NCT01269411,RO4929097 in Treating Patients With Recurrent Invasive Gliomas
PID-005,Glioblastoma,52,NCT06640582,TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
PID-005,Glioblastoma,52,NCT03389230,Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
PID-005,Glioblastoma,52,NCT07042620,A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
PID-005,Glioblastoma,52,NCT06041555,MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
PID-005,Glioblastoma,52,NCT04740190,Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd
PID-005,Glioblastoma,52,NCT05231655,Ex VIvo DEtermiNed Cancer Therapy
PID-005,Glioblastoma,52,NCT00499473,Sunitinib in Treating Patients With Recurrent Malignant Gliomas
PID-005,Glioblastoma,52,NCT02502708,"Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors"
PID-005,Glioblastoma,52,NCT06896110,Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
PID-005,Glioblastoma,52,NCT01817751,"Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma"
PID-005,Glioblastoma,52,NCT06047379,"Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis"
PID-005,Glioblastoma,52,NCT00095940,Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
PID-005,Glioblastoma,52,NCT03749187,BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
PID-005,Glioblastoma,52,NCT06625047,Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
PID-005,Glioblastoma,52,NCT01291420,Dendritic Cell Vaccination for Patients with Solid Tumors
PID-005,Glioblastoma,52,NCT05737212,"Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas"
PID-005,Glioblastoma,52,NCT03072134,Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
PID-005,Glioblastoma,52,NCT00100802,"Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas"
PID-005,Glioblastoma,52,NCT02208362,Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
PID-005,Glioblastoma,52,NCT01977677,Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
PID-005,Glioblastoma,52,NCT05370079,Control Cohort CTRL COH
PID-005,Glioblastoma,52,NCT00042991,Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
PID-005,Glioblastoma,52,NCT02800486,"Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA"
PID-005,Glioblastoma,52,NCT04978727,"A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma"
PID-005,Glioblastoma,52,NCT04678648,A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
PID-005,Glioblastoma,52,NCT01353625,"Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies."
PID-005,Glioblastoma,52,NCT03152318,A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PID-005,Glioblastoma,52,NCT06815029,Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
PID-005,Glioblastoma,52,NCT01103375,Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT01051557,Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-005,Glioblastoma,52,NCT02974738,"A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)"
PID-005,Glioblastoma,52,NCT03896568,MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT03739372,Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
PID-005,Glioblastoma,52,NCT06439420,CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
PID-005,Glioblastoma,52,NCT01598597,"An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)"
PID-005,Glioblastoma,52,NCT02465528,Ceritinib Rare Indications Study in ALK+ Tumors
PID-005,Glioblastoma,52,NCT04388033,Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
PID-005,Glioblastoma,52,NCT01723020,A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
PID-005,Glioblastoma,52,NCT00879437,"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma"
PID-005,Glioblastoma,52,NCT03973918,Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
PID-005,Glioblastoma,52,NCT03389802,Phase I Study of APX005M in Pediatric Central Nervous System Tumors
PID-005,Glioblastoma,52,NCT01849952,Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
PID-005,Glioblastoma,52,NCT00045708,A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
PID-005,Glioblastoma,52,NCT04135807,Implantable Microdevice In Primary Brain Tumors
PID-005,Glioblastoma,52,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-005,Glioblastoma,52,NCT02798406,Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
PID-005,Glioblastoma,52,NCT05956821,Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
PID-005,Glioblastoma,52,NCT04044937,Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
PID-005,Glioblastoma,52,NCT01082926,"Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2"
PID-005,Glioblastoma,52,NCT03919071,Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
PID-005,Glioblastoma,52,NCT03893487,Fimepinostat in Treating Brain Tumors in Children and Young Adults
PID-005,Glioblastoma,52,NCT03212274,"Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations"
PID-005,Glioblastoma,52,NCT02372409,Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
PID-005,Glioblastoma,52,NCT05330559,"Fluorescence, Light-microscopy, Ultrasound Integrated / Intraoperative Diagnosis to MAXimise Resection"
PID-005,Glioblastoma,52,NCT06690216,Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
PID-005,Glioblastoma,52,NCT02365662,A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
PID-005,Glioblastoma,52,NCT04970615,Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models
PID-005,Glioblastoma,52,NCT00045110,Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
PID-005,Glioblastoma,52,NCT03734913,A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
PID-005,Glioblastoma,52,NCT01234740,Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
PID-005,Glioblastoma,52,NCT02101905,Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT02457845,HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
PID-005,Glioblastoma,52,NCT02444546,Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
PID-005,Glioblastoma,52,NCT02644291,Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
PID-005,Glioblastoma,52,NCT01579253,Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
PID-005,Glioblastoma,52,NCT01884740,Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
PID-005,Glioblastoma,52,NCT01904123,STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain
PID-005,Glioblastoma,52,NCT03684811,A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
PID-005,Glioblastoma,52,NCT01922076,Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
PID-005,Glioblastoma,52,NCT00959946,Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer
PID-005,Glioblastoma,52,NCT03244995,Mind-Body Intervention in Glioma Couples
PID-005,Glioblastoma,52,NCT02498665,A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
PID-005,Glioblastoma,52,NCT03958240,Deciphering Mechanisms Underlying Cancer Immunogenicity
PID-005,Glioblastoma,52,NCT02323880,Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
PID-005,Glioblastoma,52,NCT00369590,VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
PID-005,Glioblastoma,52,NCT00093613,Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-005,Glioblastoma,52,NCT00085540,FR901228 in Treating Patients With Recurrent High-Grade Gliomas
PID-005,Glioblastoma,52,NCT06804655,Pharmacoscopy for Patients with Refractory Primary Brain Tumors
PID-005,Glioblastoma,52,NCT02709889,Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
PID-005,Glioblastoma,52,NCT01421524,"Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma"
PID-005,Glioblastoma,52,NCT01445691,More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
PID-005,Glioblastoma,52,NCT01837862,A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
PID-005,Glioblastoma,52,NCT02038699,A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer
PID-005,Glioblastoma,52,NCT02327078,"A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)"
PID-005,Glioblastoma,52,NCT00112736,Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT06717295,The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
PID-005,Glioblastoma,52,NCT06521567,A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
PID-005,Glioblastoma,52,NCT05538572,A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
PID-005,Glioblastoma,52,NCT05139056,Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
PID-005,Glioblastoma,52,NCT00679354,Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
PID-005,Glioblastoma,52,NCT06469138,A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
PID-005,Glioblastoma,52,NCT02192359,Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-005,Glioblastoma,52,NCT01172964,A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
PID-005,Glioblastoma,52,NCT00430079,Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
PID-005,Glioblastoma,52,NCT03797326,Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
PID-005,Glioblastoma,52,NCT01177397,"Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma"
PID-005,Glioblastoma,52,NCT05835687,Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
PID-005,Glioblastoma,52,NCT04427384,Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
PID-005,Glioblastoma,52,NCT03355794,A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
PID-005,Glioblastoma,52,NCT01339039,Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
PID-005,Glioblastoma,52,NCT04732065,"ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors"
PID-005,Glioblastoma,52,NCT01392209,Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
PID-005,Glioblastoma,52,NCT02186509,Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
PID-005,Glioblastoma,52,NCT06814496,Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
PID-005,Glioblastoma,52,NCT01576666,"Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors"
PID-005,Glioblastoma,52,NCT02966509,Engagement of Patients With Advanced Cancer
PID-005,Glioblastoma,52,NCT03243461,International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
PID-005,Glioblastoma,52,NCT01165632,Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
PID-005,Glioblastoma,52,NCT03043391,Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
PID-005,Glioblastoma,52,NCT02684058,Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
PID-005,Glioblastoma,52,NCT06645808,PET-imaging of Two Vartumabs in Patients With Solid Tumors
PID-005,Glioblastoma,52,NCT02255461,"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors"
PID-005,Glioblastoma,52,NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PID-005,Glioblastoma,52,NCT04541082,Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
PID-005,Glioblastoma,52,NCT02374255,Improving Goals of Care Discussion in Advanced Cancer Patients
PID-005,Glioblastoma,52,NCT02611024,Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
PID-005,Glioblastoma,52,NCT01392352,HYPAZ: Hypertension Induced by Pazopanib
PID-005,Glioblastoma,52,NCT04541225,Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
PID-005,Glioblastoma,52,NCT02223052,Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
PID-005,Glioblastoma,52,NCT02175745,18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
PID-005,Glioblastoma,52,NCT02335918,A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
PID-005,Glioblastoma,52,NCT05934630,"Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors"
PID-005,Glioblastoma,52,NCT01234805,Yoga Therapy in Treating Patients With Malignant Brain Tumors
PID-005,Glioblastoma,52,NCT01929720,"Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors"
PID-005,Glioblastoma,52,NCT03787056,Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
PID-005,Glioblastoma,52,NCT04913337,Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
PID-005,Glioblastoma,52,NCT05563272,89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
PID-005,Glioblastoma,52,NCT01631552,Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
PID-005,Glioblastoma,52,NCT05974410,Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
PID-005,Glioblastoma,52,NCT04604158,Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
PID-005,Glioblastoma,52,NCT02967380,"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases"
PID-005,Glioblastoma,52,NCT03911388,HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
PID-005,Glioblastoma,52,NCT05131815,The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
PID-005,Glioblastoma,52,NCT00110032,Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
PID-005,Glioblastoma,52,NCT03975829,Pediatric Long-Term Follow-up and Rollover Study
PID-005,Glioblastoma,52,NCT01119599,"RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma"
PID-005,Glioblastoma,52,NCT04566393,Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies
PID-005,Glioblastoma,52,NCT02194452,Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
PID-005,Glioblastoma,52,NCT03434262,SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
PID-005,Glioblastoma,52,NCT03896958,The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
PID-005,Glioblastoma,52,NCT01522820,Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
PID-005,Glioblastoma,52,NCT01131234,Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
PID-005,Glioblastoma,52,NCT03452774,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
PID-005,Glioblastoma,52,NCT01806675,18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
PID-005,Glioblastoma,52,NCT05969860,At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
PID-005,Glioblastoma,52,NCT04028479,The Registry of Oncology Outcomes Associated with Testing and Treatment
PID-005,Glioblastoma,52,NCT00030498,Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
PID-005,Glioblastoma,52,NCT03154190,Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
PID-006,Glioblastoma,44,NCT06404034,Expanded Access to Gallium Maltolate (GaM)
PID-006,Glioblastoma,44,NCT00337883,A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
PID-006,Glioblastoma,44,NCT03344250,Phase I EGFR BATs in Newly Diagnosed Glioblastoma
PID-006,Glioblastoma,44,NCT02844062,Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
PID-006,Glioblastoma,44,NCT02937844,Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
PID-006,Glioblastoma,44,NCT00704288,Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
PID-006,Glioblastoma,44,NCT04590664,Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
PID-006,Glioblastoma,44,NCT04814329,Glioblastoma Response Prediction to Apatinib
PID-006,Glioblastoma,44,NCT00116376,Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
PID-006,Glioblastoma,44,NCT02378532,The Addition of Chloroquine to Chemoradiation for Glioblastoma
PID-006,Glioblastoma,44,NCT02751138,Determination of Immune Phenotype in Glioblastoma Patients
PID-006,Glioblastoma,44,NCT03419403,UNITE Study: Understanding New Interventions With GBM ThErapy
PID-006,Glioblastoma,44,NCT04629209,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma"
PID-006,Glioblastoma,44,NCT05187624,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma"
PID-006,Glioblastoma,44,NCT03231501,HMPL-813 in Treating Patients With Glioblastoma
PID-006,Glioblastoma,44,NCT04547855,Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
PID-006,Glioblastoma,44,NCT06973096,CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PID-006,Glioblastoma,44,NCT02718443,VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
PID-006,Glioblastoma,44,NCT05168423,CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
PID-006,Glioblastoma,44,NCT03726515,CART-EGFRvIII + Pembrolizumab in GBM
PID-006,Glioblastoma,44,NCT05063682,The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
PID-006,Glioblastoma,44,NCT03603379,Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
PID-006,Glioblastoma,44,NCT00977431,Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
PID-006,Glioblastoma,44,NCT01498328,A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PID-006,Glioblastoma,44,NCT04004975,Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
PID-006,Glioblastoma,44,NCT05802693,"A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma"
PID-006,Glioblastoma,44,NCT00960492,Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
PID-006,Glioblastoma,44,NCT01110876,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)"
PID-006,Glioblastoma,44,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-006,Glioblastoma,44,NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PID-006,Glioblastoma,44,NCT06186401,Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
PID-006,Glioblastoma,44,NCT00250887,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research"
PID-006,Glioblastoma,44,NCT02573324,A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
PID-006,Glioblastoma,44,NCT02664363,EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
PID-006,Glioblastoma,44,NCT00671970,Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
PID-006,Glioblastoma,44,NCT06327451,Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
PID-006,Glioblastoma,44,NCT04903795,Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PID-006,Glioblastoma,44,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-006,Glioblastoma,44,NCT03732352,18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
PID-006,Glioblastoma,44,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-006,Glioblastoma,44,NCT03618667,GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
PID-006,Glioblastoma,44,NCT03296696,Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
PID-006,Glioblastoma,44,NCT06072586,A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
PID-006,Glioblastoma,44,NCT01520870,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
PID-006,Glioblastoma,44,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-006,Glioblastoma,44,NCT03283631,Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
PID-006,Glioblastoma,44,NCT01810744,Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
PID-006,Glioblastoma,44,NCT03311542,Expanded Access for Pembrolizumab (MK-3475)
PID-006,Glioblastoma,44,NCT01454596,CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
PID-006,Glioblastoma,44,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
PID-006,Glioblastoma,44,NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection
PID-006,Glioblastoma,44,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-006,Glioblastoma,44,NCT02365662,A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
PID-006,Glioblastoma,44,NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PID-007,Glioblastoma,74,NCT06404034,Expanded Access to Gallium Maltolate (GaM)
PID-007,Glioblastoma,74,NCT00337883,A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
PID-007,Glioblastoma,74,NCT03344250,Phase I EGFR BATs in Newly Diagnosed Glioblastoma
PID-007,Glioblastoma,74,NCT02844062,Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
PID-007,Glioblastoma,74,NCT02937844,Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
PID-007,Glioblastoma,74,NCT00704288,Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
PID-007,Glioblastoma,74,NCT04590664,Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
PID-007,Glioblastoma,74,NCT04814329,Glioblastoma Response Prediction to Apatinib
PID-007,Glioblastoma,74,NCT00116376,Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
PID-007,Glioblastoma,74,NCT02378532,The Addition of Chloroquine to Chemoradiation for Glioblastoma
PID-007,Glioblastoma,74,NCT02751138,Determination of Immune Phenotype in Glioblastoma Patients
PID-007,Glioblastoma,74,NCT03419403,UNITE Study: Understanding New Interventions With GBM ThErapy
PID-007,Glioblastoma,74,NCT04629209,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma"
PID-007,Glioblastoma,74,NCT05187624,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma"
PID-007,Glioblastoma,74,NCT03231501,HMPL-813 in Treating Patients With Glioblastoma
PID-007,Glioblastoma,74,NCT04547855,Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
PID-007,Glioblastoma,74,NCT06973096,CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PID-007,Glioblastoma,74,NCT02718443,VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
PID-007,Glioblastoma,74,NCT05168423,CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
PID-007,Glioblastoma,74,NCT03726515,CART-EGFRvIII + Pembrolizumab in GBM
PID-007,Glioblastoma,74,NCT05063682,The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
PID-007,Glioblastoma,74,NCT03603379,Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
PID-007,Glioblastoma,74,NCT00977431,Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
PID-007,Glioblastoma,74,NCT01498328,A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PID-007,Glioblastoma,74,NCT04004975,Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
PID-007,Glioblastoma,74,NCT05802693,"A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma"
PID-007,Glioblastoma,74,NCT00960492,Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
PID-007,Glioblastoma,74,NCT01110876,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)"
PID-007,Glioblastoma,74,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-007,Glioblastoma,74,NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PID-007,Glioblastoma,74,NCT06186401,Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
PID-007,Glioblastoma,74,NCT00250887,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research"
PID-007,Glioblastoma,74,NCT02573324,A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
PID-007,Glioblastoma,74,NCT02664363,EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
PID-007,Glioblastoma,74,NCT00671970,Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
PID-007,Glioblastoma,74,NCT06327451,Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
PID-007,Glioblastoma,74,NCT04903795,Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PID-007,Glioblastoma,74,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-007,Glioblastoma,74,NCT03732352,18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
PID-007,Glioblastoma,74,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-007,Glioblastoma,74,NCT03618667,GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
PID-007,Glioblastoma,74,NCT03296696,Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
PID-007,Glioblastoma,74,NCT06072586,A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
PID-007,Glioblastoma,74,NCT01520870,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
PID-007,Glioblastoma,74,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-007,Glioblastoma,74,NCT03283631,Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
PID-007,Glioblastoma,74,NCT01810744,Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
PID-007,Glioblastoma,74,NCT03311542,Expanded Access for Pembrolizumab (MK-3475)
PID-007,Glioblastoma,74,NCT01454596,CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
PID-007,Glioblastoma,74,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
PID-007,Glioblastoma,74,NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection
PID-007,Glioblastoma,74,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-007,Glioblastoma,74,NCT02365662,A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
PID-007,Glioblastoma,74,NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PID-008,Astrocytoma,37,NCT04606316,Surgical Nivolumab And Ipilimumab For Recurrent GBM
PID-008,Astrocytoma,37,NCT01700569,Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
PID-008,Astrocytoma,37,NCT06869577,A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
PID-008,Astrocytoma,37,NCT01833273,Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA
PID-008,Astrocytoma,37,NCT02795364,Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
PID-008,Astrocytoma,37,NCT02858895,Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
PID-008,Astrocytoma,37,NCT01290692,Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
PID-008,Astrocytoma,37,NCT01663012,Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
PID-008,Astrocytoma,37,NCT03538587,Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
PID-008,Astrocytoma,37,NCT05236036,Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
PID-008,Astrocytoma,37,NCT06283927,The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
PID-008,Astrocytoma,37,NCT00154375,Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
PID-008,Astrocytoma,37,NCT05218408,CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
PID-008,Astrocytoma,37,NCT06157541,T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
PID-008,Astrocytoma,37,NCT04047303,"CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma"
PID-008,Astrocytoma,37,NCT02366728,DC Migration Study for Newly-Diagnosed GBM
PID-008,Astrocytoma,37,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-008,Astrocytoma,37,NCT00921167,A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
PID-008,Astrocytoma,37,NCT00841555,Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
PID-008,Astrocytoma,37,NCT00045968,Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
PID-008,Astrocytoma,37,NCT00335075,Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
PID-008,Astrocytoma,37,NCT02062827,Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT04105374,"Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma"
PID-008,Astrocytoma,37,NCT02510950,Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
PID-008,Astrocytoma,37,NCT05879367,Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
PID-008,Astrocytoma,37,NCT02010606,Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
PID-008,Astrocytoma,37,NCT01180816,Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
PID-008,Astrocytoma,37,NCT01269853,Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
PID-008,Astrocytoma,37,NCT01386710,Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
PID-008,Astrocytoma,37,NCT00968240,Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
PID-008,Astrocytoma,37,NCT03722355,Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
PID-008,Astrocytoma,37,NCT02026271,A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
PID-008,Astrocytoma,37,NCT02022384,Immunophenotyping From Blood of Patients With Malignant Gliomas
PID-008,Astrocytoma,37,NCT05624736,Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning
PID-008,Astrocytoma,37,NCT03332355,Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
PID-008,Astrocytoma,37,NCT01351519,A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
PID-008,Astrocytoma,37,NCT04780009,Loupe-Based Intraoperative Fluorescence Imaging
PID-008,Astrocytoma,37,NCT06632236,5G-EMERALD: Amivantamab in Malignant Brain Tumours
PID-008,Astrocytoma,37,NCT06630260,5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
PID-008,Astrocytoma,37,NCT02414165,The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
PID-008,Astrocytoma,37,NCT03603405,HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
PID-008,Astrocytoma,37,NCT00606008,A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-008,Astrocytoma,37,NCT05600491,A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
PID-008,Astrocytoma,37,NCT03596086,HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
PID-008,Astrocytoma,37,NCT00943462,Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
PID-008,Astrocytoma,37,NCT02465268,Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
PID-008,Astrocytoma,37,NCT05375318,"BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels"
PID-008,Astrocytoma,37,NCT05084430,Study of Pembrolizumab and M032 (NSC 733972)
PID-008,Astrocytoma,37,NCT03020602,BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab
PID-008,Astrocytoma,37,NCT00761280,Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
PID-008,Astrocytoma,37,NCT04327011,A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
PID-008,Astrocytoma,37,NCT00409214,Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
PID-008,Astrocytoma,37,NCT06797661,Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.
PID-008,Astrocytoma,37,NCT00001148,Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
PID-008,Astrocytoma,37,NCT00115440,BNCT to Treat Glioma That Has Progressed Following Radiotherapy
PID-008,Astrocytoma,37,NCT05513859,Investigational Imaging Technique During Brain Surgery
PID-008,Astrocytoma,37,NCT02709226,Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-008,Astrocytoma,37,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-008,Astrocytoma,37,NCT03861299,The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
PID-008,Astrocytoma,37,NCT03649464,Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
PID-008,Astrocytoma,37,NCT04757662,Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
PID-008,Astrocytoma,37,NCT02666066,Radiomics for Prediction of Survival in GBM
PID-008,Astrocytoma,37,NCT02490930,A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
PID-008,Astrocytoma,37,NCT06344130,Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-008,Astrocytoma,37,NCT03370926,FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
PID-008,Astrocytoma,37,NCT01502241,Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
PID-008,Astrocytoma,37,NCT00723827,Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
PID-008,Astrocytoma,37,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-008,Astrocytoma,37,NCT00431561,Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
PID-008,Astrocytoma,37,NCT01317888,Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas
PID-008,Astrocytoma,37,NCT00089427,"IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma"
PID-008,Astrocytoma,37,NCT00028158,"Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer"
PID-008,Astrocytoma,37,NCT01044966,A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
PID-008,Astrocytoma,37,NCT01227434,A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
PID-008,Astrocytoma,37,NCT03224104,Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
PID-008,Astrocytoma,37,NCT00645385,Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
PID-008,Astrocytoma,37,NCT01240460,Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection
PID-008,Astrocytoma,37,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-008,Astrocytoma,37,NCT03633552,Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
PID-008,Astrocytoma,37,NCT04608812,Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
PID-008,Astrocytoma,37,NCT05683808,Venous Thromboembolism Prevention in Outpatients With Glioma
PID-008,Astrocytoma,37,NCT01711580,Re-irradiation of High Grade Gliomas: a Quality of Life Study
PID-008,Astrocytoma,37,NCT06273176,The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
PID-008,Astrocytoma,37,NCT07031765,Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma
PID-008,Astrocytoma,37,NCT00591058,Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT02529072,Nivolumab With DC Vaccines for Recurrent Brain Tumors
PID-008,Astrocytoma,37,NCT00612651,PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
PID-008,Astrocytoma,37,NCT01238237,Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA
PID-008,Astrocytoma,37,NCT00751270,Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
PID-008,Astrocytoma,37,NCT00610571,Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
PID-008,Astrocytoma,37,NCT00683761,A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT00473408,The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
PID-008,Astrocytoma,37,NCT01081223,Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
PID-008,Astrocytoma,37,NCT00392171,The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
PID-008,Astrocytoma,37,NCT03027388,"Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma"
PID-008,Astrocytoma,37,NCT06241391,Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
PID-008,Astrocytoma,37,NCT01967758,Phase I Study of Safety and Immunogenicity of ADU-623
PID-008,Astrocytoma,37,NCT05561374,Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma
PID-008,Astrocytoma,37,NCT01117155,A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
PID-008,Astrocytoma,37,NCT01475006,AMG 595 First-in-Human in Recurrent Gliomas
PID-008,Astrocytoma,37,NCT06017063,Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields
PID-008,Astrocytoma,37,NCT03581292,"Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations"
PID-008,Astrocytoma,37,NCT01808820,Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
PID-008,Astrocytoma,37,NCT06623565,Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
PID-008,Astrocytoma,37,NCT02629757,A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas
PID-008,Astrocytoma,37,NCT00624728,Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
PID-008,Astrocytoma,37,NCT00031538,Genetic Analysis of Brain Tumors
PID-008,Astrocytoma,37,NCT04729959,"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma"
PID-008,Astrocytoma,37,NCT00031083,Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
PID-008,Astrocytoma,37,NCT01765088,A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
PID-008,Astrocytoma,37,NCT04145115,A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden
PID-008,Astrocytoma,37,NCT01985256,Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
PID-008,Astrocytoma,37,NCT02540135,Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
PID-008,Astrocytoma,37,NCT04623931,Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
PID-008,Astrocytoma,37,NCT02942264,Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-008,Astrocytoma,37,NCT03657576,Trial of C134 in Patients With Recurrent GBM
PID-008,Astrocytoma,37,NCT01470794,Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
PID-008,Astrocytoma,37,NCT00734864,Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT03561207,3D Prediction of Patient-Specific Response
PID-008,Astrocytoma,37,NCT06108206,Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
PID-008,Astrocytoma,37,NCT00041587,Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
PID-008,Astrocytoma,37,NCT00024570,Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT00114309,131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
PID-008,Astrocytoma,37,NCT04477200,Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
PID-008,Astrocytoma,37,NCT00390299,Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-008,Astrocytoma,37,NCT00080054,A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
PID-008,Astrocytoma,37,NCT06894979,"Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma"
PID-008,Astrocytoma,37,NCT00734682,A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
PID-008,Astrocytoma,37,NCT06118723,The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
PID-008,Astrocytoma,37,NCT00009035,Natural History of Patients With Brain and Spinal Cord Tumors
PID-008,Astrocytoma,37,NCT00575887,Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
PID-008,Astrocytoma,37,NCT06614855,A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT05765812,A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
PID-008,Astrocytoma,37,NCT00589875,Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
PID-008,Astrocytoma,37,NCT05686798,Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
PID-008,Astrocytoma,37,NCT01156584,A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT00062504,Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
PID-008,Astrocytoma,37,NCT00272870,Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
PID-008,Astrocytoma,37,NCT03022578,Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
PID-008,Astrocytoma,37,NCT03900689,Social Determinants of Health in Glioblastoma Population
PID-008,Astrocytoma,37,NCT01999270,Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
PID-008,Astrocytoma,37,NCT04489420,Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
PID-008,Astrocytoma,37,NCT00995007,A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
PID-008,Astrocytoma,37,NCT01281982,(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
PID-008,Astrocytoma,37,NCT01316809,AZD8055 for Adults With Recurrent Gliomas
PID-008,Astrocytoma,37,NCT03593993,A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
PID-008,Astrocytoma,37,NCT01478321,Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
PID-008,Astrocytoma,37,NCT02039778,Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma
PID-008,Astrocytoma,37,NCT02655601,"Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001"
PID-008,Astrocytoma,37,NCT01656980,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
PID-008,Astrocytoma,37,NCT01637753,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT02885324,Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
PID-008,Astrocytoma,37,NCT01204684,Dendritic Cell Vaccine for Patients With Brain Tumors
PID-008,Astrocytoma,37,NCT01171469,Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
PID-008,Astrocytoma,37,NCT00179803,Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
PID-008,Astrocytoma,37,NCT04782609,Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT00024557,Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
PID-008,Astrocytoma,37,NCT01836549,Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
PID-008,Astrocytoma,37,NCT01250470,Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
PID-008,Astrocytoma,37,NCT00064779,Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT01648348,Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-008,Astrocytoma,37,NCT06665724,Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
PID-008,Astrocytoma,37,NCT05297864,PARP Inhibition for Gliomas (PI-4G or π4g)
PID-008,Astrocytoma,37,NCT02722512,Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
PID-008,Astrocytoma,37,NCT01514201,"Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas"
PID-008,Astrocytoma,37,NCT03971734,Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
PID-008,Astrocytoma,37,NCT00823797,Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
PID-008,Astrocytoma,37,NCT01861990,Valproic Acid in Childhood Progressive Brain Tumors
PID-008,Astrocytoma,37,NCT06193174,Re-Administration of C134 in Patients with Recurrent GBM (C134-HSV-1)
PID-008,Astrocytoma,37,NCT02168270,Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
PID-008,Astrocytoma,37,NCT00884416,Sorafenib in Newly Diagnosed High Grade Glioma
PID-008,Astrocytoma,37,NCT00004688,"Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms"
PID-008,Astrocytoma,37,NCT00243490,Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
PID-008,Astrocytoma,37,NCT01380782,BIBF 1120 for Recurrent High-Grade Gliomas
PID-008,Astrocytoma,37,NCT02758366,Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
PID-008,Astrocytoma,37,NCT06860594,"Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma"
PID-008,Astrocytoma,37,NCT01095094,Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
PID-008,Astrocytoma,37,NCT02055196,Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-008,Astrocytoma,37,NCT01144247,Cellular Immunotherapy Study for Brain Cancer
PID-008,Astrocytoma,37,NCT01189240,RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT06989086,FearLess in NeuroOncology
PID-008,Astrocytoma,37,NCT00006773,Bortezomib in Treating Patients With Recurrent Glioma
PID-008,Astrocytoma,37,NCT03956706,Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
PID-008,Astrocytoma,37,NCT05039346,Quality of Life and Patient Needs in Advanced High Grade Gliomas
PID-008,Astrocytoma,37,NCT00650923,"Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma"
PID-008,Astrocytoma,37,NCT06333899,Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
PID-008,Astrocytoma,37,NCT01151670,Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
PID-008,Astrocytoma,37,NCT00667394,Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
PID-008,Astrocytoma,37,NCT06975332,"Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression"
PID-008,Astrocytoma,37,NCT05843253,Study of Ribociclib and Everolimus in HGG and DIPG
PID-008,Astrocytoma,37,NCT05839379,Targeted Pediatric High-Grade Glioma Therapy
PID-008,Astrocytoma,37,NCT02015819,"Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas"
PID-008,Astrocytoma,37,NCT04295759,INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
PID-008,Astrocytoma,37,NCT04482933,HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
PID-008,Astrocytoma,37,NCT02031965,Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
PID-008,Astrocytoma,37,NCT05789394,Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
PID-008,Astrocytoma,37,NCT05698524,A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
PID-008,Astrocytoma,37,NCT01721577,Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
PID-008,Astrocytoma,37,NCT02238496,Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
PID-008,Astrocytoma,37,NCT01996527,3T MRI Biomarkers of Glioma Treatment Response
PID-008,Astrocytoma,37,NCT01378481,High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma
PID-008,Astrocytoma,37,NCT01148966,Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
PID-008,Astrocytoma,37,NCT01975116,p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
PID-008,Astrocytoma,37,NCT00268385,Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
PID-008,Astrocytoma,37,NCT04091503,Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma
PID-008,Astrocytoma,37,NCT00499473,Sunitinib in Treating Patients With Recurrent Malignant Gliomas
PID-008,Astrocytoma,37,NCT06896110,Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
PID-008,Astrocytoma,37,NCT06047379,"Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis"
PID-008,Astrocytoma,37,NCT00095940,Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
PID-008,Astrocytoma,37,NCT05229198,ALBATROSS Study: International Multicenter Study for Prospective Validation of Imaging Biomarkers Calculated at Vascular Habitats of High-grade Gliomas
PID-008,Astrocytoma,37,NCT06625047,Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
PID-008,Astrocytoma,37,NCT05737212,"Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas"
PID-008,Astrocytoma,37,NCT03072134,Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
PID-008,Astrocytoma,37,NCT00100802,"Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas"
PID-008,Astrocytoma,37,NCT06264388,DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
PID-008,Astrocytoma,37,NCT00042991,Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
PID-008,Astrocytoma,37,NCT02800486,"Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA"
PID-008,Astrocytoma,37,NCT04978727,"A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma"
PID-008,Astrocytoma,37,NCT03152318,A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PID-008,Astrocytoma,37,NCT06815029,Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
PID-008,Astrocytoma,37,NCT01103375,Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT01051557,Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-008,Astrocytoma,37,NCT03896568,MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
PID-008,Astrocytoma,37,NCT03739372,Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
PID-008,Astrocytoma,37,NCT06439420,CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
PID-008,Astrocytoma,37,NCT00879437,"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma"
PID-008,Astrocytoma,37,NCT03973918,Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
PID-008,Astrocytoma,37,NCT03389802,Phase I Study of APX005M in Pediatric Central Nervous System Tumors
PID-008,Astrocytoma,37,NCT01849952,Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
PID-008,Astrocytoma,37,NCT00045708,A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
PID-008,Astrocytoma,37,NCT04135807,Implantable Microdevice In Primary Brain Tumors
PID-008,Astrocytoma,37,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-008,Astrocytoma,37,NCT05956821,Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
PID-008,Astrocytoma,37,NCT01082926,"Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2"
PID-008,Astrocytoma,37,NCT03919071,Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
PID-008,Astrocytoma,37,NCT03893487,Fimepinostat in Treating Brain Tumors in Children and Young Adults
PID-008,Astrocytoma,37,NCT02372409,Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
PID-008,Astrocytoma,37,NCT04970615,Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models
PID-008,Astrocytoma,37,NCT00045110,Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
PID-008,Astrocytoma,37,NCT01234740,Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
PID-008,Astrocytoma,37,NCT02101905,Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
PID-008,Astrocytoma,37,NCT02457845,HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
PID-008,Astrocytoma,37,NCT02444546,Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
PID-008,Astrocytoma,37,NCT02644291,Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
PID-008,Astrocytoma,37,NCT01579253,Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
PID-008,Astrocytoma,37,NCT01884740,Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
PID-008,Astrocytoma,37,NCT01922076,Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
PID-008,Astrocytoma,37,NCT00369590,VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
PID-008,Astrocytoma,37,NCT00093613,Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-008,Astrocytoma,37,NCT00085540,FR901228 in Treating Patients With Recurrent High-Grade Gliomas
PID-008,Astrocytoma,37,NCT01837862,A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
PID-008,Astrocytoma,37,NCT06161974,Study of Olutasidenib and Temozolomide in HGG
PID-008,Astrocytoma,37,NCT00112736,Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT05139056,Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
PID-008,Astrocytoma,37,NCT00070525,"Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma"
PID-008,Astrocytoma,37,NCT00679354,Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
PID-008,Astrocytoma,37,NCT02192359,Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-008,Astrocytoma,37,NCT01172964,A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
PID-008,Astrocytoma,37,NCT00430079,Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
PID-008,Astrocytoma,37,NCT05303519,Safusidenib Phase 2 Study in IDH1 Mutant Glioma
PID-008,Astrocytoma,37,NCT03355794,A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
PID-008,Astrocytoma,37,NCT01339039,Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
PID-008,Astrocytoma,37,NCT01392209,Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
PID-008,Astrocytoma,37,NCT02186509,Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
PID-008,Astrocytoma,37,NCT03243461,International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
PID-008,Astrocytoma,37,NCT01165632,Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
PID-008,Astrocytoma,37,NCT03043391,Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
PID-008,Astrocytoma,37,NCT02684058,Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
PID-008,Astrocytoma,37,NCT02255461,"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors"
PID-008,Astrocytoma,37,NCT04541082,Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
PID-008,Astrocytoma,37,NCT02175745,18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
PID-008,Astrocytoma,37,NCT05934630,"Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors"
PID-008,Astrocytoma,37,NCT01234805,Yoga Therapy in Treating Patients With Malignant Brain Tumors
PID-008,Astrocytoma,37,NCT02967380,"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases"
PID-008,Astrocytoma,37,NCT03911388,HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
PID-008,Astrocytoma,37,NCT00110032,Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
PID-008,Astrocytoma,37,NCT03975829,Pediatric Long-Term Follow-up and Rollover Study
PID-008,Astrocytoma,37,NCT01119599,"RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma"
PID-008,Astrocytoma,37,NCT02194452,Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
PID-008,Astrocytoma,37,NCT00100880,"Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors"
PID-008,Astrocytoma,37,NCT00063973,Cilengitide in Treating Children With Refractory Primary Brain Tumors
PID-008,Astrocytoma,37,NCT00052780,Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
PID-008,Astrocytoma,37,NCT00946335,ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
PID-008,Astrocytoma,37,NCT00363272,Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
PID-008,Astrocytoma,37,NCT00091182,Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
PID-008,Astrocytoma,37,NCT00053963,FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
PID-008,Astrocytoma,37,NCT03434262,SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
PID-008,Astrocytoma,37,NCT04430842,"Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S"
PID-008,Astrocytoma,37,NCT01076530,Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
PID-008,Astrocytoma,37,NCT01522820,Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
PID-008,Astrocytoma,37,NCT01131234,Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
PID-008,Astrocytoma,37,NCT04028479,The Registry of Oncology Outcomes Associated with Testing and Treatment
PID-008,Astrocytoma,37,NCT00030498,Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
PID-010,Glioblastoma,62,NCT01102595,Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
PID-010,Glioblastoma,62,NCT03903419,Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
PID-010,Glioblastoma,62,NCT06650605,Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma
PID-010,Glioblastoma,62,NCT05399524,Functional and Ultrasound Guided Resection of Glioblastoma
PID-010,Glioblastoma,62,NCT03990285,[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
PID-010,Glioblastoma,62,NCT00936052,Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01252459,Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03879512,"Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG"
PID-010,Glioblastoma,62,NCT04606316,Surgical Nivolumab And Ipilimumab For Recurrent GBM
PID-010,Glioblastoma,62,NCT01700569,Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
PID-010,Glioblastoma,62,NCT06348693,Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
PID-010,Glioblastoma,62,NCT06869577,A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
PID-010,Glioblastoma,62,NCT05086497,WBSI Guided Personalized Delivery of TTFields
PID-010,Glioblastoma,62,NCT01833273,Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA
PID-010,Glioblastoma,62,NCT05896449,Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
PID-010,Glioblastoma,62,NCT03291314,Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03363659,Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02795364,Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
PID-010,Glioblastoma,62,NCT02772094,Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
PID-010,Glioblastoma,62,NCT04874506,MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT05958485,A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
PID-010,Glioblastoma,62,NCT06939400,Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
PID-010,Glioblastoma,62,NCT02945826,uPAR-PET/MRI in Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04869449,Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
PID-010,Glioblastoma,62,NCT04588454,18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT06271421,NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT06595186,JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT05423210,Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05120284,Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT05589961,Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT06404034,Expanded Access to Gallium Maltolate (GaM)
PID-010,Glioblastoma,62,NCT06466031,Application of MET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05281731,Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
PID-010,Glioblastoma,62,NCT03861598,Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
PID-010,Glioblastoma,62,NCT06451042,FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)
PID-010,Glioblastoma,62,NCT05908669,Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05500612,MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
PID-010,Glioblastoma,62,NCT00337883,A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
PID-010,Glioblastoma,62,NCT04277221,ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT01181193,Vitamin D for Treatment of Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04825275,Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: a Phase 0 Clinical Trial
PID-010,Glioblastoma,62,NCT04752813,A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
PID-010,Glioblastoma,62,NCT05353530,IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
PID-010,Glioblastoma,62,NCT05608395,11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
PID-010,Glioblastoma,62,NCT03075514,Ketogenic Diets as an Adjuvant Therapy in Glioblastoma
PID-010,Glioblastoma,62,NCT06781372,Patient's Derived Organoids for Drug Screening in Glioblastoma
PID-010,Glioblastoma,62,NCT01280552,A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT06533163,Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
PID-010,Glioblastoma,62,NCT04900792,A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
PID-010,Glioblastoma,62,NCT02864368,Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
PID-010,Glioblastoma,62,NCT01268566,A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01301430,Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
PID-010,Glioblastoma,62,NCT01865162,Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
PID-010,Glioblastoma,62,NCT01873469,Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03506139,Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02769806,Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
PID-010,Glioblastoma,62,NCT00730262,Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03344250,Phase I EGFR BATs in Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01317212,Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00190424,Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
PID-010,Glioblastoma,62,NCT03980249,Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
PID-010,Glioblastoma,62,NCT04587830,ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03707457,Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
PID-010,Glioblastoma,62,NCT01269424,BG & TMZ Therapy of Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00990496,A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT00515086,Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT03310372,Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02285959,Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04450160,Trial of AEO in New Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT03291990,5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02997423,Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT02177578,Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00209989,Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05565326,Response Assessment During MR-guided Radiation Therapy for Glioblastoma
PID-010,Glioblastoma,62,NCT05769660,A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT00323115,Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02858895,Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT02853565,A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00768911,CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02344355,A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01349660,Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00376103,Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02619864,mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02283944,TMS Electrochemotherapy for Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05402241,IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study
PID-010,Glioblastoma,62,NCT02586857,"A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)"
PID-010,Glioblastoma,62,NCT02685605,Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00544817,Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00535379,"SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT00892931,Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02296580,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT00677716,Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
PID-010,Glioblastoma,62,NCT00394628,AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00224978,Chloroquine for Treatment of Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02120287,Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01006044,Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection
PID-010,Glioblastoma,62,NCT01209442,Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02507102,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
PID-010,Glioblastoma,62,NCT01800695,Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00615186,Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy
PID-010,Glioblastoma,62,NCT07120620,PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01564914,A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT05917821,New Antigens Against Glioblastoma
PID-010,Glioblastoma,62,NCT01435395,"Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT00817284,Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT00800917,A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00083512,Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03714334,DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01285414,"Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT02844062,Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02331498,Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03347097,Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04019002,Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT00635557,Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02937844,Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04610229,Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.
PID-010,Glioblastoma,62,NCT06687681,Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
PID-010,Glioblastoma,62,NCT01752491,A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04421378,A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02550249,Neoadjuvant Nivolumab in Glioblastoma
PID-010,Glioblastoma,62,NCT05557292,RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02017249,Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01788280,Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab
PID-010,Glioblastoma,62,NCT01588769,A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients
PID-010,Glioblastoma,62,NCT01290692,Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
PID-010,Glioblastoma,62,NCT05798507,Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT02296476,A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)
PID-010,Glioblastoma,62,NCT00650949,Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
PID-010,Glioblastoma,62,NCT06346821,Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data
PID-010,Glioblastoma,62,NCT00311857,"Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)"
PID-010,Glioblastoma,62,NCT05410301,"Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma"
PID-010,Glioblastoma,62,NCT00704288,Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00083447,Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00589095,Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
PID-010,Glioblastoma,62,NCT01508117,Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
PID-010,Glioblastoma,62,NCT00792012,A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00267592,Safety and Efficacy of Talampanel in Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00590681,Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01115491,A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04801147,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00050986,Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04845919,Sonodynamic Therapy with ExAblate System in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT07052877,The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
PID-010,Glioblastoma,62,NCT07162324,"A Multicenter, Prospective Study for Glioblastoma Patients"
PID-010,Glioblastoma,62,NCT02189109,The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma
PID-010,Glioblastoma,62,NCT01663012,Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
PID-010,Glioblastoma,62,NCT05463848,Surgical Pembro +/- Olaparib w TMZ for rGBM
PID-010,Glioblastoma,62,NCT05551013,Treatment of Recurrent GBM With APG-157 Via Expanded Access
PID-010,Glioblastoma,62,NCT01604590,Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01071837,APG101 in Glioblastoma
PID-010,Glioblastoma,62,NCT06657027,Artificial Intelligence-Guided Radiotherapy Planning for Glioblastoma
PID-010,Glioblastoma,62,NCT04590664,Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
PID-010,Glioblastoma,62,NCT07119294,Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
PID-010,Glioblastoma,62,NCT06090903,Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
PID-010,Glioblastoma,62,NCT04790097,FET-PET Directed Simultaneous In-field Boost for Primary GBM
PID-010,Glioblastoma,62,NCT05190315,Chlorpromazine and Standard of Care in Glioblastoma
PID-010,Glioblastoma,62,NCT04530006,Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT06353360,TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
PID-010,Glioblastoma,62,NCT00038493,Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT07093814,A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT05970757,Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
PID-010,Glioblastoma,62,NCT07121842,Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI
PID-010,Glioblastoma,62,NCT04002804,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03866109,A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMT
PID-010,Glioblastoma,62,NCT06176066,PH Sensitive MRI Based Resections of Glioblastoma
PID-010,Glioblastoma,62,NCT02104882,INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
PID-010,Glioblastoma,62,NCT03582514,PreOperative Brain Irradiation in Glioblastoma
PID-010,Glioblastoma,62,NCT06001281,Predictive Value of Soluble CD146 in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT02029573,Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
PID-010,Glioblastoma,62,NCT01091792,Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT01450449,Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05728125,Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients
PID-010,Glioblastoma,62,NCT00984438,Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05222802,A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
PID-010,Glioblastoma,62,NCT05432375,Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
PID-010,Glioblastoma,62,NCT00797940,Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
PID-010,Glioblastoma,62,NCT01526837,Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
PID-010,Glioblastoma,62,NCT04810182,Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
PID-010,Glioblastoma,62,NCT04614909,Study of Pamiparib in Newly Diagnosed and rGBM
PID-010,Glioblastoma,62,NCT04373785,NG101m Adjuvant Therapy in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT01587144,Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
PID-010,Glioblastoma,62,NCT00076986,The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT06764537,Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma
PID-010,Glioblastoma,62,NCT01260506,Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT06749925,Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma
PID-010,Glioblastoma,62,NCT04765098,Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
PID-010,Glioblastoma,62,NCT04118036,Abemaciclib + Pembrolizumab In Glioblastoma
PID-010,Glioblastoma,62,NCT04814329,Glioblastoma Response Prediction to Apatinib
PID-010,Glioblastoma,62,NCT02047214,Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
PID-010,Glioblastoma,62,NCT03849105,131I-IPA and Concurrent XRT in Recurrent GBM
PID-010,Glioblastoma,62,NCT00116376,Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT02410577,89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03212235,Hypofractionated Radiation Therapy for Glioblastoma
PID-010,Glioblastoma,62,NCT07173829,A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
PID-010,Glioblastoma,62,NCT06336291,A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
PID-010,Glioblastoma,62,NCT05512195,Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma
PID-010,Glioblastoma,62,NCT04406272,VB-111 in Surgically Accessible Recurrent/Progressive GBM
PID-010,Glioblastoma,62,NCT05653635,Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
PID-010,Glioblastoma,62,NCT00093964,Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
PID-010,Glioblastoma,62,NCT01402063,PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
PID-010,Glioblastoma,62,NCT06061809,N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT06038604,Glioblastoma Psychosocial Support Program
PID-010,Glioblastoma,62,NCT04492163,Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
PID-010,Glioblastoma,62,NCT02378532,The Addition of Chloroquine to Chemoradiation for Glioblastoma
PID-010,Glioblastoma,62,NCT05708352,A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
PID-010,Glioblastoma,62,NCT01618747,An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse
PID-010,Glioblastoma,62,NCT07141732,Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy
PID-010,Glioblastoma,62,NCT06672575,A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02926222,Regorafenib in Relapsed Glioblastoma
PID-010,Glioblastoma,62,NCT06132438,Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
PID-010,Glioblastoma,62,NCT02751138,Determination of Immune Phenotype in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT00238797,"A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT02928575,"Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma"
PID-010,Glioblastoma,62,NCT05927610,Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
PID-010,Glioblastoma,62,NCT05366179,Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
PID-010,Glioblastoma,62,NCT05641220,Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.
PID-010,Glioblastoma,62,NCT05083754,Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
PID-010,Glioblastoma,62,NCT04977375,Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01933815,Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
PID-010,Glioblastoma,62,NCT04116411,A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT05700955,Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06490497,Expectations and Needs of a Glioblastoma Caregiver
PID-010,Glioblastoma,62,NCT04747145,Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma
PID-010,Glioblastoma,62,NCT06222138,Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00345163,A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
PID-010,Glioblastoma,62,NCT05635734,Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00916409,Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT01778530,TRC105 for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06625684,Key Longitudinal Associations With Risk and Glioblastoma Outcomes
PID-010,Glioblastoma,62,NCT07145112,Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00904852,Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT06512311,Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
PID-010,Glioblastoma,62,NCT05756985,Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
PID-010,Glioblastoma,62,NCT04552977,A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06613841,"Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma"
PID-010,Glioblastoma,62,NCT04772846,Chloroquine for Glioblastoma.
PID-010,Glioblastoma,62,NCT00684567,Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
PID-010,Glioblastoma,62,NCT01259869,A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression
PID-010,Glioblastoma,62,NCT03276286,Nativis Voyager for Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT02176720,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-010,Glioblastoma,62,NCT05781321,"Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study"
PID-010,Glioblastoma,62,NCT06845020,CSF Proteomic Characterization of Glioblastomas
PID-010,Glioblastoma,62,NCT02049489,A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02067156,"Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma"
PID-010,Glioblastoma,62,NCT03712293,ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
PID-010,Glioblastoma,62,NCT01849146,"Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma"
PID-010,Glioblastoma,62,NCT01089868,Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
PID-010,Glioblastoma,62,NCT05986851,Azeliragon in MGMT Unmethylated Glioblastoma
PID-010,Glioblastoma,62,NCT04657146,Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT05669820,Antisecretory Factor Glioblastoma Phase 2
PID-010,Glioblastoma,62,NCT04417933,Tumor Electric Fields Treatment System for Glioblastoma
PID-010,Glioblastoma,62,NCT06780592,Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
PID-010,Glioblastoma,62,NCT03048240,INtraoperative photoDYnamic Therapy of GliOblastoma
PID-010,Glioblastoma,62,NCT05015543,Physical Training in Glioblastoma Patients During Cytotoxic Therapy
PID-010,Glioblastoma,62,NCT05109728,A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
PID-010,Glioblastoma,62,NCT06218524,The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM
PID-010,Glioblastoma,62,NCT04671459,TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine
PID-010,Glioblastoma,62,NCT05556382,Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity
PID-010,Glioblastoma,62,NCT06448286,PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT05186064,Glioblastoma Targeted Treatment Option Maximization by WGS
PID-010,Glioblastoma,62,NCT06556563,EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT05515133,Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients
PID-010,Glioblastoma,62,NCT04319276,Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
PID-010,Glioblastoma,62,NCT02977780,INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
PID-010,Glioblastoma,62,NCT06831526,Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00805961,"RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM"
PID-010,Glioblastoma,62,NCT04656535,AB154 Combined With AB122 for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04391062,Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma
PID-010,Glioblastoma,62,NCT01290263,Amgen 386 for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04752280,Glioblastoma Radiotherapy Using IMRT or Proton Beams
PID-010,Glioblastoma,62,NCT06183983,Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
PID-010,Glioblastoma,62,NCT01851733,MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01493219,Biomarkers for Prognosis of Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT06524063,Targeted Survivin DC Cell Injection for the Treatment of GBM
PID-010,Glioblastoma,62,NCT03862430,A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT02815410,Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
PID-010,Glioblastoma,62,NCT05735171,Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence
PID-010,Glioblastoma,62,NCT03661723,Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06113705,Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
PID-010,Glioblastoma,62,NCT01468324,AZD7451 for Recurrent Gliomas
PID-010,Glioblastoma,62,NCT03419403,UNITE Study: Understanding New Interventions With GBM ThErapy
PID-010,Glioblastoma,62,NCT05938387,Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
PID-010,Glioblastoma,62,NCT03403803,Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
PID-010,Glioblastoma,62,NCT00892177,Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05539339,Personalized Trial in ctDNA-level-relapse Glioblastoma
PID-010,Glioblastoma,62,NCT04856852,Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT07144735,Allogeneic γδT Cells in Glioblastoma
PID-010,Glioblastoma,62,NCT00402116,Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
PID-010,Glioblastoma,62,NCT05664464,Glutamate Inhibitors in Glioblastoma
PID-010,Glioblastoma,62,NCT03687099,Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma
PID-010,Glioblastoma,62,NCT04443010,Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT04243005,Supramarginal Resection in Glioblastoma
PID-010,Glioblastoma,62,NCT00456612,Radiosurgery for Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05656300,Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?
PID-010,Glioblastoma,62,NCT04730869,Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
PID-010,Glioblastoma,62,NCT04959500,Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT05768087,Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients
PID-010,Glioblastoma,62,NCT06600399,Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma
PID-010,Glioblastoma,62,NCT04583020,Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT05303467,A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
PID-010,Glioblastoma,62,NCT04359745,Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression
PID-010,Glioblastoma,62,NCT05541042,Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
PID-010,Glioblastoma,62,NCT04599647,EAP for the Treatment of Glioblastoma With PVSRIPO
PID-010,Glioblastoma,62,NCT06297512,Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
PID-010,Glioblastoma,62,NCT06140875,Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
PID-010,Glioblastoma,62,NCT00704808,Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
PID-010,Glioblastoma,62,NCT00508456,Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
PID-010,Glioblastoma,62,NCT03139916,Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01345370,Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT05074992,A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02546102,"Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma"
PID-010,Glioblastoma,62,NCT05871021,Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
PID-010,Glioblastoma,62,NCT02850744,"Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients"
PID-010,Glioblastoma,62,NCT03194971,NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
PID-010,Glioblastoma,62,NCT03151772,Bioavailability of Disulfiram and Metformin in Glioblastomas
PID-010,Glioblastoma,62,NCT05753007,"A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients"
PID-010,Glioblastoma,62,NCT02709616,Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
PID-010,Glioblastoma,62,NCT07047066,A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02808364,Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)
PID-010,Glioblastoma,62,NCT04536649,Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.
PID-010,Glioblastoma,62,NCT05140902,Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
PID-010,Glioblastoma,62,NCT02286167,Glioma Modified Atkins-based Diet in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT00171938,Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
PID-010,Glioblastoma,62,NCT02715609,Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT05241392,Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00115453,Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
PID-010,Glioblastoma,62,NCT01907165,Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
PID-010,Glioblastoma,62,NCT02092038,Preoperative Chemoradiation for Glioblastoma
PID-010,Glioblastoma,62,NCT02780024,"Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM"
PID-010,Glioblastoma,62,NCT06146738,The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
PID-010,Glioblastoma,62,NCT04863950,Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06924099,TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
PID-010,Glioblastoma,62,NCT02880410,Feasibility Study on LITT for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02394626,Surgery for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06551909,Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
PID-010,Glioblastoma,62,NCT05183204,"Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma"
PID-010,Glioblastoma,62,NCT04716699,Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma
PID-010,Glioblastoma,62,NCT03390569,Exercise in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT04596930,MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma
PID-010,Glioblastoma,62,NCT05811793,Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
PID-010,Glioblastoma,62,NCT04250922,LAM561 With RT and TMZ for Adults With Glioblastoma
PID-010,Glioblastoma,62,NCT01109095,CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
PID-010,Glioblastoma,62,NCT04221061,18F-FluorThanatrace (PET/CT) in Glioblastoma
PID-010,Glioblastoma,62,NCT04922723,Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
PID-010,Glioblastoma,62,NCT06102525,"A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma"
PID-010,Glioblastoma,62,NCT03780569,TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT03055208,Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT03119064,BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01666600,NOA-12: BIBF1120 and R-RT in Glioblastoma
PID-010,Glioblastoma,62,NCT04280848,Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
PID-010,Glioblastoma,62,NCT03395587,Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT03293888,Spectral Analysis Probe to Identify Glioblastoma Cells
PID-010,Glioblastoma,62,NCT03529448,TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT04829097,Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma
PID-010,Glioblastoma,62,NCT04765514,Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients
PID-010,Glioblastoma,62,NCT05793021,FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
PID-010,Glioblastoma,62,NCT01562197,A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04708171,The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
PID-010,Glioblastoma,62,NCT00104091,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-010,Glioblastoma,62,NCT04691960,A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
PID-010,Glioblastoma,62,NCT01474239,A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04516733,Precoce Medical Care by the Mobil Support for Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT04826393,ASP8374 + Cemiplimab in Recurrent Glioma
PID-010,Glioblastoma,62,NCT03739333,Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.
PID-010,Glioblastoma,62,NCT05502991,Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma
PID-010,Glioblastoma,62,NCT02157103,A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT04284306,Immunohistochemical Assessment of Programmed Death ligand1 and LC3B in GBM
PID-010,Glioblastoma,62,NCT04157478,Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01478854,Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
PID-010,Glioblastoma,62,NCT03243851,Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
PID-010,Glioblastoma,62,NCT04629209,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma"
PID-010,Glioblastoma,62,NCT03743662,Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
PID-010,Glioblastoma,62,NCT02206230,Trial of Hypofractionated Radiation Therapy for Glioblastoma
PID-010,Glioblastoma,62,NCT00686725,Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
PID-010,Glioblastoma,62,NCT04881032,AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT06105619,A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
PID-010,Glioblastoma,62,NCT00262730,Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT02379572,Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
PID-010,Glioblastoma,62,NCT05304663,Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression
PID-010,Glioblastoma,62,NCT02663440,Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01777919,Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
PID-010,Glioblastoma,62,NCT02062372,Spatial Analysis and Validation of Glioblastoma on 7 T MRI
PID-010,Glioblastoma,62,NCT04219475,Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients
PID-010,Glioblastoma,62,NCT05698199,"Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)"
PID-010,Glioblastoma,62,NCT01898273,Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02202993,TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM
PID-010,Glioblastoma,62,NCT01622764,89Zr-RO5323441 PET Imaging in Glioblastoma
PID-010,Glioblastoma,62,NCT04963413,RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.
PID-010,Glioblastoma,62,NCT03491683,INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT02841332,Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00068952,Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01169415,Effects of Steroid Tapering on Functional Capacity and Neurocognition
PID-010,Glioblastoma,62,NCT05333588,The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.
PID-010,Glioblastoma,62,NCT04225039,"Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma"
PID-010,Glioblastoma,62,NCT04552886,Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma
PID-010,Glioblastoma,62,NCT02394665,Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
PID-010,Glioblastoma,62,NCT03995706,Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
PID-010,Glioblastoma,62,NCT03663725,Treatment Intensification With Temozolomide in Adults With a Glioblastoma
PID-010,Glioblastoma,62,NCT04642937,Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03493932,Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
PID-010,Glioblastoma,62,NCT02617745,Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
PID-010,Glioblastoma,62,NCT02715297,Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04471844,"Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM"
PID-010,Glioblastoma,62,NCT05187624,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma"
PID-010,Glioblastoma,62,NCT04933422,CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
PID-010,Glioblastoma,62,NCT03374943,A Trial of KB004 in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT01225510,A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06477939,Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients
PID-010,Glioblastoma,62,NCT04119674,Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT03231501,HMPL-813 in Treating Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT04574856,Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT03770468,"Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma"
PID-010,Glioblastoma,62,NCT04547855,Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
PID-010,Glioblastoma,62,NCT02146066,Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
PID-010,Glioblastoma,62,NCT02336165,Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT07076472,Sonodynamic Therapy With SONALA-001 and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02441322,Evaluating Therapeutic Response to Novo-TTF
PID-010,Glioblastoma,62,NCT04324840,A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01403285,Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT06740955,Hypofractionated Radiotherapy
PID-010,Glioblastoma,62,NCT04019262,Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT04015700,"Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-010,Glioblastoma,62,NCT01473901,A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT06676891,Expanded Access Program for GBM Subjects
PID-010,Glioblastoma,62,NCT03587038,OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02725684,Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
PID-010,Glioblastoma,62,NCT04846257,Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence
PID-010,Glioblastoma,62,NCT03246113,Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
PID-010,Glioblastoma,62,NCT01308632,Metronomic Temozolamide in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01308684,A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01782976,Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT01846871,Tivozanib for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02893137,Enhancing Optune Therapy With Targeted Craniectomy
PID-010,Glioblastoma,62,NCT03926507,F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
PID-010,Glioblastoma,62,NCT04573192,A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
PID-010,Glioblastoma,62,NCT06936046,Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression
PID-010,Glioblastoma,62,NCT02904525,Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model
PID-010,Glioblastoma,62,NCT03567135,Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma
PID-010,Glioblastoma,62,NCT03297125,Assessment of Optune Therapy for Patients with Newly Diagnosed Glioblastoma Using Advanced MRI
PID-010,Glioblastoma,62,NCT02910804,IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT01189513,SCH-900105 in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04485949,A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT00397072,Epothilone in Recurrent Glioblastoma Patients
PID-010,Glioblastoma,62,NCT00821080,Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02511405,"A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)"
PID-010,Glioblastoma,62,NCT02981940,A Study of Abemaciclib in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02630030,Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT03347617,Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT06054529,Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
PID-010,Glioblastoma,62,NCT04121455,Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
PID-010,Glioblastoma,62,NCT02254954,"Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma"
PID-010,Glioblastoma,62,NCT04047706,"Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma"
PID-010,Glioblastoma,62,NCT06973096,CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PID-010,Glioblastoma,62,NCT03388372,Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma
PID-010,Glioblastoma,62,NCT02149225,GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
PID-010,Glioblastoma,62,NCT02478164,Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
PID-010,Glioblastoma,62,NCT03679754,"Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102"
PID-010,Glioblastoma,62,NCT04006119,Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT03687034,A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT03477110,"Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma"
PID-010,Glioblastoma,62,NCT03922984,Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma
PID-010,Glioblastoma,62,NCT04762069,A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05864976,Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
PID-010,Glioblastoma,62,NCT01756352,FET-PET for Evaluation of Response of Recurrent GBM to Avastin
PID-010,Glioblastoma,62,NCT01112527,PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03548571,Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
PID-010,Glioblastoma,62,NCT01939574,A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
PID-010,Glioblastoma,62,NCT03897491,PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
PID-010,Glioblastoma,62,NCT03152708,CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT04224441,Repurposing Chlorpromazine in the Treatment of Glioblastoma
PID-010,Glioblastoma,62,NCT03535350,Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02669173,Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02902757,FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT02728349,Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma
PID-010,Glioblastoma,62,NCT02770378,A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01043536,Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
PID-010,Glioblastoma,62,NCT05376800,A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma
PID-010,Glioblastoma,62,NCT03481231,In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT02330991,A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
PID-010,Glioblastoma,62,NCT02329795,Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
PID-010,Glioblastoma,62,NCT07029100,Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.
PID-010,Glioblastoma,62,NCT04717739,"TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study"
PID-010,Glioblastoma,62,NCT01923922,CT Perfusion in the Prognostication of Cerebral High Grade Glioma
PID-010,Glioblastoma,62,NCT04007185,Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)
PID-010,Glioblastoma,62,NCT03233152,Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03636477,A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
PID-010,Glioblastoma,62,NCT04566185,Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02590497,Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
PID-010,Glioblastoma,62,NCT00509821,"Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma"
PID-010,Glioblastoma,62,NCT03439332,Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma
PID-010,Glioblastoma,62,NCT02876003,Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma
PID-010,Glioblastoma,62,NCT03223103,Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
PID-010,Glioblastoma,62,NCT05108012,Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
PID-010,Glioblastoma,62,NCT00694837,Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
PID-010,Glioblastoma,62,NCT02799238,Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT02342379,TH-302 in Combination With Bevacizumab for Glioblastoma
PID-010,Glioblastoma,62,NCT01443676,Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT05328089,Vacuolar ATPase and Drug Resistance of High Grade Gliomas
PID-010,Glioblastoma,62,NCT00943007,Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors
PID-010,Glioblastoma,62,NCT01499251,Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05664243,"A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma"
PID-010,Glioblastoma,62,NCT03383978,Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
PID-010,Glioblastoma,62,NCT01989884,An Efficacy Study Of Ortataxel In Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05900908,Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy
PID-010,Glioblastoma,62,NCT01811121,MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS
PID-010,Glioblastoma,62,NCT02654964,Cancer Stem Cell High-Throughput Drug Screening Study
PID-010,Glioblastoma,62,NCT01854099,Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens
PID-010,Glioblastoma,62,NCT03393000,Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
PID-010,Glioblastoma,62,NCT03422094,"Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-010,Glioblastoma,62,NCT03631836,"Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma"
PID-010,Glioblastoma,62,NCT03287063,"Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma"
PID-010,Glioblastoma,62,NCT00643825,"Prolonged Adjuvant Temozolomide vs ""Stop & Go"" in Glioblastoma Patients"
PID-010,Glioblastoma,62,NCT01872221,Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study
PID-010,Glioblastoma,62,NCT01260467,Memantine for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01213407,Dendritic Cell Cancer Vaccine for High-grade Glioma
PID-010,Glioblastoma,62,NCT05590689,Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
PID-010,Glioblastoma,62,NCT05342883,GammaTile and Stupp in Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT01867593,MET-PET for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02060955,Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan
PID-010,Glioblastoma,62,NCT00029783,Efficacy of Distant Healing in Glioblastoma Treatment
PID-010,Glioblastoma,62,NCT02359097,Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT03776071,"A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1"
PID-010,Glioblastoma,62,NCT05753995,"Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study"
PID-010,Glioblastoma,62,NCT01759810,Proteome-based Personalized Immunotherapy of Glioblastoma
PID-010,Glioblastoma,62,NCT00906893,Evaluation of [18F]-FMISO for Non Operated Glioblastoma
PID-010,Glioblastoma,62,NCT02718443,VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
PID-010,Glioblastoma,62,NCT02430363,Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
PID-010,Glioblastoma,62,NCT02343406,Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
PID-010,Glioblastoma,62,NCT04726397,UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial
PID-010,Glioblastoma,62,NCT01582269,A Study in Recurrent Glioblastoma (GB)
PID-010,Glioblastoma,62,NCT02939378,Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study
PID-010,Glioblastoma,62,NCT05820191,B-amyloid as a Marker for GBM Bioimaging
PID-010,Glioblastoma,62,NCT00807027,Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
PID-010,Glioblastoma,62,NCT03018288,Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT01331291,Bosutinib in Adult Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02704858,Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
PID-010,Glioblastoma,62,NCT01100177,Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients
PID-010,Glioblastoma,62,NCT02014844,Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
PID-010,Glioblastoma,62,NCT05168423,CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
PID-010,Glioblastoma,62,NCT04868396,Patient-derived Glioma Stem Cell Organoids
PID-010,Glioblastoma,62,NCT00944801,Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02866747,A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02869243,A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
PID-010,Glioblastoma,62,NCT00295815,Enzastaurin Versus Lomustine in Glioblastoma
PID-010,Glioblastoma,62,NCT03382977,"Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects"
PID-010,Glioblastoma,62,NCT01310868,Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
PID-010,Glioblastoma,62,NCT00790452,Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
PID-010,Glioblastoma,62,NCT02648633,Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04321694,Expanded Access for KHK2455
PID-010,Glioblastoma,62,NCT01856933,BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT01430351,"Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy"
PID-010,Glioblastoma,62,NCT06954636,Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
PID-010,Glioblastoma,62,NCT00941460,Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01364064,Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00385853,PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
PID-010,Glioblastoma,62,NCT03939858,Bioenergetic Profiling and Cognition in GBM Patients
PID-010,Glioblastoma,62,NCT01507506,Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
PID-010,Glioblastoma,62,NCT00703859,Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT03970447,A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02078648,"Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT00948389,Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT01310855,Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT01985087,A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
PID-010,Glioblastoma,62,NCT02315534,A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
PID-010,Glioblastoma,62,NCT00762255,A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03149003,A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
PID-010,Glioblastoma,62,NCT02209948,Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
PID-010,Glioblastoma,62,NCT02520635,Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients
PID-010,Glioblastoma,62,NCT03961971,Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
PID-010,Glioblastoma,62,NCT01083719,A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
PID-010,Glioblastoma,62,NCT04385173,Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
PID-010,Glioblastoma,62,NCT01044225,Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
PID-010,Glioblastoma,62,NCT01934361,Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00967330,A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT03454295,Easing Psychosocial Burden for Informal Caregivers
PID-010,Glioblastoma,62,NCT01464177,Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00088400,Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors
PID-010,Glioblastoma,62,NCT04528680,Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03642080,MRI Predictors of Response to Tumor Treating Fields
PID-010,Glioblastoma,62,NCT01339052,Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04313842,A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED
PID-010,Glioblastoma,62,NCT00813943,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status"
PID-010,Glioblastoma,62,NCT02968940,Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
PID-010,Glioblastoma,62,NCT04802447,SurVaxM Expanded Access Protocol
PID-010,Glioblastoma,62,NCT01880008,Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT00392548,URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol
PID-010,Glioblastoma,62,NCT02179086,Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT04838782,Role of Repeat Resection in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00689221,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status"
PID-010,Glioblastoma,62,NCT04205357,Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00725010,Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
PID-010,Glioblastoma,62,NCT03726515,CART-EGFRvIII + Pembrolizumab in GBM
PID-010,Glioblastoma,62,NCT01632228,A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00521482,Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05450744,131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)
PID-010,Glioblastoma,62,NCT03538587,Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
PID-010,Glioblastoma,62,NCT01702792,Derivation of Tumor Specific Hybridomas
PID-010,Glioblastoma,62,NCT04077866,B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
PID-010,Glioblastoma,62,NCT06136611,Preoperative Preradiotherapy TTFields
PID-010,Glioblastoma,62,NCT04915404,Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
PID-010,Glioblastoma,62,NCT03477513,Personalized Radiation Therapy for GBM
PID-010,Glioblastoma,62,NCT03452579,Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
PID-010,Glioblastoma,62,NCT05917145,ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT04474353,Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT05768919,Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
PID-010,Glioblastoma,62,NCT00501891,Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT06146725,The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
PID-010,Glioblastoma,62,NCT03008148,Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT05801159,[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT03869242,NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT05053880,A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00943826,A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01860638,A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
PID-010,Glioblastoma,62,NCT04315584,FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
PID-010,Glioblastoma,62,NCT02654041,Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
PID-010,Glioblastoma,62,NCT05326464,Tofacitinib in Recurrent GBM Patients
PID-010,Glioblastoma,62,NCT05296122,Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
PID-010,Glioblastoma,62,NCT06649851,G-CSF After Chemo-radiation in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT03688178,DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
PID-010,Glioblastoma,62,NCT03782415,Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03250299,Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02337491,Pembrolizumab +/- Bevacizumab for Recurrent GBM
PID-010,Glioblastoma,62,NCT01124539,Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
PID-010,Glioblastoma,62,NCT03927222,Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
PID-010,Glioblastoma,62,NCT02287428,Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT02905643,Discerning Pseudoprogression vs True Tumor Growth in GBMs
PID-010,Glioblastoma,62,NCT03197506,Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT06991101,Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT03258021,TTFields In GErmany in Routine Clinical Care
PID-010,Glioblastoma,62,NCT02458508,Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy
PID-010,Glioblastoma,62,NCT00003456,Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05627323,CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT04545177,Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
PID-010,Glioblastoma,62,NCT05759195,Biomolecular Analysis for Predicting Response to Regorafenib
PID-010,Glioblastoma,62,NCT02367482,Tryptophan Metabolism in Human Brain Tumors-Novocure
PID-010,Glioblastoma,62,NCT00481455,Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT00693095,Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer
PID-010,Glioblastoma,62,NCT05236036,Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
PID-010,Glioblastoma,62,NCT00003474,Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03047473,Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01208909,Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)
PID-010,Glioblastoma,62,NCT05063682,The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
PID-010,Glioblastoma,62,NCT05902169,Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
PID-010,Glioblastoma,62,NCT06815432,GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
PID-010,Glioblastoma,62,NCT03616860,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
PID-010,Glioblastoma,62,NCT03603379,Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
PID-010,Glioblastoma,62,NCT04479241,LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02085304,"Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM"
PID-010,Glioblastoma,62,NCT01186406,"Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)"
PID-010,Glioblastoma,62,NCT06917885,CUE-102 in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00977431,Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
PID-010,Glioblastoma,62,NCT00979017,Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03643549,Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
PID-010,Glioblastoma,62,NCT00290771,Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT02899663,MRI Detection of Microbleeds in Glioma Patients
PID-010,Glioblastoma,62,NCT00895180,Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05653622,Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma
PID-010,Glioblastoma,62,NCT04221503,Niraparib/TTFields in GBM
PID-010,Glioblastoma,62,NCT02698280,Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
PID-010,Glioblastoma,62,NCT05685004,Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT02631655,POSitron Emission Imaging Using 18F-FDOPA in Neurooncology
PID-010,Glioblastoma,62,NCT00576537,Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
PID-010,Glioblastoma,62,NCT02585219,Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas
PID-010,Glioblastoma,62,NCT03278249,Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
PID-010,Glioblastoma,62,NCT00687765,Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
PID-010,Glioblastoma,62,NCT00616005,Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
PID-010,Glioblastoma,62,NCT02302235,Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study
PID-010,Glioblastoma,62,NCT04003649,IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
PID-010,Glioblastoma,62,NCT02843230,Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
PID-010,Glioblastoma,62,NCT02473484,Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas
PID-010,Glioblastoma,62,NCT05432518,Pilot Trial for Treatment of Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03025893,"A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT01602588,A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)
PID-010,Glioblastoma,62,NCT06552260,A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
PID-010,Glioblastoma,62,NCT01011231,Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma
PID-010,Glioblastoma,62,NCT05977738,Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin
PID-010,Glioblastoma,62,NCT06356883,Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
PID-010,Glioblastoma,62,NCT00884741,Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00509301,Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01653834,Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
PID-010,Glioblastoma,62,NCT05868083,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01105988,Evaluating Tumor Pseudoprogression With FLT-PET and MRI
PID-010,Glioblastoma,62,NCT06039709,Sonodynamic Therapy in Patients With Recurrent GBM
PID-010,Glioblastoma,62,NCT05052957,hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
PID-010,Glioblastoma,62,NCT03235934,Glycemic Impact on Glioblastoma Outcomes
PID-010,Glioblastoma,62,NCT01535911,Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
PID-010,Glioblastoma,62,NCT06850766,The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
PID-010,Glioblastoma,62,NCT07100730,Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01251484,BIBF 1120 in Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT06283927,The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
PID-010,Glioblastoma,62,NCT05095441,A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT05131711,Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)
PID-010,Glioblastoma,62,NCT06186440,Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
PID-010,Glioblastoma,62,NCT00611728,Ph I SU011248 + Irinotecan in Treatment of Pts w MG
PID-010,Glioblastoma,62,NCT04469699,Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05663125,LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
PID-010,Glioblastoma,62,NCT01498328,A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PID-010,Glioblastoma,62,NCT00961090,Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
PID-010,Glioblastoma,62,NCT03107780,Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
PID-010,Glioblastoma,62,NCT02474966,Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study
PID-010,Glioblastoma,62,NCT01149850,Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
PID-010,Glioblastoma,62,NCT01737346,Procarbazine and Lomustine in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT07143812,A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00597493,Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM
PID-010,Glioblastoma,62,NCT07134842,A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
PID-010,Glioblastoma,62,NCT02466828,qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.
PID-010,Glioblastoma,62,NCT00574964,Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT06782984,Drug Response Testing and Repurposing Using Glioblastoma Organoid
PID-010,Glioblastoma,62,NCT06835803,Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: a Phase 2 Hybrid Randomized Trial
PID-010,Glioblastoma,62,NCT03480867,Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)
PID-010,Glioblastoma,62,NCT00306618,Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
PID-010,Glioblastoma,62,NCT06616727,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
PID-010,Glioblastoma,62,NCT01591577,Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00412542,Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
PID-010,Glioblastoma,62,NCT05666349,Reirradiation and Niraparib in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00379470,Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT00187486,"Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors"
PID-010,Glioblastoma,62,NCT06757153,Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
PID-010,Glioblastoma,62,NCT07145047,Clinical Study of Oncolytic Virus in Glioblastoma
PID-010,Glioblastoma,62,NCT05577091,Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02137759,MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
PID-010,Glioblastoma,62,NCT03463733,Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
PID-010,Glioblastoma,62,NCT02613988,Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
PID-010,Glioblastoma,62,NCT04952571,Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT01903330,ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03632135,Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04469075,Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
PID-010,Glioblastoma,62,NCT04004975,Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
PID-010,Glioblastoma,62,NCT03557372,Mathematical Model-Adapted Radiation In Glioblastoma
PID-010,Glioblastoma,62,NCT05607407,Methimazole in Patients With Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT04902586,Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT06805305,DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT03681028,Feasibility of Individualized Therapy for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02844439,Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04968366,Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
PID-010,Glioblastoma,62,NCT05737368,Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
PID-010,Glioblastoma,62,NCT06598787,A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06894225,Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
PID-010,Glioblastoma,62,NCT05743595,"Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-010,Glioblastoma,62,NCT03665545,Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
PID-010,Glioblastoma,62,NCT03672721,IA Carboplatin + Radiotherapy in Relapsing GBM
PID-010,Glioblastoma,62,NCT06934889,Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
PID-010,Glioblastoma,62,NCT04523688,Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
PID-010,Glioblastoma,62,NCT00154375,Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT05936216,TVI-Brain-1 in Expanded Access Patient
PID-010,Glioblastoma,62,NCT05736406,A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma
PID-010,Glioblastoma,62,NCT04559230,Sacituzumab Govitecan in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04888611,Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04051606,Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06368934,Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
PID-010,Glioblastoma,62,NCT04842513,Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT03452930,Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
PID-010,Glioblastoma,62,NCT06389591,RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT06418113,Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT03405792,Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
PID-010,Glioblastoma,62,NCT06220552,The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05043701,Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01957956,Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT06069726,A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
PID-010,Glioblastoma,62,NCT05720078,UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)
PID-010,Glioblastoma,62,NCT03430791,"Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma"
PID-010,Glioblastoma,62,NCT04128774,Function and Composition of Regulatory B Cells in Participants With Glioblastoma
PID-010,Glioblastoma,62,NCT06325683,Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05218408,CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
PID-010,Glioblastoma,62,NCT02649582,Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT03225963,Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.
PID-010,Glioblastoma,62,NCT05638451,Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
PID-010,Glioblastoma,62,NCT06097975,A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06011109,Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PID-010,Glioblastoma,62,NCT05911230,Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
PID-010,Glioblastoma,62,NCT02076152,FMISO PET Study of Glioblastoma
PID-010,Glioblastoma,62,NCT04674527,Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
PID-010,Glioblastoma,62,NCT03630289,Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
PID-010,Glioblastoma,62,NCT03181477,"Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas"
PID-010,Glioblastoma,62,NCT01205334,Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04717999,Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06558214,"OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial"
PID-010,Glioblastoma,62,NCT03225300,Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation
PID-010,Glioblastoma,62,NCT05284643,"Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma"
PID-010,Glioblastoma,62,NCT05201326,Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06157541,T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT05076513,Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
PID-010,Glioblastoma,62,NCT05191784,GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients
PID-010,Glioblastoma,62,NCT05540275,Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02152982,Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04116658,"First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma"
PID-010,Glioblastoma,62,NCT00575146,Ketogenic Diet for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04013672,Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
PID-010,Glioblastoma,62,NCT03916757,V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer
PID-010,Glioblastoma,62,NCT02227576,Prevention of Thrombocytopenia in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT05802693,"A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma"
PID-010,Glioblastoma,62,NCT05324501,A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04689087,"A Prospective, Open-label, Single-arm Clinical Study"
PID-010,Glioblastoma,62,NCT00960492,Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
PID-010,Glioblastoma,62,NCT00555399,"Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)"
PID-010,Glioblastoma,62,NCT05341947,Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03451799,Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT01830101,A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03232424,NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02663271,TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02060890,Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT05879120,Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04974983,Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03722342,TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03341806,Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00657267,Dose-Intense Temozolomide in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02364206,Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT03750071,VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT01110876,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)"
PID-010,Glioblastoma,62,NCT02678975,Disulfiram in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05095376,Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
PID-010,Glioblastoma,62,NCT00400322,Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
PID-010,Glioblastoma,62,NCT02207010,A Phase 0 Study of AZD1775 in Recurrent GBM Patients
PID-010,Glioblastoma,62,NCT03137888,Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
PID-010,Glioblastoma,62,NCT03856099,TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
PID-010,Glioblastoma,62,NCT05118776,Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
PID-010,Glioblastoma,62,NCT04201873,Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04988750,Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
PID-010,Glioblastoma,62,NCT03216499,HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03865355,Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
PID-010,Glioblastoma,62,NCT01349036,A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04047303,"CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma"
PID-010,Glioblastoma,62,NCT04555577,"Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma"
PID-010,Glioblastoma,62,NCT02366728,DC Migration Study for Newly-Diagnosed GBM
PID-010,Glioblastoma,62,NCT03514069,Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
PID-010,Glioblastoma,62,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-010,Glioblastoma,62,NCT04397679,"Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma"
PID-010,Glioblastoma,62,NCT02599090,Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-010,Glioblastoma,62,NCT07138001,Phase 2 Clinical Trial of KH617
PID-010,Glioblastoma,62,NCT02345824,Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
PID-010,Glioblastoma,62,NCT02919332,Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01113398,AMG 102 and Avastin for Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT00441142,Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
PID-010,Glioblastoma,62,NCT03034135,"Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma"
PID-010,Glioblastoma,62,NCT03522298,"Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma"
PID-010,Glioblastoma,62,NCT03033524,Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03867123,A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
PID-010,Glioblastoma,62,NCT02974621,Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02530502,Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02133183,Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06186401,Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
PID-010,Glioblastoma,62,NCT00921167,A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
PID-010,Glioblastoma,62,NCT00841555,Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
PID-010,Glioblastoma,62,NCT02933736,Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
PID-010,Glioblastoma,62,NCT02129335,"Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner"
PID-010,Glioblastoma,62,NCT05879250,WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02340156,Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01866449,Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02781792,Temozolomide Chronotherapy for High Grade Glioma
PID-010,Glioblastoma,62,NCT00250887,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research"
PID-010,Glioblastoma,62,NCT03401866,Multi-site Validation and Application of a Consensus DSC-MRI Protocol
PID-010,Glioblastoma,62,NCT01756729,Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
PID-010,Glioblastoma,62,NCT06419946,Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
PID-010,Glioblastoma,62,NCT03573986,Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
PID-010,Glioblastoma,62,NCT03174197,Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT05318612,Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)
PID-010,Glioblastoma,62,NCT02455557,SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00045968,Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
PID-010,Glioblastoma,62,NCT01813877,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-010,Glioblastoma,62,NCT04715620,Niraparib Combined With Radiotherapy in rGBM
PID-010,Glioblastoma,62,NCT00777153,Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04681677,Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
PID-010,Glioblastoma,62,NCT03744026,Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
PID-010,Glioblastoma,62,NCT04223999,Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)
PID-010,Glioblastoma,62,NCT01135875,Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
PID-010,Glioblastoma,62,NCT00525525,Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
PID-010,Glioblastoma,62,NCT02573324,A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
PID-010,Glioblastoma,62,NCT00365222,Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02754362,A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00734526,Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-010,Glioblastoma,62,NCT05565521,UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly
PID-010,Glioblastoma,62,NCT01987830,Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
PID-010,Glioblastoma,62,NCT05431348,Effect of StRess and ExeRcize on the Outcome After Chemo-Radiation
PID-010,Glioblastoma,62,NCT01754350,"Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma"
PID-010,Glioblastoma,62,NCT04440358,Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
PID-010,Glioblastoma,62,NCT02017717,A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT02885272,FDG PET Imaging in Diagnosing Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT04417088,Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
PID-010,Glioblastoma,62,NCT01165671,Carbon Ion Radiotherapy for Primary Glioblastoma
PID-010,Glioblastoma,62,NCT05271240,Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT05864534,Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00071539,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-010,Glioblastoma,62,NCT07089758,A Study for Cerebral Open Flow Microperfusion
PID-010,Glioblastoma,62,NCT02046187,Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01115036,A Panobinostat Presurgery
PID-010,Glioblastoma,62,NCT00612989,Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM
PID-010,Glioblastoma,62,NCT05182905,AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
PID-010,Glioblastoma,62,NCT00612339,Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
PID-010,Glioblastoma,62,NCT02717962,"Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting"
PID-010,Glioblastoma,62,NCT03158389,NCT Neuro Master Match - N²M² (NOA-20)
PID-010,Glioblastoma,62,NCT03291977,Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)
PID-010,Glioblastoma,62,NCT00250211,Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
PID-010,Glioblastoma,62,NCT00200161,Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
PID-010,Glioblastoma,62,NCT05914935,Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00335075,Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
PID-010,Glioblastoma,62,NCT02062827,Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT03014804,Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04222309,Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-010,Glioblastoma,62,NCT06095375,"Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients"
PID-010,Glioblastoma,62,NCT01956734,Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03277638,Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
PID-010,Glioblastoma,62,NCT01836536,Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients
PID-010,Glioblastoma,62,NCT05100641,AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT04105374,"Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma"
PID-010,Glioblastoma,62,NCT00615927,Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
PID-010,Glioblastoma,62,NCT00672243,Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
PID-010,Glioblastoma,62,NCT03877861,Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms
PID-010,Glioblastoma,62,NCT03868943,Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
PID-010,Glioblastoma,62,NCT01567202,Study of DC Vaccination Against Glioblastoma
PID-010,Glioblastoma,62,NCT03551249,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
PID-010,Glioblastoma,62,NCT03532295,Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
PID-010,Glioblastoma,62,NCT01702610,Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT06585527,Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT02510950,Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00613028,Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
PID-010,Glioblastoma,62,NCT05879367,Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
PID-010,Glioblastoma,62,NCT00613132,Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
PID-010,Glioblastoma,62,NCT03149575,VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
PID-010,Glioblastoma,62,NCT00611325,Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT01413438,Bevacizumab With or Without Surgery for Adult Glioblastomas
PID-010,Glioblastoma,62,NCT02010606,Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02833701,Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
PID-010,Glioblastoma,62,NCT01180816,Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
PID-010,Glioblastoma,62,NCT06455189,Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
PID-010,Glioblastoma,62,NCT02664363,EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
PID-010,Glioblastoma,62,NCT01269853,Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
PID-010,Glioblastoma,62,NCT05326334,THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)
PID-010,Glioblastoma,62,NCT00612430,Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
PID-010,Glioblastoma,62,NCT01386710,Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
PID-010,Glioblastoma,62,NCT00968240,Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
PID-010,Glioblastoma,62,NCT03722355,Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
PID-010,Glioblastoma,62,NCT00671970,Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
PID-010,Glioblastoma,62,NCT01986348,Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas
PID-010,Glioblastoma,62,NCT02026271,A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
PID-010,Glioblastoma,62,NCT06622434,"New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study"
PID-010,Glioblastoma,62,NCT01811498,Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT01067469,Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT02022384,Immunophenotyping From Blood of Patients With Malignant Gliomas
PID-010,Glioblastoma,62,NCT05990556,Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT02605746,Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis
PID-010,Glioblastoma,62,NCT02270034,Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01547546,A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT04674579,Automatic Segmentation MRI Cerebral Glioma
PID-010,Glioblastoma,62,NCT00735436,A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
PID-010,Glioblastoma,62,NCT01954576,NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00354913,Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
PID-010,Glioblastoma,62,NCT00609999,Ph I Dasatinib + Erlotinib in Recurrent MG
PID-010,Glioblastoma,62,NCT05624736,Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning
PID-010,Glioblastoma,62,NCT00586508,Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas
PID-010,Glioblastoma,62,NCT05363826,Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®
PID-010,Glioblastoma,62,NCT05660369,CARv3-TEAM-E T Cells in Glioblastoma
PID-010,Glioblastoma,62,NCT00883298,Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05941234,"Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma"
PID-010,Glioblastoma,62,NCT03050736,Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
PID-010,Glioblastoma,62,NCT00613054,Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT06279767,Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00613223,Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
PID-010,Glioblastoma,62,NCT03997136,Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.
PID-010,Glioblastoma,62,NCT00669669,O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
PID-010,Glioblastoma,62,NCT06562621,Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT00612638,Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
PID-010,Glioblastoma,62,NCT03360708,Vaccine Therapy in Treating Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03332355,Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
PID-010,Glioblastoma,62,NCT05235737,The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab
PID-010,Glioblastoma,62,NCT03170141,Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05954858,Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
PID-010,Glioblastoma,62,NCT05432804,"Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment"
PID-010,Glioblastoma,62,NCT04266977,Restrictive Use of Dexamethasone in Glioblastoma
PID-010,Glioblastoma,62,NCT00540176,The Safety and Efficacy of DCA for the Treatment of Brain Cancer
PID-010,Glioblastoma,62,NCT06327451,Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
PID-010,Glioblastoma,62,NCT02006563,Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors
PID-010,Glioblastoma,62,NCT01351519,A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
PID-010,Glioblastoma,62,NCT04780009,Loupe-Based Intraoperative Fluorescence Imaging
PID-010,Glioblastoma,62,NCT06632236,5G-EMERALD: Amivantamab in Malignant Brain Tumours
PID-010,Glioblastoma,62,NCT06630260,5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
PID-010,Glioblastoma,62,NCT02227901,"Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT02414165,The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
PID-010,Glioblastoma,62,NCT06359379,Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
PID-010,Glioblastoma,62,NCT01478178,Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT05842746,Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT03115138,Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
PID-010,Glioblastoma,62,NCT03020017,NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
PID-010,Glioblastoma,62,NCT04188535,Serial MRI Scans During Radiation Therapy
PID-010,Glioblastoma,62,NCT01174537,"New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma"
PID-010,Glioblastoma,62,NCT02590263,Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
PID-010,Glioblastoma,62,NCT04910022,Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03345095,A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01124240,Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene
PID-010,Glioblastoma,62,NCT00005856,Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02743078,Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05773664,Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma
PID-010,Glioblastoma,62,NCT06964815,"Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients"
PID-010,Glioblastoma,62,NCT03603405,HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT05694416,Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT02768389,Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05772767,Modulation of Ciliogenesis in Glioma Stem Cells
PID-010,Glioblastoma,62,NCT03294486,"Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients"
PID-010,Glioblastoma,62,NCT03144167,Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
PID-010,Glioblastoma,62,NCT00316849,"Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT00058097,Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02898012,Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
PID-010,Glioblastoma,62,NCT04391595,LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
PID-010,Glioblastoma,62,NCT04926168,6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT01805453,"Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma"
PID-010,Glioblastoma,62,NCT03834740,A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
PID-010,Glioblastoma,62,NCT00606008,A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-010,Glioblastoma,62,NCT00004262,Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT03615404,"Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma"
PID-010,Glioblastoma,62,NCT06816927,Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
PID-010,Glioblastoma,62,NCT04200066,A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03423628,A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
PID-010,Glioblastoma,62,NCT06319027,"Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial"
PID-010,Glioblastoma,62,NCT05447195,Phase 2 Study of CAN008 in Subjects With GBM
PID-010,Glioblastoma,62,NCT05600491,A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
PID-010,Glioblastoma,62,NCT00049387,"Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-010,Glioblastoma,62,NCT06177964,Lerapolturev (PVSRIPO) in GBM
PID-010,Glioblastoma,62,NCT00305864,"Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-010,Glioblastoma,62,NCT05979064,Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-010,Glioblastoma,62,NCT00052208,Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05695976,GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
PID-010,Glioblastoma,62,NCT02626364,Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
PID-010,Glioblastoma,62,NCT02761070,"Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III"
PID-010,Glioblastoma,62,NCT01811992,Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma
PID-010,Glioblastoma,62,NCT03705351,Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT00777686,Measuring Non-Enhancing Glioblastoma Progression
PID-010,Glioblastoma,62,NCT03596086,HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
PID-010,Glioblastoma,62,NCT00479765,A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
PID-010,Glioblastoma,62,NCT00039494,Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
PID-010,Glioblastoma,62,NCT00660543,MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
PID-010,Glioblastoma,62,NCT01331616,Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
PID-010,Glioblastoma,62,NCT00085254,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT01540513,PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
PID-010,Glioblastoma,62,NCT03115333,DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04741984,Monocyte Antigen Carrier Cells for Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT04937413,The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation
PID-010,Glioblastoma,62,NCT00943462,Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
PID-010,Glioblastoma,62,NCT01124461,BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor
PID-010,Glioblastoma,62,NCT05163080,SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
PID-010,Glioblastoma,62,NCT02465268,Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02375841,"Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers"
PID-010,Glioblastoma,62,NCT05091866,Natural Progesterone for the Treatment of Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03778294,18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
PID-010,Glioblastoma,62,NCT05375318,"BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels"
PID-010,Glioblastoma,62,NCT03899857,Pembrolizumab for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00613093,Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
PID-010,Glioblastoma,62,NCT05772741,Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs
PID-010,Glioblastoma,62,NCT00014170,Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05380349,Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
PID-010,Glioblastoma,62,NCT04725214,Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma
PID-010,Glioblastoma,62,NCT00902577,MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04840069,Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01609790,Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
PID-010,Glioblastoma,62,NCT01465347,Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT05033587,Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
PID-010,Glioblastoma,62,NCT00731731,"Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT02337426,"Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT05084430,Study of Pembrolizumab and M032 (NSC 733972)
PID-010,Glioblastoma,62,NCT04945148,Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
PID-010,Glioblastoma,62,NCT02395692,Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00846456,Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma
PID-010,Glioblastoma,62,NCT01022918,Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
PID-010,Glioblastoma,62,NCT05116137,The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
PID-010,Glioblastoma,62,NCT00864864,Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02575027,Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01120639,Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
PID-010,Glioblastoma,62,NCT04600817,A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)
PID-010,Glioblastoma,62,NCT04065087,Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT03619239,Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT03020602,BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab
PID-010,Glioblastoma,62,NCT02197169,DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
PID-010,Glioblastoma,62,NCT01111097,Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors
PID-010,Glioblastoma,62,NCT00761280,Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
PID-010,Glioblastoma,62,NCT07003542,A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
PID-010,Glioblastoma,62,NCT02820584,A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06329570,Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
PID-010,Glioblastoma,62,NCT04327011,A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
PID-010,Glioblastoma,62,NCT00409214,Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
PID-010,Glioblastoma,62,NCT03400917,Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT03626896,Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
PID-010,Glioblastoma,62,NCT02311920,Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-010,Glioblastoma,62,NCT06797661,Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.
PID-010,Glioblastoma,62,NCT00001148,Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
PID-010,Glioblastoma,62,NCT02047058,Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
PID-010,Glioblastoma,62,NCT00115440,BNCT to Treat Glioma That Has Progressed Following Radiotherapy
PID-010,Glioblastoma,62,NCT05513859,Investigational Imaging Technique During Brain Surgery
PID-010,Glioblastoma,62,NCT02709226,Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04998864,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
PID-010,Glioblastoma,62,NCT04903795,Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PID-010,Glioblastoma,62,NCT00165477,Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05023551,Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-010,Glioblastoma,62,NCT04424966,Infigratinib in Recurrent High-Grade Glioma Patients
PID-010,Glioblastoma,62,NCT05171127,Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
PID-010,Glioblastoma,62,NCT03861299,The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
PID-010,Glioblastoma,62,NCT06496971,A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
PID-010,Glioblastoma,62,NCT00662506,"Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma"
PID-010,Glioblastoma,62,NCT00179907,A Phase I/II Study of the Photon Radiosurgery System
PID-010,Glioblastoma,62,NCT04967690,"A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM"
PID-010,Glioblastoma,62,NCT06480721,FET-PET-Guided Management of Pseudoprogression in Glioblastoma
PID-010,Glioblastoma,62,NCT03460782,An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
PID-010,Glioblastoma,62,NCT00004146,Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
PID-010,Glioblastoma,62,NCT03951142,Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study
PID-010,Glioblastoma,62,NCT05718466,Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy
PID-010,Glioblastoma,62,NCT05904119,Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
PID-010,Glioblastoma,62,NCT04854044,ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03649464,Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
PID-010,Glioblastoma,62,NCT03732352,18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05977322,A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
PID-010,Glioblastoma,62,NCT02330562,Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab
PID-010,Glioblastoma,62,NCT06193538,The Safety and Effectiveness of NV-A01 in Glioma Patients
PID-010,Glioblastoma,62,NCT01905228,A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
PID-010,Glioblastoma,62,NCT06910306,A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02666066,Radiomics for Prediction of Survival in GBM
PID-010,Glioblastoma,62,NCT00074646,Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas
PID-010,Glioblastoma,62,NCT02903069,Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
PID-010,Glioblastoma,62,NCT00548938,"Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM"
PID-010,Glioblastoma,62,NCT02490930,A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
PID-010,Glioblastoma,62,NCT02025231,Image Guided Reirradiation of High-grade Glioma
PID-010,Glioblastoma,62,NCT06129760,Glioblastoma Remote Monitoring and Care - Research Protocol
PID-010,Glioblastoma,62,NCT06684899,Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT06773481,BC008-1A Injection for Recurrent CNS WHO G4 Glioma
PID-010,Glioblastoma,62,NCT00686387,Establishment of a Brain and Spinal Tumor Tissue Bank
PID-010,Glioblastoma,62,NCT06344130,Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01266031,Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01516905,PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
PID-010,Glioblastoma,62,NCT03370926,FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
PID-010,Glioblastoma,62,NCT06328036,Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01931098,Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
PID-010,Glioblastoma,62,NCT01502241,Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
PID-010,Glioblastoma,62,NCT00939991,"Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas"
PID-010,Glioblastoma,62,NCT03426891,Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT06719440,Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
PID-010,Glioblastoma,62,NCT00723827,Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
PID-010,Glioblastoma,62,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-010,Glioblastoma,62,NCT00431561,Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
PID-010,Glioblastoma,62,NCT01317888,Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas
PID-010,Glioblastoma,62,NCT05039281,Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05017610,Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
PID-010,Glioblastoma,62,NCT06824662,Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas
PID-010,Glioblastoma,62,NCT03618667,GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
PID-010,Glioblastoma,62,NCT00089427,"IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma"
PID-010,Glioblastoma,62,NCT00028158,"Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer"
PID-010,Glioblastoma,62,NCT01925573,Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
PID-010,Glioblastoma,62,NCT04822688,"Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues"
PID-010,Glioblastoma,62,NCT05383872,Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
PID-010,Glioblastoma,62,NCT02337686,Pembrolizumab in Treating Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03296696,Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
PID-010,Glioblastoma,62,NCT01086345,Radiosurgery Plus Bevacizumab in Glioblastoma
PID-010,Glioblastoma,62,NCT06072586,A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
PID-010,Glioblastoma,62,NCT04216329,Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT06455605,D2C7-IT + 2141-V11 Combination Post-resection in rGBM
PID-010,Glioblastoma,62,NCT01044966,A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04763031,Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT
PID-010,Glioblastoma,62,NCT04446416,Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
PID-010,Glioblastoma,62,NCT01582516,Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00753246,Nimotuzumab in Adults With Glioblastoma Multiforma
PID-010,Glioblastoma,62,NCT01227434,A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
PID-010,Glioblastoma,62,NCT03224104,Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
PID-010,Glioblastoma,62,NCT06691308,WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients
PID-010,Glioblastoma,62,NCT01004874,Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
PID-010,Glioblastoma,62,NCT02871843,RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
PID-010,Glioblastoma,62,NCT00045565,Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
PID-010,Glioblastoma,62,NCT06058988,Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
PID-010,Glioblastoma,62,NCT04817254,Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-010,Glioblastoma,62,NCT00597402,"Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas"
PID-010,Glioblastoma,62,NCT00645385,Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
PID-010,Glioblastoma,62,NCT00576641,Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
PID-010,Glioblastoma,62,NCT01520870,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
PID-010,Glioblastoma,62,NCT01240460,Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection
PID-010,Glioblastoma,62,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-010,Glioblastoma,62,NCT03633552,Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
PID-010,Glioblastoma,62,NCT05929456,Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)
PID-010,Glioblastoma,62,NCT01062425,Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT04608812,Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
PID-010,Glioblastoma,62,NCT03631823,Gut Microbiota and Glioblastoma Multiforme Prognosis
PID-010,Glioblastoma,62,NCT05565118,Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
PID-010,Glioblastoma,62,NCT04045847,CD147-CART Cells in Patients With Recurrent Malignant Glioma.
PID-010,Glioblastoma,62,NCT04289155,Individual Patient Compassionate Use of GX-I7
PID-010,Glioblastoma,62,NCT01242566,Temozolomide in Elderly Patients With KPS < 70
PID-010,Glioblastoma,62,NCT01290939,Bevacizumab and Lomustine for Recurrent GBM
PID-010,Glioblastoma,62,NCT05683808,Venous Thromboembolism Prevention in Outpatients With Glioma
PID-010,Glioblastoma,62,NCT04396860,Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
PID-010,Glioblastoma,62,NCT01294735,Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
PID-010,Glioblastoma,62,NCT04209790,Neoadjuvant Chemoradiation for Resectable Glioblastoma
PID-010,Glioblastoma,62,NCT04677049,Study of Niacin in Glioblastoma
PID-010,Glioblastoma,62,NCT05739942,Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT02253212,Safety of BBB Opening With the SonoCloud
PID-010,Glioblastoma,62,NCT06504381,"DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma"
PID-010,Glioblastoma,62,NCT01711580,Re-irradiation of High Grade Gliomas: a Quality of Life Study
PID-010,Glioblastoma,62,NCT06710249,Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
PID-010,Glioblastoma,62,NCT06883747,Clinical Trial of BMS-986504 in Recurrent GBM Patients
PID-010,Glioblastoma,62,NCT07111195,Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
PID-010,Glioblastoma,62,NCT00923117,Sunitinib to Treat Recurrent Brain Cancer
PID-010,Glioblastoma,62,NCT05671016,Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy
PID-010,Glioblastoma,62,NCT00715013,Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT02431572,A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
PID-010,Glioblastoma,62,NCT00016328,CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00540722,Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00423735,Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
PID-010,Glioblastoma,62,NCT04699773,LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
PID-010,Glioblastoma,62,NCT06273176,The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06059690,Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
PID-010,Glioblastoma,62,NCT00747253,Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
PID-010,Glioblastoma,62,NCT00980343,GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-010,Glioblastoma,62,NCT00591058,Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT03283631,Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
PID-010,Glioblastoma,62,NCT00504660,"6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients"
PID-010,Glioblastoma,62,NCT02794883,Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT00641706,"Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme"
PID-010,Glioblastoma,62,NCT00107003,GW572016 to Treat Recurrent Malignant Brain Tumors
PID-010,Glioblastoma,62,NCT06385132,Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer
PID-010,Glioblastoma,62,NCT00445588,Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT02529072,Nivolumab With DC Vaccines for Recurrent Brain Tumors
PID-010,Glioblastoma,62,NCT00612651,PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
PID-010,Glioblastoma,62,NCT01238237,Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA
PID-010,Glioblastoma,62,NCT03275558,Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma
PID-010,Glioblastoma,62,NCT00503204,Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
PID-010,Glioblastoma,62,NCT02386826,INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00704080,A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
PID-010,Glioblastoma,62,NCT04116138,Antisecretory Factor in Primary Glioblastoma 1
PID-010,Glioblastoma,62,NCT06806228,Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)
PID-010,Glioblastoma,62,NCT01790503,A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT00751270,Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
PID-010,Glioblastoma,62,NCT00610571,Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
PID-010,Glioblastoma,62,NCT00780819,Borderzone Sampling
PID-010,Glioblastoma,62,NCT00683761,A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT00473408,The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
PID-010,Glioblastoma,62,NCT07021339,Anterior Temporal Lobectomy in Temporal Glioblastoma
PID-010,Glioblastoma,62,NCT00305656,AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00335764,"Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma"
PID-010,Glioblastoma,62,NCT01081223,Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
PID-010,Glioblastoma,62,NCT00087451,Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)
PID-010,Glioblastoma,62,NCT00392171,The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
PID-010,Glioblastoma,62,NCT05734560,D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
PID-010,Glioblastoma,62,NCT00132158,ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
PID-010,Glioblastoma,62,NCT00238303,Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01575275,Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00075491,Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT05267106,Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
PID-010,Glioblastoma,62,NCT01894061,NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00112502,Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04776980,Multimodality MRI and Liquid Biopsy in GBM
PID-010,Glioblastoma,62,NCT02887417,Glioblastoma Platelet Activation Study
PID-010,Glioblastoma,62,NCT00112866,Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT04444427,Evaluation of GLR2007 for Advanced Solid Tumors
PID-010,Glioblastoma,62,NCT00895960,Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT04657315,"Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients"
PID-010,Glioblastoma,62,NCT02052648,Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
PID-010,Glioblastoma,62,NCT03027388,"Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma"
PID-010,Glioblastoma,62,NCT02661282,Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT04712721,Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
PID-010,Glioblastoma,62,NCT06241391,Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
PID-010,Glioblastoma,62,NCT04388475,Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT04143425,Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01967758,Phase I Study of Safety and Immunogenicity of ADU-623
PID-010,Glioblastoma,62,NCT03746080,Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT05561374,Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT04181684,LITT Followed by Hypofractionated RT for Recurrent Gliomas
PID-010,Glioblastoma,62,NCT03673787,A Trial of Ipatasertib in Combination With Atezolizumab
PID-010,Glioblastoma,62,NCT03367715,"Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma"
PID-010,Glioblastoma,62,NCT00459381,Pazopanib in Treating Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT05909618,Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
PID-010,Glioblastoma,62,NCT01730950,Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01753713,Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT01117155,A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
PID-010,Glioblastoma,62,NCT01475006,AMG 595 First-in-Human in Recurrent Gliomas
PID-010,Glioblastoma,62,NCT01491893,PVSRIPO for Recurrent Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT00979862,Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03539731,[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
PID-010,Glioblastoma,62,NCT01122901,Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT03176160,LITT Palliative Treatment for Patients With Malignant Gliomas
PID-010,Glioblastoma,62,NCT05929495,"Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma"
PID-010,Glioblastoma,62,NCT01972750,Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma
PID-010,Glioblastoma,62,NCT05054400,Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
PID-010,Glioblastoma,62,NCT06017063,Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields
PID-010,Glioblastoma,62,NCT01434602,Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
PID-010,Glioblastoma,62,NCT03213002,Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
PID-010,Glioblastoma,62,NCT01967810,ANG1005 in Patients With Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT03581292,"Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations"
PID-010,Glioblastoma,62,NCT03975959,Memory Perception Assessment in Central/Non-central Nervous System Cancers
PID-010,Glioblastoma,62,NCT01808820,Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
PID-010,Glioblastoma,62,NCT06623565,Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
PID-010,Glioblastoma,62,NCT02629757,A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas
PID-010,Glioblastoma,62,NCT00624728,Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
PID-010,Glioblastoma,62,NCT00562419,CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
PID-010,Glioblastoma,62,NCT02658981,Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
PID-010,Glioblastoma,62,NCT00031538,Genetic Analysis of Brain Tumors
PID-010,Glioblastoma,62,NCT00870181,ADV-TK Improves Outcome of Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT04729959,"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma"
PID-010,Glioblastoma,62,NCT00031083,Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
PID-010,Glioblastoma,62,NCT01765088,A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
PID-010,Glioblastoma,62,NCT04145115,A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden
PID-010,Glioblastoma,62,NCT02750891,A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
PID-010,Glioblastoma,62,NCT01985256,Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
PID-010,Glioblastoma,62,NCT03475186,Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
PID-010,Glioblastoma,62,NCT02540135,Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
PID-010,Glioblastoma,62,NCT01738646,Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
PID-010,Glioblastoma,62,NCT04623931,Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
PID-010,Glioblastoma,62,NCT06430424,"Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma"
PID-010,Glioblastoma,62,NCT01810744,Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
PID-010,Glioblastoma,62,NCT02942264,Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-010,Glioblastoma,62,NCT06501911,A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
PID-010,Glioblastoma,62,NCT01975701,A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
PID-010,Glioblastoma,62,NCT03657576,Trial of C134 in Patients With Recurrent GBM
PID-010,Glioblastoma,62,NCT01712542,Curcumin Bioavailability in Glioblastoma Patients
PID-010,Glioblastoma,62,NCT01470794,Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
PID-010,Glioblastoma,62,NCT01107522,Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
PID-010,Glioblastoma,62,NCT02525692,Oral ONC201 in Adult Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT07091864,Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
PID-010,Glioblastoma,62,NCT03311542,Expanded Access for Pembrolizumab (MK-3475)
PID-010,Glioblastoma,62,NCT00734864,Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT03561207,3D Prediction of Patient-Specific Response
PID-010,Glioblastoma,62,NCT03914768,Immune Modulatory DC Vaccine Against Brain Tumor
PID-010,Glioblastoma,62,NCT00102648,Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
PID-010,Glioblastoma,62,NCT07067905,Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
PID-010,Glioblastoma,62,NCT06617208,Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery
PID-010,Glioblastoma,62,NCT01814813,Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-010,Glioblastoma,62,NCT05062772,Brain Tumor Intraoperative Ultrasound Database
PID-010,Glioblastoma,62,NCT06108206,Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
PID-010,Glioblastoma,62,NCT00041587,Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
PID-010,Glioblastoma,62,NCT00024570,Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT05106296,Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
PID-010,Glioblastoma,62,NCT04267978,Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
PID-010,Glioblastoma,62,NCT00001171,Evaluation of Factors in Human Brain Tumors
PID-010,Glioblastoma,62,NCT05131763,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-010,Glioblastoma,62,NCT00114309,131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT04477200,Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
PID-010,Glioblastoma,62,NCT04270461,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-010,Glioblastoma,62,NCT01454596,CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
PID-010,Glioblastoma,62,NCT06016452,A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma
PID-010,Glioblastoma,62,NCT00379080,Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT00390299,Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT00080054,A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
PID-010,Glioblastoma,62,NCT01122888,Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT06160206,Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT06894979,"Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma"
PID-010,Glioblastoma,62,NCT00734682,A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
PID-010,Glioblastoma,62,NCT05495295,"First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours"
PID-010,Glioblastoma,62,NCT04933942,Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
PID-010,Glioblastoma,62,NCT05629702,ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
PID-010,Glioblastoma,62,NCT06118723,The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
PID-010,Glioblastoma,62,NCT01342757,Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT00009035,Natural History of Patients With Brain and Spinal Cord Tumors
PID-010,Glioblastoma,62,NCT01441388,A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
PID-010,Glioblastoma,62,NCT00575887,Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
PID-010,Glioblastoma,62,NCT04478279,A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
PID-010,Glioblastoma,62,NCT06614855,A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT04074785,Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6
PID-010,Glioblastoma,62,NCT05765812,A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT02348255,NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
PID-010,Glioblastoma,62,NCT00589875,Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
PID-010,Glioblastoma,62,NCT06492486,Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
PID-010,Glioblastoma,62,NCT05686798,Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
PID-010,Glioblastoma,62,NCT04323046,Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
PID-010,Glioblastoma,62,NCT01156584,A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT00062504,Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
PID-010,Glioblastoma,62,NCT06929819,Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
PID-010,Glioblastoma,62,NCT00272870,Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
PID-010,Glioblastoma,62,NCT06810544,Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
PID-010,Glioblastoma,62,NCT06388733,"A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma"
PID-010,Glioblastoma,62,NCT05773326,Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
PID-010,Glioblastoma,62,NCT00433381,Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
PID-010,Glioblastoma,62,NCT03022578,Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
PID-010,Glioblastoma,62,NCT04630379,Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
PID-010,Glioblastoma,62,NCT04218019,Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation
PID-010,Glioblastoma,62,NCT01999270,Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
PID-010,Glioblastoma,62,NCT04489420,Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
PID-010,Glioblastoma,62,NCT04991870,Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
PID-010,Glioblastoma,62,NCT01902771,Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
PID-010,Glioblastoma,62,NCT06038760,Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
PID-010,Glioblastoma,62,NCT00995007,A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
PID-010,Glioblastoma,62,NCT01281982,(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
PID-010,Glioblastoma,62,NCT04049669,Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
PID-010,Glioblastoma,62,NCT01316809,AZD8055 for Adults With Recurrent Gliomas
PID-010,Glioblastoma,62,NCT03593993,A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
PID-010,Glioblastoma,62,NCT01478321,Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
PID-010,Glioblastoma,62,NCT02039778,Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma
PID-010,Glioblastoma,62,NCT02655601,"Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001"
PID-010,Glioblastoma,62,NCT05465954,Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT00329719,Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT01656980,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
PID-010,Glioblastoma,62,NCT01637753,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT02885324,Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
PID-010,Glioblastoma,62,NCT01204684,Dendritic Cell Vaccine for Patients With Brain Tumors
PID-010,Glioblastoma,62,NCT03463265,Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT04314674,Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors Resection
PID-010,Glioblastoma,62,NCT01171469,Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
PID-010,Glioblastoma,62,NCT00973557,The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
PID-010,Glioblastoma,62,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
PID-010,Glioblastoma,62,NCT00179803,Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
PID-010,Glioblastoma,62,NCT04782609,Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT00024557,Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
PID-010,Glioblastoma,62,NCT01836549,Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
PID-010,Glioblastoma,62,NCT01250470,Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
PID-010,Glioblastoma,62,NCT00064779,Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT01648348,Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT06665724,Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
PID-010,Glioblastoma,62,NCT06410248,Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
PID-010,Glioblastoma,62,NCT03717142,Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
PID-010,Glioblastoma,62,NCT06902350,"Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors"
PID-010,Glioblastoma,62,NCT04614493,Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.
PID-010,Glioblastoma,62,NCT05297864,PARP Inhibition for Gliomas (PI-4G or π4g)
PID-010,Glioblastoma,62,NCT05099068,Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)
PID-010,Glioblastoma,62,NCT02722512,Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
PID-010,Glioblastoma,62,NCT01514201,"Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas"
PID-010,Glioblastoma,62,NCT04047264,Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
PID-010,Glioblastoma,62,NCT03971734,Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
PID-010,Glioblastoma,62,NCT01740258,Bevacizumab Beyond Progression (BBP)
PID-010,Glioblastoma,62,NCT03607643,"A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies"
PID-010,Glioblastoma,62,NCT00823797,Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
PID-010,Glioblastoma,62,NCT01861990,Valproic Acid in Childhood Progressive Brain Tumors
PID-010,Glioblastoma,62,NCT06193174,Re-Administration of C134 in Patients with Recurrent GBM (C134-HSV-1)
PID-010,Glioblastoma,62,NCT02168270,Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT00884416,Sorafenib in Newly Diagnosed High Grade Glioma
PID-010,Glioblastoma,62,NCT00004688,"Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms"
PID-010,Glioblastoma,62,NCT00243490,Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
PID-010,Glioblastoma,62,NCT01822275,Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-010,Glioblastoma,62,NCT01380782,BIBF 1120 for Recurrent High-Grade Gliomas
PID-010,Glioblastoma,62,NCT02758366,Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
PID-010,Glioblastoma,62,NCT06860594,"Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma"
PID-010,Glioblastoma,62,NCT01095094,Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT02055196,Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-010,Glioblastoma,62,NCT01144247,Cellular Immunotherapy Study for Brain Cancer
PID-010,Glioblastoma,62,NCT04488783,Potentiation of Chemotherapy in Brain Tumors by Zinc
PID-010,Glioblastoma,62,NCT01189240,RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT04661384,"Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma"
PID-010,Glioblastoma,62,NCT04479696,Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
PID-010,Glioblastoma,62,NCT06989086,FearLess in NeuroOncology
PID-010,Glioblastoma,62,NCT00006773,Bortezomib in Treating Patients With Recurrent Glioma
PID-010,Glioblastoma,62,NCT03956706,Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
PID-010,Glioblastoma,62,NCT06160596,Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
PID-010,Glioblastoma,62,NCT03251027,Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
PID-010,Glioblastoma,62,NCT06796335,Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
PID-010,Glioblastoma,62,NCT04734444,SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
PID-010,Glioblastoma,62,NCT03392545,Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)
PID-010,Glioblastoma,62,NCT05039346,Quality of Life and Patient Needs in Advanced High Grade Gliomas
PID-010,Glioblastoma,62,NCT05139277,Evaluation of the CONVIVO System
PID-010,Glioblastoma,62,NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection
PID-010,Glioblastoma,62,NCT00650923,"Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma"
PID-010,Glioblastoma,62,NCT06333899,Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
PID-010,Glioblastoma,62,NCT01151670,Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
PID-010,Glioblastoma,62,NCT00667394,Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
PID-010,Glioblastoma,62,NCT06975332,"Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression"
PID-010,Glioblastoma,62,NCT03914742,BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
PID-010,Glioblastoma,62,NCT05843253,Study of Ribociclib and Everolimus in HGG and DIPG
PID-010,Glioblastoma,62,NCT05839379,Targeted Pediatric High-Grade Glioma Therapy
PID-010,Glioblastoma,62,NCT01798771,Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
PID-010,Glioblastoma,62,NCT02015819,"Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas"
PID-010,Glioblastoma,62,NCT05873946,Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
PID-010,Glioblastoma,62,NCT04295759,INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
PID-010,Glioblastoma,62,NCT04482933,HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT02031965,Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
PID-010,Glioblastoma,62,NCT05789394,Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
PID-010,Glioblastoma,62,NCT05698524,A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
PID-010,Glioblastoma,62,NCT03718767,Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
PID-010,Glioblastoma,62,NCT03123952,Expanded Access to ABT-414
PID-010,Glioblastoma,62,NCT02861898,Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
PID-010,Glioblastoma,62,NCT01721577,Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
PID-010,Glioblastoma,62,NCT02238496,Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
PID-010,Glioblastoma,62,NCT04982926,A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
PID-010,Glioblastoma,62,NCT04214392,Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
PID-010,Glioblastoma,62,NCT01996527,3T MRI Biomarkers of Glioma Treatment Response
PID-010,Glioblastoma,62,NCT06926075,Early Phase Study of Kesonotide in Participants With Solid Tumours
PID-010,Glioblastoma,62,NCT01378481,High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma
PID-010,Glioblastoma,62,NCT01148966,Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
PID-010,Glioblastoma,62,NCT01975116,p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
PID-010,Glioblastoma,62,NCT00268385,Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
PID-010,Glioblastoma,62,NCT02142803,TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
PID-010,Glioblastoma,62,NCT01383135,Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
PID-010,Glioblastoma,62,NCT04573140,A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
PID-010,Glioblastoma,62,NCT01269411,RO4929097 in Treating Patients With Recurrent Invasive Gliomas
PID-010,Glioblastoma,62,NCT06640582,TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
PID-010,Glioblastoma,62,NCT03389230,Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
PID-010,Glioblastoma,62,NCT07042620,A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
PID-010,Glioblastoma,62,NCT06041555,MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
PID-010,Glioblastoma,62,NCT04740190,Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd
PID-010,Glioblastoma,62,NCT05231655,Ex VIvo DEtermiNed Cancer Therapy
PID-010,Glioblastoma,62,NCT00499473,Sunitinib in Treating Patients With Recurrent Malignant Gliomas
PID-010,Glioblastoma,62,NCT02502708,"Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors"
PID-010,Glioblastoma,62,NCT06896110,Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
PID-010,Glioblastoma,62,NCT01817751,"Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma"
PID-010,Glioblastoma,62,NCT06047379,"Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis"
PID-010,Glioblastoma,62,NCT00095940,Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
PID-010,Glioblastoma,62,NCT03749187,BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
PID-010,Glioblastoma,62,NCT06625047,Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
PID-010,Glioblastoma,62,NCT01291420,Dendritic Cell Vaccination for Patients with Solid Tumors
PID-010,Glioblastoma,62,NCT05737212,"Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas"
PID-010,Glioblastoma,62,NCT03072134,Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
PID-010,Glioblastoma,62,NCT00100802,"Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas"
PID-010,Glioblastoma,62,NCT02208362,Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
PID-010,Glioblastoma,62,NCT01977677,Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
PID-010,Glioblastoma,62,NCT05370079,Control Cohort CTRL COH
PID-010,Glioblastoma,62,NCT00042991,Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
PID-010,Glioblastoma,62,NCT02800486,"Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA"
PID-010,Glioblastoma,62,NCT04978727,"A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma"
PID-010,Glioblastoma,62,NCT04678648,A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
PID-010,Glioblastoma,62,NCT01353625,"Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies."
PID-010,Glioblastoma,62,NCT03152318,A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PID-010,Glioblastoma,62,NCT06815029,Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
PID-010,Glioblastoma,62,NCT01103375,Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT01051557,Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-010,Glioblastoma,62,NCT02974738,"A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)"
PID-010,Glioblastoma,62,NCT03896568,MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT03739372,Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
PID-010,Glioblastoma,62,NCT06439420,CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
PID-010,Glioblastoma,62,NCT01598597,"An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)"
PID-010,Glioblastoma,62,NCT02465528,Ceritinib Rare Indications Study in ALK+ Tumors
PID-010,Glioblastoma,62,NCT04388033,Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
PID-010,Glioblastoma,62,NCT01723020,A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
PID-010,Glioblastoma,62,NCT00879437,"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma"
PID-010,Glioblastoma,62,NCT03973918,Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
PID-010,Glioblastoma,62,NCT03389802,Phase I Study of APX005M in Pediatric Central Nervous System Tumors
PID-010,Glioblastoma,62,NCT01849952,Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
PID-010,Glioblastoma,62,NCT00045708,A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
PID-010,Glioblastoma,62,NCT04135807,Implantable Microdevice In Primary Brain Tumors
PID-010,Glioblastoma,62,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-010,Glioblastoma,62,NCT02798406,Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
PID-010,Glioblastoma,62,NCT05956821,Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
PID-010,Glioblastoma,62,NCT04044937,Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
PID-010,Glioblastoma,62,NCT01082926,"Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2"
PID-010,Glioblastoma,62,NCT03919071,Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
PID-010,Glioblastoma,62,NCT03893487,Fimepinostat in Treating Brain Tumors in Children and Young Adults
PID-010,Glioblastoma,62,NCT03212274,"Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations"
PID-010,Glioblastoma,62,NCT02372409,Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
PID-010,Glioblastoma,62,NCT05330559,"Fluorescence, Light-microscopy, Ultrasound Integrated / Intraoperative Diagnosis to MAXimise Resection"
PID-010,Glioblastoma,62,NCT06690216,Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
PID-010,Glioblastoma,62,NCT02365662,A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
PID-010,Glioblastoma,62,NCT04970615,Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models
PID-010,Glioblastoma,62,NCT00045110,Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
PID-010,Glioblastoma,62,NCT03734913,A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
PID-010,Glioblastoma,62,NCT01234740,Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
PID-010,Glioblastoma,62,NCT02101905,Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT02457845,HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
PID-010,Glioblastoma,62,NCT02444546,Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
PID-010,Glioblastoma,62,NCT02644291,Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
PID-010,Glioblastoma,62,NCT01579253,Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
PID-010,Glioblastoma,62,NCT01884740,Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
PID-010,Glioblastoma,62,NCT01904123,STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain
PID-010,Glioblastoma,62,NCT03684811,A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
PID-010,Glioblastoma,62,NCT01922076,Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
PID-010,Glioblastoma,62,NCT00959946,Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer
PID-010,Glioblastoma,62,NCT03244995,Mind-Body Intervention in Glioma Couples
PID-010,Glioblastoma,62,NCT02498665,A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
PID-010,Glioblastoma,62,NCT03958240,Deciphering Mechanisms Underlying Cancer Immunogenicity
PID-010,Glioblastoma,62,NCT02323880,Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
PID-010,Glioblastoma,62,NCT00369590,VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
PID-010,Glioblastoma,62,NCT00093613,Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-010,Glioblastoma,62,NCT00085540,FR901228 in Treating Patients With Recurrent High-Grade Gliomas
PID-010,Glioblastoma,62,NCT06804655,Pharmacoscopy for Patients with Refractory Primary Brain Tumors
PID-010,Glioblastoma,62,NCT02709889,Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
PID-010,Glioblastoma,62,NCT01421524,"Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma"
PID-010,Glioblastoma,62,NCT01445691,More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
PID-010,Glioblastoma,62,NCT01837862,A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
PID-010,Glioblastoma,62,NCT02038699,A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer
PID-010,Glioblastoma,62,NCT02327078,"A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)"
PID-010,Glioblastoma,62,NCT00112736,Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT06717295,The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
PID-010,Glioblastoma,62,NCT06521567,A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
PID-010,Glioblastoma,62,NCT05538572,A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
PID-010,Glioblastoma,62,NCT05139056,Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
PID-010,Glioblastoma,62,NCT00679354,Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
PID-010,Glioblastoma,62,NCT06469138,A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
PID-010,Glioblastoma,62,NCT02192359,Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-010,Glioblastoma,62,NCT01172964,A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
PID-010,Glioblastoma,62,NCT00430079,Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
PID-010,Glioblastoma,62,NCT03797326,Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
PID-010,Glioblastoma,62,NCT01177397,"Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma"
PID-010,Glioblastoma,62,NCT05835687,Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
PID-010,Glioblastoma,62,NCT04427384,Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
PID-010,Glioblastoma,62,NCT03355794,A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
PID-010,Glioblastoma,62,NCT01339039,Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
PID-010,Glioblastoma,62,NCT04732065,"ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors"
PID-010,Glioblastoma,62,NCT01392209,Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
PID-010,Glioblastoma,62,NCT02186509,Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
PID-010,Glioblastoma,62,NCT06814496,Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
PID-010,Glioblastoma,62,NCT01576666,"Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors"
PID-010,Glioblastoma,62,NCT02966509,Engagement of Patients With Advanced Cancer
PID-010,Glioblastoma,62,NCT03243461,International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
PID-010,Glioblastoma,62,NCT01165632,Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
PID-010,Glioblastoma,62,NCT03043391,Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
PID-010,Glioblastoma,62,NCT02684058,Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
PID-010,Glioblastoma,62,NCT06645808,PET-imaging of Two Vartumabs in Patients With Solid Tumors
PID-010,Glioblastoma,62,NCT02255461,"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors"
PID-010,Glioblastoma,62,NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PID-010,Glioblastoma,62,NCT04541082,Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
PID-010,Glioblastoma,62,NCT02374255,Improving Goals of Care Discussion in Advanced Cancer Patients
PID-010,Glioblastoma,62,NCT02611024,Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
PID-010,Glioblastoma,62,NCT01392352,HYPAZ: Hypertension Induced by Pazopanib
PID-010,Glioblastoma,62,NCT04541225,Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
PID-010,Glioblastoma,62,NCT02223052,Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
PID-010,Glioblastoma,62,NCT02175745,18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
PID-010,Glioblastoma,62,NCT02335918,A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
PID-010,Glioblastoma,62,NCT05934630,"Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors"
PID-010,Glioblastoma,62,NCT01234805,Yoga Therapy in Treating Patients With Malignant Brain Tumors
PID-010,Glioblastoma,62,NCT01929720,"Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors"
PID-010,Glioblastoma,62,NCT03787056,Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
PID-010,Glioblastoma,62,NCT04913337,Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
PID-010,Glioblastoma,62,NCT05563272,89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
PID-010,Glioblastoma,62,NCT01631552,Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
PID-010,Glioblastoma,62,NCT05974410,Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
PID-010,Glioblastoma,62,NCT04604158,Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
PID-010,Glioblastoma,62,NCT02967380,"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases"
PID-010,Glioblastoma,62,NCT03911388,HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
PID-010,Glioblastoma,62,NCT05131815,The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
PID-010,Glioblastoma,62,NCT00110032,Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
PID-010,Glioblastoma,62,NCT03975829,Pediatric Long-Term Follow-up and Rollover Study
PID-010,Glioblastoma,62,NCT01119599,"RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma"
PID-010,Glioblastoma,62,NCT04566393,Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies
PID-010,Glioblastoma,62,NCT02194452,Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
PID-010,Glioblastoma,62,NCT03434262,SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
PID-010,Glioblastoma,62,NCT03896958,The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
PID-010,Glioblastoma,62,NCT01522820,Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
PID-010,Glioblastoma,62,NCT01131234,Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
PID-010,Glioblastoma,62,NCT03452774,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
PID-010,Glioblastoma,62,NCT01806675,18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
PID-010,Glioblastoma,62,NCT05969860,At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
PID-010,Glioblastoma,62,NCT04028479,The Registry of Oncology Outcomes Associated with Testing and Treatment
PID-010,Glioblastoma,62,NCT00030498,Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
PID-010,Glioblastoma,62,NCT03154190,Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
PID-011,Glioblastoma,72,NCT01102595,Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
PID-011,Glioblastoma,72,NCT03903419,Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
PID-011,Glioblastoma,72,NCT06650605,Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma
PID-011,Glioblastoma,72,NCT05399524,Functional and Ultrasound Guided Resection of Glioblastoma
PID-011,Glioblastoma,72,NCT03990285,[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
PID-011,Glioblastoma,72,NCT00936052,Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01252459,Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03879512,"Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG"
PID-011,Glioblastoma,72,NCT04606316,Surgical Nivolumab And Ipilimumab For Recurrent GBM
PID-011,Glioblastoma,72,NCT01700569,Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
PID-011,Glioblastoma,72,NCT06348693,Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
PID-011,Glioblastoma,72,NCT06869577,A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
PID-011,Glioblastoma,72,NCT05086497,WBSI Guided Personalized Delivery of TTFields
PID-011,Glioblastoma,72,NCT01833273,Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA
PID-011,Glioblastoma,72,NCT05896449,Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
PID-011,Glioblastoma,72,NCT03291314,Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03363659,Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02795364,Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
PID-011,Glioblastoma,72,NCT02772094,Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
PID-011,Glioblastoma,72,NCT04874506,MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT05958485,A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
PID-011,Glioblastoma,72,NCT06939400,Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
PID-011,Glioblastoma,72,NCT02945826,uPAR-PET/MRI in Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04869449,Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
PID-011,Glioblastoma,72,NCT04588454,18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT06271421,NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT06595186,JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT05423210,Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05120284,Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT05589961,Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT06404034,Expanded Access to Gallium Maltolate (GaM)
PID-011,Glioblastoma,72,NCT06466031,Application of MET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05281731,Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
PID-011,Glioblastoma,72,NCT03861598,Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
PID-011,Glioblastoma,72,NCT06451042,FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)
PID-011,Glioblastoma,72,NCT05908669,Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05500612,MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
PID-011,Glioblastoma,72,NCT00337883,A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
PID-011,Glioblastoma,72,NCT04277221,ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT01181193,Vitamin D for Treatment of Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04825275,Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: a Phase 0 Clinical Trial
PID-011,Glioblastoma,72,NCT04752813,A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
PID-011,Glioblastoma,72,NCT05353530,IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
PID-011,Glioblastoma,72,NCT05608395,11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
PID-011,Glioblastoma,72,NCT03075514,Ketogenic Diets as an Adjuvant Therapy in Glioblastoma
PID-011,Glioblastoma,72,NCT06781372,Patient's Derived Organoids for Drug Screening in Glioblastoma
PID-011,Glioblastoma,72,NCT01280552,A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT06533163,Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
PID-011,Glioblastoma,72,NCT04900792,A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
PID-011,Glioblastoma,72,NCT02864368,Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
PID-011,Glioblastoma,72,NCT01268566,A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01301430,Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
PID-011,Glioblastoma,72,NCT01865162,Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
PID-011,Glioblastoma,72,NCT01873469,Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03506139,Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02769806,Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
PID-011,Glioblastoma,72,NCT00730262,Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03344250,Phase I EGFR BATs in Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01317212,Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00190424,Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
PID-011,Glioblastoma,72,NCT03980249,Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
PID-011,Glioblastoma,72,NCT04587830,ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03707457,Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
PID-011,Glioblastoma,72,NCT01269424,BG & TMZ Therapy of Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00990496,A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT00515086,Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT03310372,Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02285959,Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04450160,Trial of AEO in New Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT03291990,5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02997423,Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT02177578,Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00209989,Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05565326,Response Assessment During MR-guided Radiation Therapy for Glioblastoma
PID-011,Glioblastoma,72,NCT05769660,A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT00323115,Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02858895,Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT02853565,A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00768911,CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02344355,A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01349660,Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00376103,Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02619864,mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02283944,TMS Electrochemotherapy for Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05402241,IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study
PID-011,Glioblastoma,72,NCT02586857,"A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)"
PID-011,Glioblastoma,72,NCT02685605,Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00544817,Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00535379,"SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT00892931,Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02296580,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT00677716,Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
PID-011,Glioblastoma,72,NCT00394628,AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00224978,Chloroquine for Treatment of Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02120287,Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01006044,Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection
PID-011,Glioblastoma,72,NCT01209442,Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02507102,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
PID-011,Glioblastoma,72,NCT01800695,Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00615186,Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy
PID-011,Glioblastoma,72,NCT07120620,PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01564914,A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT05917821,New Antigens Against Glioblastoma
PID-011,Glioblastoma,72,NCT01435395,"Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT00817284,Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT00800917,A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00083512,Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03714334,DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01285414,"Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT02844062,Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02331498,Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03347097,Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04019002,Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT00635557,Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02937844,Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04610229,Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.
PID-011,Glioblastoma,72,NCT06687681,Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
PID-011,Glioblastoma,72,NCT01752491,A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04421378,A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02550249,Neoadjuvant Nivolumab in Glioblastoma
PID-011,Glioblastoma,72,NCT05557292,RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02017249,Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01788280,Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab
PID-011,Glioblastoma,72,NCT01588769,A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients
PID-011,Glioblastoma,72,NCT01290692,Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
PID-011,Glioblastoma,72,NCT05798507,Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT02296476,A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)
PID-011,Glioblastoma,72,NCT00650949,Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
PID-011,Glioblastoma,72,NCT06346821,Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data
PID-011,Glioblastoma,72,NCT00311857,"Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)"
PID-011,Glioblastoma,72,NCT05410301,"Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma"
PID-011,Glioblastoma,72,NCT00704288,Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00083447,Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00589095,Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
PID-011,Glioblastoma,72,NCT01508117,Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
PID-011,Glioblastoma,72,NCT00792012,A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00267592,Safety and Efficacy of Talampanel in Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00590681,Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01115491,A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04801147,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00050986,Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04845919,Sonodynamic Therapy with ExAblate System in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT07052877,The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
PID-011,Glioblastoma,72,NCT07162324,"A Multicenter, Prospective Study for Glioblastoma Patients"
PID-011,Glioblastoma,72,NCT02189109,The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma
PID-011,Glioblastoma,72,NCT01663012,Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
PID-011,Glioblastoma,72,NCT05463848,Surgical Pembro +/- Olaparib w TMZ for rGBM
PID-011,Glioblastoma,72,NCT05551013,Treatment of Recurrent GBM With APG-157 Via Expanded Access
PID-011,Glioblastoma,72,NCT01604590,Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01071837,APG101 in Glioblastoma
PID-011,Glioblastoma,72,NCT06657027,Artificial Intelligence-Guided Radiotherapy Planning for Glioblastoma
PID-011,Glioblastoma,72,NCT04590664,Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
PID-011,Glioblastoma,72,NCT07119294,Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
PID-011,Glioblastoma,72,NCT06090903,Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
PID-011,Glioblastoma,72,NCT04790097,FET-PET Directed Simultaneous In-field Boost for Primary GBM
PID-011,Glioblastoma,72,NCT05190315,Chlorpromazine and Standard of Care in Glioblastoma
PID-011,Glioblastoma,72,NCT04530006,Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT06353360,TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
PID-011,Glioblastoma,72,NCT00038493,Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT07093814,A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT05970757,Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
PID-011,Glioblastoma,72,NCT07121842,Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI
PID-011,Glioblastoma,72,NCT04002804,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03866109,A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMT
PID-011,Glioblastoma,72,NCT06176066,PH Sensitive MRI Based Resections of Glioblastoma
PID-011,Glioblastoma,72,NCT02104882,INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
PID-011,Glioblastoma,72,NCT03582514,PreOperative Brain Irradiation in Glioblastoma
PID-011,Glioblastoma,72,NCT06001281,Predictive Value of Soluble CD146 in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT02029573,Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
PID-011,Glioblastoma,72,NCT01091792,Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT01450449,Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05728125,Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients
PID-011,Glioblastoma,72,NCT00984438,Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05222802,A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
PID-011,Glioblastoma,72,NCT05432375,Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
PID-011,Glioblastoma,72,NCT00797940,Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
PID-011,Glioblastoma,72,NCT01526837,Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
PID-011,Glioblastoma,72,NCT04810182,Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
PID-011,Glioblastoma,72,NCT04614909,Study of Pamiparib in Newly Diagnosed and rGBM
PID-011,Glioblastoma,72,NCT04373785,NG101m Adjuvant Therapy in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT01587144,Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
PID-011,Glioblastoma,72,NCT00076986,The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT06764537,Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma
PID-011,Glioblastoma,72,NCT01260506,Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT06749925,Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma
PID-011,Glioblastoma,72,NCT04765098,Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
PID-011,Glioblastoma,72,NCT04118036,Abemaciclib + Pembrolizumab In Glioblastoma
PID-011,Glioblastoma,72,NCT04814329,Glioblastoma Response Prediction to Apatinib
PID-011,Glioblastoma,72,NCT02047214,Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
PID-011,Glioblastoma,72,NCT03849105,131I-IPA and Concurrent XRT in Recurrent GBM
PID-011,Glioblastoma,72,NCT00116376,Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT02410577,89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03212235,Hypofractionated Radiation Therapy for Glioblastoma
PID-011,Glioblastoma,72,NCT07173829,A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
PID-011,Glioblastoma,72,NCT06336291,A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
PID-011,Glioblastoma,72,NCT05512195,Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma
PID-011,Glioblastoma,72,NCT04406272,VB-111 in Surgically Accessible Recurrent/Progressive GBM
PID-011,Glioblastoma,72,NCT05653635,Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
PID-011,Glioblastoma,72,NCT00093964,Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
PID-011,Glioblastoma,72,NCT01402063,PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
PID-011,Glioblastoma,72,NCT06061809,N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT06038604,Glioblastoma Psychosocial Support Program
PID-011,Glioblastoma,72,NCT04492163,Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
PID-011,Glioblastoma,72,NCT02378532,The Addition of Chloroquine to Chemoradiation for Glioblastoma
PID-011,Glioblastoma,72,NCT05708352,A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
PID-011,Glioblastoma,72,NCT01618747,An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse
PID-011,Glioblastoma,72,NCT07141732,Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy
PID-011,Glioblastoma,72,NCT06672575,A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02926222,Regorafenib in Relapsed Glioblastoma
PID-011,Glioblastoma,72,NCT06132438,Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
PID-011,Glioblastoma,72,NCT02751138,Determination of Immune Phenotype in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT00238797,"A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT02928575,"Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma"
PID-011,Glioblastoma,72,NCT05927610,Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
PID-011,Glioblastoma,72,NCT05366179,Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
PID-011,Glioblastoma,72,NCT05641220,Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.
PID-011,Glioblastoma,72,NCT05083754,Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
PID-011,Glioblastoma,72,NCT04977375,Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01933815,Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
PID-011,Glioblastoma,72,NCT04116411,A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT05700955,Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06490497,Expectations and Needs of a Glioblastoma Caregiver
PID-011,Glioblastoma,72,NCT04747145,Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma
PID-011,Glioblastoma,72,NCT06222138,Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00345163,A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
PID-011,Glioblastoma,72,NCT05635734,Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00916409,Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT01778530,TRC105 for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06625684,Key Longitudinal Associations With Risk and Glioblastoma Outcomes
PID-011,Glioblastoma,72,NCT07145112,Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00904852,Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT06512311,Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
PID-011,Glioblastoma,72,NCT05756985,Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
PID-011,Glioblastoma,72,NCT04552977,A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06613841,"Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma"
PID-011,Glioblastoma,72,NCT04772846,Chloroquine for Glioblastoma.
PID-011,Glioblastoma,72,NCT00684567,Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
PID-011,Glioblastoma,72,NCT01259869,A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression
PID-011,Glioblastoma,72,NCT03276286,Nativis Voyager for Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT02176720,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-011,Glioblastoma,72,NCT05781321,"Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study"
PID-011,Glioblastoma,72,NCT06845020,CSF Proteomic Characterization of Glioblastomas
PID-011,Glioblastoma,72,NCT02049489,A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02067156,"Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma"
PID-011,Glioblastoma,72,NCT03712293,ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
PID-011,Glioblastoma,72,NCT01849146,"Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma"
PID-011,Glioblastoma,72,NCT01089868,Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
PID-011,Glioblastoma,72,NCT05986851,Azeliragon in MGMT Unmethylated Glioblastoma
PID-011,Glioblastoma,72,NCT04657146,Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT05669820,Antisecretory Factor Glioblastoma Phase 2
PID-011,Glioblastoma,72,NCT04417933,Tumor Electric Fields Treatment System for Glioblastoma
PID-011,Glioblastoma,72,NCT06780592,Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
PID-011,Glioblastoma,72,NCT03048240,INtraoperative photoDYnamic Therapy of GliOblastoma
PID-011,Glioblastoma,72,NCT05015543,Physical Training in Glioblastoma Patients During Cytotoxic Therapy
PID-011,Glioblastoma,72,NCT05109728,A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
PID-011,Glioblastoma,72,NCT06218524,The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM
PID-011,Glioblastoma,72,NCT04671459,TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine
PID-011,Glioblastoma,72,NCT05556382,Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity
PID-011,Glioblastoma,72,NCT06448286,PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT05186064,Glioblastoma Targeted Treatment Option Maximization by WGS
PID-011,Glioblastoma,72,NCT06556563,EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT05515133,Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients
PID-011,Glioblastoma,72,NCT04319276,Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
PID-011,Glioblastoma,72,NCT02977780,INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
PID-011,Glioblastoma,72,NCT06831526,Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00805961,"RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM"
PID-011,Glioblastoma,72,NCT04656535,AB154 Combined With AB122 for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04391062,Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma
PID-011,Glioblastoma,72,NCT01290263,Amgen 386 for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04752280,Glioblastoma Radiotherapy Using IMRT or Proton Beams
PID-011,Glioblastoma,72,NCT06183983,Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
PID-011,Glioblastoma,72,NCT01851733,MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01493219,Biomarkers for Prognosis of Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT06524063,Targeted Survivin DC Cell Injection for the Treatment of GBM
PID-011,Glioblastoma,72,NCT03862430,A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT02815410,Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
PID-011,Glioblastoma,72,NCT05735171,Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence
PID-011,Glioblastoma,72,NCT03661723,Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06113705,Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
PID-011,Glioblastoma,72,NCT01468324,AZD7451 for Recurrent Gliomas
PID-011,Glioblastoma,72,NCT03419403,UNITE Study: Understanding New Interventions With GBM ThErapy
PID-011,Glioblastoma,72,NCT05938387,Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
PID-011,Glioblastoma,72,NCT03403803,Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
PID-011,Glioblastoma,72,NCT00892177,Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05539339,Personalized Trial in ctDNA-level-relapse Glioblastoma
PID-011,Glioblastoma,72,NCT04856852,Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT07144735,Allogeneic γδT Cells in Glioblastoma
PID-011,Glioblastoma,72,NCT00402116,Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
PID-011,Glioblastoma,72,NCT05664464,Glutamate Inhibitors in Glioblastoma
PID-011,Glioblastoma,72,NCT03687099,Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma
PID-011,Glioblastoma,72,NCT04443010,Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT04243005,Supramarginal Resection in Glioblastoma
PID-011,Glioblastoma,72,NCT00456612,Radiosurgery for Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05656300,Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?
PID-011,Glioblastoma,72,NCT04730869,Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
PID-011,Glioblastoma,72,NCT05439278,Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma
PID-011,Glioblastoma,72,NCT04959500,Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT05768087,Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients
PID-011,Glioblastoma,72,NCT06600399,Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma
PID-011,Glioblastoma,72,NCT04583020,Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT05303467,A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
PID-011,Glioblastoma,72,NCT04359745,Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression
PID-011,Glioblastoma,72,NCT05541042,Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
PID-011,Glioblastoma,72,NCT04599647,EAP for the Treatment of Glioblastoma With PVSRIPO
PID-011,Glioblastoma,72,NCT06297512,Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
PID-011,Glioblastoma,72,NCT06140875,Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
PID-011,Glioblastoma,72,NCT00704808,Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
PID-011,Glioblastoma,72,NCT00508456,Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
PID-011,Glioblastoma,72,NCT03139916,Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03466450,Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01345370,Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT05074992,A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02546102,"Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma"
PID-011,Glioblastoma,72,NCT05871021,Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
PID-011,Glioblastoma,72,NCT02850744,"Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients"
PID-011,Glioblastoma,72,NCT03194971,NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
PID-011,Glioblastoma,72,NCT03151772,Bioavailability of Disulfiram and Metformin in Glioblastomas
PID-011,Glioblastoma,72,NCT05753007,"A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients"
PID-011,Glioblastoma,72,NCT02709616,Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
PID-011,Glioblastoma,72,NCT07047066,A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02808364,Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)
PID-011,Glioblastoma,72,NCT04536649,Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.
PID-011,Glioblastoma,72,NCT05140902,Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
PID-011,Glioblastoma,72,NCT02286167,Glioma Modified Atkins-based Diet in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT00171938,Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
PID-011,Glioblastoma,72,NCT02715609,Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT05241392,Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00115453,Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
PID-011,Glioblastoma,72,NCT01907165,Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
PID-011,Glioblastoma,72,NCT02092038,Preoperative Chemoradiation for Glioblastoma
PID-011,Glioblastoma,72,NCT02780024,"Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM"
PID-011,Glioblastoma,72,NCT06146738,The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
PID-011,Glioblastoma,72,NCT04863950,Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06924099,TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
PID-011,Glioblastoma,72,NCT02880410,Feasibility Study on LITT for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02394626,Surgery for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06551909,Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
PID-011,Glioblastoma,72,NCT05183204,"Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma"
PID-011,Glioblastoma,72,NCT04716699,Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma
PID-011,Glioblastoma,72,NCT03390569,Exercise in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT04596930,MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma
PID-011,Glioblastoma,72,NCT05811793,Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
PID-011,Glioblastoma,72,NCT04250922,LAM561 With RT and TMZ for Adults With Glioblastoma
PID-011,Glioblastoma,72,NCT01109095,CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
PID-011,Glioblastoma,72,NCT04221061,18F-FluorThanatrace (PET/CT) in Glioblastoma
PID-011,Glioblastoma,72,NCT04922723,Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
PID-011,Glioblastoma,72,NCT06102525,"A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma"
PID-011,Glioblastoma,72,NCT03780569,TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT03055208,Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03119064,BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01666600,NOA-12: BIBF1120 and R-RT in Glioblastoma
PID-011,Glioblastoma,72,NCT04280848,Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
PID-011,Glioblastoma,72,NCT03395587,Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03293888,Spectral Analysis Probe to Identify Glioblastoma Cells
PID-011,Glioblastoma,72,NCT03529448,TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT04829097,Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma
PID-011,Glioblastoma,72,NCT04765514,Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients
PID-011,Glioblastoma,72,NCT05793021,FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
PID-011,Glioblastoma,72,NCT01562197,A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04708171,The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
PID-011,Glioblastoma,72,NCT00104091,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-011,Glioblastoma,72,NCT04691960,A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
PID-011,Glioblastoma,72,NCT01474239,A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04516733,Precoce Medical Care by the Mobil Support for Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT04826393,ASP8374 + Cemiplimab in Recurrent Glioma
PID-011,Glioblastoma,72,NCT03739333,Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.
PID-011,Glioblastoma,72,NCT05502991,Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma
PID-011,Glioblastoma,72,NCT02157103,A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT04284306,Immunohistochemical Assessment of Programmed Death ligand1 and LC3B in GBM
PID-011,Glioblastoma,72,NCT04157478,Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01478854,Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
PID-011,Glioblastoma,72,NCT03243851,Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
PID-011,Glioblastoma,72,NCT04629209,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma"
PID-011,Glioblastoma,72,NCT03743662,Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
PID-011,Glioblastoma,72,NCT02206230,Trial of Hypofractionated Radiation Therapy for Glioblastoma
PID-011,Glioblastoma,72,NCT00686725,Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
PID-011,Glioblastoma,72,NCT04881032,AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT06105619,A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
PID-011,Glioblastoma,72,NCT00262730,Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT02379572,Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
PID-011,Glioblastoma,72,NCT05304663,Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression
PID-011,Glioblastoma,72,NCT02663440,Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01777919,Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
PID-011,Glioblastoma,72,NCT02062372,Spatial Analysis and Validation of Glioblastoma on 7 T MRI
PID-011,Glioblastoma,72,NCT04219475,Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients
PID-011,Glioblastoma,72,NCT05698199,"Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)"
PID-011,Glioblastoma,72,NCT01898273,Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02202993,TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM
PID-011,Glioblastoma,72,NCT01622764,89Zr-RO5323441 PET Imaging in Glioblastoma
PID-011,Glioblastoma,72,NCT04963413,RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.
PID-011,Glioblastoma,72,NCT03491683,INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT02841332,Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00068952,Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01169415,Effects of Steroid Tapering on Functional Capacity and Neurocognition
PID-011,Glioblastoma,72,NCT05333588,The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.
PID-011,Glioblastoma,72,NCT04225039,"Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma"
PID-011,Glioblastoma,72,NCT04552886,Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma
PID-011,Glioblastoma,72,NCT02394665,Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
PID-011,Glioblastoma,72,NCT03995706,Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
PID-011,Glioblastoma,72,NCT03663725,Treatment Intensification With Temozolomide in Adults With a Glioblastoma
PID-011,Glioblastoma,72,NCT04642937,Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04195139,Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
PID-011,Glioblastoma,72,NCT03493932,Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
PID-011,Glioblastoma,72,NCT02617745,Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
PID-011,Glioblastoma,72,NCT02715297,Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04471844,"Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM"
PID-011,Glioblastoma,72,NCT05187624,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma"
PID-011,Glioblastoma,72,NCT04933422,CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
PID-011,Glioblastoma,72,NCT03374943,A Trial of KB004 in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT01225510,A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06477939,Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients
PID-011,Glioblastoma,72,NCT04119674,Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03231501,HMPL-813 in Treating Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT04574856,Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03770468,"Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma"
PID-011,Glioblastoma,72,NCT04547855,Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
PID-011,Glioblastoma,72,NCT02146066,Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
PID-011,Glioblastoma,72,NCT02336165,Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT07076472,Sonodynamic Therapy With SONALA-001 and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02441322,Evaluating Therapeutic Response to Novo-TTF
PID-011,Glioblastoma,72,NCT04324840,A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01403285,Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT06740955,Hypofractionated Radiotherapy
PID-011,Glioblastoma,72,NCT04019262,Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT04015700,"Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-011,Glioblastoma,72,NCT01473901,A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT06676891,Expanded Access Program for GBM Subjects
PID-011,Glioblastoma,72,NCT03587038,OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02725684,Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
PID-011,Glioblastoma,72,NCT04846257,Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence
PID-011,Glioblastoma,72,NCT03246113,Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
PID-011,Glioblastoma,72,NCT01308632,Metronomic Temozolamide in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01308684,A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01782976,Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT01846871,Tivozanib for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02893137,Enhancing Optune Therapy With Targeted Craniectomy
PID-011,Glioblastoma,72,NCT03926507,F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
PID-011,Glioblastoma,72,NCT04573192,A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
PID-011,Glioblastoma,72,NCT06936046,Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression
PID-011,Glioblastoma,72,NCT02904525,Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model
PID-011,Glioblastoma,72,NCT03567135,Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma
PID-011,Glioblastoma,72,NCT03297125,Assessment of Optune Therapy for Patients with Newly Diagnosed Glioblastoma Using Advanced MRI
PID-011,Glioblastoma,72,NCT02910804,IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT01189513,SCH-900105 in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04485949,A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT00397072,Epothilone in Recurrent Glioblastoma Patients
PID-011,Glioblastoma,72,NCT00821080,Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02511405,"A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)"
PID-011,Glioblastoma,72,NCT02981940,A Study of Abemaciclib in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02630030,Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT03347617,Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT06054529,Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
PID-011,Glioblastoma,72,NCT04121455,Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
PID-011,Glioblastoma,72,NCT02254954,"Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma"
PID-011,Glioblastoma,72,NCT04047706,"Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma"
PID-011,Glioblastoma,72,NCT06973096,CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PID-011,Glioblastoma,72,NCT03388372,Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma
PID-011,Glioblastoma,72,NCT02149225,GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
PID-011,Glioblastoma,72,NCT02478164,Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
PID-011,Glioblastoma,72,NCT03679754,"Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102"
PID-011,Glioblastoma,72,NCT04006119,Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT03687034,A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT03477110,"Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma"
PID-011,Glioblastoma,72,NCT03922984,Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma
PID-011,Glioblastoma,72,NCT04762069,A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05864976,Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
PID-011,Glioblastoma,72,NCT01756352,FET-PET for Evaluation of Response of Recurrent GBM to Avastin
PID-011,Glioblastoma,72,NCT01112527,PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03548571,Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
PID-011,Glioblastoma,72,NCT01939574,A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
PID-011,Glioblastoma,72,NCT03897491,PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
PID-011,Glioblastoma,72,NCT03152708,CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT04224441,Repurposing Chlorpromazine in the Treatment of Glioblastoma
PID-011,Glioblastoma,72,NCT03535350,Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02669173,Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02902757,FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT02728349,Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma
PID-011,Glioblastoma,72,NCT02770378,A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01043536,Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
PID-011,Glioblastoma,72,NCT05376800,A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma
PID-011,Glioblastoma,72,NCT03481231,In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT02330991,A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
PID-011,Glioblastoma,72,NCT02329795,Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
PID-011,Glioblastoma,72,NCT07029100,Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.
PID-011,Glioblastoma,72,NCT04717739,"TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study"
PID-011,Glioblastoma,72,NCT01923922,CT Perfusion in the Prognostication of Cerebral High Grade Glioma
PID-011,Glioblastoma,72,NCT04007185,Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)
PID-011,Glioblastoma,72,NCT03233152,Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03636477,A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
PID-011,Glioblastoma,72,NCT04566185,Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02590497,Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
PID-011,Glioblastoma,72,NCT00509821,"Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma"
PID-011,Glioblastoma,72,NCT03439332,Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma
PID-011,Glioblastoma,72,NCT02876003,Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma
PID-011,Glioblastoma,72,NCT03223103,Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
PID-011,Glioblastoma,72,NCT05108012,Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
PID-011,Glioblastoma,72,NCT00694837,Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
PID-011,Glioblastoma,72,NCT02799238,Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT02342379,TH-302 in Combination With Bevacizumab for Glioblastoma
PID-011,Glioblastoma,72,NCT01443676,Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT05328089,Vacuolar ATPase and Drug Resistance of High Grade Gliomas
PID-011,Glioblastoma,72,NCT00943007,Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors
PID-011,Glioblastoma,72,NCT01499251,Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05664243,"A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma"
PID-011,Glioblastoma,72,NCT03383978,Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
PID-011,Glioblastoma,72,NCT01989884,An Efficacy Study Of Ortataxel In Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05900908,Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy
PID-011,Glioblastoma,72,NCT01811121,MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS
PID-011,Glioblastoma,72,NCT02654964,Cancer Stem Cell High-Throughput Drug Screening Study
PID-011,Glioblastoma,72,NCT01854099,Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens
PID-011,Glioblastoma,72,NCT03393000,Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
PID-011,Glioblastoma,72,NCT03422094,"Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-011,Glioblastoma,72,NCT03631836,"Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma"
PID-011,Glioblastoma,72,NCT03287063,"Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma"
PID-011,Glioblastoma,72,NCT00643825,"Prolonged Adjuvant Temozolomide vs ""Stop & Go"" in Glioblastoma Patients"
PID-011,Glioblastoma,72,NCT01872221,Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study
PID-011,Glioblastoma,72,NCT01260467,Memantine for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01213407,Dendritic Cell Cancer Vaccine for High-grade Glioma
PID-011,Glioblastoma,72,NCT05590689,Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
PID-011,Glioblastoma,72,NCT05342883,GammaTile and Stupp in Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT01867593,MET-PET for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02060955,Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan
PID-011,Glioblastoma,72,NCT00029783,Efficacy of Distant Healing in Glioblastoma Treatment
PID-011,Glioblastoma,72,NCT02359097,Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT03776071,"A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1"
PID-011,Glioblastoma,72,NCT05753995,"Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study"
PID-011,Glioblastoma,72,NCT01759810,Proteome-based Personalized Immunotherapy of Glioblastoma
PID-011,Glioblastoma,72,NCT00906893,Evaluation of [18F]-FMISO for Non Operated Glioblastoma
PID-011,Glioblastoma,72,NCT02718443,VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
PID-011,Glioblastoma,72,NCT02430363,Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
PID-011,Glioblastoma,72,NCT02343406,Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
PID-011,Glioblastoma,72,NCT04726397,UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial
PID-011,Glioblastoma,72,NCT01582269,A Study in Recurrent Glioblastoma (GB)
PID-011,Glioblastoma,72,NCT02939378,Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study
PID-011,Glioblastoma,72,NCT05820191,B-amyloid as a Marker for GBM Bioimaging
PID-011,Glioblastoma,72,NCT00807027,Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
PID-011,Glioblastoma,72,NCT03018288,Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT01331291,Bosutinib in Adult Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02704858,Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
PID-011,Glioblastoma,72,NCT01100177,Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients
PID-011,Glioblastoma,72,NCT02014844,Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
PID-011,Glioblastoma,72,NCT05168423,CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
PID-011,Glioblastoma,72,NCT04868396,Patient-derived Glioma Stem Cell Organoids
PID-011,Glioblastoma,72,NCT00944801,Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02866747,A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02869243,A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
PID-011,Glioblastoma,72,NCT00295815,Enzastaurin Versus Lomustine in Glioblastoma
PID-011,Glioblastoma,72,NCT03382977,"Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects"
PID-011,Glioblastoma,72,NCT01310868,Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
PID-011,Glioblastoma,72,NCT00790452,Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
PID-011,Glioblastoma,72,NCT02648633,Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04321694,Expanded Access for KHK2455
PID-011,Glioblastoma,72,NCT01856933,BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT01430351,"Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy"
PID-011,Glioblastoma,72,NCT06954636,Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
PID-011,Glioblastoma,72,NCT00941460,Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01364064,Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00385853,PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
PID-011,Glioblastoma,72,NCT03939858,Bioenergetic Profiling and Cognition in GBM Patients
PID-011,Glioblastoma,72,NCT01507506,Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
PID-011,Glioblastoma,72,NCT00703859,Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03970447,A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02078648,"Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT00948389,Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT01310855,Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT01985087,A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
PID-011,Glioblastoma,72,NCT02315534,A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
PID-011,Glioblastoma,72,NCT00762255,A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03149003,A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
PID-011,Glioblastoma,72,NCT02209948,Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
PID-011,Glioblastoma,72,NCT02520635,Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients
PID-011,Glioblastoma,72,NCT03961971,Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
PID-011,Glioblastoma,72,NCT01083719,A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
PID-011,Glioblastoma,72,NCT04385173,Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
PID-011,Glioblastoma,72,NCT01044225,Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
PID-011,Glioblastoma,72,NCT01934361,Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00967330,A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT03454295,Easing Psychosocial Burden for Informal Caregivers
PID-011,Glioblastoma,72,NCT01464177,Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00088400,Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors
PID-011,Glioblastoma,72,NCT04528680,Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03642080,MRI Predictors of Response to Tumor Treating Fields
PID-011,Glioblastoma,72,NCT01339052,Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04313842,A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED
PID-011,Glioblastoma,72,NCT00813943,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status"
PID-011,Glioblastoma,72,NCT02968940,Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
PID-011,Glioblastoma,72,NCT04802447,SurVaxM Expanded Access Protocol
PID-011,Glioblastoma,72,NCT01880008,Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT00392548,URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol
PID-011,Glioblastoma,72,NCT02179086,Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT04838782,Role of Repeat Resection in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01149109,Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients
PID-011,Glioblastoma,72,NCT00689221,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status"
PID-011,Glioblastoma,72,NCT04205357,Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00725010,Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
PID-011,Glioblastoma,72,NCT03726515,CART-EGFRvIII + Pembrolizumab in GBM
PID-011,Glioblastoma,72,NCT01632228,A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00521482,Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05450744,131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)
PID-011,Glioblastoma,72,NCT03538587,Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
PID-011,Glioblastoma,72,NCT01702792,Derivation of Tumor Specific Hybridomas
PID-011,Glioblastoma,72,NCT04077866,B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
PID-011,Glioblastoma,72,NCT06136611,Preoperative Preradiotherapy TTFields
PID-011,Glioblastoma,72,NCT04915404,Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
PID-011,Glioblastoma,72,NCT03477513,Personalized Radiation Therapy for GBM
PID-011,Glioblastoma,72,NCT03452579,Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
PID-011,Glioblastoma,72,NCT05917145,ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT04474353,Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT05768919,Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
PID-011,Glioblastoma,72,NCT00501891,Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT06146725,The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
PID-011,Glioblastoma,72,NCT03008148,Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT05801159,[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT03869242,NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT05053880,A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00943826,A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01860638,A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
PID-011,Glioblastoma,72,NCT04315584,FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
PID-011,Glioblastoma,72,NCT02654041,Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
PID-011,Glioblastoma,72,NCT05326464,Tofacitinib in Recurrent GBM Patients
PID-011,Glioblastoma,72,NCT05296122,Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
PID-011,Glioblastoma,72,NCT06649851,G-CSF After Chemo-radiation in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT03688178,DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
PID-011,Glioblastoma,72,NCT03782415,Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03250299,Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02337491,Pembrolizumab +/- Bevacizumab for Recurrent GBM
PID-011,Glioblastoma,72,NCT01124539,Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
PID-011,Glioblastoma,72,NCT03927222,Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
PID-011,Glioblastoma,72,NCT02287428,Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT02905643,Discerning Pseudoprogression vs True Tumor Growth in GBMs
PID-011,Glioblastoma,72,NCT03197506,Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT06991101,Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03258021,TTFields In GErmany in Routine Clinical Care
PID-011,Glioblastoma,72,NCT02458508,Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy
PID-011,Glioblastoma,72,NCT00003456,Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05627323,CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT04545177,Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
PID-011,Glioblastoma,72,NCT05759195,Biomolecular Analysis for Predicting Response to Regorafenib
PID-011,Glioblastoma,72,NCT02367482,Tryptophan Metabolism in Human Brain Tumors-Novocure
PID-011,Glioblastoma,72,NCT00481455,Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT00693095,Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer
PID-011,Glioblastoma,72,NCT05236036,Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
PID-011,Glioblastoma,72,NCT00003474,Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03047473,Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01208909,Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)
PID-011,Glioblastoma,72,NCT05063682,The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
PID-011,Glioblastoma,72,NCT05902169,Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
PID-011,Glioblastoma,72,NCT06815432,GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
PID-011,Glioblastoma,72,NCT03616860,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
PID-011,Glioblastoma,72,NCT03603379,Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
PID-011,Glioblastoma,72,NCT04479241,LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02085304,"Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM"
PID-011,Glioblastoma,72,NCT01186406,"Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)"
PID-011,Glioblastoma,72,NCT06917885,CUE-102 in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00977431,Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
PID-011,Glioblastoma,72,NCT00979017,Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03643549,Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
PID-011,Glioblastoma,72,NCT00290771,Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT02899663,MRI Detection of Microbleeds in Glioma Patients
PID-011,Glioblastoma,72,NCT00895180,Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05653622,Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma
PID-011,Glioblastoma,72,NCT04221503,Niraparib/TTFields in GBM
PID-011,Glioblastoma,72,NCT02698280,Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
PID-011,Glioblastoma,72,NCT05685004,Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT02631655,POSitron Emission Imaging Using 18F-FDOPA in Neurooncology
PID-011,Glioblastoma,72,NCT00576537,Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
PID-011,Glioblastoma,72,NCT02585219,Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas
PID-011,Glioblastoma,72,NCT03278249,Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
PID-011,Glioblastoma,72,NCT00687765,Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
PID-011,Glioblastoma,72,NCT00616005,Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
PID-011,Glioblastoma,72,NCT02302235,Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study
PID-011,Glioblastoma,72,NCT04003649,IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
PID-011,Glioblastoma,72,NCT02843230,Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
PID-011,Glioblastoma,72,NCT02473484,Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas
PID-011,Glioblastoma,72,NCT05432518,Pilot Trial for Treatment of Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03025893,"A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT01602588,A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)
PID-011,Glioblastoma,72,NCT06552260,A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
PID-011,Glioblastoma,72,NCT01011231,Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma
PID-011,Glioblastoma,72,NCT05977738,Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin
PID-011,Glioblastoma,72,NCT06356883,Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
PID-011,Glioblastoma,72,NCT00884741,Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00509301,Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01653834,Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
PID-011,Glioblastoma,72,NCT05868083,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01105988,Evaluating Tumor Pseudoprogression With FLT-PET and MRI
PID-011,Glioblastoma,72,NCT06039709,Sonodynamic Therapy in Patients With Recurrent GBM
PID-011,Glioblastoma,72,NCT05052957,hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
PID-011,Glioblastoma,72,NCT03235934,Glycemic Impact on Glioblastoma Outcomes
PID-011,Glioblastoma,72,NCT01535911,Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
PID-011,Glioblastoma,72,NCT06850766,The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
PID-011,Glioblastoma,72,NCT07100730,Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01251484,BIBF 1120 in Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT06283927,The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
PID-011,Glioblastoma,72,NCT05095441,A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT05131711,Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)
PID-011,Glioblastoma,72,NCT06186440,Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
PID-011,Glioblastoma,72,NCT00611728,Ph I SU011248 + Irinotecan in Treatment of Pts w MG
PID-011,Glioblastoma,72,NCT04469699,Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05663125,LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
PID-011,Glioblastoma,72,NCT01498328,A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PID-011,Glioblastoma,72,NCT00961090,Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
PID-011,Glioblastoma,72,NCT03107780,Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
PID-011,Glioblastoma,72,NCT02474966,Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study
PID-011,Glioblastoma,72,NCT01149850,Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
PID-011,Glioblastoma,72,NCT01737346,Procarbazine and Lomustine in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT07143812,A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00597493,Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM
PID-011,Glioblastoma,72,NCT07134842,A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
PID-011,Glioblastoma,72,NCT02466828,qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.
PID-011,Glioblastoma,72,NCT00574964,Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT06782984,Drug Response Testing and Repurposing Using Glioblastoma Organoid
PID-011,Glioblastoma,72,NCT06835803,Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: a Phase 2 Hybrid Randomized Trial
PID-011,Glioblastoma,72,NCT03480867,Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)
PID-011,Glioblastoma,72,NCT00306618,Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
PID-011,Glioblastoma,72,NCT06616727,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
PID-011,Glioblastoma,72,NCT01591577,Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00412542,Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
PID-011,Glioblastoma,72,NCT05666349,Reirradiation and Niraparib in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00379470,Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT00187486,"Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors"
PID-011,Glioblastoma,72,NCT06757153,Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
PID-011,Glioblastoma,72,NCT07145047,Clinical Study of Oncolytic Virus in Glioblastoma
PID-011,Glioblastoma,72,NCT05577091,Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02137759,MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
PID-011,Glioblastoma,72,NCT03463733,Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
PID-011,Glioblastoma,72,NCT02613988,Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
PID-011,Glioblastoma,72,NCT04952571,Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT01903330,ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03632135,Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04469075,Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
PID-011,Glioblastoma,72,NCT04004975,Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
PID-011,Glioblastoma,72,NCT03557372,Mathematical Model-Adapted Radiation In Glioblastoma
PID-011,Glioblastoma,72,NCT05607407,Methimazole in Patients With Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT04902586,Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT06805305,DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT03681028,Feasibility of Individualized Therapy for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02844439,Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04968366,Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
PID-011,Glioblastoma,72,NCT05737368,Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
PID-011,Glioblastoma,72,NCT06598787,A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06894225,Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
PID-011,Glioblastoma,72,NCT05743595,"Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-011,Glioblastoma,72,NCT03665545,Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
PID-011,Glioblastoma,72,NCT03672721,IA Carboplatin + Radiotherapy in Relapsing GBM
PID-011,Glioblastoma,72,NCT06934889,Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
PID-011,Glioblastoma,72,NCT04523688,Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
PID-011,Glioblastoma,72,NCT00154375,Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT05936216,TVI-Brain-1 in Expanded Access Patient
PID-011,Glioblastoma,72,NCT05736406,A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma
PID-011,Glioblastoma,72,NCT04559230,Sacituzumab Govitecan in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04888611,Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04051606,Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06368934,Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
PID-011,Glioblastoma,72,NCT04842513,Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03452930,Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
PID-011,Glioblastoma,72,NCT06389591,RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT06418113,Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT03405792,Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
PID-011,Glioblastoma,72,NCT06220552,The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05043701,Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01957956,Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT06069726,A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
PID-011,Glioblastoma,72,NCT05720078,UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)
PID-011,Glioblastoma,72,NCT03430791,"Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma"
PID-011,Glioblastoma,72,NCT04128774,Function and Composition of Regulatory B Cells in Participants With Glioblastoma
PID-011,Glioblastoma,72,NCT06325683,Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05218408,CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
PID-011,Glioblastoma,72,NCT02649582,Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT03225963,Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.
PID-011,Glioblastoma,72,NCT05638451,Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
PID-011,Glioblastoma,72,NCT06097975,A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06011109,Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PID-011,Glioblastoma,72,NCT05911230,Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
PID-011,Glioblastoma,72,NCT02076152,FMISO PET Study of Glioblastoma
PID-011,Glioblastoma,72,NCT04674527,Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
PID-011,Glioblastoma,72,NCT03630289,Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
PID-011,Glioblastoma,72,NCT03181477,"Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas"
PID-011,Glioblastoma,72,NCT01205334,Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04717999,Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06558214,"OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial"
PID-011,Glioblastoma,72,NCT03225300,Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation
PID-011,Glioblastoma,72,NCT05284643,"Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma"
PID-011,Glioblastoma,72,NCT05201326,Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06157541,T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT05076513,Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
PID-011,Glioblastoma,72,NCT05191784,GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients
PID-011,Glioblastoma,72,NCT05540275,Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02152982,Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04116658,"First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma"
PID-011,Glioblastoma,72,NCT00575146,Ketogenic Diet for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04013672,Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
PID-011,Glioblastoma,72,NCT03916757,V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer
PID-011,Glioblastoma,72,NCT02227576,Prevention of Thrombocytopenia in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT05802693,"A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma"
PID-011,Glioblastoma,72,NCT05324501,A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04689087,"A Prospective, Open-label, Single-arm Clinical Study"
PID-011,Glioblastoma,72,NCT00960492,Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
PID-011,Glioblastoma,72,NCT00555399,"Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)"
PID-011,Glioblastoma,72,NCT05341947,Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03451799,Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT01830101,A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03232424,NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02663271,TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02060890,Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT05879120,Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04974983,Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03722342,TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03341806,Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00657267,Dose-Intense Temozolomide in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02364206,Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03750071,VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT01110876,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)"
PID-011,Glioblastoma,72,NCT02678975,Disulfiram in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05095376,Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
PID-011,Glioblastoma,72,NCT00400322,Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
PID-011,Glioblastoma,72,NCT02207010,A Phase 0 Study of AZD1775 in Recurrent GBM Patients
PID-011,Glioblastoma,72,NCT03137888,Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
PID-011,Glioblastoma,72,NCT03856099,TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
PID-011,Glioblastoma,72,NCT05118776,Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
PID-011,Glioblastoma,72,NCT04201873,Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04988750,Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
PID-011,Glioblastoma,72,NCT03216499,HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03865355,Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
PID-011,Glioblastoma,72,NCT01349036,A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04047303,"CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma"
PID-011,Glioblastoma,72,NCT04555577,"Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma"
PID-011,Glioblastoma,72,NCT02366728,DC Migration Study for Newly-Diagnosed GBM
PID-011,Glioblastoma,72,NCT03514069,Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
PID-011,Glioblastoma,72,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-011,Glioblastoma,72,NCT04397679,"Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma"
PID-011,Glioblastoma,72,NCT02599090,Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-011,Glioblastoma,72,NCT07138001,Phase 2 Clinical Trial of KH617
PID-011,Glioblastoma,72,NCT02345824,Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
PID-011,Glioblastoma,72,NCT02919332,Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01113398,AMG 102 and Avastin for Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT00441142,Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
PID-011,Glioblastoma,72,NCT03034135,"Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma"
PID-011,Glioblastoma,72,NCT03522298,"Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma"
PID-011,Glioblastoma,72,NCT03033524,Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03867123,A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
PID-011,Glioblastoma,72,NCT02974621,Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02530502,Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02133183,Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06186401,Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
PID-011,Glioblastoma,72,NCT00921167,A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
PID-011,Glioblastoma,72,NCT00841555,Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
PID-011,Glioblastoma,72,NCT02933736,Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
PID-011,Glioblastoma,72,NCT02129335,"Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner"
PID-011,Glioblastoma,72,NCT05879250,WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02340156,Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01866449,Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02781792,Temozolomide Chronotherapy for High Grade Glioma
PID-011,Glioblastoma,72,NCT00250887,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research"
PID-011,Glioblastoma,72,NCT03401866,Multi-site Validation and Application of a Consensus DSC-MRI Protocol
PID-011,Glioblastoma,72,NCT01756729,Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
PID-011,Glioblastoma,72,NCT06419946,Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
PID-011,Glioblastoma,72,NCT03573986,Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
PID-011,Glioblastoma,72,NCT03174197,Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT05318612,Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)
PID-011,Glioblastoma,72,NCT02455557,SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00045968,Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
PID-011,Glioblastoma,72,NCT01813877,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-011,Glioblastoma,72,NCT04715620,Niraparib Combined With Radiotherapy in rGBM
PID-011,Glioblastoma,72,NCT00777153,Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04681677,Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
PID-011,Glioblastoma,72,NCT03744026,Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
PID-011,Glioblastoma,72,NCT04223999,Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)
PID-011,Glioblastoma,72,NCT01135875,Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
PID-011,Glioblastoma,72,NCT00525525,Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
PID-011,Glioblastoma,72,NCT02573324,A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
PID-011,Glioblastoma,72,NCT00365222,Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02754362,A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00734526,Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-011,Glioblastoma,72,NCT05565521,UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly
PID-011,Glioblastoma,72,NCT01987830,Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
PID-011,Glioblastoma,72,NCT05431348,Effect of StRess and ExeRcize on the Outcome After Chemo-Radiation
PID-011,Glioblastoma,72,NCT01754350,"Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma"
PID-011,Glioblastoma,72,NCT04440358,Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
PID-011,Glioblastoma,72,NCT02017717,A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT02885272,FDG PET Imaging in Diagnosing Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT04417088,Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
PID-011,Glioblastoma,72,NCT01165671,Carbon Ion Radiotherapy for Primary Glioblastoma
PID-011,Glioblastoma,72,NCT05271240,Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT05864534,Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00071539,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-011,Glioblastoma,72,NCT07089758,A Study for Cerebral Open Flow Microperfusion
PID-011,Glioblastoma,72,NCT02046187,Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01115036,A Panobinostat Presurgery
PID-011,Glioblastoma,72,NCT00612989,Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM
PID-011,Glioblastoma,72,NCT05182905,AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
PID-011,Glioblastoma,72,NCT00612339,Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
PID-011,Glioblastoma,72,NCT02717962,"Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting"
PID-011,Glioblastoma,72,NCT03158389,NCT Neuro Master Match - N²M² (NOA-20)
PID-011,Glioblastoma,72,NCT03291977,Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)
PID-011,Glioblastoma,72,NCT00250211,Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
PID-011,Glioblastoma,72,NCT00200161,Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
PID-011,Glioblastoma,72,NCT05914935,Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00335075,Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
PID-011,Glioblastoma,72,NCT02062827,Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT03014804,Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04222309,Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-011,Glioblastoma,72,NCT06095375,"Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients"
PID-011,Glioblastoma,72,NCT01956734,Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03277638,Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
PID-011,Glioblastoma,72,NCT01836536,Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients
PID-011,Glioblastoma,72,NCT05100641,AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT04105374,"Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma"
PID-011,Glioblastoma,72,NCT00615927,Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
PID-011,Glioblastoma,72,NCT00672243,Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
PID-011,Glioblastoma,72,NCT03877861,Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms
PID-011,Glioblastoma,72,NCT03868943,Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
PID-011,Glioblastoma,72,NCT01567202,Study of DC Vaccination Against Glioblastoma
PID-011,Glioblastoma,72,NCT03551249,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
PID-011,Glioblastoma,72,NCT03532295,Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
PID-011,Glioblastoma,72,NCT01702610,Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT06585527,Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT02510950,Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00613028,Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
PID-011,Glioblastoma,72,NCT05879367,Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
PID-011,Glioblastoma,72,NCT00613132,Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
PID-011,Glioblastoma,72,NCT03149575,VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
PID-011,Glioblastoma,72,NCT00611325,Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT01413438,Bevacizumab With or Without Surgery for Adult Glioblastomas
PID-011,Glioblastoma,72,NCT02010606,Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02833701,Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
PID-011,Glioblastoma,72,NCT01180816,Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
PID-011,Glioblastoma,72,NCT06455189,Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
PID-011,Glioblastoma,72,NCT02664363,EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
PID-011,Glioblastoma,72,NCT01269853,Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
PID-011,Glioblastoma,72,NCT05326334,THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)
PID-011,Glioblastoma,72,NCT00612430,Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
PID-011,Glioblastoma,72,NCT01386710,Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
PID-011,Glioblastoma,72,NCT00968240,Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
PID-011,Glioblastoma,72,NCT03722355,Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
PID-011,Glioblastoma,72,NCT00671970,Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
PID-011,Glioblastoma,72,NCT01986348,Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas
PID-011,Glioblastoma,72,NCT02026271,A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
PID-011,Glioblastoma,72,NCT06622434,"New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study"
PID-011,Glioblastoma,72,NCT01811498,Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT01067469,Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT02022384,Immunophenotyping From Blood of Patients With Malignant Gliomas
PID-011,Glioblastoma,72,NCT05990556,Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT02605746,Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis
PID-011,Glioblastoma,72,NCT02270034,Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01547546,A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT04674579,Automatic Segmentation MRI Cerebral Glioma
PID-011,Glioblastoma,72,NCT00735436,A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
PID-011,Glioblastoma,72,NCT01954576,NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00354913,Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
PID-011,Glioblastoma,72,NCT00609999,Ph I Dasatinib + Erlotinib in Recurrent MG
PID-011,Glioblastoma,72,NCT05624736,Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning
PID-011,Glioblastoma,72,NCT00586508,Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas
PID-011,Glioblastoma,72,NCT05363826,Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®
PID-011,Glioblastoma,72,NCT05660369,CARv3-TEAM-E T Cells in Glioblastoma
PID-011,Glioblastoma,72,NCT00883298,Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05941234,"Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma"
PID-011,Glioblastoma,72,NCT03050736,Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
PID-011,Glioblastoma,72,NCT00613054,Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT06279767,Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00613223,Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
PID-011,Glioblastoma,72,NCT03997136,Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.
PID-011,Glioblastoma,72,NCT00669669,O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
PID-011,Glioblastoma,72,NCT06562621,Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT00612638,Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
PID-011,Glioblastoma,72,NCT03360708,Vaccine Therapy in Treating Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03332355,Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
PID-011,Glioblastoma,72,NCT05235737,The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab
PID-011,Glioblastoma,72,NCT03170141,Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05954858,Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
PID-011,Glioblastoma,72,NCT05432804,"Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment"
PID-011,Glioblastoma,72,NCT04266977,Restrictive Use of Dexamethasone in Glioblastoma
PID-011,Glioblastoma,72,NCT00540176,The Safety and Efficacy of DCA for the Treatment of Brain Cancer
PID-011,Glioblastoma,72,NCT06327451,Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
PID-011,Glioblastoma,72,NCT02006563,Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors
PID-011,Glioblastoma,72,NCT01351519,A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
PID-011,Glioblastoma,72,NCT04780009,Loupe-Based Intraoperative Fluorescence Imaging
PID-011,Glioblastoma,72,NCT06632236,5G-EMERALD: Amivantamab in Malignant Brain Tumours
PID-011,Glioblastoma,72,NCT06630260,5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
PID-011,Glioblastoma,72,NCT02227901,"Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT02414165,The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
PID-011,Glioblastoma,72,NCT06359379,Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
PID-011,Glioblastoma,72,NCT01478178,Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT05842746,Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03115138,Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
PID-011,Glioblastoma,72,NCT03020017,NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
PID-011,Glioblastoma,72,NCT04188535,Serial MRI Scans During Radiation Therapy
PID-011,Glioblastoma,72,NCT01174537,"New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma"
PID-011,Glioblastoma,72,NCT02590263,Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
PID-011,Glioblastoma,72,NCT04910022,Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03345095,A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01124240,Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene
PID-011,Glioblastoma,72,NCT00005856,Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02743078,Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05773664,Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma
PID-011,Glioblastoma,72,NCT06964815,"Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients"
PID-011,Glioblastoma,72,NCT03603405,HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT05694416,Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT02768389,Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05772767,Modulation of Ciliogenesis in Glioma Stem Cells
PID-011,Glioblastoma,72,NCT03294486,"Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients"
PID-011,Glioblastoma,72,NCT03144167,Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
PID-011,Glioblastoma,72,NCT00316849,"Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT00058097,Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02898012,Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
PID-011,Glioblastoma,72,NCT04391595,LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
PID-011,Glioblastoma,72,NCT04926168,6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT01805453,"Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma"
PID-011,Glioblastoma,72,NCT03834740,A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
PID-011,Glioblastoma,72,NCT00606008,A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-011,Glioblastoma,72,NCT00004262,Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT03615404,"Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma"
PID-011,Glioblastoma,72,NCT06816927,Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
PID-011,Glioblastoma,72,NCT04200066,A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03423628,A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
PID-011,Glioblastoma,72,NCT06319027,"Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial"
PID-011,Glioblastoma,72,NCT05447195,Phase 2 Study of CAN008 in Subjects With GBM
PID-011,Glioblastoma,72,NCT05600491,A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
PID-011,Glioblastoma,72,NCT00049387,"Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-011,Glioblastoma,72,NCT06177964,Lerapolturev (PVSRIPO) in GBM
PID-011,Glioblastoma,72,NCT00305864,"Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-011,Glioblastoma,72,NCT05979064,Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-011,Glioblastoma,72,NCT00052208,Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05695976,GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
PID-011,Glioblastoma,72,NCT02626364,Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
PID-011,Glioblastoma,72,NCT02761070,"Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III"
PID-011,Glioblastoma,72,NCT01811992,Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma
PID-011,Glioblastoma,72,NCT03705351,Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT00777686,Measuring Non-Enhancing Glioblastoma Progression
PID-011,Glioblastoma,72,NCT03596086,HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
PID-011,Glioblastoma,72,NCT00479765,A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
PID-011,Glioblastoma,72,NCT00039494,Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
PID-011,Glioblastoma,72,NCT00660543,MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
PID-011,Glioblastoma,72,NCT01331616,Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
PID-011,Glioblastoma,72,NCT00085254,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT01540513,PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
PID-011,Glioblastoma,72,NCT03115333,DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04741984,Monocyte Antigen Carrier Cells for Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT04937413,The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation
PID-011,Glioblastoma,72,NCT00943462,Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
PID-011,Glioblastoma,72,NCT01124461,BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor
PID-011,Glioblastoma,72,NCT05163080,SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
PID-011,Glioblastoma,72,NCT02465268,Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02375841,"Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers"
PID-011,Glioblastoma,72,NCT05091866,Natural Progesterone for the Treatment of Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03778294,18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
PID-011,Glioblastoma,72,NCT05375318,"BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels"
PID-011,Glioblastoma,72,NCT03899857,Pembrolizumab for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00613093,Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
PID-011,Glioblastoma,72,NCT05772741,Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs
PID-011,Glioblastoma,72,NCT00014170,Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05380349,Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
PID-011,Glioblastoma,72,NCT04725214,Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma
PID-011,Glioblastoma,72,NCT00902577,MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04840069,Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01609790,Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
PID-011,Glioblastoma,72,NCT01465347,Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT05033587,Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
PID-011,Glioblastoma,72,NCT00731731,"Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT02337426,"Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT05084430,Study of Pembrolizumab and M032 (NSC 733972)
PID-011,Glioblastoma,72,NCT04945148,Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
PID-011,Glioblastoma,72,NCT02395692,Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00846456,Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma
PID-011,Glioblastoma,72,NCT01022918,Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
PID-011,Glioblastoma,72,NCT05116137,The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
PID-011,Glioblastoma,72,NCT00864864,Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02575027,Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01120639,Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
PID-011,Glioblastoma,72,NCT04600817,A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)
PID-011,Glioblastoma,72,NCT04065087,Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03619239,Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT03020602,BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab
PID-011,Glioblastoma,72,NCT02197169,DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
PID-011,Glioblastoma,72,NCT01111097,Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors
PID-011,Glioblastoma,72,NCT00761280,Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
PID-011,Glioblastoma,72,NCT07003542,A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
PID-011,Glioblastoma,72,NCT02820584,A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06329570,Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
PID-011,Glioblastoma,72,NCT04327011,A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
PID-011,Glioblastoma,72,NCT00409214,Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
PID-011,Glioblastoma,72,NCT03400917,Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT03626896,Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
PID-011,Glioblastoma,72,NCT02311920,Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-011,Glioblastoma,72,NCT06797661,Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.
PID-011,Glioblastoma,72,NCT00001148,Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
PID-011,Glioblastoma,72,NCT02047058,Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
PID-011,Glioblastoma,72,NCT00115440,BNCT to Treat Glioma That Has Progressed Following Radiotherapy
PID-011,Glioblastoma,72,NCT05513859,Investigational Imaging Technique During Brain Surgery
PID-011,Glioblastoma,72,NCT02709226,Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04998864,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
PID-011,Glioblastoma,72,NCT04903795,Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PID-011,Glioblastoma,72,NCT00165477,Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05023551,Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-011,Glioblastoma,72,NCT04424966,Infigratinib in Recurrent High-Grade Glioma Patients
PID-011,Glioblastoma,72,NCT05171127,Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
PID-011,Glioblastoma,72,NCT03861299,The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
PID-011,Glioblastoma,72,NCT06496971,A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
PID-011,Glioblastoma,72,NCT00662506,"Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma"
PID-011,Glioblastoma,72,NCT00179907,A Phase I/II Study of the Photon Radiosurgery System
PID-011,Glioblastoma,72,NCT04967690,"A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM"
PID-011,Glioblastoma,72,NCT06480721,FET-PET-Guided Management of Pseudoprogression in Glioblastoma
PID-011,Glioblastoma,72,NCT03460782,An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
PID-011,Glioblastoma,72,NCT00004146,Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
PID-011,Glioblastoma,72,NCT03951142,Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study
PID-011,Glioblastoma,72,NCT05718466,Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy
PID-011,Glioblastoma,72,NCT05904119,Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
PID-011,Glioblastoma,72,NCT04854044,ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03649464,Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
PID-011,Glioblastoma,72,NCT03732352,18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05977322,A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
PID-011,Glioblastoma,72,NCT02330562,Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab
PID-011,Glioblastoma,72,NCT06193538,The Safety and Effectiveness of NV-A01 in Glioma Patients
PID-011,Glioblastoma,72,NCT01905228,A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
PID-011,Glioblastoma,72,NCT06910306,A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02666066,Radiomics for Prediction of Survival in GBM
PID-011,Glioblastoma,72,NCT00074646,Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas
PID-011,Glioblastoma,72,NCT02903069,Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
PID-011,Glioblastoma,72,NCT00548938,"Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM"
PID-011,Glioblastoma,72,NCT02490930,A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
PID-011,Glioblastoma,72,NCT02025231,Image Guided Reirradiation of High-grade Glioma
PID-011,Glioblastoma,72,NCT06129760,Glioblastoma Remote Monitoring and Care - Research Protocol
PID-011,Glioblastoma,72,NCT06684899,Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT06773481,BC008-1A Injection for Recurrent CNS WHO G4 Glioma
PID-011,Glioblastoma,72,NCT00686387,Establishment of a Brain and Spinal Tumor Tissue Bank
PID-011,Glioblastoma,72,NCT06344130,Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01266031,Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01516905,PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
PID-011,Glioblastoma,72,NCT03370926,FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
PID-011,Glioblastoma,72,NCT06328036,Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01931098,Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
PID-011,Glioblastoma,72,NCT01502241,Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
PID-011,Glioblastoma,72,NCT00939991,"Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas"
PID-011,Glioblastoma,72,NCT03426891,Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT06719440,Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
PID-011,Glioblastoma,72,NCT00723827,Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
PID-011,Glioblastoma,72,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-011,Glioblastoma,72,NCT00431561,Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
PID-011,Glioblastoma,72,NCT01317888,Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas
PID-011,Glioblastoma,72,NCT05039281,Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05017610,Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
PID-011,Glioblastoma,72,NCT06824662,Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas
PID-011,Glioblastoma,72,NCT03618667,GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
PID-011,Glioblastoma,72,NCT00089427,"IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma"
PID-011,Glioblastoma,72,NCT00028158,"Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer"
PID-011,Glioblastoma,72,NCT01925573,Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
PID-011,Glioblastoma,72,NCT04822688,"Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues"
PID-011,Glioblastoma,72,NCT05383872,Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
PID-011,Glioblastoma,72,NCT02337686,Pembrolizumab in Treating Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03296696,Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
PID-011,Glioblastoma,72,NCT01086345,Radiosurgery Plus Bevacizumab in Glioblastoma
PID-011,Glioblastoma,72,NCT06072586,A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
PID-011,Glioblastoma,72,NCT04216329,Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT06455605,D2C7-IT + 2141-V11 Combination Post-resection in rGBM
PID-011,Glioblastoma,72,NCT01044966,A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04763031,Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT
PID-011,Glioblastoma,72,NCT04446416,Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
PID-011,Glioblastoma,72,NCT01582516,Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00753246,Nimotuzumab in Adults With Glioblastoma Multiforma
PID-011,Glioblastoma,72,NCT01227434,A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
PID-011,Glioblastoma,72,NCT03224104,Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
PID-011,Glioblastoma,72,NCT06691308,WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients
PID-011,Glioblastoma,72,NCT01004874,Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
PID-011,Glioblastoma,72,NCT02871843,RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
PID-011,Glioblastoma,72,NCT00045565,Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
PID-011,Glioblastoma,72,NCT06058988,Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
PID-011,Glioblastoma,72,NCT04817254,Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-011,Glioblastoma,72,NCT00597402,"Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas"
PID-011,Glioblastoma,72,NCT00645385,Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
PID-011,Glioblastoma,72,NCT00576641,Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
PID-011,Glioblastoma,72,NCT01520870,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
PID-011,Glioblastoma,72,NCT01240460,Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection
PID-011,Glioblastoma,72,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-011,Glioblastoma,72,NCT03633552,Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
PID-011,Glioblastoma,72,NCT05929456,Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)
PID-011,Glioblastoma,72,NCT01062425,Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT04608812,Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
PID-011,Glioblastoma,72,NCT03631823,Gut Microbiota and Glioblastoma Multiforme Prognosis
PID-011,Glioblastoma,72,NCT05565118,Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
PID-011,Glioblastoma,72,NCT04045847,CD147-CART Cells in Patients With Recurrent Malignant Glioma.
PID-011,Glioblastoma,72,NCT04289155,Individual Patient Compassionate Use of GX-I7
PID-011,Glioblastoma,72,NCT01242566,Temozolomide in Elderly Patients With KPS < 70
PID-011,Glioblastoma,72,NCT01290939,Bevacizumab and Lomustine for Recurrent GBM
PID-011,Glioblastoma,72,NCT05683808,Venous Thromboembolism Prevention in Outpatients With Glioma
PID-011,Glioblastoma,72,NCT04396860,Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
PID-011,Glioblastoma,72,NCT01294735,Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
PID-011,Glioblastoma,72,NCT04209790,Neoadjuvant Chemoradiation for Resectable Glioblastoma
PID-011,Glioblastoma,72,NCT04677049,Study of Niacin in Glioblastoma
PID-011,Glioblastoma,72,NCT05739942,Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT02253212,Safety of BBB Opening With the SonoCloud
PID-011,Glioblastoma,72,NCT06504381,"DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma"
PID-011,Glioblastoma,72,NCT01711580,Re-irradiation of High Grade Gliomas: a Quality of Life Study
PID-011,Glioblastoma,72,NCT06710249,Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
PID-011,Glioblastoma,72,NCT06883747,Clinical Trial of BMS-986504 in Recurrent GBM Patients
PID-011,Glioblastoma,72,NCT07111195,Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
PID-011,Glioblastoma,72,NCT00923117,Sunitinib to Treat Recurrent Brain Cancer
PID-011,Glioblastoma,72,NCT05671016,Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy
PID-011,Glioblastoma,72,NCT00715013,Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT02431572,A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
PID-011,Glioblastoma,72,NCT00016328,CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00540722,Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00423735,Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
PID-011,Glioblastoma,72,NCT04699773,LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
PID-011,Glioblastoma,72,NCT06273176,The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06059690,Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
PID-011,Glioblastoma,72,NCT00747253,Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
PID-011,Glioblastoma,72,NCT00980343,GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-011,Glioblastoma,72,NCT00591058,Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT03283631,Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
PID-011,Glioblastoma,72,NCT00504660,"6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients"
PID-011,Glioblastoma,72,NCT02794883,Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT00641706,"Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme"
PID-011,Glioblastoma,72,NCT00107003,GW572016 to Treat Recurrent Malignant Brain Tumors
PID-011,Glioblastoma,72,NCT06385132,Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer
PID-011,Glioblastoma,72,NCT00445588,Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT02529072,Nivolumab With DC Vaccines for Recurrent Brain Tumors
PID-011,Glioblastoma,72,NCT00612651,PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
PID-011,Glioblastoma,72,NCT01238237,Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA
PID-011,Glioblastoma,72,NCT03275558,Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma
PID-011,Glioblastoma,72,NCT00503204,Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
PID-011,Glioblastoma,72,NCT02386826,INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00704080,A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
PID-011,Glioblastoma,72,NCT04116138,Antisecretory Factor in Primary Glioblastoma 1
PID-011,Glioblastoma,72,NCT06806228,Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)
PID-011,Glioblastoma,72,NCT01790503,A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT00751270,Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
PID-011,Glioblastoma,72,NCT00610571,Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
PID-011,Glioblastoma,72,NCT00780819,Borderzone Sampling
PID-011,Glioblastoma,72,NCT00683761,A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT00473408,The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
PID-011,Glioblastoma,72,NCT07021339,Anterior Temporal Lobectomy in Temporal Glioblastoma
PID-011,Glioblastoma,72,NCT00305656,AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00335764,"Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma"
PID-011,Glioblastoma,72,NCT01081223,Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
PID-011,Glioblastoma,72,NCT00087451,Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)
PID-011,Glioblastoma,72,NCT00392171,The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
PID-011,Glioblastoma,72,NCT05734560,D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
PID-011,Glioblastoma,72,NCT00132158,ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
PID-011,Glioblastoma,72,NCT00238303,Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01575275,Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00075491,Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT05267106,Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
PID-011,Glioblastoma,72,NCT01894061,NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00112502,Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04776980,Multimodality MRI and Liquid Biopsy in GBM
PID-011,Glioblastoma,72,NCT02887417,Glioblastoma Platelet Activation Study
PID-011,Glioblastoma,72,NCT00112866,Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT04444427,Evaluation of GLR2007 for Advanced Solid Tumors
PID-011,Glioblastoma,72,NCT00895960,Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT04657315,"Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients"
PID-011,Glioblastoma,72,NCT02052648,Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
PID-011,Glioblastoma,72,NCT03027388,"Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma"
PID-011,Glioblastoma,72,NCT02661282,Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT04712721,Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
PID-011,Glioblastoma,72,NCT06241391,Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
PID-011,Glioblastoma,72,NCT04388475,Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT04143425,Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01967758,Phase I Study of Safety and Immunogenicity of ADU-623
PID-011,Glioblastoma,72,NCT03746080,Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT05561374,Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT04181684,LITT Followed by Hypofractionated RT for Recurrent Gliomas
PID-011,Glioblastoma,72,NCT03673787,A Trial of Ipatasertib in Combination With Atezolizumab
PID-011,Glioblastoma,72,NCT03367715,"Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma"
PID-011,Glioblastoma,72,NCT00459381,Pazopanib in Treating Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT05909618,Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
PID-011,Glioblastoma,72,NCT01730950,Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01753713,Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT01117155,A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
PID-011,Glioblastoma,72,NCT01475006,AMG 595 First-in-Human in Recurrent Gliomas
PID-011,Glioblastoma,72,NCT01491893,PVSRIPO for Recurrent Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT00979862,Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03539731,[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
PID-011,Glioblastoma,72,NCT01122901,Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT03176160,LITT Palliative Treatment for Patients With Malignant Gliomas
PID-011,Glioblastoma,72,NCT05929495,"Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma"
PID-011,Glioblastoma,72,NCT01972750,Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma
PID-011,Glioblastoma,72,NCT05054400,Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
PID-011,Glioblastoma,72,NCT06017063,Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields
PID-011,Glioblastoma,72,NCT01434602,Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
PID-011,Glioblastoma,72,NCT03213002,Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
PID-011,Glioblastoma,72,NCT01967810,ANG1005 in Patients With Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT03581292,"Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations"
PID-011,Glioblastoma,72,NCT03975959,Memory Perception Assessment in Central/Non-central Nervous System Cancers
PID-011,Glioblastoma,72,NCT00430911,Radiotherapy for Malignant Astrocytomas in the Elderly
PID-011,Glioblastoma,72,NCT01808820,Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
PID-011,Glioblastoma,72,NCT06623565,Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
PID-011,Glioblastoma,72,NCT02629757,A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas
PID-011,Glioblastoma,72,NCT00624728,Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
PID-011,Glioblastoma,72,NCT00562419,CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
PID-011,Glioblastoma,72,NCT02658981,Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
PID-011,Glioblastoma,72,NCT00031538,Genetic Analysis of Brain Tumors
PID-011,Glioblastoma,72,NCT00870181,ADV-TK Improves Outcome of Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT04729959,"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma"
PID-011,Glioblastoma,72,NCT00031083,Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
PID-011,Glioblastoma,72,NCT01765088,A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
PID-011,Glioblastoma,72,NCT04145115,A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden
PID-011,Glioblastoma,72,NCT02750891,A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
PID-011,Glioblastoma,72,NCT01985256,Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
PID-011,Glioblastoma,72,NCT03475186,Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
PID-011,Glioblastoma,72,NCT02540135,Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
PID-011,Glioblastoma,72,NCT01738646,Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
PID-011,Glioblastoma,72,NCT04623931,Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
PID-011,Glioblastoma,72,NCT06430424,"Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma"
PID-011,Glioblastoma,72,NCT01810744,Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
PID-011,Glioblastoma,72,NCT02942264,Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-011,Glioblastoma,72,NCT06501911,A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
PID-011,Glioblastoma,72,NCT01975701,A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
PID-011,Glioblastoma,72,NCT03657576,Trial of C134 in Patients With Recurrent GBM
PID-011,Glioblastoma,72,NCT01712542,Curcumin Bioavailability in Glioblastoma Patients
PID-011,Glioblastoma,72,NCT01470794,Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
PID-011,Glioblastoma,72,NCT01107522,Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
PID-011,Glioblastoma,72,NCT02525692,Oral ONC201 in Adult Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT07091864,Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
PID-011,Glioblastoma,72,NCT03311542,Expanded Access for Pembrolizumab (MK-3475)
PID-011,Glioblastoma,72,NCT00734864,Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT03561207,3D Prediction of Patient-Specific Response
PID-011,Glioblastoma,72,NCT03914768,Immune Modulatory DC Vaccine Against Brain Tumor
PID-011,Glioblastoma,72,NCT00102648,Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
PID-011,Glioblastoma,72,NCT07067905,Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
PID-011,Glioblastoma,72,NCT06617208,Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery
PID-011,Glioblastoma,72,NCT01814813,Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-011,Glioblastoma,72,NCT05062772,Brain Tumor Intraoperative Ultrasound Database
PID-011,Glioblastoma,72,NCT06108206,Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
PID-011,Glioblastoma,72,NCT00041587,Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
PID-011,Glioblastoma,72,NCT00024570,Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT05106296,Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
PID-011,Glioblastoma,72,NCT04267978,Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
PID-011,Glioblastoma,72,NCT00001171,Evaluation of Factors in Human Brain Tumors
PID-011,Glioblastoma,72,NCT05131763,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-011,Glioblastoma,72,NCT00114309,131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT04477200,Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
PID-011,Glioblastoma,72,NCT04270461,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-011,Glioblastoma,72,NCT01454596,CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
PID-011,Glioblastoma,72,NCT06016452,A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma
PID-011,Glioblastoma,72,NCT00379080,Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT00390299,Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT00080054,A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
PID-011,Glioblastoma,72,NCT01122888,Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT06160206,Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT06894979,"Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma"
PID-011,Glioblastoma,72,NCT00734682,A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
PID-011,Glioblastoma,72,NCT05495295,"First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours"
PID-011,Glioblastoma,72,NCT04933942,Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
PID-011,Glioblastoma,72,NCT05629702,ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
PID-011,Glioblastoma,72,NCT06118723,The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
PID-011,Glioblastoma,72,NCT01342757,Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT00009035,Natural History of Patients With Brain and Spinal Cord Tumors
PID-011,Glioblastoma,72,NCT01441388,A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
PID-011,Glioblastoma,72,NCT00575887,Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
PID-011,Glioblastoma,72,NCT04478279,A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
PID-011,Glioblastoma,72,NCT06614855,A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT04074785,Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6
PID-011,Glioblastoma,72,NCT05765812,A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT02348255,NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
PID-011,Glioblastoma,72,NCT00589875,Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
PID-011,Glioblastoma,72,NCT06492486,Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
PID-011,Glioblastoma,72,NCT05686798,Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
PID-011,Glioblastoma,72,NCT04323046,Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
PID-011,Glioblastoma,72,NCT01156584,A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT00062504,Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
PID-011,Glioblastoma,72,NCT06929819,Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
PID-011,Glioblastoma,72,NCT00272870,Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
PID-011,Glioblastoma,72,NCT06810544,Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
PID-011,Glioblastoma,72,NCT06388733,"A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma"
PID-011,Glioblastoma,72,NCT05773326,Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
PID-011,Glioblastoma,72,NCT00433381,Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
PID-011,Glioblastoma,72,NCT03022578,Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
PID-011,Glioblastoma,72,NCT04630379,Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
PID-011,Glioblastoma,72,NCT04218019,Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation
PID-011,Glioblastoma,72,NCT01999270,Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
PID-011,Glioblastoma,72,NCT04489420,Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
PID-011,Glioblastoma,72,NCT04991870,Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
PID-011,Glioblastoma,72,NCT01902771,Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
PID-011,Glioblastoma,72,NCT06038760,Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
PID-011,Glioblastoma,72,NCT00995007,A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
PID-011,Glioblastoma,72,NCT01281982,(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
PID-011,Glioblastoma,72,NCT04049669,Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
PID-011,Glioblastoma,72,NCT01316809,AZD8055 for Adults With Recurrent Gliomas
PID-011,Glioblastoma,72,NCT03593993,A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
PID-011,Glioblastoma,72,NCT01478321,Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
PID-011,Glioblastoma,72,NCT02039778,Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma
PID-011,Glioblastoma,72,NCT02655601,"Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001"
PID-011,Glioblastoma,72,NCT05465954,Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT00329719,Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT01656980,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
PID-011,Glioblastoma,72,NCT01637753,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT02885324,Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
PID-011,Glioblastoma,72,NCT01204684,Dendritic Cell Vaccine for Patients With Brain Tumors
PID-011,Glioblastoma,72,NCT03463265,Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT04314674,Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors Resection
PID-011,Glioblastoma,72,NCT01171469,Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
PID-011,Glioblastoma,72,NCT00973557,The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
PID-011,Glioblastoma,72,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
PID-011,Glioblastoma,72,NCT00179803,Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
PID-011,Glioblastoma,72,NCT04782609,Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT00024557,Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
PID-011,Glioblastoma,72,NCT01836549,Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
PID-011,Glioblastoma,72,NCT01250470,Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
PID-011,Glioblastoma,72,NCT00064779,Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT01648348,Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT06665724,Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
PID-011,Glioblastoma,72,NCT06410248,Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
PID-011,Glioblastoma,72,NCT03717142,Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
PID-011,Glioblastoma,72,NCT06902350,"Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors"
PID-011,Glioblastoma,72,NCT04614493,Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.
PID-011,Glioblastoma,72,NCT05297864,PARP Inhibition for Gliomas (PI-4G or π4g)
PID-011,Glioblastoma,72,NCT05099068,Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)
PID-011,Glioblastoma,72,NCT02722512,Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
PID-011,Glioblastoma,72,NCT01514201,"Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas"
PID-011,Glioblastoma,72,NCT04047264,Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
PID-011,Glioblastoma,72,NCT03971734,Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
PID-011,Glioblastoma,72,NCT01740258,Bevacizumab Beyond Progression (BBP)
PID-011,Glioblastoma,72,NCT03607643,"A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies"
PID-011,Glioblastoma,72,NCT00823797,Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
PID-011,Glioblastoma,72,NCT01861990,Valproic Acid in Childhood Progressive Brain Tumors
PID-011,Glioblastoma,72,NCT06193174,Re-Administration of C134 in Patients with Recurrent GBM (C134-HSV-1)
PID-011,Glioblastoma,72,NCT02168270,Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT00884416,Sorafenib in Newly Diagnosed High Grade Glioma
PID-011,Glioblastoma,72,NCT00004688,"Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms"
PID-011,Glioblastoma,72,NCT00243490,Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
PID-011,Glioblastoma,72,NCT01822275,Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-011,Glioblastoma,72,NCT01380782,BIBF 1120 for Recurrent High-Grade Gliomas
PID-011,Glioblastoma,72,NCT02758366,Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
PID-011,Glioblastoma,72,NCT06860594,"Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma"
PID-011,Glioblastoma,72,NCT01095094,Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT02055196,Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-011,Glioblastoma,72,NCT01144247,Cellular Immunotherapy Study for Brain Cancer
PID-011,Glioblastoma,72,NCT04488783,Potentiation of Chemotherapy in Brain Tumors by Zinc
PID-011,Glioblastoma,72,NCT01189240,RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT04661384,"Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma"
PID-011,Glioblastoma,72,NCT04479696,Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
PID-011,Glioblastoma,72,NCT06989086,FearLess in NeuroOncology
PID-011,Glioblastoma,72,NCT00006773,Bortezomib in Treating Patients With Recurrent Glioma
PID-011,Glioblastoma,72,NCT03956706,Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
PID-011,Glioblastoma,72,NCT06160596,Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
PID-011,Glioblastoma,72,NCT03251027,Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
PID-011,Glioblastoma,72,NCT06796335,Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
PID-011,Glioblastoma,72,NCT04734444,SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
PID-011,Glioblastoma,72,NCT03392545,Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)
PID-011,Glioblastoma,72,NCT05039346,Quality of Life and Patient Needs in Advanced High Grade Gliomas
PID-011,Glioblastoma,72,NCT05139277,Evaluation of the CONVIVO System
PID-011,Glioblastoma,72,NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection
PID-011,Glioblastoma,72,NCT00650923,"Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma"
PID-011,Glioblastoma,72,NCT06333899,Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
PID-011,Glioblastoma,72,NCT01151670,Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
PID-011,Glioblastoma,72,NCT00667394,Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
PID-011,Glioblastoma,72,NCT06975332,"Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression"
PID-011,Glioblastoma,72,NCT03914742,BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
PID-011,Glioblastoma,72,NCT05843253,Study of Ribociclib and Everolimus in HGG and DIPG
PID-011,Glioblastoma,72,NCT05839379,Targeted Pediatric High-Grade Glioma Therapy
PID-011,Glioblastoma,72,NCT01798771,Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
PID-011,Glioblastoma,72,NCT02015819,"Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas"
PID-011,Glioblastoma,72,NCT05873946,Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
PID-011,Glioblastoma,72,NCT04295759,INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
PID-011,Glioblastoma,72,NCT04482933,HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT02031965,Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
PID-011,Glioblastoma,72,NCT05789394,Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
PID-011,Glioblastoma,72,NCT05698524,A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
PID-011,Glioblastoma,72,NCT03718767,Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
PID-011,Glioblastoma,72,NCT03123952,Expanded Access to ABT-414
PID-011,Glioblastoma,72,NCT02861898,Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
PID-011,Glioblastoma,72,NCT01721577,Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
PID-011,Glioblastoma,72,NCT02238496,Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
PID-011,Glioblastoma,72,NCT04982926,A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
PID-011,Glioblastoma,72,NCT04214392,Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
PID-011,Glioblastoma,72,NCT01996527,3T MRI Biomarkers of Glioma Treatment Response
PID-011,Glioblastoma,72,NCT06926075,Early Phase Study of Kesonotide in Participants With Solid Tumours
PID-011,Glioblastoma,72,NCT01378481,High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma
PID-011,Glioblastoma,72,NCT01148966,Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
PID-011,Glioblastoma,72,NCT01975116,p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
PID-011,Glioblastoma,72,NCT00268385,Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
PID-011,Glioblastoma,72,NCT02142803,TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
PID-011,Glioblastoma,72,NCT01383135,Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
PID-011,Glioblastoma,72,NCT04573140,A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
PID-011,Glioblastoma,72,NCT01269411,RO4929097 in Treating Patients With Recurrent Invasive Gliomas
PID-011,Glioblastoma,72,NCT06640582,TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
PID-011,Glioblastoma,72,NCT03389230,Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
PID-011,Glioblastoma,72,NCT07042620,A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
PID-011,Glioblastoma,72,NCT06041555,MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
PID-011,Glioblastoma,72,NCT04740190,Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd
PID-011,Glioblastoma,72,NCT05231655,Ex VIvo DEtermiNed Cancer Therapy
PID-011,Glioblastoma,72,NCT00499473,Sunitinib in Treating Patients With Recurrent Malignant Gliomas
PID-011,Glioblastoma,72,NCT02502708,"Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors"
PID-011,Glioblastoma,72,NCT06896110,Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
PID-011,Glioblastoma,72,NCT01817751,"Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma"
PID-011,Glioblastoma,72,NCT06047379,"Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis"
PID-011,Glioblastoma,72,NCT00095940,Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
PID-011,Glioblastoma,72,NCT03749187,BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
PID-011,Glioblastoma,72,NCT06625047,Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
PID-011,Glioblastoma,72,NCT01291420,Dendritic Cell Vaccination for Patients with Solid Tumors
PID-011,Glioblastoma,72,NCT05737212,"Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas"
PID-011,Glioblastoma,72,NCT03072134,Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
PID-011,Glioblastoma,72,NCT00100802,"Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas"
PID-011,Glioblastoma,72,NCT02208362,Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
PID-011,Glioblastoma,72,NCT01977677,Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
PID-011,Glioblastoma,72,NCT05370079,Control Cohort CTRL COH
PID-011,Glioblastoma,72,NCT00042991,Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
PID-011,Glioblastoma,72,NCT02800486,"Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA"
PID-011,Glioblastoma,72,NCT04978727,"A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma"
PID-011,Glioblastoma,72,NCT04678648,A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
PID-011,Glioblastoma,72,NCT01353625,"Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies."
PID-011,Glioblastoma,72,NCT03152318,A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PID-011,Glioblastoma,72,NCT06815029,Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
PID-011,Glioblastoma,72,NCT01103375,Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT01051557,Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-011,Glioblastoma,72,NCT02974738,"A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)"
PID-011,Glioblastoma,72,NCT03896568,MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT03739372,Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
PID-011,Glioblastoma,72,NCT06439420,CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
PID-011,Glioblastoma,72,NCT01598597,"An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)"
PID-011,Glioblastoma,72,NCT02465528,Ceritinib Rare Indications Study in ALK+ Tumors
PID-011,Glioblastoma,72,NCT04388033,Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
PID-011,Glioblastoma,72,NCT01723020,A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
PID-011,Glioblastoma,72,NCT00879437,"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma"
PID-011,Glioblastoma,72,NCT03973918,Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
PID-011,Glioblastoma,72,NCT03389802,Phase I Study of APX005M in Pediatric Central Nervous System Tumors
PID-011,Glioblastoma,72,NCT01849952,Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
PID-011,Glioblastoma,72,NCT00045708,A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
PID-011,Glioblastoma,72,NCT04135807,Implantable Microdevice In Primary Brain Tumors
PID-011,Glioblastoma,72,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-011,Glioblastoma,72,NCT02798406,Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
PID-011,Glioblastoma,72,NCT05956821,Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
PID-011,Glioblastoma,72,NCT04044937,Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
PID-011,Glioblastoma,72,NCT01082926,"Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2"
PID-011,Glioblastoma,72,NCT03919071,Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
PID-011,Glioblastoma,72,NCT03893487,Fimepinostat in Treating Brain Tumors in Children and Young Adults
PID-011,Glioblastoma,72,NCT03212274,"Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations"
PID-011,Glioblastoma,72,NCT02372409,Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
PID-011,Glioblastoma,72,NCT05330559,"Fluorescence, Light-microscopy, Ultrasound Integrated / Intraoperative Diagnosis to MAXimise Resection"
PID-011,Glioblastoma,72,NCT06690216,Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
PID-011,Glioblastoma,72,NCT02365662,A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
PID-011,Glioblastoma,72,NCT04970615,Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models
PID-011,Glioblastoma,72,NCT00045110,Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
PID-011,Glioblastoma,72,NCT03734913,A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
PID-011,Glioblastoma,72,NCT01234740,Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
PID-011,Glioblastoma,72,NCT02101905,Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT02457845,HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
PID-011,Glioblastoma,72,NCT02444546,Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
PID-011,Glioblastoma,72,NCT02644291,Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
PID-011,Glioblastoma,72,NCT01579253,Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
PID-011,Glioblastoma,72,NCT01884740,Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
PID-011,Glioblastoma,72,NCT01904123,STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain
PID-011,Glioblastoma,72,NCT03684811,A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
PID-011,Glioblastoma,72,NCT01922076,Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
PID-011,Glioblastoma,72,NCT00959946,Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer
PID-011,Glioblastoma,72,NCT03244995,Mind-Body Intervention in Glioma Couples
PID-011,Glioblastoma,72,NCT02498665,A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
PID-011,Glioblastoma,72,NCT03958240,Deciphering Mechanisms Underlying Cancer Immunogenicity
PID-011,Glioblastoma,72,NCT02323880,Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
PID-011,Glioblastoma,72,NCT00369590,VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
PID-011,Glioblastoma,72,NCT00093613,Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-011,Glioblastoma,72,NCT00085540,FR901228 in Treating Patients With Recurrent High-Grade Gliomas
PID-011,Glioblastoma,72,NCT06804655,Pharmacoscopy for Patients with Refractory Primary Brain Tumors
PID-011,Glioblastoma,72,NCT02709889,Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
PID-011,Glioblastoma,72,NCT01421524,"Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma"
PID-011,Glioblastoma,72,NCT01445691,More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
PID-011,Glioblastoma,72,NCT01837862,A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
PID-011,Glioblastoma,72,NCT02038699,A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer
PID-011,Glioblastoma,72,NCT02327078,"A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)"
PID-011,Glioblastoma,72,NCT00112736,Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT06717295,The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
PID-011,Glioblastoma,72,NCT06521567,A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
PID-011,Glioblastoma,72,NCT05538572,A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
PID-011,Glioblastoma,72,NCT05139056,Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
PID-011,Glioblastoma,72,NCT00679354,Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
PID-011,Glioblastoma,72,NCT06469138,A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
PID-011,Glioblastoma,72,NCT02192359,Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-011,Glioblastoma,72,NCT01172964,A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
PID-011,Glioblastoma,72,NCT00430079,Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
PID-011,Glioblastoma,72,NCT03797326,Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
PID-011,Glioblastoma,72,NCT01177397,"Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma"
PID-011,Glioblastoma,72,NCT05835687,Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
PID-011,Glioblastoma,72,NCT04427384,Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
PID-011,Glioblastoma,72,NCT03355794,A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
PID-011,Glioblastoma,72,NCT01339039,Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
PID-011,Glioblastoma,72,NCT04732065,"ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors"
PID-011,Glioblastoma,72,NCT01392209,Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
PID-011,Glioblastoma,72,NCT02186509,Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
PID-011,Glioblastoma,72,NCT06814496,Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
PID-011,Glioblastoma,72,NCT01576666,"Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors"
PID-011,Glioblastoma,72,NCT02966509,Engagement of Patients With Advanced Cancer
PID-011,Glioblastoma,72,NCT03243461,International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
PID-011,Glioblastoma,72,NCT01165632,Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
PID-011,Glioblastoma,72,NCT03043391,Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
PID-011,Glioblastoma,72,NCT02684058,Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
PID-011,Glioblastoma,72,NCT06645808,PET-imaging of Two Vartumabs in Patients With Solid Tumors
PID-011,Glioblastoma,72,NCT02255461,"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors"
PID-011,Glioblastoma,72,NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PID-011,Glioblastoma,72,NCT04541082,Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
PID-011,Glioblastoma,72,NCT02374255,Improving Goals of Care Discussion in Advanced Cancer Patients
PID-011,Glioblastoma,72,NCT02611024,Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
PID-011,Glioblastoma,72,NCT01392352,HYPAZ: Hypertension Induced by Pazopanib
PID-011,Glioblastoma,72,NCT04541225,Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
PID-011,Glioblastoma,72,NCT02223052,Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
PID-011,Glioblastoma,72,NCT02175745,18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
PID-011,Glioblastoma,72,NCT02335918,A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
PID-011,Glioblastoma,72,NCT05934630,"Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors"
PID-011,Glioblastoma,72,NCT01234805,Yoga Therapy in Treating Patients With Malignant Brain Tumors
PID-011,Glioblastoma,72,NCT01929720,"Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors"
PID-011,Glioblastoma,72,NCT03787056,Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
PID-011,Glioblastoma,72,NCT04913337,Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
PID-011,Glioblastoma,72,NCT05563272,89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
PID-011,Glioblastoma,72,NCT01631552,Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
PID-011,Glioblastoma,72,NCT05974410,Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
PID-011,Glioblastoma,72,NCT04604158,Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
PID-011,Glioblastoma,72,NCT02967380,"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases"
PID-011,Glioblastoma,72,NCT03911388,HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
PID-011,Glioblastoma,72,NCT05131815,The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
PID-011,Glioblastoma,72,NCT00110032,Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
PID-011,Glioblastoma,72,NCT03975829,Pediatric Long-Term Follow-up and Rollover Study
PID-011,Glioblastoma,72,NCT01119599,"RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma"
PID-011,Glioblastoma,72,NCT04566393,Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies
PID-011,Glioblastoma,72,NCT02194452,Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
PID-011,Glioblastoma,72,NCT03434262,SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
PID-011,Glioblastoma,72,NCT03896958,The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
PID-011,Glioblastoma,72,NCT01522820,Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
PID-011,Glioblastoma,72,NCT01131234,Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
PID-011,Glioblastoma,72,NCT03452774,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
PID-011,Glioblastoma,72,NCT01806675,18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
PID-011,Glioblastoma,72,NCT05969860,At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
PID-011,Glioblastoma,72,NCT04028479,The Registry of Oncology Outcomes Associated with Testing and Treatment
PID-011,Glioblastoma,72,NCT00030498,Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
PID-011,Glioblastoma,72,NCT03154190,Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
PID-012,Glioblastoma,70,NCT06404034,Expanded Access to Gallium Maltolate (GaM)
PID-012,Glioblastoma,70,NCT00337883,A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
PID-012,Glioblastoma,70,NCT03344250,Phase I EGFR BATs in Newly Diagnosed Glioblastoma
PID-012,Glioblastoma,70,NCT02844062,Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
PID-012,Glioblastoma,70,NCT02937844,Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
PID-012,Glioblastoma,70,NCT00704288,Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
PID-012,Glioblastoma,70,NCT04590664,Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
PID-012,Glioblastoma,70,NCT04814329,Glioblastoma Response Prediction to Apatinib
PID-012,Glioblastoma,70,NCT00116376,Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
PID-012,Glioblastoma,70,NCT02378532,The Addition of Chloroquine to Chemoradiation for Glioblastoma
PID-012,Glioblastoma,70,NCT02751138,Determination of Immune Phenotype in Glioblastoma Patients
PID-012,Glioblastoma,70,NCT03419403,UNITE Study: Understanding New Interventions With GBM ThErapy
PID-012,Glioblastoma,70,NCT04629209,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma"
PID-012,Glioblastoma,70,NCT05187624,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma"
PID-012,Glioblastoma,70,NCT03231501,HMPL-813 in Treating Patients With Glioblastoma
PID-012,Glioblastoma,70,NCT04547855,Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
PID-012,Glioblastoma,70,NCT06973096,CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PID-012,Glioblastoma,70,NCT02718443,VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
PID-012,Glioblastoma,70,NCT05168423,CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
PID-012,Glioblastoma,70,NCT03726515,CART-EGFRvIII + Pembrolizumab in GBM
PID-012,Glioblastoma,70,NCT05063682,The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
PID-012,Glioblastoma,70,NCT03603379,Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
PID-012,Glioblastoma,70,NCT00977431,Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
PID-012,Glioblastoma,70,NCT01498328,A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PID-012,Glioblastoma,70,NCT04004975,Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
PID-012,Glioblastoma,70,NCT05802693,"A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma"
PID-012,Glioblastoma,70,NCT00960492,Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
PID-012,Glioblastoma,70,NCT01110876,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)"
PID-012,Glioblastoma,70,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-012,Glioblastoma,70,NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PID-012,Glioblastoma,70,NCT06186401,Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
PID-012,Glioblastoma,70,NCT00250887,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research"
PID-012,Glioblastoma,70,NCT02573324,A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
PID-012,Glioblastoma,70,NCT02664363,EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
PID-012,Glioblastoma,70,NCT00671970,Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
PID-012,Glioblastoma,70,NCT06327451,Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
PID-012,Glioblastoma,70,NCT04903795,Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PID-012,Glioblastoma,70,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-012,Glioblastoma,70,NCT03732352,18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
PID-012,Glioblastoma,70,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-012,Glioblastoma,70,NCT03618667,GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
PID-012,Glioblastoma,70,NCT03296696,Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
PID-012,Glioblastoma,70,NCT06072586,A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
PID-012,Glioblastoma,70,NCT01520870,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
PID-012,Glioblastoma,70,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-012,Glioblastoma,70,NCT03283631,Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
PID-012,Glioblastoma,70,NCT01810744,Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
PID-012,Glioblastoma,70,NCT03311542,Expanded Access for Pembrolizumab (MK-3475)
PID-012,Glioblastoma,70,NCT01454596,CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
PID-012,Glioblastoma,70,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
PID-012,Glioblastoma,70,NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection
PID-012,Glioblastoma,70,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-012,Glioblastoma,70,NCT02365662,A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
PID-012,Glioblastoma,70,NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PID-013,Meningioma,57,NCT02933736,Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
PID-013,Meningioma,57,NCT06710249,Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
PID-013,Meningioma,57,NCT01144247,Cellular Immunotherapy Study for Brain Cancer
PID-013,Meningioma,57,NCT05139277,Evaluation of the CONVIVO System
PID-013,Meningioma,57,NCT01151670,Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
PID-013,Meningioma,57,NCT06640582,TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
PID-013,Meningioma,57,NCT06439420,CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
PID-013,Meningioma,57,NCT01082926,"Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2"
PID-013,Meningioma,57,NCT00045110,Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
PID-013,Meningioma,57,NCT06804655,Pharmacoscopy for Patients with Refractory Primary Brain Tumors
PID-013,Meningioma,57,NCT04427384,Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
PID-013,Meningioma,57,NCT02255461,"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors"
PID-013,Meningioma,57,NCT04541082,Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
PID-013,Meningioma,57,NCT01234805,Yoga Therapy in Treating Patients With Malignant Brain Tumors
PID-013,Meningioma,57,NCT02967380,"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases"
PID-013,Meningioma,57,NCT00110032,Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
PID-013,Meningioma,57,NCT01119599,"RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma"
PID-013,Meningioma,57,NCT02194452,Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
PID-013,Meningioma,57,NCT00100880,"Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors"
PID-013,Meningioma,57,NCT00063973,Cilengitide in Treating Children With Refractory Primary Brain Tumors
PID-013,Meningioma,57,NCT00052780,Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
PID-013,Meningioma,57,NCT00946335,ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
PID-013,Meningioma,57,NCT00363272,Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
PID-013,Meningioma,57,NCT00053963,FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
PID-013,Meningioma,57,NCT03434262,SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
PID-013,Meningioma,57,NCT01076530,Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
PID-014,Astrocytoma,69,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-014,Astrocytoma,69,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-014,Astrocytoma,69,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-014,Astrocytoma,69,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-014,Astrocytoma,69,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-015,Glioblastoma,47,NCT06404034,Expanded Access to Gallium Maltolate (GaM)
PID-015,Glioblastoma,47,NCT00337883,A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
PID-015,Glioblastoma,47,NCT03344250,Phase I EGFR BATs in Newly Diagnosed Glioblastoma
PID-015,Glioblastoma,47,NCT02844062,Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
PID-015,Glioblastoma,47,NCT02937844,Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
PID-015,Glioblastoma,47,NCT00704288,Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
PID-015,Glioblastoma,47,NCT04590664,Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
PID-015,Glioblastoma,47,NCT04814329,Glioblastoma Response Prediction to Apatinib
PID-015,Glioblastoma,47,NCT00116376,Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
PID-015,Glioblastoma,47,NCT02378532,The Addition of Chloroquine to Chemoradiation for Glioblastoma
PID-015,Glioblastoma,47,NCT02751138,Determination of Immune Phenotype in Glioblastoma Patients
PID-015,Glioblastoma,47,NCT03419403,UNITE Study: Understanding New Interventions With GBM ThErapy
PID-015,Glioblastoma,47,NCT04629209,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma"
PID-015,Glioblastoma,47,NCT05187624,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma"
PID-015,Glioblastoma,47,NCT03231501,HMPL-813 in Treating Patients With Glioblastoma
PID-015,Glioblastoma,47,NCT04547855,Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
PID-015,Glioblastoma,47,NCT06973096,CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PID-015,Glioblastoma,47,NCT02718443,VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
PID-015,Glioblastoma,47,NCT05168423,CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
PID-015,Glioblastoma,47,NCT03726515,CART-EGFRvIII + Pembrolizumab in GBM
PID-015,Glioblastoma,47,NCT05063682,The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
PID-015,Glioblastoma,47,NCT03603379,Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
PID-015,Glioblastoma,47,NCT00977431,Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
PID-015,Glioblastoma,47,NCT01498328,A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PID-015,Glioblastoma,47,NCT04004975,Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
PID-015,Glioblastoma,47,NCT05802693,"A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma"
PID-015,Glioblastoma,47,NCT00960492,Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
PID-015,Glioblastoma,47,NCT01110876,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)"
PID-015,Glioblastoma,47,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-015,Glioblastoma,47,NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PID-015,Glioblastoma,47,NCT06186401,Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
PID-015,Glioblastoma,47,NCT00250887,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research"
PID-015,Glioblastoma,47,NCT02573324,A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
PID-015,Glioblastoma,47,NCT02664363,EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
PID-015,Glioblastoma,47,NCT00671970,Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
PID-015,Glioblastoma,47,NCT06327451,Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
PID-015,Glioblastoma,47,NCT04903795,Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PID-015,Glioblastoma,47,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-015,Glioblastoma,47,NCT03732352,18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
PID-015,Glioblastoma,47,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-015,Glioblastoma,47,NCT03618667,GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
PID-015,Glioblastoma,47,NCT03296696,Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
PID-015,Glioblastoma,47,NCT06072586,A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
PID-015,Glioblastoma,47,NCT01520870,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
PID-015,Glioblastoma,47,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-015,Glioblastoma,47,NCT03283631,Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
PID-015,Glioblastoma,47,NCT01810744,Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
PID-015,Glioblastoma,47,NCT03311542,Expanded Access for Pembrolizumab (MK-3475)
PID-015,Glioblastoma,47,NCT01454596,CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
PID-015,Glioblastoma,47,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
PID-015,Glioblastoma,47,NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection
PID-015,Glioblastoma,47,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-015,Glioblastoma,47,NCT02365662,A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
PID-015,Glioblastoma,47,NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PID-016,Glioblastoma,66,NCT01102595,Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
PID-016,Glioblastoma,66,NCT03903419,Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
PID-016,Glioblastoma,66,NCT06650605,Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma
PID-016,Glioblastoma,66,NCT05399524,Functional and Ultrasound Guided Resection of Glioblastoma
PID-016,Glioblastoma,66,NCT03990285,[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
PID-016,Glioblastoma,66,NCT00936052,Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01252459,Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03879512,"Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG"
PID-016,Glioblastoma,66,NCT04606316,Surgical Nivolumab And Ipilimumab For Recurrent GBM
PID-016,Glioblastoma,66,NCT01700569,Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
PID-016,Glioblastoma,66,NCT06348693,Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
PID-016,Glioblastoma,66,NCT06869577,A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
PID-016,Glioblastoma,66,NCT05086497,WBSI Guided Personalized Delivery of TTFields
PID-016,Glioblastoma,66,NCT01833273,Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA
PID-016,Glioblastoma,66,NCT05896449,Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
PID-016,Glioblastoma,66,NCT03291314,Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03363659,Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02795364,Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
PID-016,Glioblastoma,66,NCT02772094,Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
PID-016,Glioblastoma,66,NCT04874506,MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT05958485,A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
PID-016,Glioblastoma,66,NCT06939400,Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
PID-016,Glioblastoma,66,NCT02945826,uPAR-PET/MRI in Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04869449,Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
PID-016,Glioblastoma,66,NCT04588454,18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT06271421,NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT06595186,JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT05423210,Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05120284,Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT05589961,Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT06404034,Expanded Access to Gallium Maltolate (GaM)
PID-016,Glioblastoma,66,NCT06466031,Application of MET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05281731,Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
PID-016,Glioblastoma,66,NCT03861598,Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
PID-016,Glioblastoma,66,NCT06451042,FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)
PID-016,Glioblastoma,66,NCT05908669,Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05500612,MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
PID-016,Glioblastoma,66,NCT00337883,A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
PID-016,Glioblastoma,66,NCT04277221,ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT01181193,Vitamin D for Treatment of Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04825275,Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: a Phase 0 Clinical Trial
PID-016,Glioblastoma,66,NCT04752813,A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
PID-016,Glioblastoma,66,NCT05353530,IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
PID-016,Glioblastoma,66,NCT05608395,11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
PID-016,Glioblastoma,66,NCT03075514,Ketogenic Diets as an Adjuvant Therapy in Glioblastoma
PID-016,Glioblastoma,66,NCT06781372,Patient's Derived Organoids for Drug Screening in Glioblastoma
PID-016,Glioblastoma,66,NCT01280552,A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT06533163,Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
PID-016,Glioblastoma,66,NCT04900792,A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
PID-016,Glioblastoma,66,NCT02864368,Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
PID-016,Glioblastoma,66,NCT01268566,A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01301430,Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
PID-016,Glioblastoma,66,NCT01865162,Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
PID-016,Glioblastoma,66,NCT01873469,Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03506139,Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02769806,Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
PID-016,Glioblastoma,66,NCT00730262,Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03344250,Phase I EGFR BATs in Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01317212,Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00190424,Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
PID-016,Glioblastoma,66,NCT03980249,Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
PID-016,Glioblastoma,66,NCT04587830,ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03707457,Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
PID-016,Glioblastoma,66,NCT01269424,BG & TMZ Therapy of Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00990496,A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT00515086,Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT03310372,Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02285959,Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04450160,Trial of AEO in New Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT03291990,5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02997423,Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT02177578,Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00209989,Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05565326,Response Assessment During MR-guided Radiation Therapy for Glioblastoma
PID-016,Glioblastoma,66,NCT05769660,A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT00323115,Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02858895,Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT02853565,A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00768911,CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02344355,A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01349660,Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00376103,Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02619864,mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02283944,TMS Electrochemotherapy for Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05402241,IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study
PID-016,Glioblastoma,66,NCT02586857,"A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)"
PID-016,Glioblastoma,66,NCT02685605,Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00544817,Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00535379,"SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT00892931,Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02296580,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT00677716,Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
PID-016,Glioblastoma,66,NCT00394628,AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00224978,Chloroquine for Treatment of Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02120287,Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01006044,Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection
PID-016,Glioblastoma,66,NCT01209442,Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02507102,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
PID-016,Glioblastoma,66,NCT01800695,Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00615186,Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy
PID-016,Glioblastoma,66,NCT07120620,PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01564914,A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT05917821,New Antigens Against Glioblastoma
PID-016,Glioblastoma,66,NCT01435395,"Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT00817284,Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT00800917,A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00083512,Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03714334,DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01285414,"Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT02844062,Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02331498,Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03347097,Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04019002,Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT00635557,Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02937844,Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04610229,Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.
PID-016,Glioblastoma,66,NCT06687681,Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
PID-016,Glioblastoma,66,NCT01752491,A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04421378,A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02550249,Neoadjuvant Nivolumab in Glioblastoma
PID-016,Glioblastoma,66,NCT05557292,RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02017249,Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01788280,Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab
PID-016,Glioblastoma,66,NCT01588769,A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients
PID-016,Glioblastoma,66,NCT01290692,Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
PID-016,Glioblastoma,66,NCT05798507,Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT02296476,A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)
PID-016,Glioblastoma,66,NCT00650949,Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
PID-016,Glioblastoma,66,NCT06346821,Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data
PID-016,Glioblastoma,66,NCT00311857,"Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)"
PID-016,Glioblastoma,66,NCT05410301,"Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma"
PID-016,Glioblastoma,66,NCT00704288,Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00083447,Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00589095,Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
PID-016,Glioblastoma,66,NCT01508117,Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
PID-016,Glioblastoma,66,NCT00792012,A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00267592,Safety and Efficacy of Talampanel in Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00590681,Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01115491,A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04801147,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00050986,Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04845919,Sonodynamic Therapy with ExAblate System in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT07052877,The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
PID-016,Glioblastoma,66,NCT07162324,"A Multicenter, Prospective Study for Glioblastoma Patients"
PID-016,Glioblastoma,66,NCT02189109,The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma
PID-016,Glioblastoma,66,NCT01663012,Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
PID-016,Glioblastoma,66,NCT05463848,Surgical Pembro +/- Olaparib w TMZ for rGBM
PID-016,Glioblastoma,66,NCT05551013,Treatment of Recurrent GBM With APG-157 Via Expanded Access
PID-016,Glioblastoma,66,NCT01604590,Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01071837,APG101 in Glioblastoma
PID-016,Glioblastoma,66,NCT06657027,Artificial Intelligence-Guided Radiotherapy Planning for Glioblastoma
PID-016,Glioblastoma,66,NCT04590664,Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
PID-016,Glioblastoma,66,NCT07119294,Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
PID-016,Glioblastoma,66,NCT06090903,Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
PID-016,Glioblastoma,66,NCT04790097,FET-PET Directed Simultaneous In-field Boost for Primary GBM
PID-016,Glioblastoma,66,NCT05190315,Chlorpromazine and Standard of Care in Glioblastoma
PID-016,Glioblastoma,66,NCT04530006,Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT06353360,TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
PID-016,Glioblastoma,66,NCT00038493,Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT07093814,A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT05970757,Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
PID-016,Glioblastoma,66,NCT07121842,Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI
PID-016,Glioblastoma,66,NCT04002804,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03866109,A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMT
PID-016,Glioblastoma,66,NCT06176066,PH Sensitive MRI Based Resections of Glioblastoma
PID-016,Glioblastoma,66,NCT02104882,INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
PID-016,Glioblastoma,66,NCT03582514,PreOperative Brain Irradiation in Glioblastoma
PID-016,Glioblastoma,66,NCT06001281,Predictive Value of Soluble CD146 in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT02029573,Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
PID-016,Glioblastoma,66,NCT01091792,Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT01450449,Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05728125,Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients
PID-016,Glioblastoma,66,NCT00984438,Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05222802,A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
PID-016,Glioblastoma,66,NCT05432375,Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
PID-016,Glioblastoma,66,NCT00797940,Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
PID-016,Glioblastoma,66,NCT01526837,Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
PID-016,Glioblastoma,66,NCT04810182,Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
PID-016,Glioblastoma,66,NCT04614909,Study of Pamiparib in Newly Diagnosed and rGBM
PID-016,Glioblastoma,66,NCT04373785,NG101m Adjuvant Therapy in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT01587144,Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
PID-016,Glioblastoma,66,NCT00076986,The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT06764537,Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma
PID-016,Glioblastoma,66,NCT01260506,Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT06749925,Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma
PID-016,Glioblastoma,66,NCT04765098,Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
PID-016,Glioblastoma,66,NCT04118036,Abemaciclib + Pembrolizumab In Glioblastoma
PID-016,Glioblastoma,66,NCT04814329,Glioblastoma Response Prediction to Apatinib
PID-016,Glioblastoma,66,NCT02047214,Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
PID-016,Glioblastoma,66,NCT03849105,131I-IPA and Concurrent XRT in Recurrent GBM
PID-016,Glioblastoma,66,NCT00116376,Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT02410577,89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03212235,Hypofractionated Radiation Therapy for Glioblastoma
PID-016,Glioblastoma,66,NCT07173829,A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
PID-016,Glioblastoma,66,NCT06336291,A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
PID-016,Glioblastoma,66,NCT05512195,Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma
PID-016,Glioblastoma,66,NCT04406272,VB-111 in Surgically Accessible Recurrent/Progressive GBM
PID-016,Glioblastoma,66,NCT05653635,Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
PID-016,Glioblastoma,66,NCT00093964,Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
PID-016,Glioblastoma,66,NCT01402063,PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
PID-016,Glioblastoma,66,NCT06061809,N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT06038604,Glioblastoma Psychosocial Support Program
PID-016,Glioblastoma,66,NCT04492163,Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
PID-016,Glioblastoma,66,NCT02378532,The Addition of Chloroquine to Chemoradiation for Glioblastoma
PID-016,Glioblastoma,66,NCT05708352,A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
PID-016,Glioblastoma,66,NCT01618747,An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse
PID-016,Glioblastoma,66,NCT07141732,Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy
PID-016,Glioblastoma,66,NCT06672575,A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02926222,Regorafenib in Relapsed Glioblastoma
PID-016,Glioblastoma,66,NCT06132438,Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
PID-016,Glioblastoma,66,NCT02751138,Determination of Immune Phenotype in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT00238797,"A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT02928575,"Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma"
PID-016,Glioblastoma,66,NCT05927610,Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
PID-016,Glioblastoma,66,NCT05366179,Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
PID-016,Glioblastoma,66,NCT05641220,Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.
PID-016,Glioblastoma,66,NCT05083754,Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
PID-016,Glioblastoma,66,NCT04977375,Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01933815,Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
PID-016,Glioblastoma,66,NCT04116411,A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT05700955,Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06490497,Expectations and Needs of a Glioblastoma Caregiver
PID-016,Glioblastoma,66,NCT04747145,Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma
PID-016,Glioblastoma,66,NCT06222138,Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00345163,A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
PID-016,Glioblastoma,66,NCT05635734,Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00916409,Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT01778530,TRC105 for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06625684,Key Longitudinal Associations With Risk and Glioblastoma Outcomes
PID-016,Glioblastoma,66,NCT07145112,Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00904852,Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT06512311,Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
PID-016,Glioblastoma,66,NCT05756985,Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
PID-016,Glioblastoma,66,NCT04552977,A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06613841,"Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma"
PID-016,Glioblastoma,66,NCT04772846,Chloroquine for Glioblastoma.
PID-016,Glioblastoma,66,NCT00684567,Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
PID-016,Glioblastoma,66,NCT01259869,A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression
PID-016,Glioblastoma,66,NCT03276286,Nativis Voyager for Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT02176720,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-016,Glioblastoma,66,NCT05781321,"Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study"
PID-016,Glioblastoma,66,NCT06845020,CSF Proteomic Characterization of Glioblastomas
PID-016,Glioblastoma,66,NCT02049489,A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02067156,"Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma"
PID-016,Glioblastoma,66,NCT03712293,ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
PID-016,Glioblastoma,66,NCT01849146,"Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma"
PID-016,Glioblastoma,66,NCT01089868,Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
PID-016,Glioblastoma,66,NCT05986851,Azeliragon in MGMT Unmethylated Glioblastoma
PID-016,Glioblastoma,66,NCT04657146,Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT05669820,Antisecretory Factor Glioblastoma Phase 2
PID-016,Glioblastoma,66,NCT04417933,Tumor Electric Fields Treatment System for Glioblastoma
PID-016,Glioblastoma,66,NCT06780592,Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
PID-016,Glioblastoma,66,NCT03048240,INtraoperative photoDYnamic Therapy of GliOblastoma
PID-016,Glioblastoma,66,NCT05015543,Physical Training in Glioblastoma Patients During Cytotoxic Therapy
PID-016,Glioblastoma,66,NCT05109728,A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
PID-016,Glioblastoma,66,NCT06218524,The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM
PID-016,Glioblastoma,66,NCT04671459,TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine
PID-016,Glioblastoma,66,NCT05556382,Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity
PID-016,Glioblastoma,66,NCT06448286,PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT05186064,Glioblastoma Targeted Treatment Option Maximization by WGS
PID-016,Glioblastoma,66,NCT06556563,EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT05515133,Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients
PID-016,Glioblastoma,66,NCT04319276,Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
PID-016,Glioblastoma,66,NCT02977780,INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
PID-016,Glioblastoma,66,NCT06831526,Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00805961,"RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM"
PID-016,Glioblastoma,66,NCT04656535,AB154 Combined With AB122 for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04391062,Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma
PID-016,Glioblastoma,66,NCT01290263,Amgen 386 for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04752280,Glioblastoma Radiotherapy Using IMRT or Proton Beams
PID-016,Glioblastoma,66,NCT06183983,Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
PID-016,Glioblastoma,66,NCT01851733,MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01493219,Biomarkers for Prognosis of Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT06524063,Targeted Survivin DC Cell Injection for the Treatment of GBM
PID-016,Glioblastoma,66,NCT03862430,A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT02815410,Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
PID-016,Glioblastoma,66,NCT05735171,Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence
PID-016,Glioblastoma,66,NCT03661723,Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06113705,Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
PID-016,Glioblastoma,66,NCT01468324,AZD7451 for Recurrent Gliomas
PID-016,Glioblastoma,66,NCT03419403,UNITE Study: Understanding New Interventions With GBM ThErapy
PID-016,Glioblastoma,66,NCT05938387,Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
PID-016,Glioblastoma,66,NCT03403803,Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
PID-016,Glioblastoma,66,NCT00892177,Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05539339,Personalized Trial in ctDNA-level-relapse Glioblastoma
PID-016,Glioblastoma,66,NCT04856852,Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT07144735,Allogeneic γδT Cells in Glioblastoma
PID-016,Glioblastoma,66,NCT00402116,Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
PID-016,Glioblastoma,66,NCT05664464,Glutamate Inhibitors in Glioblastoma
PID-016,Glioblastoma,66,NCT03687099,Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma
PID-016,Glioblastoma,66,NCT04443010,Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT04243005,Supramarginal Resection in Glioblastoma
PID-016,Glioblastoma,66,NCT00456612,Radiosurgery for Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05656300,Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?
PID-016,Glioblastoma,66,NCT04730869,Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
PID-016,Glioblastoma,66,NCT04959500,Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT05768087,Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients
PID-016,Glioblastoma,66,NCT06600399,Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma
PID-016,Glioblastoma,66,NCT04583020,Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT05303467,A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
PID-016,Glioblastoma,66,NCT04359745,Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression
PID-016,Glioblastoma,66,NCT05541042,Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
PID-016,Glioblastoma,66,NCT04599647,EAP for the Treatment of Glioblastoma With PVSRIPO
PID-016,Glioblastoma,66,NCT06297512,Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
PID-016,Glioblastoma,66,NCT06140875,Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
PID-016,Glioblastoma,66,NCT00704808,Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
PID-016,Glioblastoma,66,NCT00508456,Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
PID-016,Glioblastoma,66,NCT03139916,Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01345370,Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT05074992,A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02546102,"Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma"
PID-016,Glioblastoma,66,NCT05871021,Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
PID-016,Glioblastoma,66,NCT02850744,"Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients"
PID-016,Glioblastoma,66,NCT03194971,NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
PID-016,Glioblastoma,66,NCT03151772,Bioavailability of Disulfiram and Metformin in Glioblastomas
PID-016,Glioblastoma,66,NCT05753007,"A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients"
PID-016,Glioblastoma,66,NCT02709616,Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
PID-016,Glioblastoma,66,NCT07047066,A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02808364,Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)
PID-016,Glioblastoma,66,NCT04536649,Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.
PID-016,Glioblastoma,66,NCT05140902,Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
PID-016,Glioblastoma,66,NCT02286167,Glioma Modified Atkins-based Diet in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT00171938,Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
PID-016,Glioblastoma,66,NCT02715609,Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT05241392,Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00115453,Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
PID-016,Glioblastoma,66,NCT01907165,Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
PID-016,Glioblastoma,66,NCT02092038,Preoperative Chemoradiation for Glioblastoma
PID-016,Glioblastoma,66,NCT02780024,"Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM"
PID-016,Glioblastoma,66,NCT06146738,The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
PID-016,Glioblastoma,66,NCT04863950,Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06924099,TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
PID-016,Glioblastoma,66,NCT02880410,Feasibility Study on LITT for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02394626,Surgery for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06551909,Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
PID-016,Glioblastoma,66,NCT05183204,"Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma"
PID-016,Glioblastoma,66,NCT04716699,Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma
PID-016,Glioblastoma,66,NCT03390569,Exercise in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT04596930,MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma
PID-016,Glioblastoma,66,NCT05811793,Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
PID-016,Glioblastoma,66,NCT04250922,LAM561 With RT and TMZ for Adults With Glioblastoma
PID-016,Glioblastoma,66,NCT01109095,CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
PID-016,Glioblastoma,66,NCT04221061,18F-FluorThanatrace (PET/CT) in Glioblastoma
PID-016,Glioblastoma,66,NCT04922723,Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
PID-016,Glioblastoma,66,NCT06102525,"A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma"
PID-016,Glioblastoma,66,NCT03780569,TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT03055208,Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT03119064,BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01666600,NOA-12: BIBF1120 and R-RT in Glioblastoma
PID-016,Glioblastoma,66,NCT04280848,Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
PID-016,Glioblastoma,66,NCT03395587,Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT03293888,Spectral Analysis Probe to Identify Glioblastoma Cells
PID-016,Glioblastoma,66,NCT03529448,TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT04829097,Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma
PID-016,Glioblastoma,66,NCT04765514,Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients
PID-016,Glioblastoma,66,NCT05793021,FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
PID-016,Glioblastoma,66,NCT01562197,A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04708171,The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
PID-016,Glioblastoma,66,NCT00104091,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-016,Glioblastoma,66,NCT04691960,A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
PID-016,Glioblastoma,66,NCT01474239,A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04516733,Precoce Medical Care by the Mobil Support for Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT04826393,ASP8374 + Cemiplimab in Recurrent Glioma
PID-016,Glioblastoma,66,NCT03739333,Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.
PID-016,Glioblastoma,66,NCT05502991,Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma
PID-016,Glioblastoma,66,NCT02157103,A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT04284306,Immunohistochemical Assessment of Programmed Death ligand1 and LC3B in GBM
PID-016,Glioblastoma,66,NCT04157478,Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01478854,Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
PID-016,Glioblastoma,66,NCT03243851,Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
PID-016,Glioblastoma,66,NCT04629209,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma"
PID-016,Glioblastoma,66,NCT03743662,Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
PID-016,Glioblastoma,66,NCT02206230,Trial of Hypofractionated Radiation Therapy for Glioblastoma
PID-016,Glioblastoma,66,NCT00686725,Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
PID-016,Glioblastoma,66,NCT04881032,AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT06105619,A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
PID-016,Glioblastoma,66,NCT00262730,Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT02379572,Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
PID-016,Glioblastoma,66,NCT05304663,Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression
PID-016,Glioblastoma,66,NCT02663440,Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01777919,Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
PID-016,Glioblastoma,66,NCT02062372,Spatial Analysis and Validation of Glioblastoma on 7 T MRI
PID-016,Glioblastoma,66,NCT04219475,Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients
PID-016,Glioblastoma,66,NCT05698199,"Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)"
PID-016,Glioblastoma,66,NCT01898273,Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02202993,TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM
PID-016,Glioblastoma,66,NCT01622764,89Zr-RO5323441 PET Imaging in Glioblastoma
PID-016,Glioblastoma,66,NCT04963413,RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.
PID-016,Glioblastoma,66,NCT03491683,INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT02841332,Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00068952,Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01169415,Effects of Steroid Tapering on Functional Capacity and Neurocognition
PID-016,Glioblastoma,66,NCT05333588,The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.
PID-016,Glioblastoma,66,NCT04225039,"Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma"
PID-016,Glioblastoma,66,NCT04552886,Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma
PID-016,Glioblastoma,66,NCT02394665,Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
PID-016,Glioblastoma,66,NCT03995706,Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
PID-016,Glioblastoma,66,NCT03663725,Treatment Intensification With Temozolomide in Adults With a Glioblastoma
PID-016,Glioblastoma,66,NCT04642937,Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04195139,Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
PID-016,Glioblastoma,66,NCT03493932,Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
PID-016,Glioblastoma,66,NCT02617745,Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
PID-016,Glioblastoma,66,NCT02715297,Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04471844,"Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM"
PID-016,Glioblastoma,66,NCT05187624,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma"
PID-016,Glioblastoma,66,NCT04933422,CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
PID-016,Glioblastoma,66,NCT03374943,A Trial of KB004 in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT01225510,A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06477939,Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients
PID-016,Glioblastoma,66,NCT04119674,Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT03231501,HMPL-813 in Treating Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT04574856,Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT03770468,"Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma"
PID-016,Glioblastoma,66,NCT04547855,Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
PID-016,Glioblastoma,66,NCT02146066,Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
PID-016,Glioblastoma,66,NCT02336165,Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT07076472,Sonodynamic Therapy With SONALA-001 and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02441322,Evaluating Therapeutic Response to Novo-TTF
PID-016,Glioblastoma,66,NCT04324840,A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01403285,Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT06740955,Hypofractionated Radiotherapy
PID-016,Glioblastoma,66,NCT04019262,Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT04015700,"Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-016,Glioblastoma,66,NCT01473901,A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT06676891,Expanded Access Program for GBM Subjects
PID-016,Glioblastoma,66,NCT03587038,OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02725684,Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
PID-016,Glioblastoma,66,NCT04846257,Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence
PID-016,Glioblastoma,66,NCT03246113,Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
PID-016,Glioblastoma,66,NCT01308632,Metronomic Temozolamide in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01308684,A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01782976,Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT01846871,Tivozanib for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02893137,Enhancing Optune Therapy With Targeted Craniectomy
PID-016,Glioblastoma,66,NCT03926507,F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
PID-016,Glioblastoma,66,NCT04573192,A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
PID-016,Glioblastoma,66,NCT06936046,Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression
PID-016,Glioblastoma,66,NCT02904525,Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model
PID-016,Glioblastoma,66,NCT03567135,Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma
PID-016,Glioblastoma,66,NCT03297125,Assessment of Optune Therapy for Patients with Newly Diagnosed Glioblastoma Using Advanced MRI
PID-016,Glioblastoma,66,NCT02910804,IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT01189513,SCH-900105 in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04485949,A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT00397072,Epothilone in Recurrent Glioblastoma Patients
PID-016,Glioblastoma,66,NCT00821080,Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02511405,"A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)"
PID-016,Glioblastoma,66,NCT02981940,A Study of Abemaciclib in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02630030,Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT03347617,Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT06054529,Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
PID-016,Glioblastoma,66,NCT04121455,Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
PID-016,Glioblastoma,66,NCT02254954,"Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma"
PID-016,Glioblastoma,66,NCT04047706,"Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma"
PID-016,Glioblastoma,66,NCT06973096,CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PID-016,Glioblastoma,66,NCT03388372,Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma
PID-016,Glioblastoma,66,NCT02149225,GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
PID-016,Glioblastoma,66,NCT02478164,Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
PID-016,Glioblastoma,66,NCT03679754,"Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102"
PID-016,Glioblastoma,66,NCT04006119,Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT03687034,A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT03477110,"Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma"
PID-016,Glioblastoma,66,NCT03922984,Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma
PID-016,Glioblastoma,66,NCT04762069,A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05864976,Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
PID-016,Glioblastoma,66,NCT01756352,FET-PET for Evaluation of Response of Recurrent GBM to Avastin
PID-016,Glioblastoma,66,NCT01112527,PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03548571,Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
PID-016,Glioblastoma,66,NCT01939574,A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
PID-016,Glioblastoma,66,NCT03897491,PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
PID-016,Glioblastoma,66,NCT03152708,CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT04224441,Repurposing Chlorpromazine in the Treatment of Glioblastoma
PID-016,Glioblastoma,66,NCT03535350,Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02669173,Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02902757,FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT02728349,Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma
PID-016,Glioblastoma,66,NCT02770378,A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01043536,Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
PID-016,Glioblastoma,66,NCT05376800,A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma
PID-016,Glioblastoma,66,NCT03481231,In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT02330991,A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
PID-016,Glioblastoma,66,NCT02329795,Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
PID-016,Glioblastoma,66,NCT07029100,Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.
PID-016,Glioblastoma,66,NCT04717739,"TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study"
PID-016,Glioblastoma,66,NCT01923922,CT Perfusion in the Prognostication of Cerebral High Grade Glioma
PID-016,Glioblastoma,66,NCT04007185,Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)
PID-016,Glioblastoma,66,NCT03233152,Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03636477,A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
PID-016,Glioblastoma,66,NCT04566185,Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02590497,Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
PID-016,Glioblastoma,66,NCT00509821,"Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma"
PID-016,Glioblastoma,66,NCT03439332,Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma
PID-016,Glioblastoma,66,NCT02876003,Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma
PID-016,Glioblastoma,66,NCT03223103,Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
PID-016,Glioblastoma,66,NCT05108012,Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
PID-016,Glioblastoma,66,NCT00694837,Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
PID-016,Glioblastoma,66,NCT02799238,Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT02342379,TH-302 in Combination With Bevacizumab for Glioblastoma
PID-016,Glioblastoma,66,NCT01443676,Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT05328089,Vacuolar ATPase and Drug Resistance of High Grade Gliomas
PID-016,Glioblastoma,66,NCT00943007,Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors
PID-016,Glioblastoma,66,NCT01499251,Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05664243,"A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma"
PID-016,Glioblastoma,66,NCT03383978,Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
PID-016,Glioblastoma,66,NCT01989884,An Efficacy Study Of Ortataxel In Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05900908,Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy
PID-016,Glioblastoma,66,NCT01811121,MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS
PID-016,Glioblastoma,66,NCT02654964,Cancer Stem Cell High-Throughput Drug Screening Study
PID-016,Glioblastoma,66,NCT01854099,Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens
PID-016,Glioblastoma,66,NCT03393000,Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
PID-016,Glioblastoma,66,NCT03422094,"Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-016,Glioblastoma,66,NCT03631836,"Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma"
PID-016,Glioblastoma,66,NCT03287063,"Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma"
PID-016,Glioblastoma,66,NCT00643825,"Prolonged Adjuvant Temozolomide vs ""Stop & Go"" in Glioblastoma Patients"
PID-016,Glioblastoma,66,NCT01872221,Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study
PID-016,Glioblastoma,66,NCT01260467,Memantine for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01213407,Dendritic Cell Cancer Vaccine for High-grade Glioma
PID-016,Glioblastoma,66,NCT05590689,Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
PID-016,Glioblastoma,66,NCT05342883,GammaTile and Stupp in Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT01867593,MET-PET for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02060955,Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan
PID-016,Glioblastoma,66,NCT00029783,Efficacy of Distant Healing in Glioblastoma Treatment
PID-016,Glioblastoma,66,NCT02359097,Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT03776071,"A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1"
PID-016,Glioblastoma,66,NCT05753995,"Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study"
PID-016,Glioblastoma,66,NCT01759810,Proteome-based Personalized Immunotherapy of Glioblastoma
PID-016,Glioblastoma,66,NCT00906893,Evaluation of [18F]-FMISO for Non Operated Glioblastoma
PID-016,Glioblastoma,66,NCT02718443,VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
PID-016,Glioblastoma,66,NCT02430363,Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
PID-016,Glioblastoma,66,NCT02343406,Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
PID-016,Glioblastoma,66,NCT04726397,UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial
PID-016,Glioblastoma,66,NCT01582269,A Study in Recurrent Glioblastoma (GB)
PID-016,Glioblastoma,66,NCT02939378,Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study
PID-016,Glioblastoma,66,NCT05820191,B-amyloid as a Marker for GBM Bioimaging
PID-016,Glioblastoma,66,NCT00807027,Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
PID-016,Glioblastoma,66,NCT03018288,Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT01331291,Bosutinib in Adult Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02704858,Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
PID-016,Glioblastoma,66,NCT01100177,Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients
PID-016,Glioblastoma,66,NCT02014844,Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
PID-016,Glioblastoma,66,NCT05168423,CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
PID-016,Glioblastoma,66,NCT04868396,Patient-derived Glioma Stem Cell Organoids
PID-016,Glioblastoma,66,NCT00944801,Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02866747,A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02869243,A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
PID-016,Glioblastoma,66,NCT00295815,Enzastaurin Versus Lomustine in Glioblastoma
PID-016,Glioblastoma,66,NCT03382977,"Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects"
PID-016,Glioblastoma,66,NCT01310868,Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
PID-016,Glioblastoma,66,NCT00790452,Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
PID-016,Glioblastoma,66,NCT02648633,Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04321694,Expanded Access for KHK2455
PID-016,Glioblastoma,66,NCT01856933,BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT01430351,"Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy"
PID-016,Glioblastoma,66,NCT06954636,Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
PID-016,Glioblastoma,66,NCT00941460,Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01364064,Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00385853,PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
PID-016,Glioblastoma,66,NCT03939858,Bioenergetic Profiling and Cognition in GBM Patients
PID-016,Glioblastoma,66,NCT01507506,Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
PID-016,Glioblastoma,66,NCT00703859,Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT03970447,A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02078648,"Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT00948389,Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT01310855,Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT01985087,A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
PID-016,Glioblastoma,66,NCT02315534,A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
PID-016,Glioblastoma,66,NCT00762255,A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03149003,A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
PID-016,Glioblastoma,66,NCT02209948,Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
PID-016,Glioblastoma,66,NCT02520635,Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients
PID-016,Glioblastoma,66,NCT03961971,Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
PID-016,Glioblastoma,66,NCT01083719,A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
PID-016,Glioblastoma,66,NCT04385173,Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
PID-016,Glioblastoma,66,NCT01044225,Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
PID-016,Glioblastoma,66,NCT01934361,Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00967330,A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT03454295,Easing Psychosocial Burden for Informal Caregivers
PID-016,Glioblastoma,66,NCT01464177,Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00088400,Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors
PID-016,Glioblastoma,66,NCT04528680,Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03642080,MRI Predictors of Response to Tumor Treating Fields
PID-016,Glioblastoma,66,NCT01339052,Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04313842,A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED
PID-016,Glioblastoma,66,NCT00813943,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status"
PID-016,Glioblastoma,66,NCT02968940,Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
PID-016,Glioblastoma,66,NCT04802447,SurVaxM Expanded Access Protocol
PID-016,Glioblastoma,66,NCT01880008,Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT00392548,URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol
PID-016,Glioblastoma,66,NCT02179086,Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT04838782,Role of Repeat Resection in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00689221,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status"
PID-016,Glioblastoma,66,NCT04205357,Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00725010,Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
PID-016,Glioblastoma,66,NCT03726515,CART-EGFRvIII + Pembrolizumab in GBM
PID-016,Glioblastoma,66,NCT01632228,A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00521482,Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05450744,131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)
PID-016,Glioblastoma,66,NCT03538587,Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
PID-016,Glioblastoma,66,NCT01702792,Derivation of Tumor Specific Hybridomas
PID-016,Glioblastoma,66,NCT04077866,B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
PID-016,Glioblastoma,66,NCT06136611,Preoperative Preradiotherapy TTFields
PID-016,Glioblastoma,66,NCT04915404,Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
PID-016,Glioblastoma,66,NCT03477513,Personalized Radiation Therapy for GBM
PID-016,Glioblastoma,66,NCT03452579,Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
PID-016,Glioblastoma,66,NCT05917145,ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT04474353,Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT05768919,Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
PID-016,Glioblastoma,66,NCT00501891,Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT06146725,The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
PID-016,Glioblastoma,66,NCT03008148,Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT05801159,[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT03869242,NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT05053880,A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00943826,A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01860638,A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
PID-016,Glioblastoma,66,NCT04315584,FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
PID-016,Glioblastoma,66,NCT02654041,Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
PID-016,Glioblastoma,66,NCT05326464,Tofacitinib in Recurrent GBM Patients
PID-016,Glioblastoma,66,NCT05296122,Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
PID-016,Glioblastoma,66,NCT06649851,G-CSF After Chemo-radiation in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT03688178,DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
PID-016,Glioblastoma,66,NCT03782415,Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03250299,Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02337491,Pembrolizumab +/- Bevacizumab for Recurrent GBM
PID-016,Glioblastoma,66,NCT01124539,Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
PID-016,Glioblastoma,66,NCT03927222,Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
PID-016,Glioblastoma,66,NCT02287428,Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT02905643,Discerning Pseudoprogression vs True Tumor Growth in GBMs
PID-016,Glioblastoma,66,NCT03197506,Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT06991101,Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT03258021,TTFields In GErmany in Routine Clinical Care
PID-016,Glioblastoma,66,NCT02458508,Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy
PID-016,Glioblastoma,66,NCT00003456,Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05627323,CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT04545177,Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
PID-016,Glioblastoma,66,NCT05759195,Biomolecular Analysis for Predicting Response to Regorafenib
PID-016,Glioblastoma,66,NCT02367482,Tryptophan Metabolism in Human Brain Tumors-Novocure
PID-016,Glioblastoma,66,NCT00481455,Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT00693095,Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer
PID-016,Glioblastoma,66,NCT05236036,Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
PID-016,Glioblastoma,66,NCT00003474,Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03047473,Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01208909,Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)
PID-016,Glioblastoma,66,NCT05063682,The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
PID-016,Glioblastoma,66,NCT05902169,Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
PID-016,Glioblastoma,66,NCT06815432,GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
PID-016,Glioblastoma,66,NCT03616860,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
PID-016,Glioblastoma,66,NCT03603379,Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
PID-016,Glioblastoma,66,NCT04479241,LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02085304,"Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM"
PID-016,Glioblastoma,66,NCT01186406,"Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)"
PID-016,Glioblastoma,66,NCT06917885,CUE-102 in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00977431,Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
PID-016,Glioblastoma,66,NCT00979017,Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03643549,Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
PID-016,Glioblastoma,66,NCT00290771,Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT02899663,MRI Detection of Microbleeds in Glioma Patients
PID-016,Glioblastoma,66,NCT00895180,Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05653622,Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma
PID-016,Glioblastoma,66,NCT04221503,Niraparib/TTFields in GBM
PID-016,Glioblastoma,66,NCT02698280,Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
PID-016,Glioblastoma,66,NCT05685004,Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT02631655,POSitron Emission Imaging Using 18F-FDOPA in Neurooncology
PID-016,Glioblastoma,66,NCT00576537,Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
PID-016,Glioblastoma,66,NCT02585219,Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas
PID-016,Glioblastoma,66,NCT03278249,Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
PID-016,Glioblastoma,66,NCT00687765,Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
PID-016,Glioblastoma,66,NCT00616005,Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
PID-016,Glioblastoma,66,NCT02302235,Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study
PID-016,Glioblastoma,66,NCT04003649,IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
PID-016,Glioblastoma,66,NCT02843230,Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
PID-016,Glioblastoma,66,NCT02473484,Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas
PID-016,Glioblastoma,66,NCT05432518,Pilot Trial for Treatment of Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03025893,"A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT01602588,A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)
PID-016,Glioblastoma,66,NCT06552260,A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
PID-016,Glioblastoma,66,NCT01011231,Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma
PID-016,Glioblastoma,66,NCT05977738,Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin
PID-016,Glioblastoma,66,NCT06356883,Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
PID-016,Glioblastoma,66,NCT00884741,Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00509301,Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01653834,Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
PID-016,Glioblastoma,66,NCT05868083,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01105988,Evaluating Tumor Pseudoprogression With FLT-PET and MRI
PID-016,Glioblastoma,66,NCT06039709,Sonodynamic Therapy in Patients With Recurrent GBM
PID-016,Glioblastoma,66,NCT05052957,hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
PID-016,Glioblastoma,66,NCT03235934,Glycemic Impact on Glioblastoma Outcomes
PID-016,Glioblastoma,66,NCT01535911,Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
PID-016,Glioblastoma,66,NCT06850766,The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
PID-016,Glioblastoma,66,NCT07100730,Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01251484,BIBF 1120 in Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT06283927,The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
PID-016,Glioblastoma,66,NCT05095441,A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT05131711,Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)
PID-016,Glioblastoma,66,NCT06186440,Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
PID-016,Glioblastoma,66,NCT00611728,Ph I SU011248 + Irinotecan in Treatment of Pts w MG
PID-016,Glioblastoma,66,NCT04469699,Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05663125,LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
PID-016,Glioblastoma,66,NCT01498328,A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PID-016,Glioblastoma,66,NCT00961090,Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
PID-016,Glioblastoma,66,NCT03107780,Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
PID-016,Glioblastoma,66,NCT02474966,Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study
PID-016,Glioblastoma,66,NCT01149850,Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
PID-016,Glioblastoma,66,NCT01737346,Procarbazine and Lomustine in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT07143812,A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00597493,Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM
PID-016,Glioblastoma,66,NCT07134842,A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
PID-016,Glioblastoma,66,NCT02466828,qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.
PID-016,Glioblastoma,66,NCT00574964,Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT06782984,Drug Response Testing and Repurposing Using Glioblastoma Organoid
PID-016,Glioblastoma,66,NCT06835803,Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: a Phase 2 Hybrid Randomized Trial
PID-016,Glioblastoma,66,NCT03480867,Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)
PID-016,Glioblastoma,66,NCT00306618,Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
PID-016,Glioblastoma,66,NCT06616727,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
PID-016,Glioblastoma,66,NCT01591577,Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00412542,Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
PID-016,Glioblastoma,66,NCT05666349,Reirradiation and Niraparib in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00379470,Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT00187486,"Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors"
PID-016,Glioblastoma,66,NCT06757153,Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
PID-016,Glioblastoma,66,NCT07145047,Clinical Study of Oncolytic Virus in Glioblastoma
PID-016,Glioblastoma,66,NCT05577091,Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02137759,MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
PID-016,Glioblastoma,66,NCT03463733,Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
PID-016,Glioblastoma,66,NCT02613988,Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
PID-016,Glioblastoma,66,NCT04952571,Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT01903330,ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03632135,Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04469075,Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
PID-016,Glioblastoma,66,NCT04004975,Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
PID-016,Glioblastoma,66,NCT03557372,Mathematical Model-Adapted Radiation In Glioblastoma
PID-016,Glioblastoma,66,NCT05607407,Methimazole in Patients With Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT04902586,Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT06805305,DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT03681028,Feasibility of Individualized Therapy for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02844439,Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04968366,Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
PID-016,Glioblastoma,66,NCT05737368,Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
PID-016,Glioblastoma,66,NCT06598787,A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06894225,Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
PID-016,Glioblastoma,66,NCT05743595,"Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-016,Glioblastoma,66,NCT03665545,Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
PID-016,Glioblastoma,66,NCT03672721,IA Carboplatin + Radiotherapy in Relapsing GBM
PID-016,Glioblastoma,66,NCT06934889,Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
PID-016,Glioblastoma,66,NCT04523688,Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
PID-016,Glioblastoma,66,NCT00154375,Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT05936216,TVI-Brain-1 in Expanded Access Patient
PID-016,Glioblastoma,66,NCT05736406,A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma
PID-016,Glioblastoma,66,NCT04559230,Sacituzumab Govitecan in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04888611,Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04051606,Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06368934,Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
PID-016,Glioblastoma,66,NCT04842513,Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT03452930,Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
PID-016,Glioblastoma,66,NCT06389591,RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT06418113,Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT03405792,Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
PID-016,Glioblastoma,66,NCT06220552,The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05043701,Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01957956,Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT06069726,A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
PID-016,Glioblastoma,66,NCT05720078,UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)
PID-016,Glioblastoma,66,NCT03430791,"Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma"
PID-016,Glioblastoma,66,NCT04128774,Function and Composition of Regulatory B Cells in Participants With Glioblastoma
PID-016,Glioblastoma,66,NCT06325683,Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05218408,CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
PID-016,Glioblastoma,66,NCT02649582,Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT03225963,Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.
PID-016,Glioblastoma,66,NCT05638451,Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
PID-016,Glioblastoma,66,NCT06097975,A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06011109,Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PID-016,Glioblastoma,66,NCT05911230,Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
PID-016,Glioblastoma,66,NCT02076152,FMISO PET Study of Glioblastoma
PID-016,Glioblastoma,66,NCT04674527,Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
PID-016,Glioblastoma,66,NCT03630289,Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
PID-016,Glioblastoma,66,NCT03181477,"Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas"
PID-016,Glioblastoma,66,NCT01205334,Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04717999,Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06558214,"OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial"
PID-016,Glioblastoma,66,NCT03225300,Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation
PID-016,Glioblastoma,66,NCT05284643,"Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma"
PID-016,Glioblastoma,66,NCT05201326,Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06157541,T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT05076513,Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
PID-016,Glioblastoma,66,NCT05191784,GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients
PID-016,Glioblastoma,66,NCT05540275,Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02152982,Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04116658,"First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma"
PID-016,Glioblastoma,66,NCT00575146,Ketogenic Diet for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04013672,Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
PID-016,Glioblastoma,66,NCT03916757,V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer
PID-016,Glioblastoma,66,NCT02227576,Prevention of Thrombocytopenia in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT05802693,"A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma"
PID-016,Glioblastoma,66,NCT05324501,A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04689087,"A Prospective, Open-label, Single-arm Clinical Study"
PID-016,Glioblastoma,66,NCT00960492,Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
PID-016,Glioblastoma,66,NCT00555399,"Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)"
PID-016,Glioblastoma,66,NCT05341947,Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03451799,Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT01830101,A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03232424,NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02663271,TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02060890,Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT05879120,Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04974983,Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03722342,TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03341806,Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00657267,Dose-Intense Temozolomide in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02364206,Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT03750071,VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT01110876,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)"
PID-016,Glioblastoma,66,NCT02678975,Disulfiram in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05095376,Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
PID-016,Glioblastoma,66,NCT00400322,Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
PID-016,Glioblastoma,66,NCT02207010,A Phase 0 Study of AZD1775 in Recurrent GBM Patients
PID-016,Glioblastoma,66,NCT03137888,Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
PID-016,Glioblastoma,66,NCT03856099,TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
PID-016,Glioblastoma,66,NCT05118776,Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
PID-016,Glioblastoma,66,NCT04201873,Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04988750,Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
PID-016,Glioblastoma,66,NCT03216499,HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03865355,Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
PID-016,Glioblastoma,66,NCT01349036,A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04047303,"CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma"
PID-016,Glioblastoma,66,NCT04555577,"Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma"
PID-016,Glioblastoma,66,NCT02366728,DC Migration Study for Newly-Diagnosed GBM
PID-016,Glioblastoma,66,NCT03514069,Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
PID-016,Glioblastoma,66,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-016,Glioblastoma,66,NCT04397679,"Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma"
PID-016,Glioblastoma,66,NCT02599090,Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-016,Glioblastoma,66,NCT07138001,Phase 2 Clinical Trial of KH617
PID-016,Glioblastoma,66,NCT02345824,Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
PID-016,Glioblastoma,66,NCT02919332,Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01113398,AMG 102 and Avastin for Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT00441142,Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
PID-016,Glioblastoma,66,NCT03034135,"Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma"
PID-016,Glioblastoma,66,NCT03522298,"Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma"
PID-016,Glioblastoma,66,NCT03033524,Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03867123,A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
PID-016,Glioblastoma,66,NCT02974621,Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02530502,Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02133183,Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06186401,Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
PID-016,Glioblastoma,66,NCT00921167,A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
PID-016,Glioblastoma,66,NCT00841555,Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
PID-016,Glioblastoma,66,NCT02933736,Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
PID-016,Glioblastoma,66,NCT02129335,"Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner"
PID-016,Glioblastoma,66,NCT05879250,WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02340156,Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01866449,Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02781792,Temozolomide Chronotherapy for High Grade Glioma
PID-016,Glioblastoma,66,NCT00250887,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research"
PID-016,Glioblastoma,66,NCT03401866,Multi-site Validation and Application of a Consensus DSC-MRI Protocol
PID-016,Glioblastoma,66,NCT01756729,Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
PID-016,Glioblastoma,66,NCT06419946,Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
PID-016,Glioblastoma,66,NCT03573986,Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
PID-016,Glioblastoma,66,NCT03174197,Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT05318612,Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)
PID-016,Glioblastoma,66,NCT02455557,SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00045968,Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
PID-016,Glioblastoma,66,NCT01813877,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-016,Glioblastoma,66,NCT04715620,Niraparib Combined With Radiotherapy in rGBM
PID-016,Glioblastoma,66,NCT00777153,Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04681677,Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
PID-016,Glioblastoma,66,NCT03744026,Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
PID-016,Glioblastoma,66,NCT04223999,Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)
PID-016,Glioblastoma,66,NCT01135875,Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
PID-016,Glioblastoma,66,NCT00525525,Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
PID-016,Glioblastoma,66,NCT02573324,A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
PID-016,Glioblastoma,66,NCT00365222,Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02754362,A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00734526,Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-016,Glioblastoma,66,NCT05565521,UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly
PID-016,Glioblastoma,66,NCT01987830,Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
PID-016,Glioblastoma,66,NCT05431348,Effect of StRess and ExeRcize on the Outcome After Chemo-Radiation
PID-016,Glioblastoma,66,NCT01754350,"Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma"
PID-016,Glioblastoma,66,NCT04440358,Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
PID-016,Glioblastoma,66,NCT02017717,A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT02885272,FDG PET Imaging in Diagnosing Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT04417088,Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
PID-016,Glioblastoma,66,NCT01165671,Carbon Ion Radiotherapy for Primary Glioblastoma
PID-016,Glioblastoma,66,NCT05271240,Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT05864534,Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00071539,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-016,Glioblastoma,66,NCT07089758,A Study for Cerebral Open Flow Microperfusion
PID-016,Glioblastoma,66,NCT02046187,Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01115036,A Panobinostat Presurgery
PID-016,Glioblastoma,66,NCT00612989,Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM
PID-016,Glioblastoma,66,NCT05182905,AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
PID-016,Glioblastoma,66,NCT00612339,Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
PID-016,Glioblastoma,66,NCT02717962,"Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting"
PID-016,Glioblastoma,66,NCT03158389,NCT Neuro Master Match - N²M² (NOA-20)
PID-016,Glioblastoma,66,NCT03291977,Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)
PID-016,Glioblastoma,66,NCT00250211,Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
PID-016,Glioblastoma,66,NCT00200161,Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
PID-016,Glioblastoma,66,NCT05914935,Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00335075,Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
PID-016,Glioblastoma,66,NCT02062827,Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT03014804,Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04222309,Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-016,Glioblastoma,66,NCT06095375,"Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients"
PID-016,Glioblastoma,66,NCT01956734,Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03277638,Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
PID-016,Glioblastoma,66,NCT01836536,Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients
PID-016,Glioblastoma,66,NCT05100641,AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT04105374,"Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma"
PID-016,Glioblastoma,66,NCT00615927,Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
PID-016,Glioblastoma,66,NCT00672243,Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
PID-016,Glioblastoma,66,NCT03877861,Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms
PID-016,Glioblastoma,66,NCT03868943,Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
PID-016,Glioblastoma,66,NCT01567202,Study of DC Vaccination Against Glioblastoma
PID-016,Glioblastoma,66,NCT03551249,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
PID-016,Glioblastoma,66,NCT03532295,Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
PID-016,Glioblastoma,66,NCT01702610,Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT06585527,Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT02510950,Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00613028,Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
PID-016,Glioblastoma,66,NCT05879367,Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
PID-016,Glioblastoma,66,NCT00613132,Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
PID-016,Glioblastoma,66,NCT03149575,VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
PID-016,Glioblastoma,66,NCT00611325,Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT01413438,Bevacizumab With or Without Surgery for Adult Glioblastomas
PID-016,Glioblastoma,66,NCT02010606,Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02833701,Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
PID-016,Glioblastoma,66,NCT01180816,Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
PID-016,Glioblastoma,66,NCT06455189,Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
PID-016,Glioblastoma,66,NCT02664363,EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
PID-016,Glioblastoma,66,NCT01269853,Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
PID-016,Glioblastoma,66,NCT05326334,THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)
PID-016,Glioblastoma,66,NCT00612430,Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
PID-016,Glioblastoma,66,NCT01386710,Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
PID-016,Glioblastoma,66,NCT00968240,Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
PID-016,Glioblastoma,66,NCT03722355,Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
PID-016,Glioblastoma,66,NCT00671970,Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
PID-016,Glioblastoma,66,NCT01986348,Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas
PID-016,Glioblastoma,66,NCT02026271,A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
PID-016,Glioblastoma,66,NCT06622434,"New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study"
PID-016,Glioblastoma,66,NCT01811498,Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT01067469,Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT02022384,Immunophenotyping From Blood of Patients With Malignant Gliomas
PID-016,Glioblastoma,66,NCT05990556,Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT02605746,Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis
PID-016,Glioblastoma,66,NCT02270034,Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01547546,A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT04674579,Automatic Segmentation MRI Cerebral Glioma
PID-016,Glioblastoma,66,NCT00735436,A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
PID-016,Glioblastoma,66,NCT01954576,NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00354913,Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
PID-016,Glioblastoma,66,NCT00609999,Ph I Dasatinib + Erlotinib in Recurrent MG
PID-016,Glioblastoma,66,NCT05624736,Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning
PID-016,Glioblastoma,66,NCT00586508,Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas
PID-016,Glioblastoma,66,NCT05363826,Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®
PID-016,Glioblastoma,66,NCT05660369,CARv3-TEAM-E T Cells in Glioblastoma
PID-016,Glioblastoma,66,NCT00883298,Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05941234,"Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma"
PID-016,Glioblastoma,66,NCT03050736,Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
PID-016,Glioblastoma,66,NCT00613054,Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT06279767,Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00613223,Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
PID-016,Glioblastoma,66,NCT03997136,Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.
PID-016,Glioblastoma,66,NCT00669669,O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
PID-016,Glioblastoma,66,NCT06562621,Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT00612638,Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
PID-016,Glioblastoma,66,NCT03360708,Vaccine Therapy in Treating Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03332355,Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
PID-016,Glioblastoma,66,NCT05235737,The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab
PID-016,Glioblastoma,66,NCT03170141,Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05954858,Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
PID-016,Glioblastoma,66,NCT05432804,"Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment"
PID-016,Glioblastoma,66,NCT04266977,Restrictive Use of Dexamethasone in Glioblastoma
PID-016,Glioblastoma,66,NCT00540176,The Safety and Efficacy of DCA for the Treatment of Brain Cancer
PID-016,Glioblastoma,66,NCT06327451,Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
PID-016,Glioblastoma,66,NCT02006563,Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors
PID-016,Glioblastoma,66,NCT01351519,A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
PID-016,Glioblastoma,66,NCT04780009,Loupe-Based Intraoperative Fluorescence Imaging
PID-016,Glioblastoma,66,NCT06632236,5G-EMERALD: Amivantamab in Malignant Brain Tumours
PID-016,Glioblastoma,66,NCT06630260,5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
PID-016,Glioblastoma,66,NCT02227901,"Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT02414165,The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
PID-016,Glioblastoma,66,NCT06359379,Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
PID-016,Glioblastoma,66,NCT01478178,Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT05842746,Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT03115138,Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
PID-016,Glioblastoma,66,NCT03020017,NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
PID-016,Glioblastoma,66,NCT04188535,Serial MRI Scans During Radiation Therapy
PID-016,Glioblastoma,66,NCT01174537,"New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma"
PID-016,Glioblastoma,66,NCT02590263,Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
PID-016,Glioblastoma,66,NCT04910022,Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03345095,A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01124240,Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene
PID-016,Glioblastoma,66,NCT00005856,Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02743078,Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05773664,Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma
PID-016,Glioblastoma,66,NCT06964815,"Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients"
PID-016,Glioblastoma,66,NCT03603405,HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT05694416,Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT02768389,Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05772767,Modulation of Ciliogenesis in Glioma Stem Cells
PID-016,Glioblastoma,66,NCT03294486,"Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients"
PID-016,Glioblastoma,66,NCT03144167,Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
PID-016,Glioblastoma,66,NCT00316849,"Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT00058097,Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02898012,Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
PID-016,Glioblastoma,66,NCT04391595,LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
PID-016,Glioblastoma,66,NCT04926168,6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT01805453,"Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma"
PID-016,Glioblastoma,66,NCT03834740,A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
PID-016,Glioblastoma,66,NCT00606008,A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-016,Glioblastoma,66,NCT00004262,Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT03615404,"Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma"
PID-016,Glioblastoma,66,NCT06816927,Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
PID-016,Glioblastoma,66,NCT04200066,A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03423628,A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
PID-016,Glioblastoma,66,NCT06319027,"Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial"
PID-016,Glioblastoma,66,NCT05447195,Phase 2 Study of CAN008 in Subjects With GBM
PID-016,Glioblastoma,66,NCT05600491,A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
PID-016,Glioblastoma,66,NCT00049387,"Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-016,Glioblastoma,66,NCT06177964,Lerapolturev (PVSRIPO) in GBM
PID-016,Glioblastoma,66,NCT00305864,"Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-016,Glioblastoma,66,NCT05979064,Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-016,Glioblastoma,66,NCT00052208,Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05695976,GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
PID-016,Glioblastoma,66,NCT02626364,Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
PID-016,Glioblastoma,66,NCT02761070,"Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III"
PID-016,Glioblastoma,66,NCT01811992,Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma
PID-016,Glioblastoma,66,NCT03705351,Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT00777686,Measuring Non-Enhancing Glioblastoma Progression
PID-016,Glioblastoma,66,NCT03596086,HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
PID-016,Glioblastoma,66,NCT00479765,A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
PID-016,Glioblastoma,66,NCT00039494,Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
PID-016,Glioblastoma,66,NCT00660543,MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
PID-016,Glioblastoma,66,NCT01331616,Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
PID-016,Glioblastoma,66,NCT00085254,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT01540513,PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
PID-016,Glioblastoma,66,NCT03115333,DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04741984,Monocyte Antigen Carrier Cells for Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT04937413,The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation
PID-016,Glioblastoma,66,NCT00943462,Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
PID-016,Glioblastoma,66,NCT01124461,BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor
PID-016,Glioblastoma,66,NCT05163080,SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
PID-016,Glioblastoma,66,NCT02465268,Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02375841,"Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers"
PID-016,Glioblastoma,66,NCT05091866,Natural Progesterone for the Treatment of Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03778294,18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
PID-016,Glioblastoma,66,NCT05375318,"BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels"
PID-016,Glioblastoma,66,NCT03899857,Pembrolizumab for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00613093,Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
PID-016,Glioblastoma,66,NCT05772741,Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs
PID-016,Glioblastoma,66,NCT00014170,Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05380349,Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
PID-016,Glioblastoma,66,NCT04725214,Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma
PID-016,Glioblastoma,66,NCT00902577,MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04840069,Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01609790,Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
PID-016,Glioblastoma,66,NCT01465347,Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT05033587,Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
PID-016,Glioblastoma,66,NCT00731731,"Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT02337426,"Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT05084430,Study of Pembrolizumab and M032 (NSC 733972)
PID-016,Glioblastoma,66,NCT04945148,Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
PID-016,Glioblastoma,66,NCT02395692,Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00846456,Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma
PID-016,Glioblastoma,66,NCT01022918,Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
PID-016,Glioblastoma,66,NCT05116137,The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
PID-016,Glioblastoma,66,NCT00864864,Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02575027,Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01120639,Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
PID-016,Glioblastoma,66,NCT04600817,A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)
PID-016,Glioblastoma,66,NCT04065087,Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT03619239,Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT03020602,BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab
PID-016,Glioblastoma,66,NCT02197169,DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
PID-016,Glioblastoma,66,NCT01111097,Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors
PID-016,Glioblastoma,66,NCT00761280,Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
PID-016,Glioblastoma,66,NCT07003542,A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
PID-016,Glioblastoma,66,NCT02820584,A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06329570,Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
PID-016,Glioblastoma,66,NCT04327011,A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
PID-016,Glioblastoma,66,NCT00409214,Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
PID-016,Glioblastoma,66,NCT03400917,Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT03626896,Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
PID-016,Glioblastoma,66,NCT02311920,Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-016,Glioblastoma,66,NCT06797661,Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.
PID-016,Glioblastoma,66,NCT00001148,Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
PID-016,Glioblastoma,66,NCT02047058,Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
PID-016,Glioblastoma,66,NCT00115440,BNCT to Treat Glioma That Has Progressed Following Radiotherapy
PID-016,Glioblastoma,66,NCT05513859,Investigational Imaging Technique During Brain Surgery
PID-016,Glioblastoma,66,NCT02709226,Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04998864,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
PID-016,Glioblastoma,66,NCT04903795,Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PID-016,Glioblastoma,66,NCT00165477,Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05023551,Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-016,Glioblastoma,66,NCT04424966,Infigratinib in Recurrent High-Grade Glioma Patients
PID-016,Glioblastoma,66,NCT05171127,Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
PID-016,Glioblastoma,66,NCT03861299,The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
PID-016,Glioblastoma,66,NCT06496971,A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
PID-016,Glioblastoma,66,NCT00662506,"Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma"
PID-016,Glioblastoma,66,NCT00179907,A Phase I/II Study of the Photon Radiosurgery System
PID-016,Glioblastoma,66,NCT04967690,"A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM"
PID-016,Glioblastoma,66,NCT06480721,FET-PET-Guided Management of Pseudoprogression in Glioblastoma
PID-016,Glioblastoma,66,NCT03460782,An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
PID-016,Glioblastoma,66,NCT00004146,Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
PID-016,Glioblastoma,66,NCT03951142,Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study
PID-016,Glioblastoma,66,NCT05718466,Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy
PID-016,Glioblastoma,66,NCT05904119,Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
PID-016,Glioblastoma,66,NCT04854044,ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03649464,Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
PID-016,Glioblastoma,66,NCT03732352,18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05977322,A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
PID-016,Glioblastoma,66,NCT02330562,Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab
PID-016,Glioblastoma,66,NCT06193538,The Safety and Effectiveness of NV-A01 in Glioma Patients
PID-016,Glioblastoma,66,NCT01905228,A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
PID-016,Glioblastoma,66,NCT06910306,A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02666066,Radiomics for Prediction of Survival in GBM
PID-016,Glioblastoma,66,NCT00074646,Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas
PID-016,Glioblastoma,66,NCT02903069,Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
PID-016,Glioblastoma,66,NCT00548938,"Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM"
PID-016,Glioblastoma,66,NCT02490930,A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
PID-016,Glioblastoma,66,NCT02025231,Image Guided Reirradiation of High-grade Glioma
PID-016,Glioblastoma,66,NCT06129760,Glioblastoma Remote Monitoring and Care - Research Protocol
PID-016,Glioblastoma,66,NCT06684899,Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT06773481,BC008-1A Injection for Recurrent CNS WHO G4 Glioma
PID-016,Glioblastoma,66,NCT00686387,Establishment of a Brain and Spinal Tumor Tissue Bank
PID-016,Glioblastoma,66,NCT06344130,Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01266031,Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01516905,PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
PID-016,Glioblastoma,66,NCT03370926,FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
PID-016,Glioblastoma,66,NCT06328036,Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01931098,Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
PID-016,Glioblastoma,66,NCT01502241,Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
PID-016,Glioblastoma,66,NCT00939991,"Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas"
PID-016,Glioblastoma,66,NCT03426891,Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT06719440,Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
PID-016,Glioblastoma,66,NCT00723827,Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
PID-016,Glioblastoma,66,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-016,Glioblastoma,66,NCT00431561,Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
PID-016,Glioblastoma,66,NCT01317888,Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas
PID-016,Glioblastoma,66,NCT05039281,Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05017610,Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
PID-016,Glioblastoma,66,NCT06824662,Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas
PID-016,Glioblastoma,66,NCT03618667,GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
PID-016,Glioblastoma,66,NCT00089427,"IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma"
PID-016,Glioblastoma,66,NCT00028158,"Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer"
PID-016,Glioblastoma,66,NCT01925573,Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
PID-016,Glioblastoma,66,NCT04822688,"Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues"
PID-016,Glioblastoma,66,NCT05383872,Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
PID-016,Glioblastoma,66,NCT02337686,Pembrolizumab in Treating Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03296696,Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
PID-016,Glioblastoma,66,NCT01086345,Radiosurgery Plus Bevacizumab in Glioblastoma
PID-016,Glioblastoma,66,NCT06072586,A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
PID-016,Glioblastoma,66,NCT04216329,Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT06455605,D2C7-IT + 2141-V11 Combination Post-resection in rGBM
PID-016,Glioblastoma,66,NCT01044966,A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04763031,Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT
PID-016,Glioblastoma,66,NCT04446416,Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
PID-016,Glioblastoma,66,NCT01582516,Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00753246,Nimotuzumab in Adults With Glioblastoma Multiforma
PID-016,Glioblastoma,66,NCT01227434,A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
PID-016,Glioblastoma,66,NCT03224104,Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
PID-016,Glioblastoma,66,NCT06691308,WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients
PID-016,Glioblastoma,66,NCT01004874,Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
PID-016,Glioblastoma,66,NCT02871843,RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
PID-016,Glioblastoma,66,NCT00045565,Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
PID-016,Glioblastoma,66,NCT06058988,Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
PID-016,Glioblastoma,66,NCT04817254,Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-016,Glioblastoma,66,NCT00597402,"Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas"
PID-016,Glioblastoma,66,NCT00645385,Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
PID-016,Glioblastoma,66,NCT00576641,Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
PID-016,Glioblastoma,66,NCT01520870,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
PID-016,Glioblastoma,66,NCT01240460,Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection
PID-016,Glioblastoma,66,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-016,Glioblastoma,66,NCT03633552,Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
PID-016,Glioblastoma,66,NCT05929456,Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)
PID-016,Glioblastoma,66,NCT01062425,Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT04608812,Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
PID-016,Glioblastoma,66,NCT03631823,Gut Microbiota and Glioblastoma Multiforme Prognosis
PID-016,Glioblastoma,66,NCT05565118,Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
PID-016,Glioblastoma,66,NCT04045847,CD147-CART Cells in Patients With Recurrent Malignant Glioma.
PID-016,Glioblastoma,66,NCT04289155,Individual Patient Compassionate Use of GX-I7
PID-016,Glioblastoma,66,NCT01242566,Temozolomide in Elderly Patients With KPS < 70
PID-016,Glioblastoma,66,NCT01290939,Bevacizumab and Lomustine for Recurrent GBM
PID-016,Glioblastoma,66,NCT05683808,Venous Thromboembolism Prevention in Outpatients With Glioma
PID-016,Glioblastoma,66,NCT04396860,Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
PID-016,Glioblastoma,66,NCT01294735,Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
PID-016,Glioblastoma,66,NCT04209790,Neoadjuvant Chemoradiation for Resectable Glioblastoma
PID-016,Glioblastoma,66,NCT04677049,Study of Niacin in Glioblastoma
PID-016,Glioblastoma,66,NCT05739942,Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT02253212,Safety of BBB Opening With the SonoCloud
PID-016,Glioblastoma,66,NCT06504381,"DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma"
PID-016,Glioblastoma,66,NCT01711580,Re-irradiation of High Grade Gliomas: a Quality of Life Study
PID-016,Glioblastoma,66,NCT06710249,Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
PID-016,Glioblastoma,66,NCT06883747,Clinical Trial of BMS-986504 in Recurrent GBM Patients
PID-016,Glioblastoma,66,NCT07111195,Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
PID-016,Glioblastoma,66,NCT00923117,Sunitinib to Treat Recurrent Brain Cancer
PID-016,Glioblastoma,66,NCT05671016,Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy
PID-016,Glioblastoma,66,NCT00715013,Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT02431572,A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
PID-016,Glioblastoma,66,NCT00016328,CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00540722,Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00423735,Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
PID-016,Glioblastoma,66,NCT04699773,LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
PID-016,Glioblastoma,66,NCT06273176,The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06059690,Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
PID-016,Glioblastoma,66,NCT00747253,Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
PID-016,Glioblastoma,66,NCT00980343,GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-016,Glioblastoma,66,NCT00591058,Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT03283631,Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
PID-016,Glioblastoma,66,NCT00504660,"6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients"
PID-016,Glioblastoma,66,NCT02794883,Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT00641706,"Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme"
PID-016,Glioblastoma,66,NCT00107003,GW572016 to Treat Recurrent Malignant Brain Tumors
PID-016,Glioblastoma,66,NCT06385132,Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer
PID-016,Glioblastoma,66,NCT00445588,Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT02529072,Nivolumab With DC Vaccines for Recurrent Brain Tumors
PID-016,Glioblastoma,66,NCT00612651,PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
PID-016,Glioblastoma,66,NCT01238237,Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA
PID-016,Glioblastoma,66,NCT03275558,Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma
PID-016,Glioblastoma,66,NCT00503204,Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
PID-016,Glioblastoma,66,NCT02386826,INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00704080,A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
PID-016,Glioblastoma,66,NCT04116138,Antisecretory Factor in Primary Glioblastoma 1
PID-016,Glioblastoma,66,NCT06806228,Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)
PID-016,Glioblastoma,66,NCT01790503,A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT00751270,Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
PID-016,Glioblastoma,66,NCT00610571,Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
PID-016,Glioblastoma,66,NCT00780819,Borderzone Sampling
PID-016,Glioblastoma,66,NCT00683761,A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT00473408,The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
PID-016,Glioblastoma,66,NCT07021339,Anterior Temporal Lobectomy in Temporal Glioblastoma
PID-016,Glioblastoma,66,NCT00305656,AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00335764,"Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma"
PID-016,Glioblastoma,66,NCT01081223,Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
PID-016,Glioblastoma,66,NCT00087451,Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)
PID-016,Glioblastoma,66,NCT00392171,The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
PID-016,Glioblastoma,66,NCT05734560,D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
PID-016,Glioblastoma,66,NCT00132158,ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
PID-016,Glioblastoma,66,NCT00238303,Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01575275,Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00075491,Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT05267106,Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
PID-016,Glioblastoma,66,NCT01894061,NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00112502,Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04776980,Multimodality MRI and Liquid Biopsy in GBM
PID-016,Glioblastoma,66,NCT02887417,Glioblastoma Platelet Activation Study
PID-016,Glioblastoma,66,NCT00112866,Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT04444427,Evaluation of GLR2007 for Advanced Solid Tumors
PID-016,Glioblastoma,66,NCT00895960,Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT04657315,"Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients"
PID-016,Glioblastoma,66,NCT02052648,Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
PID-016,Glioblastoma,66,NCT03027388,"Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma"
PID-016,Glioblastoma,66,NCT02661282,Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT04712721,Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
PID-016,Glioblastoma,66,NCT06241391,Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
PID-016,Glioblastoma,66,NCT04388475,Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT04143425,Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01967758,Phase I Study of Safety and Immunogenicity of ADU-623
PID-016,Glioblastoma,66,NCT03746080,Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT05561374,Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT04181684,LITT Followed by Hypofractionated RT for Recurrent Gliomas
PID-016,Glioblastoma,66,NCT03673787,A Trial of Ipatasertib in Combination With Atezolizumab
PID-016,Glioblastoma,66,NCT03367715,"Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma"
PID-016,Glioblastoma,66,NCT00459381,Pazopanib in Treating Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT05909618,Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
PID-016,Glioblastoma,66,NCT01730950,Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01753713,Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT01117155,A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
PID-016,Glioblastoma,66,NCT01475006,AMG 595 First-in-Human in Recurrent Gliomas
PID-016,Glioblastoma,66,NCT01491893,PVSRIPO for Recurrent Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT00979862,Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03539731,[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
PID-016,Glioblastoma,66,NCT01122901,Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT03176160,LITT Palliative Treatment for Patients With Malignant Gliomas
PID-016,Glioblastoma,66,NCT05929495,"Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma"
PID-016,Glioblastoma,66,NCT01972750,Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma
PID-016,Glioblastoma,66,NCT05054400,Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
PID-016,Glioblastoma,66,NCT06017063,Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields
PID-016,Glioblastoma,66,NCT01434602,Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
PID-016,Glioblastoma,66,NCT03213002,Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
PID-016,Glioblastoma,66,NCT01967810,ANG1005 in Patients With Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT03581292,"Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations"
PID-016,Glioblastoma,66,NCT03975959,Memory Perception Assessment in Central/Non-central Nervous System Cancers
PID-016,Glioblastoma,66,NCT01808820,Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
PID-016,Glioblastoma,66,NCT06623565,Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
PID-016,Glioblastoma,66,NCT02629757,A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas
PID-016,Glioblastoma,66,NCT00624728,Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
PID-016,Glioblastoma,66,NCT00562419,CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
PID-016,Glioblastoma,66,NCT02658981,Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
PID-016,Glioblastoma,66,NCT00031538,Genetic Analysis of Brain Tumors
PID-016,Glioblastoma,66,NCT00870181,ADV-TK Improves Outcome of Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT04729959,"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma"
PID-016,Glioblastoma,66,NCT00031083,Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
PID-016,Glioblastoma,66,NCT01765088,A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
PID-016,Glioblastoma,66,NCT04145115,A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden
PID-016,Glioblastoma,66,NCT02750891,A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
PID-016,Glioblastoma,66,NCT01985256,Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
PID-016,Glioblastoma,66,NCT03475186,Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
PID-016,Glioblastoma,66,NCT02540135,Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
PID-016,Glioblastoma,66,NCT01738646,Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
PID-016,Glioblastoma,66,NCT04623931,Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
PID-016,Glioblastoma,66,NCT06430424,"Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma"
PID-016,Glioblastoma,66,NCT01810744,Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
PID-016,Glioblastoma,66,NCT02942264,Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-016,Glioblastoma,66,NCT06501911,A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
PID-016,Glioblastoma,66,NCT01975701,A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
PID-016,Glioblastoma,66,NCT03657576,Trial of C134 in Patients With Recurrent GBM
PID-016,Glioblastoma,66,NCT01712542,Curcumin Bioavailability in Glioblastoma Patients
PID-016,Glioblastoma,66,NCT01470794,Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
PID-016,Glioblastoma,66,NCT01107522,Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
PID-016,Glioblastoma,66,NCT02525692,Oral ONC201 in Adult Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT07091864,Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
PID-016,Glioblastoma,66,NCT03311542,Expanded Access for Pembrolizumab (MK-3475)
PID-016,Glioblastoma,66,NCT00734864,Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT03561207,3D Prediction of Patient-Specific Response
PID-016,Glioblastoma,66,NCT03914768,Immune Modulatory DC Vaccine Against Brain Tumor
PID-016,Glioblastoma,66,NCT00102648,Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
PID-016,Glioblastoma,66,NCT07067905,Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
PID-016,Glioblastoma,66,NCT06617208,Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery
PID-016,Glioblastoma,66,NCT01814813,Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-016,Glioblastoma,66,NCT05062772,Brain Tumor Intraoperative Ultrasound Database
PID-016,Glioblastoma,66,NCT06108206,Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
PID-016,Glioblastoma,66,NCT00041587,Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
PID-016,Glioblastoma,66,NCT00024570,Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT05106296,Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
PID-016,Glioblastoma,66,NCT04267978,Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
PID-016,Glioblastoma,66,NCT00001171,Evaluation of Factors in Human Brain Tumors
PID-016,Glioblastoma,66,NCT05131763,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-016,Glioblastoma,66,NCT00114309,131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT04477200,Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
PID-016,Glioblastoma,66,NCT04270461,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-016,Glioblastoma,66,NCT01454596,CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
PID-016,Glioblastoma,66,NCT06016452,A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma
PID-016,Glioblastoma,66,NCT00379080,Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT00390299,Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT00080054,A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
PID-016,Glioblastoma,66,NCT01122888,Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT06160206,Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT06894979,"Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma"
PID-016,Glioblastoma,66,NCT00734682,A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
PID-016,Glioblastoma,66,NCT05495295,"First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours"
PID-016,Glioblastoma,66,NCT04933942,Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
PID-016,Glioblastoma,66,NCT05629702,ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
PID-016,Glioblastoma,66,NCT06118723,The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
PID-016,Glioblastoma,66,NCT01342757,Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT00009035,Natural History of Patients With Brain and Spinal Cord Tumors
PID-016,Glioblastoma,66,NCT01441388,A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
PID-016,Glioblastoma,66,NCT00575887,Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
PID-016,Glioblastoma,66,NCT04478279,A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
PID-016,Glioblastoma,66,NCT06614855,A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT04074785,Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6
PID-016,Glioblastoma,66,NCT05765812,A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT02348255,NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
PID-016,Glioblastoma,66,NCT00589875,Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
PID-016,Glioblastoma,66,NCT06492486,Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
PID-016,Glioblastoma,66,NCT05686798,Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
PID-016,Glioblastoma,66,NCT04323046,Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
PID-016,Glioblastoma,66,NCT01156584,A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT00062504,Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
PID-016,Glioblastoma,66,NCT06929819,Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
PID-016,Glioblastoma,66,NCT00272870,Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
PID-016,Glioblastoma,66,NCT06810544,Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
PID-016,Glioblastoma,66,NCT06388733,"A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma"
PID-016,Glioblastoma,66,NCT05773326,Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
PID-016,Glioblastoma,66,NCT00433381,Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
PID-016,Glioblastoma,66,NCT03022578,Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
PID-016,Glioblastoma,66,NCT04630379,Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
PID-016,Glioblastoma,66,NCT04218019,Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation
PID-016,Glioblastoma,66,NCT01999270,Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
PID-016,Glioblastoma,66,NCT04489420,Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
PID-016,Glioblastoma,66,NCT04991870,Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
PID-016,Glioblastoma,66,NCT01902771,Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
PID-016,Glioblastoma,66,NCT06038760,Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
PID-016,Glioblastoma,66,NCT00995007,A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
PID-016,Glioblastoma,66,NCT01281982,(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
PID-016,Glioblastoma,66,NCT04049669,Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
PID-016,Glioblastoma,66,NCT01316809,AZD8055 for Adults With Recurrent Gliomas
PID-016,Glioblastoma,66,NCT03593993,A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
PID-016,Glioblastoma,66,NCT01478321,Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
PID-016,Glioblastoma,66,NCT02039778,Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma
PID-016,Glioblastoma,66,NCT02655601,"Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001"
PID-016,Glioblastoma,66,NCT05465954,Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT00329719,Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT01656980,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
PID-016,Glioblastoma,66,NCT01637753,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT02885324,Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
PID-016,Glioblastoma,66,NCT01204684,Dendritic Cell Vaccine for Patients With Brain Tumors
PID-016,Glioblastoma,66,NCT03463265,Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT04314674,Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors Resection
PID-016,Glioblastoma,66,NCT01171469,Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
PID-016,Glioblastoma,66,NCT00973557,The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
PID-016,Glioblastoma,66,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
PID-016,Glioblastoma,66,NCT00179803,Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
PID-016,Glioblastoma,66,NCT04782609,Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT00024557,Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
PID-016,Glioblastoma,66,NCT01836549,Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
PID-016,Glioblastoma,66,NCT01250470,Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
PID-016,Glioblastoma,66,NCT00064779,Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT01648348,Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT06665724,Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
PID-016,Glioblastoma,66,NCT06410248,Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
PID-016,Glioblastoma,66,NCT03717142,Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
PID-016,Glioblastoma,66,NCT06902350,"Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors"
PID-016,Glioblastoma,66,NCT04614493,Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.
PID-016,Glioblastoma,66,NCT05297864,PARP Inhibition for Gliomas (PI-4G or π4g)
PID-016,Glioblastoma,66,NCT05099068,Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)
PID-016,Glioblastoma,66,NCT02722512,Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
PID-016,Glioblastoma,66,NCT01514201,"Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas"
PID-016,Glioblastoma,66,NCT04047264,Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
PID-016,Glioblastoma,66,NCT03971734,Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
PID-016,Glioblastoma,66,NCT01740258,Bevacizumab Beyond Progression (BBP)
PID-016,Glioblastoma,66,NCT03607643,"A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies"
PID-016,Glioblastoma,66,NCT00823797,Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
PID-016,Glioblastoma,66,NCT01861990,Valproic Acid in Childhood Progressive Brain Tumors
PID-016,Glioblastoma,66,NCT06193174,Re-Administration of C134 in Patients with Recurrent GBM (C134-HSV-1)
PID-016,Glioblastoma,66,NCT02168270,Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT00884416,Sorafenib in Newly Diagnosed High Grade Glioma
PID-016,Glioblastoma,66,NCT00004688,"Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms"
PID-016,Glioblastoma,66,NCT00243490,Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
PID-016,Glioblastoma,66,NCT01822275,Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-016,Glioblastoma,66,NCT01380782,BIBF 1120 for Recurrent High-Grade Gliomas
PID-016,Glioblastoma,66,NCT02758366,Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
PID-016,Glioblastoma,66,NCT06860594,"Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma"
PID-016,Glioblastoma,66,NCT01095094,Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT02055196,Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-016,Glioblastoma,66,NCT01144247,Cellular Immunotherapy Study for Brain Cancer
PID-016,Glioblastoma,66,NCT04488783,Potentiation of Chemotherapy in Brain Tumors by Zinc
PID-016,Glioblastoma,66,NCT01189240,RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT04661384,"Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma"
PID-016,Glioblastoma,66,NCT04479696,Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
PID-016,Glioblastoma,66,NCT06989086,FearLess in NeuroOncology
PID-016,Glioblastoma,66,NCT00006773,Bortezomib in Treating Patients With Recurrent Glioma
PID-016,Glioblastoma,66,NCT03956706,Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
PID-016,Glioblastoma,66,NCT06160596,Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
PID-016,Glioblastoma,66,NCT03251027,Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
PID-016,Glioblastoma,66,NCT06796335,Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
PID-016,Glioblastoma,66,NCT04734444,SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
PID-016,Glioblastoma,66,NCT03392545,Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)
PID-016,Glioblastoma,66,NCT05039346,Quality of Life and Patient Needs in Advanced High Grade Gliomas
PID-016,Glioblastoma,66,NCT05139277,Evaluation of the CONVIVO System
PID-016,Glioblastoma,66,NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection
PID-016,Glioblastoma,66,NCT00650923,"Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma"
PID-016,Glioblastoma,66,NCT06333899,Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
PID-016,Glioblastoma,66,NCT01151670,Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
PID-016,Glioblastoma,66,NCT00667394,Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
PID-016,Glioblastoma,66,NCT06975332,"Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression"
PID-016,Glioblastoma,66,NCT03914742,BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
PID-016,Glioblastoma,66,NCT05843253,Study of Ribociclib and Everolimus in HGG and DIPG
PID-016,Glioblastoma,66,NCT05839379,Targeted Pediatric High-Grade Glioma Therapy
PID-016,Glioblastoma,66,NCT01798771,Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
PID-016,Glioblastoma,66,NCT02015819,"Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas"
PID-016,Glioblastoma,66,NCT05873946,Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
PID-016,Glioblastoma,66,NCT04295759,INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
PID-016,Glioblastoma,66,NCT04482933,HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT02031965,Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
PID-016,Glioblastoma,66,NCT05789394,Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
PID-016,Glioblastoma,66,NCT05698524,A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
PID-016,Glioblastoma,66,NCT03718767,Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
PID-016,Glioblastoma,66,NCT03123952,Expanded Access to ABT-414
PID-016,Glioblastoma,66,NCT02861898,Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
PID-016,Glioblastoma,66,NCT01721577,Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
PID-016,Glioblastoma,66,NCT02238496,Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
PID-016,Glioblastoma,66,NCT04982926,A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
PID-016,Glioblastoma,66,NCT04214392,Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
PID-016,Glioblastoma,66,NCT01996527,3T MRI Biomarkers of Glioma Treatment Response
PID-016,Glioblastoma,66,NCT06926075,Early Phase Study of Kesonotide in Participants With Solid Tumours
PID-016,Glioblastoma,66,NCT01378481,High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma
PID-016,Glioblastoma,66,NCT01148966,Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
PID-016,Glioblastoma,66,NCT01975116,p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
PID-016,Glioblastoma,66,NCT00268385,Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
PID-016,Glioblastoma,66,NCT02142803,TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
PID-016,Glioblastoma,66,NCT01383135,Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
PID-016,Glioblastoma,66,NCT04573140,A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
PID-016,Glioblastoma,66,NCT01269411,RO4929097 in Treating Patients With Recurrent Invasive Gliomas
PID-016,Glioblastoma,66,NCT06640582,TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
PID-016,Glioblastoma,66,NCT03389230,Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
PID-016,Glioblastoma,66,NCT07042620,A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
PID-016,Glioblastoma,66,NCT06041555,MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
PID-016,Glioblastoma,66,NCT04740190,Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd
PID-016,Glioblastoma,66,NCT05231655,Ex VIvo DEtermiNed Cancer Therapy
PID-016,Glioblastoma,66,NCT00499473,Sunitinib in Treating Patients With Recurrent Malignant Gliomas
PID-016,Glioblastoma,66,NCT02502708,"Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors"
PID-016,Glioblastoma,66,NCT06896110,Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
PID-016,Glioblastoma,66,NCT01817751,"Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma"
PID-016,Glioblastoma,66,NCT06047379,"Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis"
PID-016,Glioblastoma,66,NCT00095940,Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
PID-016,Glioblastoma,66,NCT03749187,BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
PID-016,Glioblastoma,66,NCT06625047,Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
PID-016,Glioblastoma,66,NCT01291420,Dendritic Cell Vaccination for Patients with Solid Tumors
PID-016,Glioblastoma,66,NCT05737212,"Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas"
PID-016,Glioblastoma,66,NCT03072134,Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
PID-016,Glioblastoma,66,NCT00100802,"Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas"
PID-016,Glioblastoma,66,NCT02208362,Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
PID-016,Glioblastoma,66,NCT01977677,Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
PID-016,Glioblastoma,66,NCT05370079,Control Cohort CTRL COH
PID-016,Glioblastoma,66,NCT00042991,Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
PID-016,Glioblastoma,66,NCT02800486,"Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA"
PID-016,Glioblastoma,66,NCT04978727,"A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma"
PID-016,Glioblastoma,66,NCT04678648,A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
PID-016,Glioblastoma,66,NCT01353625,"Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies."
PID-016,Glioblastoma,66,NCT03152318,A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PID-016,Glioblastoma,66,NCT06815029,Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
PID-016,Glioblastoma,66,NCT01103375,Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT01051557,Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-016,Glioblastoma,66,NCT02974738,"A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)"
PID-016,Glioblastoma,66,NCT03896568,MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT03739372,Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
PID-016,Glioblastoma,66,NCT06439420,CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
PID-016,Glioblastoma,66,NCT01598597,"An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)"
PID-016,Glioblastoma,66,NCT02465528,Ceritinib Rare Indications Study in ALK+ Tumors
PID-016,Glioblastoma,66,NCT04388033,Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
PID-016,Glioblastoma,66,NCT01723020,A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
PID-016,Glioblastoma,66,NCT00879437,"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma"
PID-016,Glioblastoma,66,NCT03973918,Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
PID-016,Glioblastoma,66,NCT03389802,Phase I Study of APX005M in Pediatric Central Nervous System Tumors
PID-016,Glioblastoma,66,NCT01849952,Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
PID-016,Glioblastoma,66,NCT00045708,A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
PID-016,Glioblastoma,66,NCT04135807,Implantable Microdevice In Primary Brain Tumors
PID-016,Glioblastoma,66,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-016,Glioblastoma,66,NCT02798406,Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
PID-016,Glioblastoma,66,NCT05956821,Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
PID-016,Glioblastoma,66,NCT04044937,Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
PID-016,Glioblastoma,66,NCT01082926,"Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2"
PID-016,Glioblastoma,66,NCT03919071,Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
PID-016,Glioblastoma,66,NCT03893487,Fimepinostat in Treating Brain Tumors in Children and Young Adults
PID-016,Glioblastoma,66,NCT03212274,"Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations"
PID-016,Glioblastoma,66,NCT02372409,Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
PID-016,Glioblastoma,66,NCT05330559,"Fluorescence, Light-microscopy, Ultrasound Integrated / Intraoperative Diagnosis to MAXimise Resection"
PID-016,Glioblastoma,66,NCT06690216,Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
PID-016,Glioblastoma,66,NCT02365662,A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
PID-016,Glioblastoma,66,NCT04970615,Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models
PID-016,Glioblastoma,66,NCT00045110,Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
PID-016,Glioblastoma,66,NCT03734913,A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
PID-016,Glioblastoma,66,NCT01234740,Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
PID-016,Glioblastoma,66,NCT02101905,Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT02457845,HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
PID-016,Glioblastoma,66,NCT02444546,Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
PID-016,Glioblastoma,66,NCT02644291,Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
PID-016,Glioblastoma,66,NCT01579253,Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
PID-016,Glioblastoma,66,NCT01884740,Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
PID-016,Glioblastoma,66,NCT01904123,STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain
PID-016,Glioblastoma,66,NCT03684811,A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
PID-016,Glioblastoma,66,NCT01922076,Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
PID-016,Glioblastoma,66,NCT00959946,Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer
PID-016,Glioblastoma,66,NCT03244995,Mind-Body Intervention in Glioma Couples
PID-016,Glioblastoma,66,NCT02498665,A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
PID-016,Glioblastoma,66,NCT03958240,Deciphering Mechanisms Underlying Cancer Immunogenicity
PID-016,Glioblastoma,66,NCT02323880,Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
PID-016,Glioblastoma,66,NCT00369590,VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
PID-016,Glioblastoma,66,NCT00093613,Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-016,Glioblastoma,66,NCT00085540,FR901228 in Treating Patients With Recurrent High-Grade Gliomas
PID-016,Glioblastoma,66,NCT06804655,Pharmacoscopy for Patients with Refractory Primary Brain Tumors
PID-016,Glioblastoma,66,NCT02709889,Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
PID-016,Glioblastoma,66,NCT01421524,"Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma"
PID-016,Glioblastoma,66,NCT01445691,More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
PID-016,Glioblastoma,66,NCT01837862,A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
PID-016,Glioblastoma,66,NCT02038699,A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer
PID-016,Glioblastoma,66,NCT02327078,"A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)"
PID-016,Glioblastoma,66,NCT00112736,Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT06717295,The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
PID-016,Glioblastoma,66,NCT06521567,A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
PID-016,Glioblastoma,66,NCT05538572,A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
PID-016,Glioblastoma,66,NCT05139056,Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
PID-016,Glioblastoma,66,NCT00679354,Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
PID-016,Glioblastoma,66,NCT06469138,A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
PID-016,Glioblastoma,66,NCT02192359,Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-016,Glioblastoma,66,NCT01172964,A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
PID-016,Glioblastoma,66,NCT00430079,Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
PID-016,Glioblastoma,66,NCT03797326,Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
PID-016,Glioblastoma,66,NCT01177397,"Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma"
PID-016,Glioblastoma,66,NCT05835687,Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
PID-016,Glioblastoma,66,NCT04427384,Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
PID-016,Glioblastoma,66,NCT03355794,A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
PID-016,Glioblastoma,66,NCT01339039,Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
PID-016,Glioblastoma,66,NCT04732065,"ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors"
PID-016,Glioblastoma,66,NCT01392209,Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
PID-016,Glioblastoma,66,NCT02186509,Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
PID-016,Glioblastoma,66,NCT06814496,Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
PID-016,Glioblastoma,66,NCT01576666,"Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors"
PID-016,Glioblastoma,66,NCT02966509,Engagement of Patients With Advanced Cancer
PID-016,Glioblastoma,66,NCT03243461,International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
PID-016,Glioblastoma,66,NCT01165632,Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
PID-016,Glioblastoma,66,NCT03043391,Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
PID-016,Glioblastoma,66,NCT02684058,Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
PID-016,Glioblastoma,66,NCT06645808,PET-imaging of Two Vartumabs in Patients With Solid Tumors
PID-016,Glioblastoma,66,NCT02255461,"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors"
PID-016,Glioblastoma,66,NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PID-016,Glioblastoma,66,NCT04541082,Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
PID-016,Glioblastoma,66,NCT02374255,Improving Goals of Care Discussion in Advanced Cancer Patients
PID-016,Glioblastoma,66,NCT02611024,Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
PID-016,Glioblastoma,66,NCT01392352,HYPAZ: Hypertension Induced by Pazopanib
PID-016,Glioblastoma,66,NCT04541225,Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
PID-016,Glioblastoma,66,NCT02223052,Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
PID-016,Glioblastoma,66,NCT02175745,18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
PID-016,Glioblastoma,66,NCT02335918,A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
PID-016,Glioblastoma,66,NCT05934630,"Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors"
PID-016,Glioblastoma,66,NCT01234805,Yoga Therapy in Treating Patients With Malignant Brain Tumors
PID-016,Glioblastoma,66,NCT01929720,"Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors"
PID-016,Glioblastoma,66,NCT03787056,Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
PID-016,Glioblastoma,66,NCT04913337,Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
PID-016,Glioblastoma,66,NCT05563272,89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
PID-016,Glioblastoma,66,NCT01631552,Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
PID-016,Glioblastoma,66,NCT05974410,Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
PID-016,Glioblastoma,66,NCT04604158,Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
PID-016,Glioblastoma,66,NCT02967380,"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases"
PID-016,Glioblastoma,66,NCT03911388,HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
PID-016,Glioblastoma,66,NCT05131815,The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
PID-016,Glioblastoma,66,NCT00110032,Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
PID-016,Glioblastoma,66,NCT03975829,Pediatric Long-Term Follow-up and Rollover Study
PID-016,Glioblastoma,66,NCT01119599,"RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma"
PID-016,Glioblastoma,66,NCT04566393,Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies
PID-016,Glioblastoma,66,NCT02194452,Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
PID-016,Glioblastoma,66,NCT03434262,SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
PID-016,Glioblastoma,66,NCT03896958,The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
PID-016,Glioblastoma,66,NCT01522820,Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
PID-016,Glioblastoma,66,NCT01131234,Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
PID-016,Glioblastoma,66,NCT03452774,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
PID-016,Glioblastoma,66,NCT01806675,18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
PID-016,Glioblastoma,66,NCT05969860,At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
PID-016,Glioblastoma,66,NCT04028479,The Registry of Oncology Outcomes Associated with Testing and Treatment
PID-016,Glioblastoma,66,NCT00030498,Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
PID-016,Glioblastoma,66,NCT03154190,Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
PID-017,Astrocytoma,47,NCT04606316,Surgical Nivolumab And Ipilimumab For Recurrent GBM
PID-017,Astrocytoma,47,NCT01700569,Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
PID-017,Astrocytoma,47,NCT06869577,A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
PID-017,Astrocytoma,47,NCT01833273,Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA
PID-017,Astrocytoma,47,NCT02795364,Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
PID-017,Astrocytoma,47,NCT02858895,Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
PID-017,Astrocytoma,47,NCT01290692,Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
PID-017,Astrocytoma,47,NCT01663012,Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
PID-017,Astrocytoma,47,NCT03538587,Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
PID-017,Astrocytoma,47,NCT05236036,Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
PID-017,Astrocytoma,47,NCT06283927,The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
PID-017,Astrocytoma,47,NCT00154375,Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
PID-017,Astrocytoma,47,NCT05218408,CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
PID-017,Astrocytoma,47,NCT06157541,T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
PID-017,Astrocytoma,47,NCT04047303,"CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma"
PID-017,Astrocytoma,47,NCT02366728,DC Migration Study for Newly-Diagnosed GBM
PID-017,Astrocytoma,47,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-017,Astrocytoma,47,NCT00921167,A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
PID-017,Astrocytoma,47,NCT00841555,Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
PID-017,Astrocytoma,47,NCT00045968,Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
PID-017,Astrocytoma,47,NCT00335075,Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
PID-017,Astrocytoma,47,NCT02062827,Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT04105374,"Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma"
PID-017,Astrocytoma,47,NCT02510950,Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
PID-017,Astrocytoma,47,NCT05879367,Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
PID-017,Astrocytoma,47,NCT02010606,Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
PID-017,Astrocytoma,47,NCT01180816,Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
PID-017,Astrocytoma,47,NCT01269853,Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
PID-017,Astrocytoma,47,NCT01386710,Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
PID-017,Astrocytoma,47,NCT00968240,Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
PID-017,Astrocytoma,47,NCT03722355,Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
PID-017,Astrocytoma,47,NCT02026271,A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
PID-017,Astrocytoma,47,NCT02022384,Immunophenotyping From Blood of Patients With Malignant Gliomas
PID-017,Astrocytoma,47,NCT05624736,Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning
PID-017,Astrocytoma,47,NCT03332355,Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
PID-017,Astrocytoma,47,NCT01351519,A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
PID-017,Astrocytoma,47,NCT04780009,Loupe-Based Intraoperative Fluorescence Imaging
PID-017,Astrocytoma,47,NCT06632236,5G-EMERALD: Amivantamab in Malignant Brain Tumours
PID-017,Astrocytoma,47,NCT06630260,5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
PID-017,Astrocytoma,47,NCT02414165,The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
PID-017,Astrocytoma,47,NCT03603405,HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
PID-017,Astrocytoma,47,NCT00606008,A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-017,Astrocytoma,47,NCT05600491,A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
PID-017,Astrocytoma,47,NCT03596086,HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
PID-017,Astrocytoma,47,NCT00943462,Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
PID-017,Astrocytoma,47,NCT02465268,Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
PID-017,Astrocytoma,47,NCT05375318,"BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels"
PID-017,Astrocytoma,47,NCT05084430,Study of Pembrolizumab and M032 (NSC 733972)
PID-017,Astrocytoma,47,NCT03020602,BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab
PID-017,Astrocytoma,47,NCT00761280,Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
PID-017,Astrocytoma,47,NCT04327011,A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
PID-017,Astrocytoma,47,NCT00409214,Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
PID-017,Astrocytoma,47,NCT06797661,Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.
PID-017,Astrocytoma,47,NCT00001148,Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
PID-017,Astrocytoma,47,NCT00115440,BNCT to Treat Glioma That Has Progressed Following Radiotherapy
PID-017,Astrocytoma,47,NCT05513859,Investigational Imaging Technique During Brain Surgery
PID-017,Astrocytoma,47,NCT02709226,Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-017,Astrocytoma,47,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-017,Astrocytoma,47,NCT03861299,The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
PID-017,Astrocytoma,47,NCT03649464,Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
PID-017,Astrocytoma,47,NCT04757662,Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
PID-017,Astrocytoma,47,NCT02666066,Radiomics for Prediction of Survival in GBM
PID-017,Astrocytoma,47,NCT02490930,A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
PID-017,Astrocytoma,47,NCT06344130,Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-017,Astrocytoma,47,NCT03370926,FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
PID-017,Astrocytoma,47,NCT01502241,Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
PID-017,Astrocytoma,47,NCT00723827,Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
PID-017,Astrocytoma,47,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-017,Astrocytoma,47,NCT00431561,Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
PID-017,Astrocytoma,47,NCT01317888,Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas
PID-017,Astrocytoma,47,NCT00089427,"IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma"
PID-017,Astrocytoma,47,NCT00028158,"Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer"
PID-017,Astrocytoma,47,NCT01044966,A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
PID-017,Astrocytoma,47,NCT01227434,A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
PID-017,Astrocytoma,47,NCT03224104,Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
PID-017,Astrocytoma,47,NCT00645385,Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
PID-017,Astrocytoma,47,NCT01240460,Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection
PID-017,Astrocytoma,47,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-017,Astrocytoma,47,NCT03633552,Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
PID-017,Astrocytoma,47,NCT04608812,Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
PID-017,Astrocytoma,47,NCT05683808,Venous Thromboembolism Prevention in Outpatients With Glioma
PID-017,Astrocytoma,47,NCT01711580,Re-irradiation of High Grade Gliomas: a Quality of Life Study
PID-017,Astrocytoma,47,NCT06273176,The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
PID-017,Astrocytoma,47,NCT07031765,Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma
PID-017,Astrocytoma,47,NCT00591058,Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT02529072,Nivolumab With DC Vaccines for Recurrent Brain Tumors
PID-017,Astrocytoma,47,NCT00612651,PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
PID-017,Astrocytoma,47,NCT01238237,Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA
PID-017,Astrocytoma,47,NCT00751270,Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
PID-017,Astrocytoma,47,NCT00610571,Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
PID-017,Astrocytoma,47,NCT00683761,A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT00473408,The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
PID-017,Astrocytoma,47,NCT01081223,Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
PID-017,Astrocytoma,47,NCT00392171,The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
PID-017,Astrocytoma,47,NCT03027388,"Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma"
PID-017,Astrocytoma,47,NCT06241391,Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
PID-017,Astrocytoma,47,NCT01967758,Phase I Study of Safety and Immunogenicity of ADU-623
PID-017,Astrocytoma,47,NCT05561374,Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma
PID-017,Astrocytoma,47,NCT01117155,A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
PID-017,Astrocytoma,47,NCT01475006,AMG 595 First-in-Human in Recurrent Gliomas
PID-017,Astrocytoma,47,NCT06017063,Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields
PID-017,Astrocytoma,47,NCT03581292,"Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations"
PID-017,Astrocytoma,47,NCT01808820,Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
PID-017,Astrocytoma,47,NCT06623565,Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
PID-017,Astrocytoma,47,NCT02629757,A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas
PID-017,Astrocytoma,47,NCT00624728,Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
PID-017,Astrocytoma,47,NCT00031538,Genetic Analysis of Brain Tumors
PID-017,Astrocytoma,47,NCT04729959,"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma"
PID-017,Astrocytoma,47,NCT00031083,Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
PID-017,Astrocytoma,47,NCT01765088,A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
PID-017,Astrocytoma,47,NCT04145115,A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden
PID-017,Astrocytoma,47,NCT01985256,Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
PID-017,Astrocytoma,47,NCT02540135,Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
PID-017,Astrocytoma,47,NCT04623931,Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
PID-017,Astrocytoma,47,NCT02942264,Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-017,Astrocytoma,47,NCT03657576,Trial of C134 in Patients With Recurrent GBM
PID-017,Astrocytoma,47,NCT01470794,Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
PID-017,Astrocytoma,47,NCT00734864,Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT03561207,3D Prediction of Patient-Specific Response
PID-017,Astrocytoma,47,NCT06108206,Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
PID-017,Astrocytoma,47,NCT00041587,Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
PID-017,Astrocytoma,47,NCT00024570,Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT00114309,131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
PID-017,Astrocytoma,47,NCT04477200,Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
PID-017,Astrocytoma,47,NCT00390299,Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-017,Astrocytoma,47,NCT00080054,A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
PID-017,Astrocytoma,47,NCT06894979,"Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma"
PID-017,Astrocytoma,47,NCT00734682,A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
PID-017,Astrocytoma,47,NCT06118723,The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
PID-017,Astrocytoma,47,NCT00009035,Natural History of Patients With Brain and Spinal Cord Tumors
PID-017,Astrocytoma,47,NCT00575887,Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
PID-017,Astrocytoma,47,NCT06614855,A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT05765812,A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
PID-017,Astrocytoma,47,NCT00589875,Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
PID-017,Astrocytoma,47,NCT05686798,Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
PID-017,Astrocytoma,47,NCT01156584,A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT00062504,Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
PID-017,Astrocytoma,47,NCT00272870,Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
PID-017,Astrocytoma,47,NCT03022578,Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
PID-017,Astrocytoma,47,NCT03900689,Social Determinants of Health in Glioblastoma Population
PID-017,Astrocytoma,47,NCT01999270,Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
PID-017,Astrocytoma,47,NCT04489420,Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
PID-017,Astrocytoma,47,NCT00995007,A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
PID-017,Astrocytoma,47,NCT01281982,(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
PID-017,Astrocytoma,47,NCT01316809,AZD8055 for Adults With Recurrent Gliomas
PID-017,Astrocytoma,47,NCT03593993,A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
PID-017,Astrocytoma,47,NCT01478321,Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
PID-017,Astrocytoma,47,NCT02039778,Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma
PID-017,Astrocytoma,47,NCT02655601,"Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001"
PID-017,Astrocytoma,47,NCT01656980,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
PID-017,Astrocytoma,47,NCT01637753,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT02885324,Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
PID-017,Astrocytoma,47,NCT01204684,Dendritic Cell Vaccine for Patients With Brain Tumors
PID-017,Astrocytoma,47,NCT01171469,Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
PID-017,Astrocytoma,47,NCT00179803,Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
PID-017,Astrocytoma,47,NCT04782609,Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT00024557,Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
PID-017,Astrocytoma,47,NCT01836549,Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
PID-017,Astrocytoma,47,NCT01250470,Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
PID-017,Astrocytoma,47,NCT00064779,Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT01648348,Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-017,Astrocytoma,47,NCT06665724,Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
PID-017,Astrocytoma,47,NCT05297864,PARP Inhibition for Gliomas (PI-4G or π4g)
PID-017,Astrocytoma,47,NCT02722512,Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
PID-017,Astrocytoma,47,NCT01514201,"Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas"
PID-017,Astrocytoma,47,NCT03971734,Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
PID-017,Astrocytoma,47,NCT00823797,Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
PID-017,Astrocytoma,47,NCT01861990,Valproic Acid in Childhood Progressive Brain Tumors
PID-017,Astrocytoma,47,NCT06193174,Re-Administration of C134 in Patients with Recurrent GBM (C134-HSV-1)
PID-017,Astrocytoma,47,NCT02168270,Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
PID-017,Astrocytoma,47,NCT00884416,Sorafenib in Newly Diagnosed High Grade Glioma
PID-017,Astrocytoma,47,NCT00004688,"Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms"
PID-017,Astrocytoma,47,NCT00243490,Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
PID-017,Astrocytoma,47,NCT01380782,BIBF 1120 for Recurrent High-Grade Gliomas
PID-017,Astrocytoma,47,NCT02758366,Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
PID-017,Astrocytoma,47,NCT06860594,"Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma"
PID-017,Astrocytoma,47,NCT01095094,Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
PID-017,Astrocytoma,47,NCT02055196,Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-017,Astrocytoma,47,NCT01144247,Cellular Immunotherapy Study for Brain Cancer
PID-017,Astrocytoma,47,NCT01189240,RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT06989086,FearLess in NeuroOncology
PID-017,Astrocytoma,47,NCT00006773,Bortezomib in Treating Patients With Recurrent Glioma
PID-017,Astrocytoma,47,NCT03956706,Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
PID-017,Astrocytoma,47,NCT05039346,Quality of Life and Patient Needs in Advanced High Grade Gliomas
PID-017,Astrocytoma,47,NCT00650923,"Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma"
PID-017,Astrocytoma,47,NCT06333899,Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
PID-017,Astrocytoma,47,NCT01151670,Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
PID-017,Astrocytoma,47,NCT00667394,Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
PID-017,Astrocytoma,47,NCT06975332,"Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression"
PID-017,Astrocytoma,47,NCT05843253,Study of Ribociclib and Everolimus in HGG and DIPG
PID-017,Astrocytoma,47,NCT05839379,Targeted Pediatric High-Grade Glioma Therapy
PID-017,Astrocytoma,47,NCT02015819,"Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas"
PID-017,Astrocytoma,47,NCT04295759,INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
PID-017,Astrocytoma,47,NCT04482933,HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
PID-017,Astrocytoma,47,NCT02031965,Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
PID-017,Astrocytoma,47,NCT05789394,Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
PID-017,Astrocytoma,47,NCT05698524,A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
PID-017,Astrocytoma,47,NCT01721577,Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
PID-017,Astrocytoma,47,NCT02238496,Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
PID-017,Astrocytoma,47,NCT01996527,3T MRI Biomarkers of Glioma Treatment Response
PID-017,Astrocytoma,47,NCT01378481,High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma
PID-017,Astrocytoma,47,NCT01148966,Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
PID-017,Astrocytoma,47,NCT01975116,p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
PID-017,Astrocytoma,47,NCT00268385,Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
PID-017,Astrocytoma,47,NCT04091503,Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma
PID-017,Astrocytoma,47,NCT00499473,Sunitinib in Treating Patients With Recurrent Malignant Gliomas
PID-017,Astrocytoma,47,NCT06896110,Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
PID-017,Astrocytoma,47,NCT06047379,"Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis"
PID-017,Astrocytoma,47,NCT00095940,Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
PID-017,Astrocytoma,47,NCT05229198,ALBATROSS Study: International Multicenter Study for Prospective Validation of Imaging Biomarkers Calculated at Vascular Habitats of High-grade Gliomas
PID-017,Astrocytoma,47,NCT06625047,Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
PID-017,Astrocytoma,47,NCT05737212,"Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas"
PID-017,Astrocytoma,47,NCT03072134,Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
PID-017,Astrocytoma,47,NCT00100802,"Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas"
PID-017,Astrocytoma,47,NCT06264388,DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
PID-017,Astrocytoma,47,NCT00042991,Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
PID-017,Astrocytoma,47,NCT02800486,"Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA"
PID-017,Astrocytoma,47,NCT04978727,"A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma"
PID-017,Astrocytoma,47,NCT03152318,A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PID-017,Astrocytoma,47,NCT06815029,Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
PID-017,Astrocytoma,47,NCT01103375,Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT01051557,Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-017,Astrocytoma,47,NCT03896568,MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
PID-017,Astrocytoma,47,NCT03739372,Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
PID-017,Astrocytoma,47,NCT06439420,CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
PID-017,Astrocytoma,47,NCT00879437,"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma"
PID-017,Astrocytoma,47,NCT03973918,Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
PID-017,Astrocytoma,47,NCT03389802,Phase I Study of APX005M in Pediatric Central Nervous System Tumors
PID-017,Astrocytoma,47,NCT01849952,Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
PID-017,Astrocytoma,47,NCT00045708,A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
PID-017,Astrocytoma,47,NCT04135807,Implantable Microdevice In Primary Brain Tumors
PID-017,Astrocytoma,47,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-017,Astrocytoma,47,NCT05956821,Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
PID-017,Astrocytoma,47,NCT01082926,"Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2"
PID-017,Astrocytoma,47,NCT03919071,Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
PID-017,Astrocytoma,47,NCT03893487,Fimepinostat in Treating Brain Tumors in Children and Young Adults
PID-017,Astrocytoma,47,NCT02372409,Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
PID-017,Astrocytoma,47,NCT04970615,Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models
PID-017,Astrocytoma,47,NCT00045110,Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
PID-017,Astrocytoma,47,NCT01234740,Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
PID-017,Astrocytoma,47,NCT02101905,Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
PID-017,Astrocytoma,47,NCT02457845,HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
PID-017,Astrocytoma,47,NCT02444546,Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
PID-017,Astrocytoma,47,NCT02644291,Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
PID-017,Astrocytoma,47,NCT01579253,Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
PID-017,Astrocytoma,47,NCT01884740,Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
PID-017,Astrocytoma,47,NCT01922076,Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
PID-017,Astrocytoma,47,NCT00369590,VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
PID-017,Astrocytoma,47,NCT00093613,Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-017,Astrocytoma,47,NCT00085540,FR901228 in Treating Patients With Recurrent High-Grade Gliomas
PID-017,Astrocytoma,47,NCT01837862,A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
PID-017,Astrocytoma,47,NCT06161974,Study of Olutasidenib and Temozolomide in HGG
PID-017,Astrocytoma,47,NCT00112736,Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT05139056,Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
PID-017,Astrocytoma,47,NCT00070525,"Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma"
PID-017,Astrocytoma,47,NCT00679354,Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
PID-017,Astrocytoma,47,NCT02192359,Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-017,Astrocytoma,47,NCT01172964,A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
PID-017,Astrocytoma,47,NCT00430079,Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
PID-017,Astrocytoma,47,NCT05303519,Safusidenib Phase 2 Study in IDH1 Mutant Glioma
PID-017,Astrocytoma,47,NCT03355794,A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
PID-017,Astrocytoma,47,NCT01339039,Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
PID-017,Astrocytoma,47,NCT01392209,Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
PID-017,Astrocytoma,47,NCT02186509,Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
PID-017,Astrocytoma,47,NCT03243461,International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
PID-017,Astrocytoma,47,NCT01165632,Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
PID-017,Astrocytoma,47,NCT03043391,Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
PID-017,Astrocytoma,47,NCT02684058,Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
PID-017,Astrocytoma,47,NCT02255461,"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors"
PID-017,Astrocytoma,47,NCT04541082,Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
PID-017,Astrocytoma,47,NCT02175745,18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
PID-017,Astrocytoma,47,NCT05934630,"Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors"
PID-017,Astrocytoma,47,NCT01234805,Yoga Therapy in Treating Patients With Malignant Brain Tumors
PID-017,Astrocytoma,47,NCT02967380,"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases"
PID-017,Astrocytoma,47,NCT03911388,HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
PID-017,Astrocytoma,47,NCT00110032,Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
PID-017,Astrocytoma,47,NCT03975829,Pediatric Long-Term Follow-up and Rollover Study
PID-017,Astrocytoma,47,NCT01119599,"RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma"
PID-017,Astrocytoma,47,NCT02194452,Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
PID-017,Astrocytoma,47,NCT00100880,"Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors"
PID-017,Astrocytoma,47,NCT00063973,Cilengitide in Treating Children With Refractory Primary Brain Tumors
PID-017,Astrocytoma,47,NCT00052780,Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
PID-017,Astrocytoma,47,NCT00946335,ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
PID-017,Astrocytoma,47,NCT00363272,Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
PID-017,Astrocytoma,47,NCT00091182,Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
PID-017,Astrocytoma,47,NCT00053963,FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
PID-017,Astrocytoma,47,NCT03434262,SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
PID-017,Astrocytoma,47,NCT04430842,"Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S"
PID-017,Astrocytoma,47,NCT01076530,Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
PID-017,Astrocytoma,47,NCT01522820,Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
PID-017,Astrocytoma,47,NCT01131234,Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
PID-017,Astrocytoma,47,NCT04028479,The Registry of Oncology Outcomes Associated with Testing and Treatment
PID-017,Astrocytoma,47,NCT00030498,Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
PID-018,Glioblastoma,74,NCT01102595,Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
PID-018,Glioblastoma,74,NCT03903419,Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
PID-018,Glioblastoma,74,NCT06650605,Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma
PID-018,Glioblastoma,74,NCT05399524,Functional and Ultrasound Guided Resection of Glioblastoma
PID-018,Glioblastoma,74,NCT03990285,[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
PID-018,Glioblastoma,74,NCT00936052,Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01252459,Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03879512,"Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG"
PID-018,Glioblastoma,74,NCT04606316,Surgical Nivolumab And Ipilimumab For Recurrent GBM
PID-018,Glioblastoma,74,NCT01700569,Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
PID-018,Glioblastoma,74,NCT06348693,Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
PID-018,Glioblastoma,74,NCT06869577,A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
PID-018,Glioblastoma,74,NCT05086497,WBSI Guided Personalized Delivery of TTFields
PID-018,Glioblastoma,74,NCT01833273,Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA
PID-018,Glioblastoma,74,NCT05896449,Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
PID-018,Glioblastoma,74,NCT03291314,Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03363659,Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02795364,Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
PID-018,Glioblastoma,74,NCT02772094,Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
PID-018,Glioblastoma,74,NCT04874506,MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT05958485,A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
PID-018,Glioblastoma,74,NCT06939400,Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
PID-018,Glioblastoma,74,NCT02945826,uPAR-PET/MRI in Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04869449,Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
PID-018,Glioblastoma,74,NCT04588454,18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT06271421,NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT06595186,JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT05423210,Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05120284,Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT05589961,Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT06404034,Expanded Access to Gallium Maltolate (GaM)
PID-018,Glioblastoma,74,NCT06466031,Application of MET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05281731,Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
PID-018,Glioblastoma,74,NCT03861598,Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
PID-018,Glioblastoma,74,NCT06451042,FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)
PID-018,Glioblastoma,74,NCT05908669,Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05500612,MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
PID-018,Glioblastoma,74,NCT00337883,A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
PID-018,Glioblastoma,74,NCT04277221,ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT01181193,Vitamin D for Treatment of Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04825275,Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: a Phase 0 Clinical Trial
PID-018,Glioblastoma,74,NCT04752813,A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
PID-018,Glioblastoma,74,NCT05353530,IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
PID-018,Glioblastoma,74,NCT05608395,11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
PID-018,Glioblastoma,74,NCT03075514,Ketogenic Diets as an Adjuvant Therapy in Glioblastoma
PID-018,Glioblastoma,74,NCT06781372,Patient's Derived Organoids for Drug Screening in Glioblastoma
PID-018,Glioblastoma,74,NCT01280552,A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT06533163,Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
PID-018,Glioblastoma,74,NCT04900792,A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
PID-018,Glioblastoma,74,NCT02864368,Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
PID-018,Glioblastoma,74,NCT01268566,A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01301430,Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
PID-018,Glioblastoma,74,NCT01865162,Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
PID-018,Glioblastoma,74,NCT01873469,Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03506139,Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02769806,Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
PID-018,Glioblastoma,74,NCT00730262,Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03344250,Phase I EGFR BATs in Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01317212,Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00190424,Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
PID-018,Glioblastoma,74,NCT03980249,Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
PID-018,Glioblastoma,74,NCT04587830,ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03707457,Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
PID-018,Glioblastoma,74,NCT01269424,BG & TMZ Therapy of Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00990496,A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT00515086,Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT03310372,Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02285959,Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04450160,Trial of AEO in New Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT03291990,5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02997423,Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT02177578,Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00209989,Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05565326,Response Assessment During MR-guided Radiation Therapy for Glioblastoma
PID-018,Glioblastoma,74,NCT05769660,A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT00323115,Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02858895,Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT02853565,A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00768911,CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02344355,A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01349660,Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00376103,Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02619864,mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02283944,TMS Electrochemotherapy for Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05402241,IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study
PID-018,Glioblastoma,74,NCT02586857,"A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)"
PID-018,Glioblastoma,74,NCT02685605,Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00544817,Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00535379,"SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT00892931,Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02296580,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT00677716,Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
PID-018,Glioblastoma,74,NCT00394628,AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00224978,Chloroquine for Treatment of Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02120287,Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01006044,Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection
PID-018,Glioblastoma,74,NCT01209442,Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02507102,A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
PID-018,Glioblastoma,74,NCT01800695,Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00615186,Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy
PID-018,Glioblastoma,74,NCT07120620,PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01564914,A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT05917821,New Antigens Against Glioblastoma
PID-018,Glioblastoma,74,NCT01435395,"Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT00817284,Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT00800917,A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00083512,Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03714334,DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01285414,"Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT02844062,Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02331498,Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03347097,Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04019002,Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT00635557,Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02937844,Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04610229,Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.
PID-018,Glioblastoma,74,NCT06687681,Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
PID-018,Glioblastoma,74,NCT01752491,A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04421378,A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02550249,Neoadjuvant Nivolumab in Glioblastoma
PID-018,Glioblastoma,74,NCT05557292,RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02017249,Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01788280,Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab
PID-018,Glioblastoma,74,NCT01588769,A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients
PID-018,Glioblastoma,74,NCT01290692,Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
PID-018,Glioblastoma,74,NCT05798507,Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT02296476,A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)
PID-018,Glioblastoma,74,NCT00650949,Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
PID-018,Glioblastoma,74,NCT06346821,Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data
PID-018,Glioblastoma,74,NCT00311857,"Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)"
PID-018,Glioblastoma,74,NCT05410301,"Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma"
PID-018,Glioblastoma,74,NCT00704288,Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00083447,Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00589095,Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
PID-018,Glioblastoma,74,NCT01508117,Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
PID-018,Glioblastoma,74,NCT00792012,A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00267592,Safety and Efficacy of Talampanel in Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00590681,Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01115491,A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04801147,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00050986,Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04845919,Sonodynamic Therapy with ExAblate System in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT07052877,The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
PID-018,Glioblastoma,74,NCT07162324,"A Multicenter, Prospective Study for Glioblastoma Patients"
PID-018,Glioblastoma,74,NCT02189109,The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma
PID-018,Glioblastoma,74,NCT01663012,Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
PID-018,Glioblastoma,74,NCT05463848,Surgical Pembro +/- Olaparib w TMZ for rGBM
PID-018,Glioblastoma,74,NCT05551013,Treatment of Recurrent GBM With APG-157 Via Expanded Access
PID-018,Glioblastoma,74,NCT01604590,Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01071837,APG101 in Glioblastoma
PID-018,Glioblastoma,74,NCT06657027,Artificial Intelligence-Guided Radiotherapy Planning for Glioblastoma
PID-018,Glioblastoma,74,NCT04590664,Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
PID-018,Glioblastoma,74,NCT07119294,Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
PID-018,Glioblastoma,74,NCT06090903,Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
PID-018,Glioblastoma,74,NCT04790097,FET-PET Directed Simultaneous In-field Boost for Primary GBM
PID-018,Glioblastoma,74,NCT05190315,Chlorpromazine and Standard of Care in Glioblastoma
PID-018,Glioblastoma,74,NCT04530006,Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT06353360,TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
PID-018,Glioblastoma,74,NCT00038493,Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT07093814,A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT05970757,Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
PID-018,Glioblastoma,74,NCT07121842,Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI
PID-018,Glioblastoma,74,NCT04002804,Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03866109,A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMT
PID-018,Glioblastoma,74,NCT06176066,PH Sensitive MRI Based Resections of Glioblastoma
PID-018,Glioblastoma,74,NCT02104882,INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
PID-018,Glioblastoma,74,NCT03582514,PreOperative Brain Irradiation in Glioblastoma
PID-018,Glioblastoma,74,NCT06001281,Predictive Value of Soluble CD146 in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT02029573,Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
PID-018,Glioblastoma,74,NCT01091792,Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT01450449,Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05728125,Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients
PID-018,Glioblastoma,74,NCT00984438,Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05222802,A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
PID-018,Glioblastoma,74,NCT05432375,Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
PID-018,Glioblastoma,74,NCT00797940,Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
PID-018,Glioblastoma,74,NCT01526837,Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
PID-018,Glioblastoma,74,NCT04810182,Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
PID-018,Glioblastoma,74,NCT04614909,Study of Pamiparib in Newly Diagnosed and rGBM
PID-018,Glioblastoma,74,NCT04373785,NG101m Adjuvant Therapy in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT01587144,Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
PID-018,Glioblastoma,74,NCT00076986,The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT06764537,Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma
PID-018,Glioblastoma,74,NCT01260506,Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT06749925,Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma
PID-018,Glioblastoma,74,NCT04765098,Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
PID-018,Glioblastoma,74,NCT04118036,Abemaciclib + Pembrolizumab In Glioblastoma
PID-018,Glioblastoma,74,NCT04814329,Glioblastoma Response Prediction to Apatinib
PID-018,Glioblastoma,74,NCT02047214,Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
PID-018,Glioblastoma,74,NCT03849105,131I-IPA and Concurrent XRT in Recurrent GBM
PID-018,Glioblastoma,74,NCT00116376,Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT02410577,89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03212235,Hypofractionated Radiation Therapy for Glioblastoma
PID-018,Glioblastoma,74,NCT07173829,A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
PID-018,Glioblastoma,74,NCT06336291,A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
PID-018,Glioblastoma,74,NCT05512195,Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma
PID-018,Glioblastoma,74,NCT04406272,VB-111 in Surgically Accessible Recurrent/Progressive GBM
PID-018,Glioblastoma,74,NCT05653635,Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
PID-018,Glioblastoma,74,NCT00093964,Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
PID-018,Glioblastoma,74,NCT01402063,PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
PID-018,Glioblastoma,74,NCT06061809,N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT06038604,Glioblastoma Psychosocial Support Program
PID-018,Glioblastoma,74,NCT04492163,Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
PID-018,Glioblastoma,74,NCT02378532,The Addition of Chloroquine to Chemoradiation for Glioblastoma
PID-018,Glioblastoma,74,NCT05708352,A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
PID-018,Glioblastoma,74,NCT01618747,An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse
PID-018,Glioblastoma,74,NCT07141732,Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy
PID-018,Glioblastoma,74,NCT06672575,A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02926222,Regorafenib in Relapsed Glioblastoma
PID-018,Glioblastoma,74,NCT06132438,Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
PID-018,Glioblastoma,74,NCT02751138,Determination of Immune Phenotype in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT00238797,"A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT02928575,"Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma"
PID-018,Glioblastoma,74,NCT05927610,Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
PID-018,Glioblastoma,74,NCT05366179,Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
PID-018,Glioblastoma,74,NCT05641220,Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.
PID-018,Glioblastoma,74,NCT05083754,Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
PID-018,Glioblastoma,74,NCT04977375,Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01933815,Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
PID-018,Glioblastoma,74,NCT04116411,A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT05700955,Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06490497,Expectations and Needs of a Glioblastoma Caregiver
PID-018,Glioblastoma,74,NCT04747145,Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma
PID-018,Glioblastoma,74,NCT06222138,Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00345163,A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
PID-018,Glioblastoma,74,NCT05635734,Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00916409,Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT01778530,TRC105 for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06625684,Key Longitudinal Associations With Risk and Glioblastoma Outcomes
PID-018,Glioblastoma,74,NCT07145112,Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00904852,Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT06512311,Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
PID-018,Glioblastoma,74,NCT05756985,Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
PID-018,Glioblastoma,74,NCT04552977,A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06613841,"Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma"
PID-018,Glioblastoma,74,NCT04772846,Chloroquine for Glioblastoma.
PID-018,Glioblastoma,74,NCT00684567,Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
PID-018,Glioblastoma,74,NCT01259869,A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression
PID-018,Glioblastoma,74,NCT03276286,Nativis Voyager for Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT02176720,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-018,Glioblastoma,74,NCT05781321,"Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study"
PID-018,Glioblastoma,74,NCT06845020,CSF Proteomic Characterization of Glioblastomas
PID-018,Glioblastoma,74,NCT02049489,A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02067156,"Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma"
PID-018,Glioblastoma,74,NCT03712293,ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
PID-018,Glioblastoma,74,NCT01849146,"Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma"
PID-018,Glioblastoma,74,NCT01089868,Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
PID-018,Glioblastoma,74,NCT05986851,Azeliragon in MGMT Unmethylated Glioblastoma
PID-018,Glioblastoma,74,NCT04657146,Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT05669820,Antisecretory Factor Glioblastoma Phase 2
PID-018,Glioblastoma,74,NCT04417933,Tumor Electric Fields Treatment System for Glioblastoma
PID-018,Glioblastoma,74,NCT06780592,Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
PID-018,Glioblastoma,74,NCT03048240,INtraoperative photoDYnamic Therapy of GliOblastoma
PID-018,Glioblastoma,74,NCT05015543,Physical Training in Glioblastoma Patients During Cytotoxic Therapy
PID-018,Glioblastoma,74,NCT05109728,A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
PID-018,Glioblastoma,74,NCT06218524,The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM
PID-018,Glioblastoma,74,NCT04671459,TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine
PID-018,Glioblastoma,74,NCT05556382,Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity
PID-018,Glioblastoma,74,NCT06448286,PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT05186064,Glioblastoma Targeted Treatment Option Maximization by WGS
PID-018,Glioblastoma,74,NCT06556563,EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT05515133,Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients
PID-018,Glioblastoma,74,NCT04319276,Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
PID-018,Glioblastoma,74,NCT02977780,INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
PID-018,Glioblastoma,74,NCT06831526,Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00805961,"RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM"
PID-018,Glioblastoma,74,NCT04656535,AB154 Combined With AB122 for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04391062,Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma
PID-018,Glioblastoma,74,NCT01290263,Amgen 386 for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04752280,Glioblastoma Radiotherapy Using IMRT or Proton Beams
PID-018,Glioblastoma,74,NCT06183983,Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
PID-018,Glioblastoma,74,NCT01851733,MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01493219,Biomarkers for Prognosis of Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT06524063,Targeted Survivin DC Cell Injection for the Treatment of GBM
PID-018,Glioblastoma,74,NCT03862430,A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT02815410,Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
PID-018,Glioblastoma,74,NCT05735171,Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence
PID-018,Glioblastoma,74,NCT03661723,Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06113705,Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
PID-018,Glioblastoma,74,NCT01468324,AZD7451 for Recurrent Gliomas
PID-018,Glioblastoma,74,NCT03419403,UNITE Study: Understanding New Interventions With GBM ThErapy
PID-018,Glioblastoma,74,NCT05938387,Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
PID-018,Glioblastoma,74,NCT03403803,Prognosis and Therapeutic Biomarkers for Glioblastoma Patients
PID-018,Glioblastoma,74,NCT00892177,Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05539339,Personalized Trial in ctDNA-level-relapse Glioblastoma
PID-018,Glioblastoma,74,NCT04856852,Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT07144735,Allogeneic γδT Cells in Glioblastoma
PID-018,Glioblastoma,74,NCT00402116,Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
PID-018,Glioblastoma,74,NCT05664464,Glutamate Inhibitors in Glioblastoma
PID-018,Glioblastoma,74,NCT03687099,Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma
PID-018,Glioblastoma,74,NCT04443010,Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT04243005,Supramarginal Resection in Glioblastoma
PID-018,Glioblastoma,74,NCT00456612,Radiosurgery for Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05656300,Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?
PID-018,Glioblastoma,74,NCT04730869,Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
PID-018,Glioblastoma,74,NCT05439278,Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma
PID-018,Glioblastoma,74,NCT04959500,Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT05768087,Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients
PID-018,Glioblastoma,74,NCT06600399,Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma
PID-018,Glioblastoma,74,NCT04583020,Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT05303467,A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
PID-018,Glioblastoma,74,NCT04359745,Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression
PID-018,Glioblastoma,74,NCT05541042,Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
PID-018,Glioblastoma,74,NCT04599647,EAP for the Treatment of Glioblastoma With PVSRIPO
PID-018,Glioblastoma,74,NCT06297512,Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
PID-018,Glioblastoma,74,NCT06140875,Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
PID-018,Glioblastoma,74,NCT00704808,Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
PID-018,Glioblastoma,74,NCT00508456,Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
PID-018,Glioblastoma,74,NCT03139916,Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03466450,Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01345370,Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT05074992,A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02546102,"Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma"
PID-018,Glioblastoma,74,NCT05871021,Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
PID-018,Glioblastoma,74,NCT02850744,"Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients"
PID-018,Glioblastoma,74,NCT03194971,NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
PID-018,Glioblastoma,74,NCT03151772,Bioavailability of Disulfiram and Metformin in Glioblastomas
PID-018,Glioblastoma,74,NCT05753007,"A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients"
PID-018,Glioblastoma,74,NCT02709616,Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
PID-018,Glioblastoma,74,NCT07047066,A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02808364,Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)
PID-018,Glioblastoma,74,NCT04536649,Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.
PID-018,Glioblastoma,74,NCT05140902,Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
PID-018,Glioblastoma,74,NCT02286167,Glioma Modified Atkins-based Diet in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT00171938,Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
PID-018,Glioblastoma,74,NCT02715609,Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT05241392,Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00115453,Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
PID-018,Glioblastoma,74,NCT01907165,Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide
PID-018,Glioblastoma,74,NCT02092038,Preoperative Chemoradiation for Glioblastoma
PID-018,Glioblastoma,74,NCT02780024,"Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM"
PID-018,Glioblastoma,74,NCT06146738,The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
PID-018,Glioblastoma,74,NCT04863950,Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06924099,TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
PID-018,Glioblastoma,74,NCT02880410,Feasibility Study on LITT for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02394626,Surgery for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06551909,Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
PID-018,Glioblastoma,74,NCT05183204,"Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma"
PID-018,Glioblastoma,74,NCT04716699,Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma
PID-018,Glioblastoma,74,NCT03390569,Exercise in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT04596930,MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma
PID-018,Glioblastoma,74,NCT05811793,Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
PID-018,Glioblastoma,74,NCT04250922,LAM561 With RT and TMZ for Adults With Glioblastoma
PID-018,Glioblastoma,74,NCT01109095,CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
PID-018,Glioblastoma,74,NCT04221061,18F-FluorThanatrace (PET/CT) in Glioblastoma
PID-018,Glioblastoma,74,NCT04922723,Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
PID-018,Glioblastoma,74,NCT06102525,"A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma"
PID-018,Glioblastoma,74,NCT03780569,TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT03055208,Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03119064,BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01666600,NOA-12: BIBF1120 and R-RT in Glioblastoma
PID-018,Glioblastoma,74,NCT04280848,Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
PID-018,Glioblastoma,74,NCT03395587,Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03293888,Spectral Analysis Probe to Identify Glioblastoma Cells
PID-018,Glioblastoma,74,NCT03529448,TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT04829097,Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma
PID-018,Glioblastoma,74,NCT04765514,Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients
PID-018,Glioblastoma,74,NCT05793021,FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
PID-018,Glioblastoma,74,NCT01562197,A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04708171,The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
PID-018,Glioblastoma,74,NCT00104091,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-018,Glioblastoma,74,NCT04691960,A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
PID-018,Glioblastoma,74,NCT01474239,A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04516733,Precoce Medical Care by the Mobil Support for Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT04826393,ASP8374 + Cemiplimab in Recurrent Glioma
PID-018,Glioblastoma,74,NCT03739333,Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.
PID-018,Glioblastoma,74,NCT05502991,Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma
PID-018,Glioblastoma,74,NCT02157103,A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT04284306,Immunohistochemical Assessment of Programmed Death ligand1 and LC3B in GBM
PID-018,Glioblastoma,74,NCT04157478,Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01478854,Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
PID-018,Glioblastoma,74,NCT03243851,Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
PID-018,Glioblastoma,74,NCT04629209,"A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma"
PID-018,Glioblastoma,74,NCT03743662,Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
PID-018,Glioblastoma,74,NCT02206230,Trial of Hypofractionated Radiation Therapy for Glioblastoma
PID-018,Glioblastoma,74,NCT00686725,Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
PID-018,Glioblastoma,74,NCT04881032,AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT06105619,A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
PID-018,Glioblastoma,74,NCT00262730,Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT02379572,Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
PID-018,Glioblastoma,74,NCT05304663,Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression
PID-018,Glioblastoma,74,NCT02663440,Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01777919,Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
PID-018,Glioblastoma,74,NCT02062372,Spatial Analysis and Validation of Glioblastoma on 7 T MRI
PID-018,Glioblastoma,74,NCT04219475,Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients
PID-018,Glioblastoma,74,NCT05698199,"Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)"
PID-018,Glioblastoma,74,NCT01898273,Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02202993,TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM
PID-018,Glioblastoma,74,NCT01622764,89Zr-RO5323441 PET Imaging in Glioblastoma
PID-018,Glioblastoma,74,NCT04963413,RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.
PID-018,Glioblastoma,74,NCT03491683,INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT02841332,Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00068952,Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01169415,Effects of Steroid Tapering on Functional Capacity and Neurocognition
PID-018,Glioblastoma,74,NCT05333588,The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.
PID-018,Glioblastoma,74,NCT04225039,"Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma"
PID-018,Glioblastoma,74,NCT04552886,Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma
PID-018,Glioblastoma,74,NCT02394665,Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
PID-018,Glioblastoma,74,NCT03995706,Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
PID-018,Glioblastoma,74,NCT03663725,Treatment Intensification With Temozolomide in Adults With a Glioblastoma
PID-018,Glioblastoma,74,NCT04642937,Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04195139,Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
PID-018,Glioblastoma,74,NCT03493932,Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
PID-018,Glioblastoma,74,NCT02617745,Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
PID-018,Glioblastoma,74,NCT02715297,Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04471844,"Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM"
PID-018,Glioblastoma,74,NCT05187624,"A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma"
PID-018,Glioblastoma,74,NCT04933422,CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
PID-018,Glioblastoma,74,NCT03374943,A Trial of KB004 in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT01225510,A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06477939,Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients
PID-018,Glioblastoma,74,NCT04119674,Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03231501,HMPL-813 in Treating Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT04574856,Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03770468,"Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma"
PID-018,Glioblastoma,74,NCT04547855,Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen
PID-018,Glioblastoma,74,NCT02146066,Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
PID-018,Glioblastoma,74,NCT02336165,Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT07076472,Sonodynamic Therapy With SONALA-001 and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02441322,Evaluating Therapeutic Response to Novo-TTF
PID-018,Glioblastoma,74,NCT04324840,A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01403285,Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT06740955,Hypofractionated Radiotherapy
PID-018,Glioblastoma,74,NCT04019262,Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT04015700,"Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-018,Glioblastoma,74,NCT01473901,A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT06676891,Expanded Access Program for GBM Subjects
PID-018,Glioblastoma,74,NCT03587038,OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02725684,Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
PID-018,Glioblastoma,74,NCT04846257,Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence
PID-018,Glioblastoma,74,NCT03246113,Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
PID-018,Glioblastoma,74,NCT01308632,Metronomic Temozolamide in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01308684,A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01782976,Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT01846871,Tivozanib for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02893137,Enhancing Optune Therapy With Targeted Craniectomy
PID-018,Glioblastoma,74,NCT03926507,F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
PID-018,Glioblastoma,74,NCT04573192,A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
PID-018,Glioblastoma,74,NCT06936046,Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression
PID-018,Glioblastoma,74,NCT02904525,Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model
PID-018,Glioblastoma,74,NCT03567135,Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma
PID-018,Glioblastoma,74,NCT03297125,Assessment of Optune Therapy for Patients with Newly Diagnosed Glioblastoma Using Advanced MRI
PID-018,Glioblastoma,74,NCT02910804,IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT01189513,SCH-900105 in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04485949,A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT00397072,Epothilone in Recurrent Glioblastoma Patients
PID-018,Glioblastoma,74,NCT00821080,Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02511405,"A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)"
PID-018,Glioblastoma,74,NCT02981940,A Study of Abemaciclib in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02630030,Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT03347617,Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT06054529,Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
PID-018,Glioblastoma,74,NCT04121455,Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
PID-018,Glioblastoma,74,NCT02254954,"Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma"
PID-018,Glioblastoma,74,NCT04047706,"Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma"
PID-018,Glioblastoma,74,NCT06973096,CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PID-018,Glioblastoma,74,NCT03388372,Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma
PID-018,Glioblastoma,74,NCT02149225,GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
PID-018,Glioblastoma,74,NCT02478164,Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
PID-018,Glioblastoma,74,NCT03679754,"Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102"
PID-018,Glioblastoma,74,NCT04006119,Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT03687034,A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT03477110,"Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma"
PID-018,Glioblastoma,74,NCT03922984,Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma
PID-018,Glioblastoma,74,NCT04762069,A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05864976,Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
PID-018,Glioblastoma,74,NCT01756352,FET-PET for Evaluation of Response of Recurrent GBM to Avastin
PID-018,Glioblastoma,74,NCT01112527,PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03548571,Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
PID-018,Glioblastoma,74,NCT01939574,A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
PID-018,Glioblastoma,74,NCT03897491,PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
PID-018,Glioblastoma,74,NCT03152708,CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT04224441,Repurposing Chlorpromazine in the Treatment of Glioblastoma
PID-018,Glioblastoma,74,NCT03535350,Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02669173,Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02902757,FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT02728349,Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma
PID-018,Glioblastoma,74,NCT02770378,A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01043536,Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
PID-018,Glioblastoma,74,NCT05376800,A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma
PID-018,Glioblastoma,74,NCT03481231,In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT02330991,A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse
PID-018,Glioblastoma,74,NCT02329795,Image-derived Prediction of Response to Chemo-radiation in Glioblastoma
PID-018,Glioblastoma,74,NCT07029100,Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.
PID-018,Glioblastoma,74,NCT04717739,"TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study"
PID-018,Glioblastoma,74,NCT01923922,CT Perfusion in the Prognostication of Cerebral High Grade Glioma
PID-018,Glioblastoma,74,NCT04007185,Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)
PID-018,Glioblastoma,74,NCT03233152,Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03636477,A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
PID-018,Glioblastoma,74,NCT04566185,Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02590497,Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
PID-018,Glioblastoma,74,NCT00509821,"Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma"
PID-018,Glioblastoma,74,NCT03439332,Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma
PID-018,Glioblastoma,74,NCT02876003,Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma
PID-018,Glioblastoma,74,NCT03223103,Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
PID-018,Glioblastoma,74,NCT05108012,Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
PID-018,Glioblastoma,74,NCT00694837,Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
PID-018,Glioblastoma,74,NCT02799238,Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT02342379,TH-302 in Combination With Bevacizumab for Glioblastoma
PID-018,Glioblastoma,74,NCT01443676,Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT05328089,Vacuolar ATPase and Drug Resistance of High Grade Gliomas
PID-018,Glioblastoma,74,NCT00943007,Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors
PID-018,Glioblastoma,74,NCT01499251,Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05664243,"A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma"
PID-018,Glioblastoma,74,NCT03383978,Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
PID-018,Glioblastoma,74,NCT01989884,An Efficacy Study Of Ortataxel In Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05900908,Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy
PID-018,Glioblastoma,74,NCT01811121,MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS
PID-018,Glioblastoma,74,NCT02654964,Cancer Stem Cell High-Throughput Drug Screening Study
PID-018,Glioblastoma,74,NCT01854099,Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens
PID-018,Glioblastoma,74,NCT03393000,Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
PID-018,Glioblastoma,74,NCT03422094,"Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-018,Glioblastoma,74,NCT03631836,"Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma"
PID-018,Glioblastoma,74,NCT03287063,"Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma"
PID-018,Glioblastoma,74,NCT00643825,"Prolonged Adjuvant Temozolomide vs ""Stop & Go"" in Glioblastoma Patients"
PID-018,Glioblastoma,74,NCT01872221,Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study
PID-018,Glioblastoma,74,NCT01260467,Memantine for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01213407,Dendritic Cell Cancer Vaccine for High-grade Glioma
PID-018,Glioblastoma,74,NCT05590689,Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
PID-018,Glioblastoma,74,NCT05342883,GammaTile and Stupp in Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT01867593,MET-PET for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02060955,Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan
PID-018,Glioblastoma,74,NCT00029783,Efficacy of Distant Healing in Glioblastoma Treatment
PID-018,Glioblastoma,74,NCT02359097,Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT03776071,"A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1"
PID-018,Glioblastoma,74,NCT05753995,"Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study"
PID-018,Glioblastoma,74,NCT01759810,Proteome-based Personalized Immunotherapy of Glioblastoma
PID-018,Glioblastoma,74,NCT00906893,Evaluation of [18F]-FMISO for Non Operated Glioblastoma
PID-018,Glioblastoma,74,NCT02718443,VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
PID-018,Glioblastoma,74,NCT02430363,Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
PID-018,Glioblastoma,74,NCT02343406,Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
PID-018,Glioblastoma,74,NCT04726397,UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial
PID-018,Glioblastoma,74,NCT01582269,A Study in Recurrent Glioblastoma (GB)
PID-018,Glioblastoma,74,NCT02939378,Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study
PID-018,Glioblastoma,74,NCT05820191,B-amyloid as a Marker for GBM Bioimaging
PID-018,Glioblastoma,74,NCT00807027,Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
PID-018,Glioblastoma,74,NCT03018288,Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT01331291,Bosutinib in Adult Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02704858,Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
PID-018,Glioblastoma,74,NCT01100177,Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients
PID-018,Glioblastoma,74,NCT02014844,Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
PID-018,Glioblastoma,74,NCT05168423,CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
PID-018,Glioblastoma,74,NCT04868396,Patient-derived Glioma Stem Cell Organoids
PID-018,Glioblastoma,74,NCT00944801,Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02866747,A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02869243,A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
PID-018,Glioblastoma,74,NCT00295815,Enzastaurin Versus Lomustine in Glioblastoma
PID-018,Glioblastoma,74,NCT03382977,"Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects"
PID-018,Glioblastoma,74,NCT01310868,Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
PID-018,Glioblastoma,74,NCT00790452,Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
PID-018,Glioblastoma,74,NCT02648633,Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04321694,Expanded Access for KHK2455
PID-018,Glioblastoma,74,NCT01856933,BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT01430351,"Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy"
PID-018,Glioblastoma,74,NCT06954636,Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
PID-018,Glioblastoma,74,NCT00941460,Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01364064,Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00385853,PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
PID-018,Glioblastoma,74,NCT03939858,Bioenergetic Profiling and Cognition in GBM Patients
PID-018,Glioblastoma,74,NCT01507506,Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
PID-018,Glioblastoma,74,NCT00703859,Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03970447,A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02078648,"Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT00948389,Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT01310855,Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT01985087,A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
PID-018,Glioblastoma,74,NCT02315534,A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
PID-018,Glioblastoma,74,NCT00762255,A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03149003,A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
PID-018,Glioblastoma,74,NCT02209948,Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
PID-018,Glioblastoma,74,NCT02520635,Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients
PID-018,Glioblastoma,74,NCT03961971,Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
PID-018,Glioblastoma,74,NCT01083719,A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
PID-018,Glioblastoma,74,NCT04385173,Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
PID-018,Glioblastoma,74,NCT01044225,Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
PID-018,Glioblastoma,74,NCT01934361,Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00967330,A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT03454295,Easing Psychosocial Burden for Informal Caregivers
PID-018,Glioblastoma,74,NCT01464177,Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00088400,Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors
PID-018,Glioblastoma,74,NCT04528680,Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03642080,MRI Predictors of Response to Tumor Treating Fields
PID-018,Glioblastoma,74,NCT01339052,Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04313842,A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED
PID-018,Glioblastoma,74,NCT00813943,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status"
PID-018,Glioblastoma,74,NCT02968940,Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
PID-018,Glioblastoma,74,NCT04802447,SurVaxM Expanded Access Protocol
PID-018,Glioblastoma,74,NCT01880008,Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT00392548,URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol
PID-018,Glioblastoma,74,NCT02179086,Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT04838782,Role of Repeat Resection in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01149109,Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients
PID-018,Glioblastoma,74,NCT00689221,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status"
PID-018,Glioblastoma,74,NCT04205357,Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00725010,Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
PID-018,Glioblastoma,74,NCT03726515,CART-EGFRvIII + Pembrolizumab in GBM
PID-018,Glioblastoma,74,NCT01632228,A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00521482,Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05450744,131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)
PID-018,Glioblastoma,74,NCT03538587,Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
PID-018,Glioblastoma,74,NCT01702792,Derivation of Tumor Specific Hybridomas
PID-018,Glioblastoma,74,NCT04077866,B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
PID-018,Glioblastoma,74,NCT06136611,Preoperative Preradiotherapy TTFields
PID-018,Glioblastoma,74,NCT04915404,Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
PID-018,Glioblastoma,74,NCT03477513,Personalized Radiation Therapy for GBM
PID-018,Glioblastoma,74,NCT03452579,Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
PID-018,Glioblastoma,74,NCT05917145,ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT04474353,Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT05768919,Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
PID-018,Glioblastoma,74,NCT00501891,Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT06146725,The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
PID-018,Glioblastoma,74,NCT03008148,Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT05801159,[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT03869242,NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT05053880,A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00943826,A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01860638,A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma
PID-018,Glioblastoma,74,NCT04315584,FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
PID-018,Glioblastoma,74,NCT02654041,Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
PID-018,Glioblastoma,74,NCT05326464,Tofacitinib in Recurrent GBM Patients
PID-018,Glioblastoma,74,NCT05296122,Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
PID-018,Glioblastoma,74,NCT06649851,G-CSF After Chemo-radiation in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT03688178,DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
PID-018,Glioblastoma,74,NCT03782415,Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03250299,Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02337491,Pembrolizumab +/- Bevacizumab for Recurrent GBM
PID-018,Glioblastoma,74,NCT01124539,Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
PID-018,Glioblastoma,74,NCT03927222,Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
PID-018,Glioblastoma,74,NCT02287428,Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT02905643,Discerning Pseudoprogression vs True Tumor Growth in GBMs
PID-018,Glioblastoma,74,NCT03197506,Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT06991101,Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03258021,TTFields In GErmany in Routine Clinical Care
PID-018,Glioblastoma,74,NCT02458508,Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy
PID-018,Glioblastoma,74,NCT00003456,Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05627323,CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT04545177,Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
PID-018,Glioblastoma,74,NCT05759195,Biomolecular Analysis for Predicting Response to Regorafenib
PID-018,Glioblastoma,74,NCT02367482,Tryptophan Metabolism in Human Brain Tumors-Novocure
PID-018,Glioblastoma,74,NCT00481455,Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT00693095,Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer
PID-018,Glioblastoma,74,NCT05236036,Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
PID-018,Glioblastoma,74,NCT00003474,Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03047473,Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01208909,Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)
PID-018,Glioblastoma,74,NCT05063682,The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients
PID-018,Glioblastoma,74,NCT05902169,Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
PID-018,Glioblastoma,74,NCT06815432,GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
PID-018,Glioblastoma,74,NCT03616860,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
PID-018,Glioblastoma,74,NCT03603379,Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas
PID-018,Glioblastoma,74,NCT04479241,LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02085304,"Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM"
PID-018,Glioblastoma,74,NCT01186406,"Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)"
PID-018,Glioblastoma,74,NCT06917885,CUE-102 in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00977431,Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
PID-018,Glioblastoma,74,NCT00979017,Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03643549,Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
PID-018,Glioblastoma,74,NCT00290771,Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT02899663,MRI Detection of Microbleeds in Glioma Patients
PID-018,Glioblastoma,74,NCT00895180,Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05653622,Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma
PID-018,Glioblastoma,74,NCT04221503,Niraparib/TTFields in GBM
PID-018,Glioblastoma,74,NCT02698280,Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
PID-018,Glioblastoma,74,NCT05685004,Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT02631655,POSitron Emission Imaging Using 18F-FDOPA in Neurooncology
PID-018,Glioblastoma,74,NCT00576537,Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
PID-018,Glioblastoma,74,NCT02585219,Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas
PID-018,Glioblastoma,74,NCT03278249,Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
PID-018,Glioblastoma,74,NCT00687765,Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
PID-018,Glioblastoma,74,NCT00616005,Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
PID-018,Glioblastoma,74,NCT02302235,Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study
PID-018,Glioblastoma,74,NCT04003649,IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
PID-018,Glioblastoma,74,NCT02843230,Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
PID-018,Glioblastoma,74,NCT02473484,Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas
PID-018,Glioblastoma,74,NCT05432518,Pilot Trial for Treatment of Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03025893,"A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT01602588,A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)
PID-018,Glioblastoma,74,NCT06552260,A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
PID-018,Glioblastoma,74,NCT01011231,Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma
PID-018,Glioblastoma,74,NCT05977738,Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin
PID-018,Glioblastoma,74,NCT06356883,Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
PID-018,Glioblastoma,74,NCT00884741,Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00509301,Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01653834,Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
PID-018,Glioblastoma,74,NCT05868083,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01105988,Evaluating Tumor Pseudoprogression With FLT-PET and MRI
PID-018,Glioblastoma,74,NCT06039709,Sonodynamic Therapy in Patients With Recurrent GBM
PID-018,Glioblastoma,74,NCT05052957,hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
PID-018,Glioblastoma,74,NCT03235934,Glycemic Impact on Glioblastoma Outcomes
PID-018,Glioblastoma,74,NCT01535911,Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
PID-018,Glioblastoma,74,NCT06850766,The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
PID-018,Glioblastoma,74,NCT07100730,Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01251484,BIBF 1120 in Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT06283927,The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
PID-018,Glioblastoma,74,NCT05095441,A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT05131711,Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)
PID-018,Glioblastoma,74,NCT06186440,Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
PID-018,Glioblastoma,74,NCT00611728,Ph I SU011248 + Irinotecan in Treatment of Pts w MG
PID-018,Glioblastoma,74,NCT04469699,Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05663125,LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
PID-018,Glioblastoma,74,NCT01498328,A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
PID-018,Glioblastoma,74,NCT00961090,Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
PID-018,Glioblastoma,74,NCT03107780,Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
PID-018,Glioblastoma,74,NCT02474966,Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study
PID-018,Glioblastoma,74,NCT01149850,Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
PID-018,Glioblastoma,74,NCT01737346,Procarbazine and Lomustine in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT07143812,A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00597493,Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM
PID-018,Glioblastoma,74,NCT07134842,A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
PID-018,Glioblastoma,74,NCT02466828,qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.
PID-018,Glioblastoma,74,NCT00574964,Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT06782984,Drug Response Testing and Repurposing Using Glioblastoma Organoid
PID-018,Glioblastoma,74,NCT06835803,Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: a Phase 2 Hybrid Randomized Trial
PID-018,Glioblastoma,74,NCT03480867,Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)
PID-018,Glioblastoma,74,NCT00306618,Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
PID-018,Glioblastoma,74,NCT06616727,The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
PID-018,Glioblastoma,74,NCT01591577,Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00412542,Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
PID-018,Glioblastoma,74,NCT05666349,Reirradiation and Niraparib in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00379470,Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT00187486,"Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors"
PID-018,Glioblastoma,74,NCT06757153,Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
PID-018,Glioblastoma,74,NCT07145047,Clinical Study of Oncolytic Virus in Glioblastoma
PID-018,Glioblastoma,74,NCT05577091,Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02137759,MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
PID-018,Glioblastoma,74,NCT03463733,Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
PID-018,Glioblastoma,74,NCT02613988,Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
PID-018,Glioblastoma,74,NCT04952571,Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT01903330,ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03632135,Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04469075,Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
PID-018,Glioblastoma,74,NCT04004975,Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
PID-018,Glioblastoma,74,NCT03557372,Mathematical Model-Adapted Radiation In Glioblastoma
PID-018,Glioblastoma,74,NCT05607407,Methimazole in Patients With Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT04902586,Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT06805305,DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT03681028,Feasibility of Individualized Therapy for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02844439,Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04968366,Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
PID-018,Glioblastoma,74,NCT05737368,Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
PID-018,Glioblastoma,74,NCT06598787,A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06894225,Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
PID-018,Glioblastoma,74,NCT05743595,"Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma"
PID-018,Glioblastoma,74,NCT03665545,Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
PID-018,Glioblastoma,74,NCT03672721,IA Carboplatin + Radiotherapy in Relapsing GBM
PID-018,Glioblastoma,74,NCT06934889,Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
PID-018,Glioblastoma,74,NCT04523688,Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
PID-018,Glioblastoma,74,NCT00154375,Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT05936216,TVI-Brain-1 in Expanded Access Patient
PID-018,Glioblastoma,74,NCT05736406,A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma
PID-018,Glioblastoma,74,NCT04559230,Sacituzumab Govitecan in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04888611,Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04051606,Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06368934,Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
PID-018,Glioblastoma,74,NCT04842513,Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03452930,Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
PID-018,Glioblastoma,74,NCT06389591,RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT06418113,Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT03405792,Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
PID-018,Glioblastoma,74,NCT06220552,The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05043701,Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01957956,Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT06069726,A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
PID-018,Glioblastoma,74,NCT05720078,UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)
PID-018,Glioblastoma,74,NCT03430791,"Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma"
PID-018,Glioblastoma,74,NCT04128774,Function and Composition of Regulatory B Cells in Participants With Glioblastoma
PID-018,Glioblastoma,74,NCT06325683,Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05218408,CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
PID-018,Glioblastoma,74,NCT02649582,Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT03225963,Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.
PID-018,Glioblastoma,74,NCT05638451,Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
PID-018,Glioblastoma,74,NCT06097975,A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06011109,Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PID-018,Glioblastoma,74,NCT05911230,Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
PID-018,Glioblastoma,74,NCT02076152,FMISO PET Study of Glioblastoma
PID-018,Glioblastoma,74,NCT04674527,Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
PID-018,Glioblastoma,74,NCT03630289,Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
PID-018,Glioblastoma,74,NCT03181477,"Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas"
PID-018,Glioblastoma,74,NCT01205334,Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04717999,Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06558214,"OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial"
PID-018,Glioblastoma,74,NCT03225300,Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation
PID-018,Glioblastoma,74,NCT05284643,"Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma"
PID-018,Glioblastoma,74,NCT05201326,Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06157541,T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT05076513,Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
PID-018,Glioblastoma,74,NCT05191784,GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients
PID-018,Glioblastoma,74,NCT05540275,Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02152982,Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04116658,"First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma"
PID-018,Glioblastoma,74,NCT00575146,Ketogenic Diet for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04013672,Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
PID-018,Glioblastoma,74,NCT03916757,V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer
PID-018,Glioblastoma,74,NCT02227576,Prevention of Thrombocytopenia in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT05802693,"A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma"
PID-018,Glioblastoma,74,NCT05324501,A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04689087,"A Prospective, Open-label, Single-arm Clinical Study"
PID-018,Glioblastoma,74,NCT00960492,Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
PID-018,Glioblastoma,74,NCT00555399,"Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)"
PID-018,Glioblastoma,74,NCT05341947,Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03451799,Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT01830101,A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03232424,NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02663271,TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02060890,Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT05879120,Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04974983,Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03722342,TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03341806,Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00657267,Dose-Intense Temozolomide in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02364206,Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03750071,VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT01110876,"Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)"
PID-018,Glioblastoma,74,NCT02678975,Disulfiram in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05095376,Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
PID-018,Glioblastoma,74,NCT00400322,Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
PID-018,Glioblastoma,74,NCT02207010,A Phase 0 Study of AZD1775 in Recurrent GBM Patients
PID-018,Glioblastoma,74,NCT03137888,Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
PID-018,Glioblastoma,74,NCT03856099,TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
PID-018,Glioblastoma,74,NCT05118776,Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
PID-018,Glioblastoma,74,NCT04201873,Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04988750,Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
PID-018,Glioblastoma,74,NCT03216499,HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03865355,Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
PID-018,Glioblastoma,74,NCT01349036,A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04047303,"CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma"
PID-018,Glioblastoma,74,NCT04555577,"Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma"
PID-018,Glioblastoma,74,NCT02366728,DC Migration Study for Newly-Diagnosed GBM
PID-018,Glioblastoma,74,NCT03514069,Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
PID-018,Glioblastoma,74,NCT00301418,Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
PID-018,Glioblastoma,74,NCT04397679,"Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma"
PID-018,Glioblastoma,74,NCT02599090,Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-018,Glioblastoma,74,NCT07138001,Phase 2 Clinical Trial of KH617
PID-018,Glioblastoma,74,NCT02345824,Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
PID-018,Glioblastoma,74,NCT02919332,Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT01480479,Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01113398,AMG 102 and Avastin for Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT00441142,Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
PID-018,Glioblastoma,74,NCT03034135,"Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma"
PID-018,Glioblastoma,74,NCT03522298,"Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma"
PID-018,Glioblastoma,74,NCT03033524,Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03867123,A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
PID-018,Glioblastoma,74,NCT02974621,Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02530502,Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02133183,Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06186401,Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
PID-018,Glioblastoma,74,NCT00921167,A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
PID-018,Glioblastoma,74,NCT00841555,Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
PID-018,Glioblastoma,74,NCT02933736,Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
PID-018,Glioblastoma,74,NCT02129335,"Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner"
PID-018,Glioblastoma,74,NCT05879250,WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02340156,Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01866449,Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02781792,Temozolomide Chronotherapy for High Grade Glioma
PID-018,Glioblastoma,74,NCT00250887,"Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research"
PID-018,Glioblastoma,74,NCT03401866,Multi-site Validation and Application of a Consensus DSC-MRI Protocol
PID-018,Glioblastoma,74,NCT01756729,Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
PID-018,Glioblastoma,74,NCT06419946,Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
PID-018,Glioblastoma,74,NCT03573986,Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
PID-018,Glioblastoma,74,NCT03174197,Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT05318612,Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)
PID-018,Glioblastoma,74,NCT02455557,SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00045968,Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
PID-018,Glioblastoma,74,NCT01813877,Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
PID-018,Glioblastoma,74,NCT04715620,Niraparib Combined With Radiotherapy in rGBM
PID-018,Glioblastoma,74,NCT00777153,Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04681677,Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
PID-018,Glioblastoma,74,NCT03744026,Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
PID-018,Glioblastoma,74,NCT04223999,Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)
PID-018,Glioblastoma,74,NCT01135875,Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
PID-018,Glioblastoma,74,NCT00525525,Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
PID-018,Glioblastoma,74,NCT02573324,A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
PID-018,Glioblastoma,74,NCT00365222,Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02754362,A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00734526,Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
PID-018,Glioblastoma,74,NCT05565521,UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly
PID-018,Glioblastoma,74,NCT01987830,Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
PID-018,Glioblastoma,74,NCT05431348,Effect of StRess and ExeRcize on the Outcome After Chemo-Radiation
PID-018,Glioblastoma,74,NCT01754350,"Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma"
PID-018,Glioblastoma,74,NCT04440358,Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
PID-018,Glioblastoma,74,NCT02017717,A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT02885272,FDG PET Imaging in Diagnosing Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT04417088,Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
PID-018,Glioblastoma,74,NCT01165671,Carbon Ion Radiotherapy for Primary Glioblastoma
PID-018,Glioblastoma,74,NCT05271240,Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT05864534,Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00071539,Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
PID-018,Glioblastoma,74,NCT07089758,A Study for Cerebral Open Flow Microperfusion
PID-018,Glioblastoma,74,NCT02046187,Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01115036,A Panobinostat Presurgery
PID-018,Glioblastoma,74,NCT00612989,Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM
PID-018,Glioblastoma,74,NCT05182905,AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
PID-018,Glioblastoma,74,NCT00612339,Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
PID-018,Glioblastoma,74,NCT02717962,"Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting"
PID-018,Glioblastoma,74,NCT03158389,NCT Neuro Master Match - N²M² (NOA-20)
PID-018,Glioblastoma,74,NCT03291977,Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)
PID-018,Glioblastoma,74,NCT00250211,Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
PID-018,Glioblastoma,74,NCT00200161,Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
PID-018,Glioblastoma,74,NCT05914935,Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00335075,Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
PID-018,Glioblastoma,74,NCT02062827,Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT03014804,Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04222309,Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-018,Glioblastoma,74,NCT06095375,"Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients"
PID-018,Glioblastoma,74,NCT01956734,Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03277638,Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
PID-018,Glioblastoma,74,NCT01836536,Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients
PID-018,Glioblastoma,74,NCT05100641,AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT04105374,"Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma"
PID-018,Glioblastoma,74,NCT00615927,Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
PID-018,Glioblastoma,74,NCT00672243,Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
PID-018,Glioblastoma,74,NCT03877861,Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms
PID-018,Glioblastoma,74,NCT03868943,Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
PID-018,Glioblastoma,74,NCT01567202,Study of DC Vaccination Against Glioblastoma
PID-018,Glioblastoma,74,NCT03551249,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
PID-018,Glioblastoma,74,NCT03532295,Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
PID-018,Glioblastoma,74,NCT01702610,Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT06585527,Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT02510950,Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00613028,Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
PID-018,Glioblastoma,74,NCT05879367,Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
PID-018,Glioblastoma,74,NCT00613132,Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
PID-018,Glioblastoma,74,NCT03149575,VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
PID-018,Glioblastoma,74,NCT00611325,Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT01413438,Bevacizumab With or Without Surgery for Adult Glioblastomas
PID-018,Glioblastoma,74,NCT02010606,Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02833701,Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
PID-018,Glioblastoma,74,NCT01180816,Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
PID-018,Glioblastoma,74,NCT06455189,Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
PID-018,Glioblastoma,74,NCT02664363,EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
PID-018,Glioblastoma,74,NCT01269853,Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
PID-018,Glioblastoma,74,NCT05326334,THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)
PID-018,Glioblastoma,74,NCT00612430,Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
PID-018,Glioblastoma,74,NCT01386710,Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
PID-018,Glioblastoma,74,NCT00968240,Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
PID-018,Glioblastoma,74,NCT03722355,Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
PID-018,Glioblastoma,74,NCT00671970,Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
PID-018,Glioblastoma,74,NCT01986348,Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas
PID-018,Glioblastoma,74,NCT02026271,A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
PID-018,Glioblastoma,74,NCT06622434,"New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study"
PID-018,Glioblastoma,74,NCT01811498,Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT01067469,Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT02022384,Immunophenotyping From Blood of Patients With Malignant Gliomas
PID-018,Glioblastoma,74,NCT05990556,Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT02605746,Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis
PID-018,Glioblastoma,74,NCT02270034,Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01547546,A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT04674579,Automatic Segmentation MRI Cerebral Glioma
PID-018,Glioblastoma,74,NCT00735436,A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
PID-018,Glioblastoma,74,NCT01954576,NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00354913,Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
PID-018,Glioblastoma,74,NCT00609999,Ph I Dasatinib + Erlotinib in Recurrent MG
PID-018,Glioblastoma,74,NCT05624736,Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning
PID-018,Glioblastoma,74,NCT00586508,Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas
PID-018,Glioblastoma,74,NCT05363826,Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®
PID-018,Glioblastoma,74,NCT05660369,CARv3-TEAM-E T Cells in Glioblastoma
PID-018,Glioblastoma,74,NCT00883298,Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05941234,"Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma"
PID-018,Glioblastoma,74,NCT03050736,Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
PID-018,Glioblastoma,74,NCT00613054,Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT06279767,Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00613223,Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
PID-018,Glioblastoma,74,NCT03997136,Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.
PID-018,Glioblastoma,74,NCT00669669,O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
PID-018,Glioblastoma,74,NCT06562621,Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT00612638,Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
PID-018,Glioblastoma,74,NCT03360708,Vaccine Therapy in Treating Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03332355,Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
PID-018,Glioblastoma,74,NCT05235737,The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab
PID-018,Glioblastoma,74,NCT03170141,Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05954858,Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
PID-018,Glioblastoma,74,NCT05432804,"Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment"
PID-018,Glioblastoma,74,NCT04266977,Restrictive Use of Dexamethasone in Glioblastoma
PID-018,Glioblastoma,74,NCT00540176,The Safety and Efficacy of DCA for the Treatment of Brain Cancer
PID-018,Glioblastoma,74,NCT06327451,Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
PID-018,Glioblastoma,74,NCT02006563,Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors
PID-018,Glioblastoma,74,NCT01351519,A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
PID-018,Glioblastoma,74,NCT04780009,Loupe-Based Intraoperative Fluorescence Imaging
PID-018,Glioblastoma,74,NCT06632236,5G-EMERALD: Amivantamab in Malignant Brain Tumours
PID-018,Glioblastoma,74,NCT06630260,5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
PID-018,Glioblastoma,74,NCT02227901,"Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT02414165,The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
PID-018,Glioblastoma,74,NCT06359379,Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
PID-018,Glioblastoma,74,NCT01478178,Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT05842746,Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03115138,Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
PID-018,Glioblastoma,74,NCT03020017,NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
PID-018,Glioblastoma,74,NCT04188535,Serial MRI Scans During Radiation Therapy
PID-018,Glioblastoma,74,NCT01174537,"New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma"
PID-018,Glioblastoma,74,NCT02590263,Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
PID-018,Glioblastoma,74,NCT04910022,Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03345095,A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01124240,Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene
PID-018,Glioblastoma,74,NCT00005856,Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02743078,Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05773664,Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma
PID-018,Glioblastoma,74,NCT06964815,"Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients"
PID-018,Glioblastoma,74,NCT03603405,HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT05694416,Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT02768389,Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05772767,Modulation of Ciliogenesis in Glioma Stem Cells
PID-018,Glioblastoma,74,NCT03294486,"Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients"
PID-018,Glioblastoma,74,NCT03144167,Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
PID-018,Glioblastoma,74,NCT00316849,"Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT00058097,Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02898012,Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
PID-018,Glioblastoma,74,NCT04391595,LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
PID-018,Glioblastoma,74,NCT04926168,6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT01805453,"Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma"
PID-018,Glioblastoma,74,NCT03834740,A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
PID-018,Glioblastoma,74,NCT00606008,A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-018,Glioblastoma,74,NCT00004262,Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT03615404,"Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma"
PID-018,Glioblastoma,74,NCT06816927,Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
PID-018,Glioblastoma,74,NCT04200066,A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03423628,A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
PID-018,Glioblastoma,74,NCT06319027,"Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial"
PID-018,Glioblastoma,74,NCT05447195,Phase 2 Study of CAN008 in Subjects With GBM
PID-018,Glioblastoma,74,NCT05600491,A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
PID-018,Glioblastoma,74,NCT00049387,"Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-018,Glioblastoma,74,NCT06177964,Lerapolturev (PVSRIPO) in GBM
PID-018,Glioblastoma,74,NCT00305864,"Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma"
PID-018,Glioblastoma,74,NCT05979064,Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
PID-018,Glioblastoma,74,NCT00052208,Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05695976,GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
PID-018,Glioblastoma,74,NCT02626364,Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
PID-018,Glioblastoma,74,NCT02761070,"Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III"
PID-018,Glioblastoma,74,NCT01811992,Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma
PID-018,Glioblastoma,74,NCT03705351,Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT00777686,Measuring Non-Enhancing Glioblastoma Progression
PID-018,Glioblastoma,74,NCT03596086,HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
PID-018,Glioblastoma,74,NCT00479765,A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
PID-018,Glioblastoma,74,NCT00039494,Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
PID-018,Glioblastoma,74,NCT00660543,MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
PID-018,Glioblastoma,74,NCT01331616,Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
PID-018,Glioblastoma,74,NCT00085254,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT01540513,PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
PID-018,Glioblastoma,74,NCT03115333,DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04741984,Monocyte Antigen Carrier Cells for Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT04937413,The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation
PID-018,Glioblastoma,74,NCT00943462,Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
PID-018,Glioblastoma,74,NCT01124461,BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor
PID-018,Glioblastoma,74,NCT05163080,SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
PID-018,Glioblastoma,74,NCT02465268,Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02375841,"Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers"
PID-018,Glioblastoma,74,NCT05091866,Natural Progesterone for the Treatment of Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03778294,18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
PID-018,Glioblastoma,74,NCT05375318,"BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels"
PID-018,Glioblastoma,74,NCT03899857,Pembrolizumab for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00613093,Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
PID-018,Glioblastoma,74,NCT05772741,Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs
PID-018,Glioblastoma,74,NCT00014170,Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05380349,Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
PID-018,Glioblastoma,74,NCT04725214,Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma
PID-018,Glioblastoma,74,NCT00902577,MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04840069,Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01609790,Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
PID-018,Glioblastoma,74,NCT01465347,Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT05033587,Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
PID-018,Glioblastoma,74,NCT00731731,"Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT02337426,"Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT05084430,Study of Pembrolizumab and M032 (NSC 733972)
PID-018,Glioblastoma,74,NCT04945148,Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
PID-018,Glioblastoma,74,NCT02395692,Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00846456,Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma
PID-018,Glioblastoma,74,NCT01022918,Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
PID-018,Glioblastoma,74,NCT05116137,The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
PID-018,Glioblastoma,74,NCT00864864,Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02575027,Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01120639,Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
PID-018,Glioblastoma,74,NCT04600817,A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)
PID-018,Glioblastoma,74,NCT04065087,Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03619239,Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT03020602,BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab
PID-018,Glioblastoma,74,NCT02197169,DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
PID-018,Glioblastoma,74,NCT01111097,Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors
PID-018,Glioblastoma,74,NCT00761280,Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
PID-018,Glioblastoma,74,NCT07003542,A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
PID-018,Glioblastoma,74,NCT02820584,A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06329570,Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
PID-018,Glioblastoma,74,NCT04327011,A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
PID-018,Glioblastoma,74,NCT00409214,Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
PID-018,Glioblastoma,74,NCT03400917,Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT03626896,Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
PID-018,Glioblastoma,74,NCT02311920,Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-018,Glioblastoma,74,NCT06797661,Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.
PID-018,Glioblastoma,74,NCT00001148,Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
PID-018,Glioblastoma,74,NCT02047058,Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
PID-018,Glioblastoma,74,NCT00115440,BNCT to Treat Glioma That Has Progressed Following Radiotherapy
PID-018,Glioblastoma,74,NCT05513859,Investigational Imaging Technique During Brain Surgery
PID-018,Glioblastoma,74,NCT02709226,Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04998864,Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
PID-018,Glioblastoma,74,NCT04903795,Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PID-018,Glioblastoma,74,NCT00165477,Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05023551,Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT07089641,"ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial"
PID-018,Glioblastoma,74,NCT04424966,Infigratinib in Recurrent High-Grade Glioma Patients
PID-018,Glioblastoma,74,NCT05171127,Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
PID-018,Glioblastoma,74,NCT03861299,The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
PID-018,Glioblastoma,74,NCT06496971,A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
PID-018,Glioblastoma,74,NCT00662506,"Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma"
PID-018,Glioblastoma,74,NCT00179907,A Phase I/II Study of the Photon Radiosurgery System
PID-018,Glioblastoma,74,NCT04967690,"A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM"
PID-018,Glioblastoma,74,NCT06480721,FET-PET-Guided Management of Pseudoprogression in Glioblastoma
PID-018,Glioblastoma,74,NCT03460782,An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
PID-018,Glioblastoma,74,NCT00004146,Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
PID-018,Glioblastoma,74,NCT03951142,Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study
PID-018,Glioblastoma,74,NCT05718466,Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy
PID-018,Glioblastoma,74,NCT05904119,Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
PID-018,Glioblastoma,74,NCT04854044,ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03649464,Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
PID-018,Glioblastoma,74,NCT03732352,18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05977322,A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
PID-018,Glioblastoma,74,NCT02330562,Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab
PID-018,Glioblastoma,74,NCT06193538,The Safety and Effectiveness of NV-A01 in Glioma Patients
PID-018,Glioblastoma,74,NCT01905228,A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
PID-018,Glioblastoma,74,NCT06910306,A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02666066,Radiomics for Prediction of Survival in GBM
PID-018,Glioblastoma,74,NCT00074646,Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas
PID-018,Glioblastoma,74,NCT02903069,Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
PID-018,Glioblastoma,74,NCT00548938,"Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM"
PID-018,Glioblastoma,74,NCT02490930,A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
PID-018,Glioblastoma,74,NCT02025231,Image Guided Reirradiation of High-grade Glioma
PID-018,Glioblastoma,74,NCT06129760,Glioblastoma Remote Monitoring and Care - Research Protocol
PID-018,Glioblastoma,74,NCT06684899,Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT06773481,BC008-1A Injection for Recurrent CNS WHO G4 Glioma
PID-018,Glioblastoma,74,NCT00686387,Establishment of a Brain and Spinal Tumor Tissue Bank
PID-018,Glioblastoma,74,NCT06344130,Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01266031,Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01516905,PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
PID-018,Glioblastoma,74,NCT03370926,FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
PID-018,Glioblastoma,74,NCT06328036,Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01931098,Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
PID-018,Glioblastoma,74,NCT01502241,Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
PID-018,Glioblastoma,74,NCT00939991,"Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas"
PID-018,Glioblastoma,74,NCT03426891,Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT06719440,Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
PID-018,Glioblastoma,74,NCT00723827,Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
PID-018,Glioblastoma,74,NCT02432417,"The Addition of Chloroquine to Chemoradiation for Glioblastoma,"
PID-018,Glioblastoma,74,NCT00431561,Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
PID-018,Glioblastoma,74,NCT01317888,Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas
PID-018,Glioblastoma,74,NCT05039281,Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05017610,Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
PID-018,Glioblastoma,74,NCT06824662,Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas
PID-018,Glioblastoma,74,NCT03618667,GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
PID-018,Glioblastoma,74,NCT00089427,"IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma"
PID-018,Glioblastoma,74,NCT00028158,"Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer"
PID-018,Glioblastoma,74,NCT01925573,Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
PID-018,Glioblastoma,74,NCT04822688,"Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues"
PID-018,Glioblastoma,74,NCT05383872,Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
PID-018,Glioblastoma,74,NCT02337686,Pembrolizumab in Treating Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03296696,Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
PID-018,Glioblastoma,74,NCT01086345,Radiosurgery Plus Bevacizumab in Glioblastoma
PID-018,Glioblastoma,74,NCT06072586,A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
PID-018,Glioblastoma,74,NCT04216329,Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT06455605,D2C7-IT + 2141-V11 Combination Post-resection in rGBM
PID-018,Glioblastoma,74,NCT01044966,A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04763031,Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT
PID-018,Glioblastoma,74,NCT04446416,Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
PID-018,Glioblastoma,74,NCT01582516,Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00753246,Nimotuzumab in Adults With Glioblastoma Multiforma
PID-018,Glioblastoma,74,NCT01227434,A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
PID-018,Glioblastoma,74,NCT03224104,Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
PID-018,Glioblastoma,74,NCT06691308,WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients
PID-018,Glioblastoma,74,NCT01004874,Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
PID-018,Glioblastoma,74,NCT02871843,RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
PID-018,Glioblastoma,74,NCT00045565,Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
PID-018,Glioblastoma,74,NCT06058988,Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
PID-018,Glioblastoma,74,NCT04817254,Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PID-018,Glioblastoma,74,NCT00597402,"Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas"
PID-018,Glioblastoma,74,NCT00645385,Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
PID-018,Glioblastoma,74,NCT00576641,Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
PID-018,Glioblastoma,74,NCT01520870,"Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT."
PID-018,Glioblastoma,74,NCT01240460,Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection
PID-018,Glioblastoma,74,NCT02766699,"A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM"
PID-018,Glioblastoma,74,NCT03633552,Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
PID-018,Glioblastoma,74,NCT05929456,Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)
PID-018,Glioblastoma,74,NCT01062425,Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT04608812,Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
PID-018,Glioblastoma,74,NCT03631823,Gut Microbiota and Glioblastoma Multiforme Prognosis
PID-018,Glioblastoma,74,NCT05565118,Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
PID-018,Glioblastoma,74,NCT04045847,CD147-CART Cells in Patients With Recurrent Malignant Glioma.
PID-018,Glioblastoma,74,NCT04289155,Individual Patient Compassionate Use of GX-I7
PID-018,Glioblastoma,74,NCT01242566,Temozolomide in Elderly Patients With KPS < 70
PID-018,Glioblastoma,74,NCT01290939,Bevacizumab and Lomustine for Recurrent GBM
PID-018,Glioblastoma,74,NCT05683808,Venous Thromboembolism Prevention in Outpatients With Glioma
PID-018,Glioblastoma,74,NCT04396860,Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
PID-018,Glioblastoma,74,NCT01294735,Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
PID-018,Glioblastoma,74,NCT04209790,Neoadjuvant Chemoradiation for Resectable Glioblastoma
PID-018,Glioblastoma,74,NCT04677049,Study of Niacin in Glioblastoma
PID-018,Glioblastoma,74,NCT05739942,Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT02253212,Safety of BBB Opening With the SonoCloud
PID-018,Glioblastoma,74,NCT06504381,"DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma"
PID-018,Glioblastoma,74,NCT01711580,Re-irradiation of High Grade Gliomas: a Quality of Life Study
PID-018,Glioblastoma,74,NCT06710249,Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
PID-018,Glioblastoma,74,NCT06883747,Clinical Trial of BMS-986504 in Recurrent GBM Patients
PID-018,Glioblastoma,74,NCT07111195,Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
PID-018,Glioblastoma,74,NCT00923117,Sunitinib to Treat Recurrent Brain Cancer
PID-018,Glioblastoma,74,NCT05671016,Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy
PID-018,Glioblastoma,74,NCT00715013,Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT02431572,A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
PID-018,Glioblastoma,74,NCT00016328,CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00540722,Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00423735,Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
PID-018,Glioblastoma,74,NCT04699773,LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
PID-018,Glioblastoma,74,NCT06273176,The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06059690,Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
PID-018,Glioblastoma,74,NCT00747253,Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
PID-018,Glioblastoma,74,NCT00980343,GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-018,Glioblastoma,74,NCT00591058,Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT03283631,Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
PID-018,Glioblastoma,74,NCT00504660,"6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients"
PID-018,Glioblastoma,74,NCT02794883,Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT00641706,"Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme"
PID-018,Glioblastoma,74,NCT00107003,GW572016 to Treat Recurrent Malignant Brain Tumors
PID-018,Glioblastoma,74,NCT06385132,Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer
PID-018,Glioblastoma,74,NCT00445588,Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT02529072,Nivolumab With DC Vaccines for Recurrent Brain Tumors
PID-018,Glioblastoma,74,NCT00612651,PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
PID-018,Glioblastoma,74,NCT01238237,Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA
PID-018,Glioblastoma,74,NCT03275558,Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma
PID-018,Glioblastoma,74,NCT00503204,Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
PID-018,Glioblastoma,74,NCT02386826,INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00704080,A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
PID-018,Glioblastoma,74,NCT04116138,Antisecretory Factor in Primary Glioblastoma 1
PID-018,Glioblastoma,74,NCT06806228,Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)
PID-018,Glioblastoma,74,NCT01790503,A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT00751270,Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
PID-018,Glioblastoma,74,NCT00610571,Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas
PID-018,Glioblastoma,74,NCT00780819,Borderzone Sampling
PID-018,Glioblastoma,74,NCT00683761,A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT00473408,The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
PID-018,Glioblastoma,74,NCT07021339,Anterior Temporal Lobectomy in Temporal Glioblastoma
PID-018,Glioblastoma,74,NCT00305656,AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00335764,"Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma"
PID-018,Glioblastoma,74,NCT01081223,Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
PID-018,Glioblastoma,74,NCT00087451,Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)
PID-018,Glioblastoma,74,NCT00392171,The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
PID-018,Glioblastoma,74,NCT05734560,D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
PID-018,Glioblastoma,74,NCT00132158,ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
PID-018,Glioblastoma,74,NCT00238303,Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01575275,Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00075491,Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT05267106,Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
PID-018,Glioblastoma,74,NCT01894061,NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00112502,Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04776980,Multimodality MRI and Liquid Biopsy in GBM
PID-018,Glioblastoma,74,NCT02887417,Glioblastoma Platelet Activation Study
PID-018,Glioblastoma,74,NCT00112866,Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT04444427,Evaluation of GLR2007 for Advanced Solid Tumors
PID-018,Glioblastoma,74,NCT00895960,Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT04657315,"Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients"
PID-018,Glioblastoma,74,NCT02052648,Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
PID-018,Glioblastoma,74,NCT03027388,"Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma"
PID-018,Glioblastoma,74,NCT02661282,Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT04712721,Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
PID-018,Glioblastoma,74,NCT06241391,Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas
PID-018,Glioblastoma,74,NCT04388475,Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT04143425,Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01967758,Phase I Study of Safety and Immunogenicity of ADU-623
PID-018,Glioblastoma,74,NCT03746080,Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT05561374,Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT04181684,LITT Followed by Hypofractionated RT for Recurrent Gliomas
PID-018,Glioblastoma,74,NCT03673787,A Trial of Ipatasertib in Combination With Atezolizumab
PID-018,Glioblastoma,74,NCT03367715,"Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma"
PID-018,Glioblastoma,74,NCT00459381,Pazopanib in Treating Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT05909618,Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
PID-018,Glioblastoma,74,NCT01730950,Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01753713,Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT01117155,A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
PID-018,Glioblastoma,74,NCT01475006,AMG 595 First-in-Human in Recurrent Gliomas
PID-018,Glioblastoma,74,NCT01491893,PVSRIPO for Recurrent Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT00979862,Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03539731,[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
PID-018,Glioblastoma,74,NCT01122901,Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT03176160,LITT Palliative Treatment for Patients With Malignant Gliomas
PID-018,Glioblastoma,74,NCT05929495,"Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma"
PID-018,Glioblastoma,74,NCT01972750,Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma
PID-018,Glioblastoma,74,NCT05054400,Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
PID-018,Glioblastoma,74,NCT06017063,Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields
PID-018,Glioblastoma,74,NCT01434602,Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
PID-018,Glioblastoma,74,NCT03213002,Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
PID-018,Glioblastoma,74,NCT01967810,ANG1005 in Patients With Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT03581292,"Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations"
PID-018,Glioblastoma,74,NCT03975959,Memory Perception Assessment in Central/Non-central Nervous System Cancers
PID-018,Glioblastoma,74,NCT00430911,Radiotherapy for Malignant Astrocytomas in the Elderly
PID-018,Glioblastoma,74,NCT01808820,Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
PID-018,Glioblastoma,74,NCT06623565,Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
PID-018,Glioblastoma,74,NCT02629757,A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas
PID-018,Glioblastoma,74,NCT00624728,Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
PID-018,Glioblastoma,74,NCT00562419,CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
PID-018,Glioblastoma,74,NCT02658981,Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
PID-018,Glioblastoma,74,NCT00031538,Genetic Analysis of Brain Tumors
PID-018,Glioblastoma,74,NCT00870181,ADV-TK Improves Outcome of Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT04729959,"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma"
PID-018,Glioblastoma,74,NCT00031083,Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
PID-018,Glioblastoma,74,NCT01765088,A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
PID-018,Glioblastoma,74,NCT04145115,A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden
PID-018,Glioblastoma,74,NCT02750891,A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
PID-018,Glioblastoma,74,NCT01985256,Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
PID-018,Glioblastoma,74,NCT03475186,Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
PID-018,Glioblastoma,74,NCT02540135,Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
PID-018,Glioblastoma,74,NCT01738646,Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
PID-018,Glioblastoma,74,NCT04623931,Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
PID-018,Glioblastoma,74,NCT06430424,"Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma"
PID-018,Glioblastoma,74,NCT01810744,Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
PID-018,Glioblastoma,74,NCT02942264,Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
PID-018,Glioblastoma,74,NCT06501911,A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma
PID-018,Glioblastoma,74,NCT01975701,A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
PID-018,Glioblastoma,74,NCT03657576,Trial of C134 in Patients With Recurrent GBM
PID-018,Glioblastoma,74,NCT01712542,Curcumin Bioavailability in Glioblastoma Patients
PID-018,Glioblastoma,74,NCT01470794,Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
PID-018,Glioblastoma,74,NCT01107522,Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
PID-018,Glioblastoma,74,NCT02525692,Oral ONC201 in Adult Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT07091864,Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
PID-018,Glioblastoma,74,NCT03311542,Expanded Access for Pembrolizumab (MK-3475)
PID-018,Glioblastoma,74,NCT00734864,Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT03561207,3D Prediction of Patient-Specific Response
PID-018,Glioblastoma,74,NCT03914768,Immune Modulatory DC Vaccine Against Brain Tumor
PID-018,Glioblastoma,74,NCT00102648,Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
PID-018,Glioblastoma,74,NCT07067905,Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
PID-018,Glioblastoma,74,NCT06617208,Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery
PID-018,Glioblastoma,74,NCT01814813,Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
PID-018,Glioblastoma,74,NCT05062772,Brain Tumor Intraoperative Ultrasound Database
PID-018,Glioblastoma,74,NCT06108206,Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
PID-018,Glioblastoma,74,NCT00041587,Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
PID-018,Glioblastoma,74,NCT00024570,Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT05106296,Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
PID-018,Glioblastoma,74,NCT04267978,Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
PID-018,Glioblastoma,74,NCT00001171,Evaluation of Factors in Human Brain Tumors
PID-018,Glioblastoma,74,NCT05131763,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-018,Glioblastoma,74,NCT00114309,131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT04477200,Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
PID-018,Glioblastoma,74,NCT04270461,NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
PID-018,Glioblastoma,74,NCT01454596,CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
PID-018,Glioblastoma,74,NCT06016452,A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma
PID-018,Glioblastoma,74,NCT00379080,Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT00390299,Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT00080054,A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
PID-018,Glioblastoma,74,NCT01122888,Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT06160206,Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT06894979,"Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma"
PID-018,Glioblastoma,74,NCT00734682,A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
PID-018,Glioblastoma,74,NCT05495295,"First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours"
PID-018,Glioblastoma,74,NCT04933942,Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
PID-018,Glioblastoma,74,NCT05629702,ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
PID-018,Glioblastoma,74,NCT06118723,The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
PID-018,Glioblastoma,74,NCT01342757,Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT00009035,Natural History of Patients With Brain and Spinal Cord Tumors
PID-018,Glioblastoma,74,NCT01441388,A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.
PID-018,Glioblastoma,74,NCT00575887,Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
PID-018,Glioblastoma,74,NCT04478279,A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
PID-018,Glioblastoma,74,NCT06614855,A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT04074785,Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6
PID-018,Glioblastoma,74,NCT05765812,A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT02348255,NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
PID-018,Glioblastoma,74,NCT00589875,Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
PID-018,Glioblastoma,74,NCT06492486,Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
PID-018,Glioblastoma,74,NCT05686798,Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
PID-018,Glioblastoma,74,NCT04323046,Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
PID-018,Glioblastoma,74,NCT01156584,A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT00062504,Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
PID-018,Glioblastoma,74,NCT06929819,Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
PID-018,Glioblastoma,74,NCT00272870,Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy
PID-018,Glioblastoma,74,NCT06810544,Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
PID-018,Glioblastoma,74,NCT06388733,"A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma"
PID-018,Glioblastoma,74,NCT05773326,Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
PID-018,Glioblastoma,74,NCT00433381,Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
PID-018,Glioblastoma,74,NCT03022578,Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
PID-018,Glioblastoma,74,NCT04630379,Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
PID-018,Glioblastoma,74,NCT04218019,Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation
PID-018,Glioblastoma,74,NCT01999270,Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
PID-018,Glioblastoma,74,NCT04489420,Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
PID-018,Glioblastoma,74,NCT04991870,Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
PID-018,Glioblastoma,74,NCT01902771,Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
PID-018,Glioblastoma,74,NCT06038760,Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
PID-018,Glioblastoma,74,NCT00995007,A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
PID-018,Glioblastoma,74,NCT01281982,(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
PID-018,Glioblastoma,74,NCT04049669,Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
PID-018,Glioblastoma,74,NCT01316809,AZD8055 for Adults With Recurrent Gliomas
PID-018,Glioblastoma,74,NCT03593993,A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
PID-018,Glioblastoma,74,NCT01478321,Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
PID-018,Glioblastoma,74,NCT02039778,Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma
PID-018,Glioblastoma,74,NCT02655601,"Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001"
PID-018,Glioblastoma,74,NCT05465954,Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT00329719,Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT01656980,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
PID-018,Glioblastoma,74,NCT01637753,Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT02885324,Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
PID-018,Glioblastoma,74,NCT01204684,Dendritic Cell Vaccine for Patients With Brain Tumors
PID-018,Glioblastoma,74,NCT03463265,Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT04314674,Comparison of Hypertonic Saline and Mannitol on Brain Relaxation During Supratentorial Tumors Resection
PID-018,Glioblastoma,74,NCT01171469,Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
PID-018,Glioblastoma,74,NCT00973557,The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
PID-018,Glioblastoma,74,NCT02521090,EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
PID-018,Glioblastoma,74,NCT00179803,Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
PID-018,Glioblastoma,74,NCT04782609,Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT00024557,Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
PID-018,Glioblastoma,74,NCT01836549,Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
PID-018,Glioblastoma,74,NCT01250470,Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
PID-018,Glioblastoma,74,NCT00064779,Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT01648348,Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT06665724,Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
PID-018,Glioblastoma,74,NCT06410248,Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
PID-018,Glioblastoma,74,NCT03717142,Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
PID-018,Glioblastoma,74,NCT06902350,"Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors"
PID-018,Glioblastoma,74,NCT04614493,Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.
PID-018,Glioblastoma,74,NCT05297864,PARP Inhibition for Gliomas (PI-4G or π4g)
PID-018,Glioblastoma,74,NCT05099068,Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)
PID-018,Glioblastoma,74,NCT02722512,Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
PID-018,Glioblastoma,74,NCT01514201,"Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas"
PID-018,Glioblastoma,74,NCT04047264,Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
PID-018,Glioblastoma,74,NCT03971734,Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
PID-018,Glioblastoma,74,NCT01740258,Bevacizumab Beyond Progression (BBP)
PID-018,Glioblastoma,74,NCT03607643,"A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies"
PID-018,Glioblastoma,74,NCT00823797,Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
PID-018,Glioblastoma,74,NCT01861990,Valproic Acid in Childhood Progressive Brain Tumors
PID-018,Glioblastoma,74,NCT06193174,Re-Administration of C134 in Patients with Recurrent GBM (C134-HSV-1)
PID-018,Glioblastoma,74,NCT02168270,Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT00884416,Sorafenib in Newly Diagnosed High Grade Glioma
PID-018,Glioblastoma,74,NCT00004688,"Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms"
PID-018,Glioblastoma,74,NCT00243490,Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
PID-018,Glioblastoma,74,NCT01822275,Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
PID-018,Glioblastoma,74,NCT01380782,BIBF 1120 for Recurrent High-Grade Gliomas
PID-018,Glioblastoma,74,NCT02758366,Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
PID-018,Glioblastoma,74,NCT06860594,"Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma"
PID-018,Glioblastoma,74,NCT01095094,Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT02055196,Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-018,Glioblastoma,74,NCT01144247,Cellular Immunotherapy Study for Brain Cancer
PID-018,Glioblastoma,74,NCT04488783,Potentiation of Chemotherapy in Brain Tumors by Zinc
PID-018,Glioblastoma,74,NCT01189240,RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT04661384,"Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma"
PID-018,Glioblastoma,74,NCT04479696,Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
PID-018,Glioblastoma,74,NCT06989086,FearLess in NeuroOncology
PID-018,Glioblastoma,74,NCT00006773,Bortezomib in Treating Patients With Recurrent Glioma
PID-018,Glioblastoma,74,NCT03956706,Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
PID-018,Glioblastoma,74,NCT06160596,Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
PID-018,Glioblastoma,74,NCT03251027,Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
PID-018,Glioblastoma,74,NCT06796335,Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
PID-018,Glioblastoma,74,NCT04734444,SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
PID-018,Glioblastoma,74,NCT03392545,Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)
PID-018,Glioblastoma,74,NCT05039346,Quality of Life and Patient Needs in Advanced High Grade Gliomas
PID-018,Glioblastoma,74,NCT05139277,Evaluation of the CONVIVO System
PID-018,Glioblastoma,74,NCT05476341,A Phase I Clinical Trial of Bevacizumab Injection
PID-018,Glioblastoma,74,NCT00650923,"Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma"
PID-018,Glioblastoma,74,NCT06333899,Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
PID-018,Glioblastoma,74,NCT01151670,Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
PID-018,Glioblastoma,74,NCT00667394,Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
PID-018,Glioblastoma,74,NCT06975332,"Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression"
PID-018,Glioblastoma,74,NCT03914742,BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
PID-018,Glioblastoma,74,NCT05843253,Study of Ribociclib and Everolimus in HGG and DIPG
PID-018,Glioblastoma,74,NCT05839379,Targeted Pediatric High-Grade Glioma Therapy
PID-018,Glioblastoma,74,NCT01798771,Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
PID-018,Glioblastoma,74,NCT02015819,"Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas"
PID-018,Glioblastoma,74,NCT05873946,Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
PID-018,Glioblastoma,74,NCT04295759,INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
PID-018,Glioblastoma,74,NCT04482933,HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT02031965,Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
PID-018,Glioblastoma,74,NCT05789394,Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
PID-018,Glioblastoma,74,NCT05698524,A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
PID-018,Glioblastoma,74,NCT03718767,Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
PID-018,Glioblastoma,74,NCT03123952,Expanded Access to ABT-414
PID-018,Glioblastoma,74,NCT02861898,Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
PID-018,Glioblastoma,74,NCT01721577,Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
PID-018,Glioblastoma,74,NCT02238496,Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
PID-018,Glioblastoma,74,NCT04982926,A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
PID-018,Glioblastoma,74,NCT04214392,Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
PID-018,Glioblastoma,74,NCT01996527,3T MRI Biomarkers of Glioma Treatment Response
PID-018,Glioblastoma,74,NCT06926075,Early Phase Study of Kesonotide in Participants With Solid Tumours
PID-018,Glioblastoma,74,NCT01378481,High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma
PID-018,Glioblastoma,74,NCT01148966,Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
PID-018,Glioblastoma,74,NCT01975116,p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
PID-018,Glioblastoma,74,NCT00268385,Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
PID-018,Glioblastoma,74,NCT02142803,TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
PID-018,Glioblastoma,74,NCT01383135,Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
PID-018,Glioblastoma,74,NCT04573140,A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
PID-018,Glioblastoma,74,NCT01269411,RO4929097 in Treating Patients With Recurrent Invasive Gliomas
PID-018,Glioblastoma,74,NCT06640582,TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
PID-018,Glioblastoma,74,NCT03389230,Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
PID-018,Glioblastoma,74,NCT07042620,A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
PID-018,Glioblastoma,74,NCT06041555,MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
PID-018,Glioblastoma,74,NCT04740190,Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd
PID-018,Glioblastoma,74,NCT05231655,Ex VIvo DEtermiNed Cancer Therapy
PID-018,Glioblastoma,74,NCT00499473,Sunitinib in Treating Patients With Recurrent Malignant Gliomas
PID-018,Glioblastoma,74,NCT02502708,"Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors"
PID-018,Glioblastoma,74,NCT06896110,Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
PID-018,Glioblastoma,74,NCT01817751,"Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma"
PID-018,Glioblastoma,74,NCT06047379,"Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis"
PID-018,Glioblastoma,74,NCT00095940,Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
PID-018,Glioblastoma,74,NCT03749187,BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
PID-018,Glioblastoma,74,NCT06625047,Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
PID-018,Glioblastoma,74,NCT01291420,Dendritic Cell Vaccination for Patients with Solid Tumors
PID-018,Glioblastoma,74,NCT05737212,"Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas"
PID-018,Glioblastoma,74,NCT03072134,Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
PID-018,Glioblastoma,74,NCT00100802,"Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas"
PID-018,Glioblastoma,74,NCT02208362,Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
PID-018,Glioblastoma,74,NCT01977677,Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
PID-018,Glioblastoma,74,NCT05370079,Control Cohort CTRL COH
PID-018,Glioblastoma,74,NCT00042991,Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
PID-018,Glioblastoma,74,NCT02800486,"Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA"
PID-018,Glioblastoma,74,NCT04978727,"A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma"
PID-018,Glioblastoma,74,NCT04678648,A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
PID-018,Glioblastoma,74,NCT01353625,"Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies."
PID-018,Glioblastoma,74,NCT03152318,A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PID-018,Glioblastoma,74,NCT06815029,Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
PID-018,Glioblastoma,74,NCT01103375,Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT01051557,Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-018,Glioblastoma,74,NCT02974738,"A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)"
PID-018,Glioblastoma,74,NCT03896568,MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT03739372,Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
PID-018,Glioblastoma,74,NCT06439420,CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
PID-018,Glioblastoma,74,NCT01598597,"An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)"
PID-018,Glioblastoma,74,NCT02465528,Ceritinib Rare Indications Study in ALK+ Tumors
PID-018,Glioblastoma,74,NCT04388033,Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
PID-018,Glioblastoma,74,NCT01723020,A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
PID-018,Glioblastoma,74,NCT00879437,"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma"
PID-018,Glioblastoma,74,NCT03973918,Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
PID-018,Glioblastoma,74,NCT03389802,Phase I Study of APX005M in Pediatric Central Nervous System Tumors
PID-018,Glioblastoma,74,NCT01849952,Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
PID-018,Glioblastoma,74,NCT00045708,A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
PID-018,Glioblastoma,74,NCT04135807,Implantable Microdevice In Primary Brain Tumors
PID-018,Glioblastoma,74,NCT04197934,"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases"
PID-018,Glioblastoma,74,NCT02798406,Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
PID-018,Glioblastoma,74,NCT05956821,Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
PID-018,Glioblastoma,74,NCT04044937,Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
PID-018,Glioblastoma,74,NCT01082926,"Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2"
PID-018,Glioblastoma,74,NCT03919071,Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
PID-018,Glioblastoma,74,NCT03893487,Fimepinostat in Treating Brain Tumors in Children and Young Adults
PID-018,Glioblastoma,74,NCT03212274,"Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations"
PID-018,Glioblastoma,74,NCT02372409,Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
PID-018,Glioblastoma,74,NCT05330559,"Fluorescence, Light-microscopy, Ultrasound Integrated / Intraoperative Diagnosis to MAXimise Resection"
PID-018,Glioblastoma,74,NCT06690216,Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
PID-018,Glioblastoma,74,NCT02365662,A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
PID-018,Glioblastoma,74,NCT04970615,Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models
PID-018,Glioblastoma,74,NCT00045110,Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
PID-018,Glioblastoma,74,NCT03734913,A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
PID-018,Glioblastoma,74,NCT01234740,Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
PID-018,Glioblastoma,74,NCT02101905,Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT02457845,HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
PID-018,Glioblastoma,74,NCT02444546,Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
PID-018,Glioblastoma,74,NCT02644291,Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
PID-018,Glioblastoma,74,NCT01579253,Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
PID-018,Glioblastoma,74,NCT01884740,Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
PID-018,Glioblastoma,74,NCT01904123,STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain
PID-018,Glioblastoma,74,NCT03684811,A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
PID-018,Glioblastoma,74,NCT01922076,Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
PID-018,Glioblastoma,74,NCT00959946,Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer
PID-018,Glioblastoma,74,NCT03244995,Mind-Body Intervention in Glioma Couples
PID-018,Glioblastoma,74,NCT02498665,A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
PID-018,Glioblastoma,74,NCT03958240,Deciphering Mechanisms Underlying Cancer Immunogenicity
PID-018,Glioblastoma,74,NCT02323880,Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
PID-018,Glioblastoma,74,NCT00369590,VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
PID-018,Glioblastoma,74,NCT00093613,Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
PID-018,Glioblastoma,74,NCT00085540,FR901228 in Treating Patients With Recurrent High-Grade Gliomas
PID-018,Glioblastoma,74,NCT06804655,Pharmacoscopy for Patients with Refractory Primary Brain Tumors
PID-018,Glioblastoma,74,NCT02709889,Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
PID-018,Glioblastoma,74,NCT01421524,"Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma"
PID-018,Glioblastoma,74,NCT01445691,More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
PID-018,Glioblastoma,74,NCT01837862,A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
PID-018,Glioblastoma,74,NCT02038699,A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer
PID-018,Glioblastoma,74,NCT02327078,"A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)"
PID-018,Glioblastoma,74,NCT00112736,Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT06717295,The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
PID-018,Glioblastoma,74,NCT06521567,A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
PID-018,Glioblastoma,74,NCT05538572,A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
PID-018,Glioblastoma,74,NCT05139056,Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
PID-018,Glioblastoma,74,NCT00679354,Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
PID-018,Glioblastoma,74,NCT06469138,A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
PID-018,Glioblastoma,74,NCT02192359,Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
PID-018,Glioblastoma,74,NCT01172964,A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
PID-018,Glioblastoma,74,NCT00430079,Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
PID-018,Glioblastoma,74,NCT03797326,Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
PID-018,Glioblastoma,74,NCT01177397,"Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma"
PID-018,Glioblastoma,74,NCT05835687,Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
PID-018,Glioblastoma,74,NCT04427384,Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
PID-018,Glioblastoma,74,NCT03355794,A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
PID-018,Glioblastoma,74,NCT01339039,Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
PID-018,Glioblastoma,74,NCT04732065,"ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors"
PID-018,Glioblastoma,74,NCT01392209,Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
PID-018,Glioblastoma,74,NCT02186509,Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
PID-018,Glioblastoma,74,NCT06814496,Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
PID-018,Glioblastoma,74,NCT01576666,"Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors"
PID-018,Glioblastoma,74,NCT02966509,Engagement of Patients With Advanced Cancer
PID-018,Glioblastoma,74,NCT03243461,International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
PID-018,Glioblastoma,74,NCT01165632,Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
PID-018,Glioblastoma,74,NCT03043391,Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
PID-018,Glioblastoma,74,NCT02684058,Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
PID-018,Glioblastoma,74,NCT06645808,PET-imaging of Two Vartumabs in Patients With Solid Tumors
PID-018,Glioblastoma,74,NCT02255461,"Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors"
PID-018,Glioblastoma,74,NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PID-018,Glioblastoma,74,NCT04541082,Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
PID-018,Glioblastoma,74,NCT02374255,Improving Goals of Care Discussion in Advanced Cancer Patients
PID-018,Glioblastoma,74,NCT02611024,Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
PID-018,Glioblastoma,74,NCT01392352,HYPAZ: Hypertension Induced by Pazopanib
PID-018,Glioblastoma,74,NCT04541225,Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
PID-018,Glioblastoma,74,NCT02223052,Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
PID-018,Glioblastoma,74,NCT02175745,18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
PID-018,Glioblastoma,74,NCT02335918,A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
PID-018,Glioblastoma,74,NCT05934630,"Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors"
PID-018,Glioblastoma,74,NCT01234805,Yoga Therapy in Treating Patients With Malignant Brain Tumors
PID-018,Glioblastoma,74,NCT01929720,"Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors"
PID-018,Glioblastoma,74,NCT03787056,Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
PID-018,Glioblastoma,74,NCT04913337,Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
PID-018,Glioblastoma,74,NCT05563272,89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
PID-018,Glioblastoma,74,NCT01631552,Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
PID-018,Glioblastoma,74,NCT05974410,Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
PID-018,Glioblastoma,74,NCT04604158,Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
PID-018,Glioblastoma,74,NCT02967380,"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases"
PID-018,Glioblastoma,74,NCT03911388,HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
PID-018,Glioblastoma,74,NCT05131815,The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
PID-018,Glioblastoma,74,NCT00110032,Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
PID-018,Glioblastoma,74,NCT03975829,Pediatric Long-Term Follow-up and Rollover Study
PID-018,Glioblastoma,74,NCT01119599,"RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma"
PID-018,Glioblastoma,74,NCT04566393,Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies
PID-018,Glioblastoma,74,NCT02194452,Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
PID-018,Glioblastoma,74,NCT03434262,SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
PID-018,Glioblastoma,74,NCT03896958,The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
PID-018,Glioblastoma,74,NCT01522820,Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
PID-018,Glioblastoma,74,NCT01131234,Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
PID-018,Glioblastoma,74,NCT03452774,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
PID-018,Glioblastoma,74,NCT01806675,18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
PID-018,Glioblastoma,74,NCT05969860,At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
PID-018,Glioblastoma,74,NCT04028479,The Registry of Oncology Outcomes Associated with Testing and Treatment
PID-018,Glioblastoma,74,NCT00030498,Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
PID-018,Glioblastoma,74,NCT03154190,Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
